data_2lra_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lra _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.412 ' HG3' ' HD2' ' A' ' 5' ' ' PHE . 10.6 tpt . . . . . 0 C--O 1.235 0.334 0 N-CA-C 109.958 -0.386 . . . . 75.25 109.958 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.27 66.81 2.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.411 0.523 . . . . 72.53 112.411 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.412 ' HD2' ' HG3' ' A' ' 3' ' ' MET . 91.8 m-85 -145.35 90.49 2.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.774 -0.648 . . . . 73.54 109.33 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -131.96 -74.5 0.51 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.874 -0.331 . . . . 74.13 110.802 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.714 ' HA2' ' NH1' ' A' ' 18' ' ' ARG . . . 115.75 85.37 1.22 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 119.977 -1.106 . . . . 55.11 113.713 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.673 ' HG3' ' HG2' ' A' ' 10' ' ' GLU . 10.6 tp10 -71.36 146.1 49.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.643 -0.873 . . . . 73.4 108.643 171.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -91.81 -8.5 46.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.379 0.511 . . . . 73.4 112.379 -168.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.673 ' HG2' ' HG3' ' A' ' 8' ' ' GLU . 12.6 pt-20 -90.79 3.42 54.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.868 0.322 . . . . 75.31 111.868 -175.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 1.026 HG22 ' HB2' ' A' ' 17' ' ' ASP . 27.4 m -113.24 157.59 13.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.684 0.278 . . . . 74.24 110.98 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -101.49 -11.3 19.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.366 . . . . 75.04 111.038 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.07 143.16 15.61 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.612 -0.804 . . . . 72.31 111.983 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.16 -67.28 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.414 2.076 . . . . 74.4 112.222 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -70.17 -26.53 63.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.043 -0.526 . . . . 72.23 109.927 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HA ' HG21 ' A' ' 35' ' ' VAL . . . -55.83 -27.1 49.76 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.278 -0.874 . . . . 71.53 111.503 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 1.026 ' HB2' HG22 ' A' ' 11' ' ' VAL . 3.9 t70 -85.36 -55.6 3.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.985 -0.552 . . . . 71.11 111.265 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.714 ' NH1' ' HA2' ' A' ' 7' ' ' GLY . 17.0 mmt-85 -59.26 -46.4 88.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.805 -0.634 . . . . 73.34 111.01 -170.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.722 ' HB1' ' HE1' ' A' ' 66' ' ' PHE . . . -73.36 -35.78 66.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.461 . . . . 62.44 111.478 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.493 ' O ' HG23 ' A' ' 24' ' ' VAL . 46.3 ttt-85 -65.89 -41.69 91.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.906 -0.588 . . . . 73.23 110.512 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.15 86.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.972 0.415 . . . . 62.23 111.088 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.64 76.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.102 -0.499 . . . . 74.01 110.812 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.54 ' HB2' HG12 ' A' ' 48' ' ' VAL . . . -63.9 -43.89 94.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 70.01 111.506 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 20' ' ' ARG . 57.5 t -56.76 -32.07 37.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 74.24 110.986 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -80.72 -13.0 59.38 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.844 -0.617 . . . . 74.44 111.269 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.02 -30.14 12.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.402 -0.363 . . . . 70.31 111.559 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.7 120.35 43.98 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.234 0.54 . . . . 70.02 111.095 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.1 99.66 0.91 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.566 2.177 . . . . 71.22 112.72 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.4 35.14 77.89 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.931 -0.577 . . . . 60.33 112.726 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.11 177.31 33.77 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.574 -0.822 . . . . 51.21 112.335 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.692 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 31.4 m -79.48 116.37 19.66 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.203 -0.295 . . . . 73.2 110.203 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.85 133.43 53.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.295 -0.411 . . . . 54.34 110.339 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -125.28 162.13 19.62 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.497 -0.641 . . . . 53.33 111.497 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.421 ' HB2' ' HB1' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -63.89 142.3 58.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.368 0.604 . . . . 74.02 110.937 178.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 16' ' ' ALA . 12.1 m -104.29 155.71 5.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.646 -0.706 . . . . 74.24 110.884 -173.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -119.12 156.62 29.44 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.81 -0.441 . . . . 64.53 109.81 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.3 p -73.47 125.78 28.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.396 -0.366 . . . . 73.1 111.093 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' OE1' ' HD2' ' A' ' 61' ' ' HIS . 38.0 mt-10 -79.79 -166.61 1.03 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.859 -0.61 . . . . 72.4 109.846 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -60.05 129.15 40.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.455 -0.339 . . . . 74.22 110.653 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.35 91.12 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.975 -0.557 . . . . 70.33 112.712 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -83.92 113.39 20.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.867 0.365 . . . . 73.03 110.287 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.14 -156.21 26.78 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.78 -0.646 . . . . 61.2 111.5 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.04 -41.16 5.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.044 0.449 . . . . 72.35 110.427 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.02 112.21 23.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.639 . . . . 72.14 110.195 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.63 -26.39 12.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.977 -0.556 . . . . 64.43 111.009 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -126.35 132.52 51.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.079 -0.509 . . . . 73.23 110.186 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.76 112.26 2.94 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.533 -0.841 . . . . 65.41 111.536 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.576 HG23 ' HB2' ' A' ' 19' ' ' ALA . 39.0 t -97.59 109.29 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.752 0.31 . . . . 73.54 111.117 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 pp -86.86 117.38 25.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.178 0.513 . . . . 63.42 110.631 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 23' ' ' ALA . 16.4 m -135.74 150.08 28.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.934 -0.576 . . . . 74.15 110.077 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.692 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 28.3 m -136.39 126.03 25.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.34 -0.391 . . . . 64.43 111.061 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.437 ' HB2' HG21 ' A' ' 56' ' ' THR . 6.6 mpt_? -80.04 142.2 55.45 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.784 -0.821 . . . . 73.31 108.784 173.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.47 -12.7 11.53 Favored 'Trans proline' 0 N--CA 1.475 0.412 0 C-N-CA 123.338 2.692 . . . . 73.23 112.955 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -68.55 -9.51 49.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.929 -0.578 . . . . 71.24 111.158 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.85 32.41 7.2 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.605 -0.807 . . . . 65.3 111.742 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.437 HG21 ' HB2' ' A' ' 52' ' ' ARG . 5.5 t -128.28 119.42 25.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.416 0.627 . . . . 75.14 110.737 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -105.29 127.0 52.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.303 -0.862 . . . . 73.22 110.386 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.553 HG11 ' HB ' ' A' ' 71' ' ' THR . 98.3 t -131.7 138.76 52.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.97 -0.559 . . . . 74.24 109.765 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.525 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 9.4 pt-20 -106.98 121.69 44.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.463 0.649 . . . . 75.14 110.196 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.571 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 21.5 t -85.07 119.19 33.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.207 -0.906 . . . . 72.44 109.586 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.46 ' HD2' ' OE1' ' A' ' 38' ' ' GLU . 46.4 m80 -91.53 118.82 30.92 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.28 0.562 . . . . 74.31 110.495 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.599 HD23 ' HD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -109.44 147.58 32.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.897 -1.047 . . . . 74.24 110.733 -174.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.524 ' HB3' HD22 ' A' ' 69' ' ' LEU . 5.4 p-10 -90.89 -163.2 1.0 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.229 -0.441 . . . . 73.21 110.071 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -66.9 -15.9 63.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.266 -0.424 . . . . 73.45 111.779 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -121.31 16.88 11.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 72.23 111.236 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.722 ' HE1' ' HB1' ' A' ' 19' ' ' ALA . 31.8 m-85 65.67 29.38 10.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.964 -0.562 . . . . 73.05 112.244 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -89.26 134.68 33.95 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.922 -0.77 . . . . 74.41 108.922 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -63.19 113.06 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.434 0.635 . . . . 73.42 111.006 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 63' ' ' ASP . 87.9 mt -83.84 -52.23 6.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.774 -0.648 . . . . 74.13 110.1 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -173.81 160.09 3.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.993 -0.549 . . . . 75.14 110.047 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.553 ' HB ' HG11 ' A' ' 58' ' ' VAL . 19.8 p -128.93 111.43 13.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.039 -0.528 . . . . 74.23 111.121 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -112.84 143.84 29.86 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.315 -0.402 . . . . 75.33 110.692 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.23 128.88 26.44 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.127 2.551 . . . . 70.42 112.048 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.525 ' HB2' ' HG2' ' A' ' 59' ' ' GLU . . . -104.99 122.74 46.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.911 -0.586 . . . . 73.33 110.936 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 115.858 -0.61 . . . . 61.05 109.784 179.101 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 C--O 1.233 0.214 0 N-CA-C 109.958 -0.386 . . . . 74.43 109.958 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.22 69.78 9.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.185 -0.461 . . . . 74.45 111.8 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -98.6 113.1 25.01 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.201 -0.666 . . . . 73.44 109.201 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.433 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 19.3 t70 63.91 101.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.915 0.759 . . . . 74.43 110.331 -171.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.72 -108.04 1.95 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.71 -0.677 . . . . 73.31 112.49 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.604 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 31.2 tt0 -107.51 177.41 4.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.802 0.334 . . . . 73.03 110.678 -177.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.604 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 28.4 t70 -75.14 -8.94 57.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.943 -0.571 . . . . 62.4 111.829 -175.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -65.56 97.36 0.3 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.957 0.408 . . . . 55.34 110.703 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 51.7 t -83.04 86.17 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.457 0.646 . . . . 74.34 111.006 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 t -101.66 -13.33 17.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.757 0.789 . . . . 70.05 109.066 171.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.645 ' HA3' ' HB2' ' A' ' 16' ' ' ALA . . . 170.71 135.81 1.98 Allowed Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.592 -1.185 . . . . 74.12 110.345 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -54.67 -70.15 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 123.016 2.478 . . . . 74.34 112.153 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -89.69 -20.72 23.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.827 -0.624 . . . . 74.54 110.147 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HB2' ' HA3' ' A' ' 13' ' ' GLY . . . -59.65 -49.54 77.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.424 -0.807 . . . . 70.41 111.311 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -58.0 -40.93 81.94 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.203 0.525 . . . . 74.43 111.469 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.433 ' NE ' ' HA ' ' A' ' 6' ' ' ASP . 17.4 mmt180 -65.06 -43.91 90.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.595 -0.73 . . . . 75.44 110.827 -171.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.92 -28.1 28.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.438 -0.346 . . . . 62.03 111.347 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.919 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 63.0 ttt180 -65.7 -35.99 82.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.507 -0.315 . . . . 74.11 110.364 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -62.77 -34.01 76.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.854 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.09 -35.59 61.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 70.54 110.348 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.443 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -58.92 -55.45 34.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 73.44 111.032 177.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.19 -11.04 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.37 0.605 . . . . 70.33 110.891 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.5 tp-100 -88.25 -24.64 23.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 73.45 110.11 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.5 18.87 20.46 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.055 -0.52 . . . . 72.41 111.753 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.03 125.19 11.39 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 121.014 0.435 . . . . 72.21 110.35 176.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.93 82.56 1.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.431 2.087 . . . . 74.33 112.584 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.94 28.47 71.79 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.772 -0.649 . . . . 74.2 112.875 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.55 175.44 29.15 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.712 -0.756 . . . . 72.55 112.113 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.775 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 58.0 m -78.09 105.9 9.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.267 0.556 . . . . 73.24 110.964 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.6 120.62 37.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.684 -0.689 . . . . 51.4 109.881 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.499 ' HA3' HD11 ' A' ' 49' ' ' LEU . . . -101.19 160.43 18.51 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.524 -0.846 . . . . 74.24 112.285 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.919 ' HG2' ' HD2' ' A' ' 20' ' ' ARG . 23.4 mt-10 -79.25 151.64 31.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.984 -0.376 . . . . 63.54 109.984 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.504 HG12 HD23 ' A' ' 49' ' ' LEU . 26.7 m -128.72 155.54 40.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.956 -0.565 . . . . 74.32 111.547 -171.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.13 158.85 17.88 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.419 -0.585 . . . . 75.03 109.419 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -72.92 113.28 9.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.012 0.434 . . . . 71.45 110.972 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.21 139.54 56.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 74.41 109.632 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.5 p -138.48 173.89 11.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.832 0.349 . . . . 63.43 111.422 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.74 -115.02 3.27 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.797 -0.716 . . . . 42.4 112.132 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -131.03 172.58 11.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.819 0.342 . . . . 74.43 110.46 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.9 -139.77 14.56 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.169 -0.772 . . . . 51.11 111.169 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 -12.98 4.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.894 0.347 . . . . 71.33 111.456 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.45 133.05 38.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 70.12 111.261 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.77 -28.72 2.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.947 -0.57 . . . . 65.11 110.75 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -131.23 155.77 46.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.435 -0.348 . . . . 73.5 110.274 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.83 145.39 16.82 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.469 -0.872 . . . . 71.31 112.193 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 23' ' ' ALA . 70.1 t -128.91 105.4 12.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.308 -0.627 . . . . 73.42 109.308 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.504 HD23 HG12 ' A' ' 35' ' ' VAL . 3.3 pp -102.18 123.82 46.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.423 0.63 . . . . 74.2 110.648 -177.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 m -124.61 120.64 59.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.463 -0.79 . . . . 72.55 110.42 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.775 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 12.5 m -92.71 104.28 16.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.822 -0.626 . . . . 73.25 109.995 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -66.09 139.9 96.77 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.877 -0.601 . . . . 75.02 109.438 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.93 -9.56 6.19 Favored 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.169 2.579 . . . . 74.53 112.939 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.99 -13.7 60.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 72.12 110.475 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.28 33.01 5.85 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.771 -0.728 . . . . 64.01 112.563 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -131.2 143.02 50.28 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.096 -0.335 . . . . 62.22 110.096 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -107.23 119.7 40.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.886 0.374 . . . . 75.14 110.087 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.39 114.79 48.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.122 -0.49 . . . . 73.22 110.021 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.54 112.02 24.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.554 0.693 . . . . 75.44 110.431 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.5 t -88.66 124.45 41.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.195 -0.911 . . . . 74.42 109.891 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 70' ' ' ASP . 35.9 m170 -96.06 122.6 39.07 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.909 -0.587 . . . . 74.22 110.667 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -109.78 154.95 22.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.71 -0.677 . . . . 65.11 110.468 -177.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.981 ' HB3' HD11 ' A' ' 69' ' ' LEU . 3.9 p30 -92.14 -164.23 1.15 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.977 0.417 . . . . 74.3 110.481 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.472 ' H ' ' HG3' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -62.81 -29.16 70.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.725 -0.671 . . . . 73.23 111.191 -175.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -100.27 17.27 21.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.175 -0.466 . . . . 64.01 111.316 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 69.02 19.86 7.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.848 -0.615 . . . . 75.11 111.507 172.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.523 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . 40.3 ttm180 -90.63 145.81 24.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.769 0.319 . . . . 72.25 110.522 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.554 ' HA ' HD13 ' A' ' 62' ' ' LEU . 5.3 p -67.06 126.47 26.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.211 0.529 . . . . 72.53 110.904 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.981 HD11 ' HB3' ' A' ' 63' ' ' ASP . 61.3 mt -112.72 -61.39 1.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.898 -0.592 . . . . 73.4 111.016 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 61' ' ' HIS . 23.0 t70 -132.03 139.83 48.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.551 -0.749 . . . . 72.1 111.315 -169.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.2 m -117.52 110.43 17.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.357 -0.383 . . . . 75.34 110.364 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -114.96 117.53 41.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.953 0.406 . . . . 73.02 111.872 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.23 93.99 0.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.757 2.305 . . . . 73.21 109.998 168.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.92 147.3 48.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.388 -0.369 . . . . 73.02 111.292 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 116.065 -0.516 . . . . 64.24 109.927 177.865 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.836 -0.431 . . . . 74.41 109.836 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.39 66.85 4.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.268 0.556 . . . . 74.55 111.507 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -113.12 57.5 0.67 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.492 0.663 . . . . 72.41 109.308 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -153.69 117.72 4.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.004 -0.998 . . . . 74.33 109.179 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.81 155.07 25.93 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.776 -0.726 . . . . 72.22 111.614 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.46 165.76 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.523 0.678 . . . . 74.43 111.678 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.55 2.8 55.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.038 -0.983 . . . . 73.33 111.197 -173.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.89 22.26 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 74.41 112.092 -173.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.485 HG21 ' HB2' ' A' ' 17' ' ' ASP . 19.6 m -131.08 173.58 14.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.417 -0.356 . . . . 74.32 110.234 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -93.38 102.4 14.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.922 -0.77 . . . . 74.21 108.922 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.88 92.99 0.54 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.347 -1.101 . . . . 72.32 110.347 -169.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.28 -13.36 19.72 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 123.233 2.622 . . . . 75.31 114.13 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.574 ' HA ' ' CG ' ' A' ' 18' ' ' ARG . 54.0 m-20 -73.04 -15.63 61.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.26 0.552 . . . . 75.23 109.721 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -68.41 -31.99 71.73 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.263 -0.88 . . . . 75.32 109.974 171.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.485 ' HB2' HG21 ' A' ' 11' ' ' VAL . 11.6 t70 -83.41 -28.33 28.94 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.168 -0.469 . . . . 73.51 111.584 -173.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.574 ' CG ' ' HA ' ' A' ' 15' ' ' ASP . 5.5 mmt180 -54.28 -55.1 31.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.56 0.695 . . . . 74.24 109.931 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.83 ' HB2' HG22 ' A' ' 48' ' ' VAL . . . -81.15 -21.61 39.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.247 -0.888 . . . . 73.02 111.141 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 28.0 ttt180 -66.54 -36.24 82.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.0 0.428 . . . . 74.14 110.372 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.34 70.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.291 0.567 . . . . 74.05 110.484 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.27 -38.13 36.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 73.3 110.268 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.85 76.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.712 -0.676 . . . . 72.24 111.777 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 p -66.2 -18.69 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.996 0.427 . . . . 72.31 111.213 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.76 -19.69 21.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.973 0.416 . . . . 71.25 110.695 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.55 -31.54 22.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.068 -0.515 . . . . 73.23 111.427 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.0 120.33 33.96 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.955 0.407 . . . . 70.22 110.541 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.83 104.59 1.19 Allowed 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.741 2.294 . . . . 65.32 112.625 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.19 26.19 71.43 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.913 -0.585 . . . . 74.11 112.584 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.5 -173.28 35.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.743 -0.742 . . . . 73.43 112.068 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.778 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 63.6 m -90.25 111.44 22.62 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.971 0.415 . . . . 72.44 110.745 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.03 100.64 11.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.644 -0.707 . . . . 74.23 109.592 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.599 ' HA3' HD13 ' A' ' 49' ' ' LEU . . . -89.45 160.95 29.58 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.786 -0.721 . . . . 61.44 112.309 -176.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 34' ' ' GLU . 5.3 pt-20 -70.13 127.67 33.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.275 0.56 . . . . 74.34 110.125 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.696 HG22 ' HB3' ' A' ' 19' ' ' ALA . 20.4 m -103.96 153.92 6.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.699 -0.682 . . . . 70.22 111.417 -173.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -106.73 155.57 19.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.39 -0.368 . . . . 73.42 110.283 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.3 m -76.64 111.29 11.98 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.85 -0.426 . . . . 64.13 109.85 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 36.1 mt-10 -78.62 111.24 14.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.174 0.511 . . . . 74.22 110.449 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.4 p -117.66 124.68 49.14 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.011 -0.541 . . . . 72.44 110.646 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.63 -110.69 0.38 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.46 -0.876 . . . . 72.32 112.618 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -113.94 165.77 12.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.957 0.408 . . . . 73.13 111.291 -174.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.97 -150.27 29.03 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.848 -0.691 . . . . 71.43 111.959 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.13 4.95 10.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.143 0.497 . . . . 72.3 110.695 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.51 103.01 12.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 74.01 110.4 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 38' ' ' GLU . . . -103.85 -13.64 16.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.138 -0.483 . . . . 73.03 111.019 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -141.74 133.69 27.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 75.43 110.191 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.426 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -116.41 113.62 2.85 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.859 -0.686 . . . . 62.24 111.785 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.83 HG22 ' HB2' ' A' ' 19' ' ' ALA . 34.7 t -95.5 117.09 38.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 110.031 -0.359 . . . . 61.41 110.031 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.599 HD13 ' HA3' ' A' ' 33' ' ' GLY . 1.3 pp -98.39 107.64 20.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.473 0.654 . . . . 71.51 110.276 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.2 m -110.19 107.05 21.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 64.15 110.761 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.778 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 22.4 m -95.6 113.76 25.44 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.845 -0.616 . . . . 64.51 110.76 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -71.21 146.08 91.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.176 -0.676 . . . . 71.2 109.176 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.98 -2.84 6.09 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.718 2.279 . . . . 62.55 112.17 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -83.08 0.5 44.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.682 -0.69 . . . . 73.54 110.539 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.18 33.21 12.24 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.635 -0.793 . . . . 71.52 112.579 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t -135.9 125.56 25.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.136 0.493 . . . . 74.14 110.886 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 54.3 ttt180 -103.75 126.26 50.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.931 -0.577 . . . . 75.0 110.648 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 49.4 t -112.96 132.77 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.184 -0.462 . . . . 72.01 110.262 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -93.06 108.32 19.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.282 -0.417 . . . . 73.13 110.383 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.756 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 21.6 t -89.28 108.36 19.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.204 -0.665 . . . . 71.5 109.204 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -90.1 127.16 36.02 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.989 0.423 . . . . 70.5 110.823 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -115.74 159.36 21.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.513 -0.767 . . . . 72.33 111.103 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.456 ' HB2' HD21 ' A' ' 69' ' ' LEU . 11.2 t70 -90.43 173.73 7.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.047 -0.979 . . . . 74.12 110.138 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -57.58 -29.43 64.44 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.451 0.7 . . . . 74.41 111.411 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -89.18 5.35 45.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.084 0.469 . . . . 72.11 110.37 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 71.34 21.65 4.55 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.404 -0.816 . . . . 75.2 110.592 -176.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.49 133.13 37.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.894 -0.593 . . . . 74.41 109.877 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.7 ' HA ' HD13 ' A' ' 62' ' ' LEU . 7.2 p -65.55 131.23 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.879 0.371 . . . . 74.11 111.004 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' A' ' 63' ' ' ASP . 92.1 mt -101.19 -64.25 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.292 -0.413 . . . . 71.11 110.561 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -166.61 175.8 7.71 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.702 -0.481 . . . . 64.53 109.702 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.409 HG22 HG21 ' A' ' 60' ' ' VAL . 46.9 p -139.09 114.22 9.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.721 0.296 . . . . 70.24 111.384 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -125.4 139.53 34.1 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.096 -0.335 . . . . 75.35 110.096 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 40.6 Cg_endo -69.22 152.08 72.09 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.407 2.071 . . . . 73.1 112.3 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.06 111.56 23.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.324 -0.398 . . . . 71.11 111.598 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.9 t0 . . . . . 0 C--N 1.325 -0.48 0 N-CA-C 109.243 -0.651 . . . . 60.2 109.243 175.613 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.41 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 4.5 mpp? . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.904 0.383 . . . . 73.54 110.209 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.01 89.7 6.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 70.11 111.136 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.426 ' HZ ' ' HA ' ' A' ' 65' ' ' ASP . 79.1 m-85 -117.55 58.14 0.8 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.338 0.59 . . . . 75.23 109.899 175.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -146.56 145.4 30.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.537 -0.756 . . . . 73.11 109.306 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.14 164.9 35.1 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.562 -0.828 . . . . 65.25 111.664 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.93 162.05 20.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.056 0.428 . . . . 75.22 110.706 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -95.22 -10.19 31.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.36 -0.382 . . . . 74.52 111.513 -172.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -85.74 5.1 33.79 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.166 0.432 . . . . 75.43 112.166 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.14 158.19 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.522 -0.547 . . . . 72.21 109.522 172.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.9 m -92.76 -34.75 13.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.785 0.326 . . . . 73.04 110.384 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.99 109.51 3.12 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.64 -0.79 . . . . 74.11 111.439 175.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.99 -66.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.608 2.206 . . . . 75.42 112.007 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.589 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 5.4 p-10 -71.17 -20.61 62.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.094 -0.503 . . . . 73.12 110.629 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.403 ' HB1' ' HB3' ' A' ' 34' ' ' GLU . . . -56.46 -45.91 80.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.523 -0.762 . . . . 74.33 112.43 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.92 -54.79 25.21 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.548 0.573 . . . . 61.12 112.548 -173.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.655 ' HD2' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -63.64 -32.58 74.1 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.904 -0.318 . . . . 74.14 110.995 -177.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.499 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . . . -68.94 -44.72 72.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.282 0.563 . . . . 65.44 110.262 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 24' ' ' VAL . 38.4 ttp180 -60.09 -46.86 88.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.258 -0.883 . . . . 73.12 110.912 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.39 89.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.95 -0.568 . . . . 71.41 111.671 -177.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.56 -38.15 90.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.975 0.417 . . . . 70.44 111.268 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.22 -16.97 57.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.043 -0.526 . . . . 62.25 112.327 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 20' ' ' ARG . 96.0 t -57.53 -39.27 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.951 0.405 . . . . 73.23 111.254 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -70.02 -13.13 62.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.376 -0.375 . . . . 74.53 111.318 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.66 12.31 36.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.36 -0.382 . . . . 74.13 111.15 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.48 114.42 3.82 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.242 0.544 . . . . 75.52 110.693 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.26 93.64 0.66 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.449 2.099 . . . . 53.33 112.699 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.26 43.88 94.58 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.694 -0.684 . . . . 65.11 112.615 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.407 ' HA2' ' HG3' ' A' ' 53' ' ' PRO . . . -110.66 -172.96 19.99 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.585 -0.817 . . . . 72.23 112.638 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.748 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 37.9 m -92.06 114.52 27.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.859 0.361 . . . . 74.35 111.205 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.93 119.83 39.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.824 -0.625 . . . . 75.22 109.999 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.84 161.04 12.88 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.551 -0.833 . . . . 73.43 112.755 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.403 ' HB3' ' HB1' ' A' ' 16' ' ' ALA . 1.6 mp0 -67.17 137.26 56.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.058 -0.349 . . . . 74.21 110.058 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.734 HG13 ' HA ' ' A' ' 48' ' ' VAL . 31.1 m -134.01 154.42 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.254 -0.43 . . . . 75.13 111.269 -174.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -106.67 160.63 15.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.276 -0.42 . . . . 72.5 110.118 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 p -71.52 148.75 46.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.055 0.455 . . . . 72.43 111.625 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.59 97.08 6.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 74.45 110.201 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.1 m -89.54 117.6 28.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.984 -0.553 . . . . 74.44 110.532 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.88 -139.19 6.66 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.782 -0.723 . . . . 72.21 112.199 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -95.78 178.06 5.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.969 0.414 . . . . 65.55 110.716 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.49 -168.18 19.5 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.054 -0.593 . . . . 72.34 112.362 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.25 8.45 14.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.939 0.399 . . . . 73.23 110.504 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.24 170.34 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 75.41 110.663 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.11 -36.93 0.17 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.478 -0.328 . . . . 74.34 111.531 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.541 ' HE2' ' HB2' ' A' ' 15' ' ' ASP . 76.3 m-85 -124.61 131.74 53.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.955 -0.387 . . . . 72.32 109.955 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.3 112.28 2.06 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.204 -0.998 . . . . 64.42 110.971 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.734 ' HA ' HG13 ' A' ' 35' ' ' VAL . 12.0 t -109.07 126.17 66.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.736 0.303 . . . . 74.24 111.08 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.517 ' H ' HG13 ' A' ' 35' ' ' VAL . 3.4 pp -87.07 130.71 34.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.215 -0.448 . . . . 75.15 109.992 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.17 114.17 25.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.638 0.733 . . . . 73.34 110.498 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.748 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 11.6 m -97.92 122.83 41.5 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.411 -0.813 . . . . 72.03 110.77 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.474 ' C ' ' H ' ' A' ' 54' ' ' ASP . 8.0 mpt_? -74.32 140.35 76.07 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.686 -0.857 . . . . 74.35 108.686 171.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.407 ' HG3' ' HA2' ' A' ' 30' ' ' GLY . 16.4 Cg_exo -68.88 17.95 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.17 2.58 . . . . 62.5 112.957 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.474 ' H ' ' C ' ' A' ' 52' ' ' ARG . 12.3 t70 -109.42 -15.64 14.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.138 0.494 . . . . 73.43 110.331 177.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.22 -19.31 8.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.621 -0.8 . . . . 71.43 112.424 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.89 115.28 18.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.412 0.625 . . . . 73.23 111.091 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -115.74 120.51 39.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.609 -0.723 . . . . 63.54 110.482 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 73' ' ' PRO . 31.5 m -123.62 163.45 22.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.37 -0.377 . . . . 74.43 110.302 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -122.85 133.92 54.41 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.044 0.45 . . . . 62.2 110.039 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.401 HG12 HD11 ' A' ' 62' ' ' LEU . 22.8 t -101.61 120.13 50.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.482 -0.562 . . . . 52.42 109.482 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -92.2 121.66 33.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.562 . . . . 74.52 110.229 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.35 156.69 22.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.893 -1.049 . . . . 75.23 110.929 -172.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 67' ' ' ARG . 10.9 t70 -90.73 172.11 8.88 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.313 -0.858 . . . . 72.41 109.722 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -50.23 -44.57 53.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.546 0.738 . . . . 61.54 112.352 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 67' ' ' ARG . 27.1 m-20 -96.52 26.14 4.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.911 0.386 . . . . 74.25 110.604 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.499 ' CE1' ' HA ' ' A' ' 19' ' ' ALA . 26.2 m-85 67.1 32.67 6.06 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.216 0.821 . . . . 75.23 113.216 174.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.519 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -77.94 126.82 31.4 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.172 -0.677 . . . . 74.34 109.172 169.168 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.655 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.5 p -69.55 120.65 17.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.053 0.454 . . . . 73.45 110.371 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.9 mt -96.18 -62.58 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.24 -0.436 . . . . 75.53 110.896 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -150.71 170.19 19.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 72.4 110.092 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.0 m -147.61 115.79 6.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.041 0.448 . . . . 65.35 110.363 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -133.08 159.45 72.59 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.022 -0.535 . . . . 62.11 110.194 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HA ' HG12 ' A' ' 58' ' ' VAL . 18.3 Cg_endo -59.91 143.1 99.64 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.733 2.289 . . . . 62.44 112.476 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.56 122.22 36.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.873 -0.603 . . . . 71.34 110.804 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--N 1.323 -0.573 0 N-CA-C 110.029 -0.36 . . . . 64.51 110.029 179.505 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.523 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 1.6 mpt? . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.96 -0.756 . . . . 75.43 108.96 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.05 81.75 3.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.155 0.503 . . . . 72.12 112.125 -172.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.523 ' CE2' ' HB3' ' A' ' 3' ' ' MET . 91.3 m-85 -121.35 57.52 1.01 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.727 0.775 . . . . 75.12 109.053 174.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.566 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 7.9 t70 -147.83 -142.75 0.13 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.389 -1.337 . . . . 70.32 107.389 -177.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.61 175.83 33.06 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.007 -1.092 . . . . 70.34 112.581 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.6 -178.67 6.95 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.649 -0.5 . . . . 75.11 109.649 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -92.66 -9.55 40.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.439 0.638 . . . . 73.1 109.585 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.13 53.92 2.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.55 -0.75 . . . . 74.44 109.363 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 m -60.14 96.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.858 0.837 . . . . 73.32 112.186 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 t -93.72 -21.83 19.1 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.104 -0.953 . . . . 73.13 109.021 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.739 ' HA3' ' HB3' ' A' ' 16' ' ' ALA . . . -152.27 143.76 10.76 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.153 -0.93 . . . . 65.13 111.096 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -60.75 -68.91 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.819 2.346 . . . . 64.04 111.876 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.566 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 10.8 m-20 -90.01 -22.29 21.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.519 -0.549 . . . . 74.13 109.519 176.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.739 ' HB3' ' HA3' ' A' ' 13' ' ' GLY . . . -58.91 -37.34 76.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.077 -0.965 . . . . 74.12 111.445 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 14.9 t70 -55.57 -57.77 10.56 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.165 -0.471 . . . . 71.12 111.545 -175.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.566 ' NE ' ' HA ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -69.07 -35.75 76.87 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.945 0.35 . . . . 75.15 111.945 -176.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.48 -42.45 78.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.101 0.477 . . . . 74.04 110.812 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -71.12 -36.91 72.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.839 -0.619 . . . . 73.32 110.56 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.25 -24.07 66.52 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.431 -0.349 . . . . 70.21 111.49 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 -29.89 33.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.402 -0.363 . . . . 74.02 111.152 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.41 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -62.21 -31.77 72.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.045 -0.525 . . . . 72.55 112.034 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.6 p -69.02 -14.01 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.819 0.343 . . . . 74.12 111.731 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -85.36 -31.85 22.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.858 0.361 . . . . 75.54 110.357 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.13 -32.23 39.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.067 -0.515 . . . . 54.33 111.382 -176.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 14.6 p -111.15 133.9 21.21 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.854 0.359 . . . . 72.55 110.53 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 27' ' ' VAL . 8.9 Cg_endo -82.49 99.88 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.828 2.352 . . . . 71.41 111.871 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.45 39.44 97.8 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.039 -0.601 . . . . 71.42 112.184 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.432 ' HA3' ' CG2' ' A' ' 27' ' ' VAL . . . -104.49 168.12 16.12 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.591 -0.814 . . . . 72.04 112.411 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 1.03 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 39.8 m -82.04 106.11 13.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.233 0.539 . . . . 75.11 111.201 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.87 111.91 22.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.395 -0.821 . . . . 61.13 109.29 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.37 162.87 17.86 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.184 -0.532 . . . . 72.51 112.839 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -61.72 106.94 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 74.31 110.232 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.603 HG12 ' HA ' ' A' ' 48' ' ' VAL . 33.9 m -91.25 150.3 3.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.921 -0.581 . . . . 71.25 110.845 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -108.67 150.06 28.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.272 -0.422 . . . . 73.25 110.032 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.74 131.01 39.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.183 0.516 . . . . 73.1 110.999 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.83 133.8 38.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.674 -0.694 . . . . 73.21 110.365 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -91.49 117.67 29.9 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.936 -0.765 . . . . 63.11 108.936 168.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.67 93.62 0.15 Allowed Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.214 -0.993 . . . . 75.12 112.612 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -51.4 114.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.504 -0.554 . . . . 73.15 109.504 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.14 -54.61 0.61 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.736 -0.745 . . . . 55.32 112.149 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -175.13 -38.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.804 0.298 . . . . 74.14 111.804 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.88 130.28 45.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.048 0.452 . . . . 71.11 111.796 -174.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.78 -36.4 0.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.756 -0.656 . . . . 73.1 110.788 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.547 ' HE2' ' HB3' ' A' ' 15' ' ' ASP . 91.8 m-85 -124.84 133.65 53.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 74.22 110.49 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.29 113.46 2.03 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.335 -0.706 . . . . 74.13 111.335 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.603 ' HA ' HG12 ' A' ' 35' ' ' VAL . 45.7 t -101.18 112.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.734 0.302 . . . . 73.32 111.01 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.597 ' HG ' HG11 ' A' ' 35' ' ' VAL . 2.3 pp -85.8 117.05 24.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 74.44 110.042 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.67 114.42 47.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.661 -0.7 . . . . 74.51 110.277 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 1.03 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 20.3 m -96.13 104.92 16.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.233 -0.44 . . . . 74.51 110.461 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -67.04 138.71 95.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.165 -0.68 . . . . 73.52 109.165 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HD3' ' HA2' ' A' ' 30' ' ' GLY . 17.9 Cg_endo -60.05 -7.94 7.21 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.131 2.554 . . . . 70.21 112.998 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -74.25 -14.45 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 73.32 110.537 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.34 33.36 5.17 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.398 -0.906 . . . . 71.35 112.662 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 t -131.84 142.27 49.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.905 0.383 . . . . 72.51 110.949 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.477 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 58.9 ttt180 -110.08 122.69 48.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 72.41 111.362 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.48 139.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.406 -0.59 . . . . 73.42 109.406 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -108.2 136.12 48.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.217 0.532 . . . . 73.25 110.858 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.503 HG22 HG23 ' A' ' 71' ' ' THR . 23.6 t -106.01 118.18 53.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.514 -0.766 . . . . 62.1 109.672 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -89.55 125.32 35.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.09 -0.504 . . . . 72.24 111.521 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.809 HD13 ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -117.16 147.21 42.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.474 -0.784 . . . . 73.03 109.816 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.862 ' HB3' HD21 ' A' ' 69' ' ' LEU . 1.9 p-10 -91.96 -167.1 1.69 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.951 -0.3 . . . . 74.44 110.439 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -55.27 -38.08 68.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.014 -0.539 . . . . 74.55 111.933 -176.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -89.67 16.45 7.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.019 0.377 . . . . 75.22 112.019 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 65.83 21.84 11.46 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.208 0.528 . . . . 75.22 111.127 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.703 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 9.0 tpt180 -88.34 134.84 33.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.212 -0.449 . . . . 75.04 110.178 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.809 ' HA ' HD13 ' A' ' 62' ' ' LEU . 4.5 p -61.58 116.05 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.242 0.544 . . . . 72.01 111.256 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.862 HD21 ' HB3' ' A' ' 63' ' ' ASP . 85.5 mt -84.42 -49.06 9.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.754 -0.657 . . . . 64.32 109.611 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -170.35 -179.34 3.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.487 -0.778 . . . . 73.42 108.981 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.503 HG23 HG22 ' A' ' 60' ' ' VAL . 23.8 m -145.83 108.22 4.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.741 0.305 . . . . 75.04 110.352 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 1.5 pm0 -120.86 147.07 45.26 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.899 0.381 . . . . 71.12 111.077 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 24.0 Cg_exo -63.72 132.34 34.78 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.944 2.429 . . . . 63.14 112.022 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.477 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . . . -107.73 100.09 9.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.461 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 C--N 1.321 -0.633 0 CA-C-N 116.118 -0.492 . . . . 64.13 110.109 179.766 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.884 0.374 . . . . 73.35 110.336 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.09 77.88 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.218 -0.447 . . . . 74.31 111.109 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.667 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 88.2 m-85 -131.76 56.45 1.82 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 74.32 110.551 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.8 t70 175.6 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.732 -0.667 . . . . 72.02 110.071 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.0 -80.71 1.53 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.052 -0.819 . . . . 60.44 111.052 174.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -146.51 133.4 20.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.15 0.5 . . . . 74.53 110.064 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -75.96 4.85 7.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.8 -0.636 . . . . 73.24 111.779 -170.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.12 -17.16 60.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.569 -0.287 . . . . 72.55 111.697 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 17' ' ' ASP . 35.5 m -92.34 162.85 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.762 0.315 . . . . 75.22 111.278 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.5 p -101.44 -0.16 35.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.288 -0.414 . . . . 72.54 111.6 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.01 105.45 1.99 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.727 -0.749 . . . . 75.51 111.608 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 22.4 Cg_endo -62.08 -50.9 4.23 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.68 2.254 . . . . 73.02 111.986 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -71.14 -35.05 71.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.953 -0.567 . . . . 75.55 110.427 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -62.31 -43.57 98.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.842 -0.617 . . . . 72.22 110.833 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.573 ' HB2' HG22 ' A' ' 11' ' ' VAL . 8.8 t70 -56.43 -53.66 54.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 72.33 111.739 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.667 ' HD2' ' HA ' ' A' ' 5' ' ' PHE . 12.0 mmt180 -56.76 -51.01 70.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.966 -0.561 . . . . 75.11 111.315 -171.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.831 ' HB3' HG23 ' A' ' 35' ' ' VAL . . . -78.64 -33.2 47.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.932 -0.576 . . . . 72.33 111.865 -174.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -69.62 -34.58 74.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 73.53 110.107 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.15 85.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 64.33 110.598 176.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.72 -32.29 63.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 70.03 110.877 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.431 ' O ' HG11 ' A' ' 27' ' ' VAL . . . -56.27 -31.26 63.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.824 -0.626 . . . . 73.41 111.818 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.36 -32.19 40.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.978 0.418 . . . . 64.23 111.085 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.44 -13.73 25.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.267 -0.424 . . . . 63.2 110.815 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.57 ' HB1' HG11 ' A' ' 50' ' ' VAL . . . -85.76 -29.65 23.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.276 -0.42 . . . . 73.33 111.283 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.929 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 9.9 p -111.02 128.05 25.93 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.887 0.375 . . . . 73.34 110.399 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 27' ' ' VAL . 3.0 Cg_exo -72.95 93.06 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.798 2.332 . . . . 75.21 112.37 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.23 21.43 72.04 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.146 -0.549 . . . . 71.41 112.972 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.84 -164.43 32.71 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.732 -0.747 . . . . 74.33 112.255 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.453 ' CG2' ' HB ' ' A' ' 51' ' ' THR . 4.9 t -103.64 136.34 43.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.061 0.458 . . . . 64.53 110.469 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.16 110.23 22.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 64.55 110.365 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.78 160.75 31.53 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.686 -0.769 . . . . 74.45 112.222 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -75.32 140.99 43.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 75.54 110.22 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.831 HG23 ' HB3' ' A' ' 19' ' ' ALA . 12.8 m -116.02 155.88 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.949 -0.569 . . . . 73.3 111.837 -169.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -114.46 156.96 23.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 75.34 109.502 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 p -74.04 123.56 24.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.606 0.241 . . . . 75.32 110.817 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.9 134.33 47.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.844 -0.428 . . . . 73.53 109.844 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.5 m -121.55 118.21 28.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.779 0.323 . . . . 72.52 110.408 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.98 -148.34 7.92 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.173 -0.771 . . . . 71.04 111.173 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -111.32 116.67 31.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.035 0.445 . . . . 64.32 110.426 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.84 -170.8 29.94 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.013 -0.835 . . . . 73.23 111.013 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.51 -5.39 49.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.911 0.386 . . . . 73.52 110.789 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.76 112.04 14.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 72.03 110.851 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.73 -16.73 11.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.098 -0.501 . . . . 71.34 111.061 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.426 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 90.9 m-85 -130.88 132.33 45.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.492 -0.322 . . . . 72.24 110.736 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.31 112.84 2.57 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.668 -0.777 . . . . 72.45 111.21 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.791 HG23 ' HB2' ' A' ' 19' ' ' ALA . 38.8 t -99.95 119.81 48.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.666 0.269 . . . . 71.35 111.035 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.503 HD22 HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -94.12 107.79 19.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.339 0.59 . . . . 74.15 110.336 177.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.929 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 2.7 m -115.12 102.5 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.528 0.68 . . . . 74.45 110.663 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.453 ' HB ' ' CG2' ' A' ' 31' ' ' THR . 10.0 m -92.64 122.67 35.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.358 -0.837 . . . . 75.32 110.867 -175.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HD2' HG22 ' A' ' 27' ' ' VAL . 12.6 mpt_? -79.53 153.05 76.05 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.163 -0.472 . . . . 71.52 110.36 177.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.2 1.78 3.23 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.967 2.445 . . . . 62.43 111.44 174.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -85.66 -13.49 48.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.101 -0.954 . . . . 71.21 109.816 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.08 -7.33 48.08 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.843 -0.694 . . . . 64.11 112.668 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 t -91.8 126.88 37.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 75.23 111.364 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 35.8 ttp180 -107.93 124.27 49.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.609 -0.723 . . . . 63.21 109.45 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 30.2 t -122.46 137.05 57.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.509 -0.314 . . . . 75.24 110.935 -175.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 34.0 mt-10 -93.07 122.4 35.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.012 0.434 . . . . 74.55 110.747 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.452 HG22 HG23 ' A' ' 71' ' ' THR . 16.9 t -103.12 109.34 26.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.689 -0.856 . . . . 74.23 108.689 173.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.5 m170 -90.15 127.03 36.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.889 0.376 . . . . 65.13 110.297 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.727 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -112.86 159.82 18.65 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.611 -0.722 . . . . 74.12 112.185 -171.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.646 ' HB2' HD22 ' A' ' 69' ' ' LEU . 16.0 t70 -90.5 169.84 10.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.559 -1.2 . . . . 75.54 109.797 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -31.54 64.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.766 0.426 . . . . 75.23 111.102 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -94.35 17.33 13.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.551 -0.295 . . . . 74.21 111.122 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 64.02 38.87 8.31 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.827 0.677 . . . . 72.31 112.827 175.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -99.32 147.52 25.11 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.631 -0.507 . . . . 74.24 109.631 169.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.727 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.4 p -74.25 119.85 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.333 0.587 . . . . 75.24 110.561 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.646 HD22 ' HB2' ' A' ' 63' ' ' ASP . 93.0 mt -89.12 -47.42 8.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.867 -0.606 . . . . 72.51 110.339 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -164.55 156.47 16.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.117 -0.492 . . . . 75.33 110.498 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.452 HG23 HG22 ' A' ' 60' ' ' VAL . 8.0 m -124.23 118.04 25.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.858 -0.61 . . . . 71.52 109.977 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -134.1 121.58 15.73 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 74.51 111.319 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 37.3 Cg_exo -61.59 120.19 7.7 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.751 2.301 . . . . 74.43 111.3 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HB2' ' HG3' ' A' ' 59' ' ' GLU . . . -143.25 164.92 28.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.981 0.419 . . . . 62.05 111.637 -173.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.94 -0.573 . . . . 71.35 110.064 177.606 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.753 -0.462 . . . . 73.53 109.753 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.43 72.78 2.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.192 0.52 . . . . 64.22 112.068 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -128.14 108.01 10.28 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.078 -0.712 . . . . 75.33 109.078 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.629 ' H ' ' HD3' ' A' ' 18' ' ' ARG . 29.7 t70 67.62 110.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.109 0.88 . . . . 74.32 111.233 -173.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.81 -77.76 0.11 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.705 -0.759 . . . . 54.35 112.092 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.717 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 9.3 tp10 -85.96 157.34 20.16 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.059 -0.348 . . . . 64.44 110.059 177.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -83.88 -9.39 58.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.579 0.704 . . . . 44.1 109.642 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.717 ' H ' ' HG3' ' A' ' 8' ' ' GLU . 10.6 mm-40 -84.56 88.57 7.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.191 -0.913 . . . . 75.23 109.561 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.62 90.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.131 0.491 . . . . 63.43 110.713 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.8 p -93.86 -5.56 47.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.949 -0.569 . . . . 73.35 110.597 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.73 146.77 5.68 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.033 -0.827 . . . . 71.22 111.033 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.431 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 25.2 Cg_endo -62.18 -53.82 1.78 Allowed 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.668 2.246 . . . . 73.21 112.156 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -97.85 -37.67 9.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.959 -0.564 . . . . 74.23 110.905 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.67 -48.79 58.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.77 -0.65 . . . . 74.34 112.213 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -65.68 -50.96 62.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.277 0.561 . . . . 74.34 111.569 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.683 HH11 ' HG2' ' A' ' 18' ' ' ARG . 12.5 mtt-85 -72.75 -37.39 67.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.549 -0.75 . . . . 72.3 111.592 -168.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.528 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -67.15 -42.01 85.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.07 0.462 . . . . 62.14 110.237 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -62.65 -46.19 89.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.546 -0.752 . . . . 74.41 110.775 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.27 -21.78 63.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 72.33 111.607 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.1 -40.04 16.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.905 0.383 . . . . 71.04 111.338 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.568 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . -69.73 -22.44 63.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.457 0.54 . . . . 64.03 112.457 -174.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 p -63.43 -22.99 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.831 0.348 . . . . 71.04 111.128 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -78.03 -16.43 58.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.662 0.268 . . . . 73.2 111.216 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.88 -14.37 23.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.932 0.396 . . . . 70.4 111.302 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.431 ' CG2' ' HA3' ' A' ' 30' ' ' GLY . 7.3 p -116.14 122.2 32.61 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.047 0.451 . . . . 73.31 110.992 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.93 100.89 1.4 Allowed 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.899 2.399 . . . . 74.23 112.239 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.85 38.21 91.99 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.88 -0.6 . . . . 72.13 112.501 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.431 ' HA3' ' CG2' ' A' ' 27' ' ' VAL . . . -102.87 -172.1 26.5 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.71 -0.757 . . . . 54.31 112.526 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.1 m -98.88 115.36 28.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.746 0.308 . . . . 61.44 110.577 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.84 105.0 15.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.903 -0.59 . . . . 65.32 110.093 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.09 161.98 18.3 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.944 -0.646 . . . . 71.32 112.445 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.04 141.26 52.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.051 0.453 . . . . 75.03 110.437 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.81 HG11 ' HA ' ' A' ' 48' ' ' VAL . 34.9 m -126.73 156.0 37.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.937 -0.574 . . . . 73.44 111.451 -172.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -105.52 155.82 18.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.03 -0.532 . . . . 71.31 110.053 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.95 124.07 25.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.282 -0.417 . . . . 75.4 110.449 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.69 122.34 21.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.889 0.376 . . . . 75.04 110.24 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.0 t -77.43 129.41 35.72 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.182 -0.463 . . . . 72.34 110.078 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.94 -150.95 9.55 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.638 -0.792 . . . . 72.44 112.216 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -151.25 132.42 14.43 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.06 -0.719 . . . . 72.3 109.06 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.65 -135.17 9.68 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.624 -0.798 . . . . 63.44 112.283 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.577 ' O ' ' HA ' ' A' ' 63' ' ' ASP . . . -87.69 -30.84 20.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.693 0.282 . . . . 75.21 110.744 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.22 102.71 3.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.087 0.47 . . . . 73.54 111.076 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.07 -42.86 2.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.857 -0.61 . . . . 54.4 111.072 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 46.0 m-85 -114.61 133.58 55.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.528 -0.305 . . . . 73.3 110.229 -177.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.83 112.94 2.34 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.865 -0.894 . . . . 75.11 110.865 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.81 ' HA ' HG11 ' A' ' 35' ' ' VAL . 6.3 t -110.25 139.61 32.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.838 0.351 . . . . 74.12 110.642 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 49' ' ' LEU . 2.8 pp -105.16 126.74 52.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.136 0.493 . . . . 73.45 110.813 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 m -129.09 120.3 51.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.17 0.51 . . . . 74.44 110.791 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -102.94 126.33 50.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.843 -0.617 . . . . 55.42 110.831 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.536 ' HB2' HG21 ' A' ' 56' ' ' THR . 10.6 mpt_? -81.56 152.28 69.64 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.341 -0.614 . . . . 72.13 109.341 173.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.48 -23.15 46.13 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.823 2.348 . . . . 74.34 112.839 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.61 -27.48 68.97 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.917 0.389 . . . . 75.21 111.168 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.72 -12.67 15.25 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.692 -0.766 . . . . 74.24 112.107 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.536 HG21 ' HB2' ' A' ' 52' ' ' ARG . 5.5 t -72.23 128.63 36.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.505 0.669 . . . . 71.11 110.46 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 57' ' ' ARG . 12.2 ttt180 -118.48 119.75 35.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.447 -0.797 . . . . 75.11 109.385 -175.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -107.51 137.22 39.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.219 -0.446 . . . . 71.12 111.16 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.55 112.21 24.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.407 0.623 . . . . 74.21 109.432 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.469 HG21 HG22 ' A' ' 71' ' ' THR . 25.4 t -97.37 114.61 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.995 -0.548 . . . . 73.33 109.973 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -89.59 122.85 33.12 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.081 0.467 . . . . 74.41 110.528 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.627 HD13 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -113.07 145.93 40.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.1 -0.955 . . . . 74.13 110.144 -177.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.577 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 20.7 p30 -91.91 -167.71 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.008 0.432 . . . . 74.0 111.431 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -65.99 -17.98 65.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.588 -0.733 . . . . 73.31 111.849 -172.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -109.54 13.51 23.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.752 -0.204 . . . . 73.11 110.904 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 65.37 30.76 10.86 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.279 0.561 . . . . 72.14 111.229 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.402 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . 26.2 ttp180 -93.52 137.37 32.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.532 -0.758 . . . . 74.33 109.795 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.627 ' HA ' HD13 ' A' ' 62' ' ' LEU . 5.5 p -65.06 117.18 5.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.362 0.601 . . . . 71.23 111.574 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 63' ' ' ASP . 96.2 mt -90.93 -60.01 2.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.679 -0.692 . . . . 74.52 110.991 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -157.52 147.59 20.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 61.33 110.085 -172.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.469 HG22 HG21 ' A' ' 60' ' ' VAL . 17.0 p -124.01 109.52 13.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.901 0.382 . . . . 75.31 110.901 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -107.35 155.44 39.47 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.077 -0.51 . . . . 71.55 110.828 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -74.57 122.29 7.3 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.467 2.112 . . . . 74.0 110.885 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.16 156.48 23.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.416 -0.357 . . . . 54.01 110.298 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 116.393 -0.367 . . . . 65.41 110.336 -179.51 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 CA--C 1.515 -0.372 0 N-CA-C 108.697 -0.853 . . . . 64.15 108.697 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.35 75.12 3.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.047 0.451 . . . . 72.34 111.77 -174.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.91 54.69 0.74 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.65 0.738 . . . . 74.24 109.117 172.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.577 ' N ' ' HD2' ' A' ' 18' ' ' ARG . 25.1 t70 174.23 101.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.075 -1.421 . . . . 71.31 107.84 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.76 -78.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.865 -0.683 . . . . 65.04 112.814 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.656 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 11.2 tt0 -156.26 -166.1 2.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.676 0.274 . . . . 74.32 110.708 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.656 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 4.8 m-20 -66.5 -6.66 15.63 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.939 0.718 . . . . 73.42 112.939 -172.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.79 84.16 1.88 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.034 0.445 . . . . 72.23 111.047 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -91.95 87.42 2.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.416 -0.587 . . . . 75.22 109.416 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 t -114.24 130.22 56.64 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.632 -0.713 . . . . 62.11 110.098 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.65 -151.5 41.38 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.233 -0.984 . . . . 61.44 111.703 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.468 ' HB2' ' H ' ' A' ' 15' ' ' ASP . 63.9 Cg_endo -73.29 -142.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.772 2.315 . . . . 73.14 112.144 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 3.2 m-20 -74.41 12.08 0.85 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.398 0.518 . . . . 72.42 112.398 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.62 ' HA ' HG23 ' A' ' 35' ' ' VAL . . . -49.72 -34.15 18.06 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.9 0.381 . . . . 72.23 111.353 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.71 -42.38 71.44 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.393 -0.821 . . . . 74.12 112.278 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 15' ' ' ASP . 12.1 mmt180 -64.71 -57.91 7.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.287 0.565 . . . . 75.51 111.123 -170.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.735 ' HB1' HG21 ' A' ' 35' ' ' VAL . . . -73.38 -26.94 61.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.522 -0.763 . . . . 74.45 111.946 -173.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -66.73 -35.84 81.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 74.34 110.858 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.49 -39.51 88.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 74.52 110.862 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.35 -28.88 63.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.028 -0.533 . . . . 73.44 111.297 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 -27.36 68.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.08 -0.509 . . . . 71.2 111.859 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.0 t -59.47 -38.26 74.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.458 . . . . 64.32 111.266 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -81.13 -12.38 59.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.289 -0.414 . . . . 71.23 111.143 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.63 -6.87 58.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 75.31 111.452 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.05 124.08 7.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.017 0.437 . . . . 74.11 111.483 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.75 105.68 2.11 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.401 2.067 . . . . 75.43 112.136 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.78 39.54 89.94 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.081 -0.581 . . . . 72.32 112.417 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.714 ' HA2' ' HD3' ' A' ' 53' ' ' PRO . . . -101.92 -147.77 20.25 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.581 -0.819 . . . . 73.24 112.697 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.655 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 58.6 m -137.63 131.26 31.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.699 0.285 . . . . 71.34 110.574 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.05 120.44 41.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.298 -0.41 . . . . 74.43 110.641 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.68 161.16 13.33 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.841 -0.695 . . . . 53.45 111.582 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.439 ' O ' HD23 ' A' ' 49' ' ' LEU . 1.4 mp0 -62.5 128.13 34.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.338 . . . . 71.34 110.428 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.735 HG21 ' HB1' ' A' ' 19' ' ' ALA . 19.8 m -90.21 154.77 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.013 -0.539 . . . . 74.03 110.769 -175.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -112.67 153.61 27.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.14 -0.482 . . . . 72.44 111.059 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 m -85.22 115.27 22.9 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.702 -0.851 . . . . 74.42 108.702 171.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -75.61 130.18 38.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.242 0.544 . . . . 75.54 111.9 -172.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.2 p -88.9 118.27 28.49 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.962 -0.755 . . . . 72.31 108.962 171.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.95 -125.04 0.8 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.9 -1.143 . . . . 73.44 113.338 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.88 158.36 44.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.724 0.297 . . . . 73.5 110.481 -172.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.9 -116.18 4.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.05 -0.595 . . . . 63.12 113.077 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.84 10.06 5.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.559 0.219 . . . . 72.02 111.219 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.06 107.07 3.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.053 -0.351 . . . . 72.24 110.053 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.72 -54.35 2.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.094 -0.503 . . . . 74.12 111.646 -175.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -115.64 133.41 56.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.0 0.428 . . . . 74.2 111.405 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.18 112.49 3.06 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.675 -0.774 . . . . 65.41 111.261 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 19' ' ' ALA . 27.4 t -95.24 109.72 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.633 0.254 . . . . 74.43 110.687 -175.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.623 HD21 ' H ' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -85.51 102.7 13.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.28 0.562 . . . . 74.13 110.74 -179.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.3 t -97.1 110.34 24.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.716 -0.674 . . . . 74.52 110.016 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.655 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 14.0 m -91.92 116.6 29.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.11 -0.495 . . . . 75.45 110.548 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -96.94 135.84 21.86 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.185 -0.461 . . . . 72.2 110.023 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.714 ' HD3' ' HA2' ' A' ' 30' ' ' GLY . 37.1 Cg_endo -65.68 -8.81 20.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.878 2.386 . . . . 71.25 111.386 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -64.12 -26.75 68.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.89 -1.05 . . . . 75.52 110.487 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.46 32.64 2.28 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.67 -0.776 . . . . 73.44 112.352 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 t -145.38 144.93 30.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.102 0.477 . . . . 73.43 110.956 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -107.89 118.5 36.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.705 -0.68 . . . . 73.32 109.263 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 45.5 t -112.33 115.7 50.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.771 -0.455 . . . . 70.12 109.771 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 12.4 pt-20 -101.81 113.21 26.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.659 0.742 . . . . 74.42 110.823 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.604 HG22 HG21 ' A' ' 71' ' ' THR . 18.6 t -89.12 118.57 34.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.179 -0.918 . . . . 75.2 109.224 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -93.35 123.22 36.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.345 -0.389 . . . . 73.23 110.345 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.528 HD13 ' HA ' ' A' ' 68' ' ' VAL . 1.0 OUTLIER -115.64 152.21 33.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.889 -0.596 . . . . 65.04 111.157 -174.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.584 ' HB3' HD21 ' A' ' 69' ' ' LEU . 3.7 p-10 -94.47 -164.52 1.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.882 -0.599 . . . . 75.15 110.531 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.6 mtt-85 -71.66 -24.57 61.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.121 -0.491 . . . . 71.54 111.26 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.45 0.08 56.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.04 0.448 . . . . 73.15 109.801 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 67.99 32.48 5.05 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.332 -0.849 . . . . 73.22 110.678 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -101.06 154.53 18.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.065 -0.516 . . . . 75.43 109.884 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.528 ' HA ' HD13 ' A' ' 62' ' ' LEU . 7.1 p -71.13 118.8 16.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.41 0.624 . . . . 75.53 111.435 -176.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 63' ' ' ASP . 96.1 mt -85.52 -51.21 6.66 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.002 -0.74 . . . . 75.32 109.002 172.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -155.05 166.15 34.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.676 -0.693 . . . . 75.44 109.923 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.604 HG21 HG22 ' A' ' 60' ' ' VAL . 27.7 m -148.49 109.1 4.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.564 -0.532 . . . . 75.23 109.564 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -130.57 135.98 28.23 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.139 0.495 . . . . 72.32 111.649 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 6.0 Cg_exo -79.79 92.83 1.09 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.863 2.375 . . . . 72.12 110.531 171.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.35 110.31 21.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.171 -0.468 . . . . 73.22 111.161 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 73.15 109.93 177.678 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 CA--C 1.518 -0.28 0 N-CA-C 109.41 -0.589 . . . . 73.45 109.41 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.23 67.23 8.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.29 0.567 . . . . 70.22 110.735 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -131.85 57.63 1.77 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.638 -0.71 . . . . 74.15 110.007 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -127.11 -58.07 1.29 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.707 -0.679 . . . . 71.53 109.338 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.89 178.66 51.1 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.911 -0.662 . . . . 72.05 112.319 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.773 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 24.6 tt0 -124.07 -172.21 2.49 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 122.681 -0.305 . . . . 75.04 110.185 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.773 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 11.9 m-20 -77.83 -9.28 58.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.588 -0.278 . . . . 74.32 111.594 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.39 93.94 7.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.412 . . . . 73.43 110.342 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -76.27 86.92 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.456 0.646 . . . . 73.24 109.79 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 t -107.11 -0.12 23.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.593 -0.73 . . . . 75.12 110.483 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.38 175.96 23.72 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.403 -0.679 . . . . 74.24 111.403 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.506 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 5.7 Cg_exo -76.14 -76.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.614 2.21 . . . . 74.31 111.818 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -70.8 -35.65 72.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.698 -0.683 . . . . 74.12 111.104 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HA ' HG21 ' A' ' 35' ' ' VAL . . . -54.21 -49.31 69.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 75.45 111.478 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.52 -43.65 89.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 71.11 111.407 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 14' ' ' PRO . 7.2 mmt85 -64.07 -41.81 97.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.175 -0.466 . . . . 65.23 110.96 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.66 ' HB1' HG22 ' A' ' 35' ' ' VAL . . . -81.08 -35.01 32.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.248 -0.433 . . . . 75.03 112.061 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -65.21 -28.5 69.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.013 0.435 . . . . 74.45 110.291 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.39 -38.22 84.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 75.21 110.779 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.35 -30.86 57.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.047 0.451 . . . . 65.24 111.073 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.532 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . . . -55.88 -35.88 66.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.568 -0.742 . . . . 62.44 112.076 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.4 t -55.77 -40.51 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 75.05 111.808 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -86.86 -12.86 46.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.262 -0.426 . . . . 75.23 111.319 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.4 -34.7 17.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.416 -0.356 . . . . 64.23 111.105 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 14.3 p -91.63 130.53 38.74 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.936 0.398 . . . . 74.33 110.593 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.94 86.71 0.73 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.44 2.093 . . . . 74.12 112.42 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.47 38.73 96.15 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.733 -0.667 . . . . 73.2 112.586 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.58 -175.88 19.2 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.587 -0.816 . . . . 72.05 112.481 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.7 m -96.35 126.63 41.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.865 0.364 . . . . 64.11 110.986 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.09 131.28 37.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.086 -0.506 . . . . 72.42 109.824 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.96 162.01 15.89 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.543 -0.837 . . . . 74.22 112.378 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -55.05 119.85 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.128 0.489 . . . . 73.53 110.917 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.66 HG22 ' HB1' ' A' ' 19' ' ' ALA . 17.9 m -96.38 155.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.472 -0.785 . . . . 74.11 110.373 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -125.9 144.94 50.47 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.428 -0.351 . . . . 72.44 110.129 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.3 p -76.7 142.3 40.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.245 -0.434 . . . . 74.55 110.355 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -83.66 84.24 7.62 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.758 -0.83 . . . . 73.34 108.758 172.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -72.93 123.27 23.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.189 -0.914 . . . . 75.24 110.335 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.2 -26.93 6.55 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.763 -0.935 . . . . 63.53 110.763 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.26 146.47 28.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.263 -0.469 . . . . 71.21 110.303 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.95 -40.05 4.17 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.788 -0.72 . . . . 64.43 112.122 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.33 -65.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.697 0.284 . . . . 62.21 111.15 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.12 93.68 5.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.058 0.456 . . . . 70.53 110.901 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.52 -40.32 19.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.889 -0.596 . . . . 70.3 111.162 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -115.79 143.26 45.65 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.556 -0.293 . . . . 73.35 110.564 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -124.21 112.23 1.77 Allowed Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.793 -0.923 . . . . 74.42 110.793 171.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 19' ' ' ALA . 89.0 t -96.82 110.73 25.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.72 0.295 . . . . 74.42 110.639 -176.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.53 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.5 pp -96.42 115.23 27.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.399 0.618 . . . . 72.04 110.873 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 5.1 m -115.1 126.55 72.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.636 -0.711 . . . . 64.22 110.533 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.2 m -92.23 106.63 18.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.919 -0.582 . . . . 75.23 110.153 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 52' ' ' ARG . 56.6 mtt180 -72.0 149.38 92.3 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.891 -0.411 . . . . 75.44 109.891 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.91 -12.05 27.42 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.555 2.17 . . . . 65.03 111.11 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -68.61 -26.72 65.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.97 -1.013 . . . . 74.4 110.541 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.97 -17.21 15.33 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.851 -0.69 . . . . 72.33 112.755 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 t -89.57 149.35 22.9 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.878 0.371 . . . . 74.55 111.287 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -103.31 119.99 39.92 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.383 -0.599 . . . . 71.51 109.383 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 58.8 t -102.74 124.18 56.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.439 -0.578 . . . . 75.44 109.439 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 9.7 pt-20 -108.9 111.58 23.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.843 0.83 . . . . 75.12 110.314 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.645 HG22 HG22 ' A' ' 71' ' ' THR . 16.6 t -86.69 116.39 29.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.433 -0.803 . . . . 73.11 109.881 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -79.76 118.35 21.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.244 -0.435 . . . . 75.24 110.218 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.686 HD11 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -115.67 154.6 29.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.618 -0.719 . . . . 72.24 111.575 -173.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.669 ' HB2' HD23 ' A' ' 69' ' ' LEU . 20.6 t70 -89.87 173.77 8.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.168 -0.924 . . . . 71.31 109.421 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -52.02 -37.74 54.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.946 0.498 . . . . 73.31 111.615 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.26 14.82 11.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.441 . . . . 73.0 111.542 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.417 ' CD2' HD22 ' A' ' 62' ' ' LEU . 7.7 m-85 65.63 25.42 11.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.144 0.497 . . . . 71.41 111.475 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -80.48 137.52 36.48 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.971 -0.752 . . . . 62.43 108.971 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.686 ' HA ' HD11 ' A' ' 62' ' ' LEU . 8.6 p -70.91 125.6 29.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.313 0.578 . . . . 63.32 111.187 -176.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.669 HD23 ' HB2' ' A' ' 63' ' ' ASP . 71.6 mt -97.26 -58.58 1.98 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.664 -0.698 . . . . 70.22 109.674 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -155.7 141.11 17.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.947 -0.569 . . . . 71.34 110.088 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.645 HG22 HG22 ' A' ' 60' ' ' VAL . 18.5 m -107.8 111.6 23.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.544 -0.539 . . . . 64.34 109.544 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 12.3 pt-20 -135.32 129.24 18.67 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.18 0.514 . . . . 73.35 112.072 -173.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 2.0 Cg_endo -82.52 130.56 6.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.825 2.35 . . . . 62.05 110.263 169.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.57 172.16 7.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.969 0.414 . . . . 61.02 111.652 -175.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.797 -0.638 . . . . 75.32 109.834 179.136 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 mpp? . . . . . 0 C--O 1.233 0.204 0 N-CA-C 109.968 -0.382 . . . . 74.41 109.968 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' A' ' 18' ' ' ARG . . . -80.86 73.75 7.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.033 0.444 . . . . 65.43 110.892 -178.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -135.14 93.71 3.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.115 0.483 . . . . 73.42 110.511 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -150.29 -77.97 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.819 -0.808 . . . . 74.33 108.819 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.578 ' HA2' ' OD1' ' A' ' 17' ' ' ASP . . . 79.0 140.06 1.81 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.824 -0.625 . . . . 74.52 114.029 171.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.536 ' O ' HG23 ' A' ' 11' ' ' VAL . 34.5 tt0 -80.98 134.03 35.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.582 -0.895 . . . . 74.1 108.582 171.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.35 1.89 20.44 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.997 0.369 . . . . 75.13 111.997 -170.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.89 8.01 20.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.826 0.306 . . . . 75.04 111.826 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.617 HG21 ' HB2' ' A' ' 17' ' ' ASP . 28.5 m -84.11 159.03 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.735 -0.386 . . . . 73.44 109.996 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 p -94.37 -25.22 17.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.86 -0.336 . . . . 72.12 111.293 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.409 ' HA2' ' HD2' ' A' ' 14' ' ' PRO . . . -95.1 111.23 4.16 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.853 -0.689 . . . . 61.1 111.581 174.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD2' ' HA2' ' A' ' 13' ' ' GLY . 13.5 Cg_endo -56.76 -55.83 2.41 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.983 2.456 . . . . 74.21 112.695 -175.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -89.06 -9.2 52.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.029 0.442 . . . . 55.13 110.698 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 1.076 ' HA ' HG21 ' A' ' 35' ' ' VAL . . . -66.28 -43.44 86.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.531 -0.759 . . . . 74.1 111.937 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.617 ' HB2' HG21 ' A' ' 11' ' ' VAL . 8.6 t70 -52.47 -57.46 9.82 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.066 -0.516 . . . . 75.12 112.148 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.505 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -71.42 -31.7 67.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.242 0.46 . . . . 75.53 112.242 -173.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.635 ' HB1' ' HE1' ' A' ' 66' ' ' PHE . . . -69.01 -39.91 79.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.075 0.464 . . . . 74.45 110.5 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -25.87 55.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.953 -0.567 . . . . 73.52 110.503 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.38 -32.91 62.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.354 . . . . 73.34 110.939 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.08 -26.89 62.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.178 0.513 . . . . 61.34 111.09 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.541 ' HB1' HG11 ' A' ' 48' ' ' VAL . . . -71.5 -23.15 61.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.915 -0.584 . . . . 61.22 111.442 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -63.13 -25.03 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.17 0.51 . . . . 74.03 111.239 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -80.31 -13.64 59.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.874 0.368 . . . . 74.25 110.963 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.49 1.3 29.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.264 -0.425 . . . . 73.33 111.381 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.08 116.34 5.63 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.144 0.497 . . . . 73.15 111.272 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.21 96.02 0.53 Allowed 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.484 2.123 . . . . 74.34 112.392 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.25 42.21 83.93 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.796 -0.638 . . . . 42.24 112.594 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.03 162.57 20.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.633 -0.794 . . . . 73.54 112.367 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.53 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 28.1 m -87.58 112.0 21.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.952 0.406 . . . . 74.34 110.617 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.53 131.78 53.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.102 -0.499 . . . . 75.33 110.612 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 49' ' ' LEU . . . -106.97 160.74 14.09 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.517 -0.849 . . . . 54.21 111.168 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.76 136.02 57.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.416 0.627 . . . . 70.35 110.323 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 1.076 HG21 ' HA ' ' A' ' 16' ' ' ALA . 2.5 m -90.7 157.1 2.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.148 -0.933 . . . . 75.43 111.437 -169.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -104.71 141.83 35.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.875 -0.602 . . . . 75.5 110.074 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.73 104.23 5.3 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.693 -0.685 . . . . 75.44 109.931 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -72.62 138.39 46.74 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.918 -0.401 . . . . 74.22 109.918 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -127.46 153.51 46.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.272 -0.422 . . . . 73.24 110.66 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.47 -19.03 49.44 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.908 -0.663 . . . . 72.32 111.838 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.0 154.51 17.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.458 -0.571 . . . . 73.34 109.458 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.81 -31.48 20.85 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.903 -0.665 . . . . 74.2 112.715 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.618 ' O ' ' HA ' ' A' ' 63' ' ' ASP . . . -111.72 -52.46 2.78 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.75 -0.265 . . . . 74.35 110.976 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 101.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.248 0.547 . . . . 54.23 110.918 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.44 -13.64 14.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 74.24 111.229 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.529 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 20.4 m-85 -135.27 132.64 38.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.723 -0.473 . . . . 70.04 109.723 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.577 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -115.35 112.56 2.72 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.748 -0.739 . . . . 75.13 111.535 177.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.621 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 22.1 t -96.4 129.67 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 122.253 0.221 . . . . 74.34 110.996 -175.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.535 HD11 ' HA3' ' A' ' 33' ' ' GLY . 1.1 pp -101.91 111.22 23.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.214 0.53 . . . . 74.12 110.452 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.1 t -114.65 119.9 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.774 -0.648 . . . . 72.25 110.952 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.53 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 23.8 m -101.32 104.46 15.46 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.75 -0.463 . . . . 71.44 109.75 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -75.62 147.98 82.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.034 -0.53 . . . . 74.11 110.646 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.99 -18.22 41.8 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.169 2.579 . . . . 71.15 112.543 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -70.17 -15.05 62.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.545 . . . . 64.32 110.896 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.9 32.69 7.02 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.587 -0.816 . . . . 61.45 112.39 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -130.09 147.79 51.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.772 0.32 . . . . 71.53 110.372 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -107.17 120.99 43.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.201 -0.454 . . . . 75.15 110.543 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 57.1 t -119.48 133.66 65.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.762 -0.653 . . . . 64.34 109.629 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 11.5 pt-20 -107.6 124.18 49.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.34 0.591 . . . . 75.01 110.479 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.621 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 25.9 t -94.92 125.98 47.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.425 -0.807 . . . . 74.42 109.853 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -99.16 123.61 43.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.1 0.476 . . . . 72.31 110.509 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -112.17 149.85 31.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.652 -0.704 . . . . 75.52 111.083 -176.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.62 ' HB2' HD21 ' A' ' 69' ' ' LEU . 18.4 t70 -90.19 171.53 9.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.962 -0.563 . . . . 74.33 109.883 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.448 ' H ' ' HG3' ' A' ' 64' ' ' ARG . 0.3 OUTLIER -42.81 -51.92 5.24 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.033 0.933 . . . . 74.33 111.949 -178.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -86.0 18.46 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.875 -0.602 . . . . 74.05 111.203 -174.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.635 ' HE1' ' HB1' ' A' ' 19' ' ' ALA . 6.3 m-85 66.97 27.98 8.66 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.872 -0.603 . . . . 75.44 111.586 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -80.32 124.02 28.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.949 -0.76 . . . . 73.52 108.949 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.654 ' HA ' HD13 ' A' ' 62' ' ' LEU . 7.3 p -63.53 122.83 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.169 0.509 . . . . 75.32 110.536 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' A' ' 63' ' ' ASP . 97.7 mt -87.89 -57.62 2.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.682 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -170.89 176.72 4.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.696 -0.483 . . . . 72.44 109.696 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.581 HG21 HG21 ' A' ' 60' ' ' VAL . 16.8 p -140.24 109.42 6.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.317 -0.402 . . . . 73.13 110.656 -177.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -117.74 129.66 25.21 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 121.141 0.496 . . . . 62.11 111.052 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 57.3 Cg_endo -73.91 105.04 1.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.383 2.056 . . . . 75.04 111.948 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.37 93.2 4.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.149 -0.478 . . . . 74.12 111.01 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.674 -0.694 . . . . 75.22 109.266 175.962 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.962 -0.455 . . . . 74.42 111.962 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.66 124.84 34.95 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.984 -0.376 . . . . 62.24 109.984 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.412 ' HG3' ' HD2' ' A' ' 5' ' ' PHE . 10.6 tpt -75.2 133.54 41.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.127 -0.488 . . . . 75.25 109.958 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.27 66.81 2.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.411 0.523 . . . . 72.53 112.411 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.412 ' HD2' ' HG3' ' A' ' 3' ' ' MET . 91.8 m-85 -145.35 90.49 2.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.774 -0.648 . . . . 73.54 109.33 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -131.96 -74.5 0.51 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.874 -0.331 . . . . 74.13 110.802 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.714 ' HA2' ' NH1' ' A' ' 18' ' ' ARG . . . 115.75 85.37 1.22 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 119.977 -1.106 . . . . 55.11 113.713 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.673 ' HG3' ' HG2' ' A' ' 10' ' ' GLU . 10.6 tp10 -71.36 146.1 49.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.643 -0.873 . . . . 73.4 108.643 171.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -91.81 -8.5 46.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.379 0.511 . . . . 73.4 112.379 -168.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.673 ' HG2' ' HG3' ' A' ' 8' ' ' GLU . 12.6 pt-20 -90.79 3.42 54.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.868 0.322 . . . . 75.31 111.868 -175.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 1.026 HG22 ' HB2' ' A' ' 17' ' ' ASP . 27.4 m -113.24 157.59 13.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.684 0.278 . . . . 74.24 110.98 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -101.49 -11.3 19.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.366 . . . . 75.04 111.038 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.07 143.16 15.61 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.612 -0.804 . . . . 72.31 111.983 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.16 -67.28 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.414 2.076 . . . . 74.4 112.222 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -70.17 -26.53 63.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.043 -0.526 . . . . 72.23 109.927 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HA ' HG21 ' A' ' 35' ' ' VAL . . . -55.83 -27.1 49.76 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.278 -0.874 . . . . 71.53 111.503 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 1.026 ' HB2' HG22 ' A' ' 11' ' ' VAL . 3.9 t70 -85.36 -55.6 3.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.985 -0.552 . . . . 71.11 111.265 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.714 ' NH1' ' HA2' ' A' ' 7' ' ' GLY . 17.0 mmt-85 -59.26 -46.4 88.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.805 -0.634 . . . . 73.34 111.01 -170.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.722 ' HB1' ' HE1' ' A' ' 66' ' ' PHE . . . -73.36 -35.78 66.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.461 . . . . 62.44 111.478 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.493 ' O ' HG23 ' A' ' 24' ' ' VAL . 46.3 ttt-85 -65.89 -41.69 91.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.906 -0.588 . . . . 73.23 110.512 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.15 86.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.972 0.415 . . . . 62.23 111.088 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.64 76.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.102 -0.499 . . . . 74.01 110.812 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.54 ' HB2' HG12 ' A' ' 48' ' ' VAL . . . -63.9 -43.89 94.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 70.01 111.506 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 20' ' ' ARG . 57.5 t -56.76 -32.07 37.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 74.24 110.986 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -80.72 -13.0 59.38 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.844 -0.617 . . . . 74.44 111.269 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.02 -30.14 12.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.402 -0.363 . . . . 70.31 111.559 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.7 120.35 43.98 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.234 0.54 . . . . 70.02 111.095 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.1 99.66 0.91 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.566 2.177 . . . . 71.22 112.72 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.4 35.14 77.89 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.931 -0.577 . . . . 60.33 112.726 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.11 177.31 33.77 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.574 -0.822 . . . . 51.21 112.335 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.692 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 31.4 m -79.48 116.37 19.66 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.203 -0.295 . . . . 73.2 110.203 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.85 133.43 53.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.295 -0.411 . . . . 54.34 110.339 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -125.28 162.13 19.62 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.497 -0.641 . . . . 53.33 111.497 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.421 ' HB2' ' HB1' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -63.89 142.3 58.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.368 0.604 . . . . 74.02 110.937 178.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 16' ' ' ALA . 12.1 m -104.29 155.71 5.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.646 -0.706 . . . . 74.24 110.884 -173.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -119.12 156.62 29.44 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.81 -0.441 . . . . 64.53 109.81 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.3 p -73.47 125.78 28.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.396 -0.366 . . . . 73.1 111.093 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' OE1' ' HD2' ' A' ' 61' ' ' HIS . 38.0 mt-10 -79.79 -166.61 1.03 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.859 -0.61 . . . . 72.4 109.846 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -60.05 129.15 40.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.455 -0.339 . . . . 74.22 110.653 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.35 91.12 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.975 -0.557 . . . . 70.33 112.712 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -83.92 113.39 20.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.867 0.365 . . . . 73.03 110.287 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.14 -156.21 26.78 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.78 -0.646 . . . . 61.2 111.5 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.04 -41.16 5.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.044 0.449 . . . . 72.35 110.427 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.02 112.21 23.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.639 . . . . 72.14 110.195 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.63 -26.39 12.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.977 -0.556 . . . . 64.43 111.009 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -126.35 132.52 51.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.079 -0.509 . . . . 73.23 110.186 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.76 112.26 2.94 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.533 -0.841 . . . . 65.41 111.536 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.576 HG23 ' HB2' ' A' ' 19' ' ' ALA . 39.0 t -97.59 109.29 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.752 0.31 . . . . 73.54 111.117 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 pp -86.86 117.38 25.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.178 0.513 . . . . 63.42 110.631 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.453 HG13 ' HB3' ' A' ' 23' ' ' ALA . 16.4 m -135.74 150.08 28.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.934 -0.576 . . . . 74.15 110.077 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.692 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 28.3 m -136.39 126.03 25.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.34 -0.391 . . . . 64.43 111.061 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.437 ' HB2' HG21 ' A' ' 56' ' ' THR . 6.6 mpt_? -80.04 142.2 55.45 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.784 -0.821 . . . . 73.31 108.784 173.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.47 -12.7 11.53 Favored 'Trans proline' 0 N--CA 1.475 0.412 0 C-N-CA 123.338 2.692 . . . . 73.23 112.955 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -68.55 -9.51 49.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.929 -0.578 . . . . 71.24 111.158 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.85 32.41 7.2 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.605 -0.807 . . . . 65.3 111.742 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.437 HG21 ' HB2' ' A' ' 52' ' ' ARG . 5.5 t -128.28 119.42 25.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.416 0.627 . . . . 75.14 110.737 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -105.29 127.0 52.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.303 -0.862 . . . . 73.22 110.386 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.553 HG11 ' HB ' ' A' ' 71' ' ' THR . 98.3 t -131.7 138.76 52.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.97 -0.559 . . . . 74.24 109.765 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.525 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 9.4 pt-20 -106.98 121.69 44.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.463 0.649 . . . . 75.14 110.196 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.571 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 21.5 t -85.07 119.19 33.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.207 -0.906 . . . . 72.44 109.586 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.46 ' HD2' ' OE1' ' A' ' 38' ' ' GLU . 46.4 m80 -91.53 118.82 30.92 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.28 0.562 . . . . 74.31 110.495 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.599 HD23 ' HD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -109.44 147.58 32.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.897 -1.047 . . . . 74.24 110.733 -174.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.524 ' HB3' HD22 ' A' ' 69' ' ' LEU . 5.4 p-10 -90.89 -163.2 1.0 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.229 -0.441 . . . . 73.21 110.071 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -66.9 -15.9 63.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.266 -0.424 . . . . 73.45 111.779 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -121.31 16.88 11.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 72.23 111.236 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.722 ' HE1' ' HB1' ' A' ' 19' ' ' ALA . 31.8 m-85 65.67 29.38 10.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.964 -0.562 . . . . 73.05 112.244 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -89.26 134.68 33.95 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.922 -0.77 . . . . 74.41 108.922 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -63.19 113.06 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.434 0.635 . . . . 73.42 111.006 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 63' ' ' ASP . 87.9 mt -83.84 -52.23 6.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.774 -0.648 . . . . 74.13 110.1 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -173.81 160.09 3.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.993 -0.549 . . . . 75.14 110.047 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.553 ' HB ' HG11 ' A' ' 58' ' ' VAL . 19.8 p -128.93 111.43 13.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.039 -0.528 . . . . 74.23 111.121 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -112.84 143.84 29.86 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.315 -0.402 . . . . 75.33 110.692 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.23 128.88 26.44 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.127 2.551 . . . . 70.42 112.048 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.525 ' HB2' ' HG2' ' A' ' 59' ' ' GLU . . . -104.99 122.74 46.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.911 -0.586 . . . . 73.33 110.936 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -111.04 175.35 5.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.858 -0.61 . . . . 61.05 109.784 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -130.87 34.37 2.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.531 -0.842 . . . . 63.12 112.677 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -94.37 -19.14 20.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.081 0.467 . . . . 72.5 110.321 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.37 89.03 1.45 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.816 -0.706 . . . . 64.23 112.72 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.52 -177.07 51.62 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.472 -0.651 . . . . 70.4 111.472 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 80' ' ' LEU . 2.0 pt? -145.36 114.59 7.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.868 0.366 . . . . 64.33 110.638 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.703 -0.665 . . . . 74.21 109.429 178.17 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 112.138 -0.385 . . . . 73.12 112.138 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.53 170.9 7.65 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.159 -0.312 . . . . 74.0 110.159 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -71.14 121.9 19.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.958 -0.386 . . . . 74.43 109.958 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.22 69.78 9.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.185 -0.461 . . . . 74.45 111.8 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -98.6 113.1 25.01 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.201 -0.666 . . . . 73.44 109.201 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.433 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 19.3 t70 63.91 101.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.915 0.759 . . . . 74.43 110.331 -171.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.72 -108.04 1.95 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.71 -0.677 . . . . 73.31 112.49 -177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.604 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 31.2 tt0 -107.51 177.41 4.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.802 0.334 . . . . 73.03 110.678 -177.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.604 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 28.4 t70 -75.14 -8.94 57.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.943 -0.571 . . . . 62.4 111.829 -175.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -65.56 97.36 0.3 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.957 0.408 . . . . 55.34 110.703 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 51.7 t -83.04 86.17 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.457 0.646 . . . . 74.34 111.006 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 t -101.66 -13.33 17.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.757 0.789 . . . . 70.05 109.066 171.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.645 ' HA3' ' HB2' ' A' ' 16' ' ' ALA . . . 170.71 135.81 1.98 Allowed Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.592 -1.185 . . . . 74.12 110.345 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -54.67 -70.15 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 123.016 2.478 . . . . 74.34 112.153 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -89.69 -20.72 23.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.827 -0.624 . . . . 74.54 110.147 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HB2' ' HA3' ' A' ' 13' ' ' GLY . . . -59.65 -49.54 77.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.424 -0.807 . . . . 70.41 111.311 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -58.0 -40.93 81.94 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.203 0.525 . . . . 74.43 111.469 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.433 ' NE ' ' HA ' ' A' ' 6' ' ' ASP . 17.4 mmt180 -65.06 -43.91 90.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.595 -0.73 . . . . 75.44 110.827 -171.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.92 -28.1 28.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.438 -0.346 . . . . 62.03 111.347 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.919 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 63.0 ttt180 -65.7 -35.99 82.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.507 -0.315 . . . . 74.11 110.364 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -62.77 -34.01 76.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.854 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.09 -35.59 61.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 70.54 110.348 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.443 ' HB3' HG13 ' A' ' 48' ' ' VAL . . . -58.92 -55.45 34.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 73.44 111.032 177.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.19 -11.04 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.37 0.605 . . . . 70.33 110.891 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.5 tp-100 -88.25 -24.64 23.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 73.45 110.11 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.5 18.87 20.46 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.055 -0.52 . . . . 72.41 111.753 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.03 125.19 11.39 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 121.014 0.435 . . . . 72.21 110.35 176.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.93 82.56 1.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.431 2.087 . . . . 74.33 112.584 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.94 28.47 71.79 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.772 -0.649 . . . . 74.2 112.875 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.55 175.44 29.15 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.712 -0.756 . . . . 72.55 112.113 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.775 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 58.0 m -78.09 105.9 9.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.267 0.556 . . . . 73.24 110.964 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.6 120.62 37.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.684 -0.689 . . . . 51.4 109.881 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.499 ' HA3' HD11 ' A' ' 49' ' ' LEU . . . -101.19 160.43 18.51 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.524 -0.846 . . . . 74.24 112.285 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.919 ' HG2' ' HD2' ' A' ' 20' ' ' ARG . 23.4 mt-10 -79.25 151.64 31.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.984 -0.376 . . . . 63.54 109.984 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.504 HG12 HD23 ' A' ' 49' ' ' LEU . 26.7 m -128.72 155.54 40.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.956 -0.565 . . . . 74.32 111.547 -171.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.13 158.85 17.88 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.419 -0.585 . . . . 75.03 109.419 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -72.92 113.28 9.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.012 0.434 . . . . 71.45 110.972 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.21 139.54 56.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 74.41 109.632 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.5 p -138.48 173.89 11.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.832 0.349 . . . . 63.43 111.422 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.74 -115.02 3.27 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.797 -0.716 . . . . 42.4 112.132 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -131.03 172.58 11.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.819 0.342 . . . . 74.43 110.46 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.9 -139.77 14.56 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.169 -0.772 . . . . 51.11 111.169 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 -12.98 4.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.894 0.347 . . . . 71.33 111.456 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.45 133.05 38.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 70.12 111.261 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.77 -28.72 2.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.947 -0.57 . . . . 65.11 110.75 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -131.23 155.77 46.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.435 -0.348 . . . . 73.5 110.274 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.83 145.39 16.82 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.469 -0.872 . . . . 71.31 112.193 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 23' ' ' ALA . 70.1 t -128.91 105.4 12.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.308 -0.627 . . . . 73.42 109.308 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.504 HD23 HG12 ' A' ' 35' ' ' VAL . 3.3 pp -102.18 123.82 46.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.423 0.63 . . . . 74.2 110.648 -177.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 m -124.61 120.64 59.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.463 -0.79 . . . . 72.55 110.42 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.775 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 12.5 m -92.71 104.28 16.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.822 -0.626 . . . . 73.25 109.995 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -66.09 139.9 96.77 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.877 -0.601 . . . . 75.02 109.438 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.93 -9.56 6.19 Favored 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.169 2.579 . . . . 74.53 112.939 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.99 -13.7 60.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 72.12 110.475 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.28 33.01 5.85 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.771 -0.728 . . . . 64.01 112.563 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -131.2 143.02 50.28 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.096 -0.335 . . . . 62.22 110.096 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -107.23 119.7 40.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.886 0.374 . . . . 75.14 110.087 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.39 114.79 48.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.122 -0.49 . . . . 73.22 110.021 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.54 112.02 24.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.554 0.693 . . . . 75.44 110.431 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.5 t -88.66 124.45 41.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.195 -0.911 . . . . 74.42 109.891 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 70' ' ' ASP . 35.9 m170 -96.06 122.6 39.07 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.909 -0.587 . . . . 74.22 110.667 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -109.78 154.95 22.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.71 -0.677 . . . . 65.11 110.468 -177.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.981 ' HB3' HD11 ' A' ' 69' ' ' LEU . 3.9 p30 -92.14 -164.23 1.15 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.977 0.417 . . . . 74.3 110.481 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.472 ' H ' ' HG3' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -62.81 -29.16 70.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.725 -0.671 . . . . 73.23 111.191 -175.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -100.27 17.27 21.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.175 -0.466 . . . . 64.01 111.316 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 69.02 19.86 7.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.848 -0.615 . . . . 75.11 111.507 172.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.523 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . 40.3 ttm180 -90.63 145.81 24.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.769 0.319 . . . . 72.25 110.522 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.554 ' HA ' HD13 ' A' ' 62' ' ' LEU . 5.3 p -67.06 126.47 26.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.211 0.529 . . . . 72.53 110.904 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.981 HD11 ' HB3' ' A' ' 63' ' ' ASP . 61.3 mt -112.72 -61.39 1.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.898 -0.592 . . . . 73.4 111.016 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 61' ' ' HIS . 23.0 t70 -132.03 139.83 48.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.551 -0.749 . . . . 72.1 111.315 -169.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.2 m -117.52 110.43 17.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.357 -0.383 . . . . 75.34 110.364 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -114.96 117.53 41.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.953 0.406 . . . . 73.02 111.872 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.23 93.99 0.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.757 2.305 . . . . 73.21 109.998 168.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.92 147.3 48.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.388 -0.369 . . . . 73.02 111.292 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -109.24 155.49 21.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.065 -0.516 . . . . 64.24 109.927 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.61 2.43 67.28 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.547 -0.835 . . . . 73.34 114.013 -172.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.98 -57.81 3.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.671 0.735 . . . . 72.33 110.927 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.17 -101.02 2.39 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.752 -0.737 . . . . 72.34 112.435 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.46 -172.06 45.07 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.865 -0.683 . . . . 73.42 112.222 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.831 HD23 ' HG3' ' A' ' 81' ' ' GLU . 9.1 tt -108.75 130.36 55.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.026 -0.731 . . . . 73.11 109.026 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.831 ' HG3' HD23 ' A' ' 80' ' ' LEU . 52.5 mt-10 . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.724 -0.655 . . . . 72.32 110.283 -173.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.493 0 N-CA-C 111.58 -0.608 . . . . 41.12 111.58 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.3 108.35 5.2 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.796 -0.446 . . . . 73.53 109.796 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -72.84 152.07 41.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.886 -0.597 . . . . 74.41 109.836 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.39 66.85 4.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.268 0.556 . . . . 74.55 111.507 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -113.12 57.5 0.67 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.492 0.663 . . . . 72.41 109.308 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -153.69 117.72 4.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.004 -0.998 . . . . 74.33 109.179 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.81 155.07 25.93 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.776 -0.726 . . . . 72.22 111.614 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.46 165.76 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.523 0.678 . . . . 74.43 111.678 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.55 2.8 55.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.038 -0.983 . . . . 73.33 111.197 -173.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.89 22.26 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 74.41 112.092 -173.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.485 HG21 ' HB2' ' A' ' 17' ' ' ASP . 19.6 m -131.08 173.58 14.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.417 -0.356 . . . . 74.32 110.234 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -93.38 102.4 14.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.922 -0.77 . . . . 74.21 108.922 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.88 92.99 0.54 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.347 -1.101 . . . . 72.32 110.347 -169.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.28 -13.36 19.72 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 123.233 2.622 . . . . 75.31 114.13 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.574 ' HA ' ' CG ' ' A' ' 18' ' ' ARG . 54.0 m-20 -73.04 -15.63 61.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.26 0.552 . . . . 75.23 109.721 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -68.41 -31.99 71.73 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.263 -0.88 . . . . 75.32 109.974 171.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.485 ' HB2' HG21 ' A' ' 11' ' ' VAL . 11.6 t70 -83.41 -28.33 28.94 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.168 -0.469 . . . . 73.51 111.584 -173.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.574 ' CG ' ' HA ' ' A' ' 15' ' ' ASP . 5.5 mmt180 -54.28 -55.1 31.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.56 0.695 . . . . 74.24 109.931 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.83 ' HB2' HG22 ' A' ' 48' ' ' VAL . . . -81.15 -21.61 39.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.247 -0.888 . . . . 73.02 111.141 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 28.0 ttt180 -66.54 -36.24 82.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.0 0.428 . . . . 74.14 110.372 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.34 70.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.291 0.567 . . . . 74.05 110.484 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.27 -38.13 36.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 73.3 110.268 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.48 -48.85 76.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.712 -0.676 . . . . 72.24 111.777 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 p -66.2 -18.69 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.996 0.427 . . . . 72.31 111.213 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.76 -19.69 21.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.973 0.416 . . . . 71.25 110.695 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.55 -31.54 22.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.068 -0.515 . . . . 73.23 111.427 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.0 120.33 33.96 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.955 0.407 . . . . 70.22 110.541 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.83 104.59 1.19 Allowed 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.741 2.294 . . . . 65.32 112.625 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.19 26.19 71.43 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.913 -0.585 . . . . 74.11 112.584 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.5 -173.28 35.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.743 -0.742 . . . . 73.43 112.068 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.778 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 63.6 m -90.25 111.44 22.62 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.971 0.415 . . . . 72.44 110.745 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.03 100.64 11.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.644 -0.707 . . . . 74.23 109.592 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.599 ' HA3' HD13 ' A' ' 49' ' ' LEU . . . -89.45 160.95 29.58 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.786 -0.721 . . . . 61.44 112.309 -176.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.413 ' H ' ' HG2' ' A' ' 34' ' ' GLU . 5.3 pt-20 -70.13 127.67 33.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.275 0.56 . . . . 74.34 110.125 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.696 HG22 ' HB3' ' A' ' 19' ' ' ALA . 20.4 m -103.96 153.92 6.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.699 -0.682 . . . . 70.22 111.417 -173.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -106.73 155.57 19.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.39 -0.368 . . . . 73.42 110.283 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.3 m -76.64 111.29 11.98 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.85 -0.426 . . . . 64.13 109.85 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 36.1 mt-10 -78.62 111.24 14.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.174 0.511 . . . . 74.22 110.449 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.4 p -117.66 124.68 49.14 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.011 -0.541 . . . . 72.44 110.646 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.63 -110.69 0.38 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.46 -0.876 . . . . 72.32 112.618 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -113.94 165.77 12.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.957 0.408 . . . . 73.13 111.291 -174.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.97 -150.27 29.03 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.848 -0.691 . . . . 71.43 111.959 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.13 4.95 10.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.143 0.497 . . . . 72.3 110.695 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.51 103.01 12.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 74.01 110.4 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 38' ' ' GLU . . . -103.85 -13.64 16.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.138 -0.483 . . . . 73.03 111.019 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -141.74 133.69 27.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 75.43 110.191 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.426 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -116.41 113.62 2.85 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.859 -0.686 . . . . 62.24 111.785 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.83 HG22 ' HB2' ' A' ' 19' ' ' ALA . 34.7 t -95.5 117.09 38.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 110.031 -0.359 . . . . 61.41 110.031 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.599 HD13 ' HA3' ' A' ' 33' ' ' GLY . 1.3 pp -98.39 107.64 20.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.473 0.654 . . . . 71.51 110.276 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.2 m -110.19 107.05 21.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 64.15 110.761 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.778 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 22.4 m -95.6 113.76 25.44 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.845 -0.616 . . . . 64.51 110.76 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -71.21 146.08 91.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.176 -0.676 . . . . 71.2 109.176 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.98 -2.84 6.09 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.718 2.279 . . . . 62.55 112.17 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -83.08 0.5 44.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.682 -0.69 . . . . 73.54 110.539 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.18 33.21 12.24 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.635 -0.793 . . . . 71.52 112.579 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t -135.9 125.56 25.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.136 0.493 . . . . 74.14 110.886 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 54.3 ttt180 -103.75 126.26 50.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.931 -0.577 . . . . 75.0 110.648 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 49.4 t -112.96 132.77 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.184 -0.462 . . . . 72.01 110.262 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -93.06 108.32 19.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.282 -0.417 . . . . 73.13 110.383 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.756 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 21.6 t -89.28 108.36 19.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.204 -0.665 . . . . 71.5 109.204 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -90.1 127.16 36.02 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.989 0.423 . . . . 70.5 110.823 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -115.74 159.36 21.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.513 -0.767 . . . . 72.33 111.103 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.456 ' HB2' HD21 ' A' ' 69' ' ' LEU . 11.2 t70 -90.43 173.73 7.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.047 -0.979 . . . . 74.12 110.138 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -57.58 -29.43 64.44 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.451 0.7 . . . . 74.41 111.411 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -89.18 5.35 45.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.084 0.469 . . . . 72.11 110.37 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 71.34 21.65 4.55 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.404 -0.816 . . . . 75.2 110.592 -176.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.49 133.13 37.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.894 -0.593 . . . . 74.41 109.877 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.7 ' HA ' HD13 ' A' ' 62' ' ' LEU . 7.2 p -65.55 131.23 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.879 0.371 . . . . 74.11 111.004 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' A' ' 63' ' ' ASP . 92.1 mt -101.19 -64.25 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.292 -0.413 . . . . 71.11 110.561 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -166.61 175.8 7.71 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.702 -0.481 . . . . 64.53 109.702 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.409 HG22 HG21 ' A' ' 60' ' ' VAL . 46.9 p -139.09 114.22 9.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.721 0.296 . . . . 70.24 111.384 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -125.4 139.53 34.1 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.096 -0.335 . . . . 75.35 110.096 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 40.6 Cg_endo -69.22 152.08 72.09 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.407 2.071 . . . . 73.1 112.3 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.06 111.56 23.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.324 -0.398 . . . . 71.11 111.598 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -139.5 111.49 7.4 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.243 -0.651 . . . . 60.2 109.243 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -108.83 57.17 0.44 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.81 -0.71 . . . . 64.43 113.65 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -97.01 -48.88 5.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.157 -0.682 . . . . 74.13 109.157 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -132.12 56.0 0.75 Allowed Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.923 -1.035 . . . . 70.13 110.824 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.22 73.57 2.57 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.027 -0.606 . . . . 73.34 112.067 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.1 mt -119.18 143.29 47.32 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.505 -0.554 . . . . 74.1 109.505 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.355 -0.831 . . . . 75.24 108.774 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.647 -0.581 . . . . 71.34 111.647 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.69 113.02 25.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.88 0.372 . . . . 74.15 110.607 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.41 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 4.5 mpp? -84.4 108.43 17.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.154 -0.476 . . . . 73.54 110.209 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.01 89.7 6.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 70.11 111.136 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.426 ' HZ ' ' HA ' ' A' ' 65' ' ' ASP . 79.1 m-85 -117.55 58.14 0.8 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.338 0.59 . . . . 75.23 109.899 175.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -146.56 145.4 30.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.537 -0.756 . . . . 73.11 109.306 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.14 164.9 35.1 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.562 -0.828 . . . . 65.25 111.664 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.93 162.05 20.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.056 0.428 . . . . 75.22 110.706 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -95.22 -10.19 31.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.36 -0.382 . . . . 74.52 111.513 -172.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -85.74 5.1 33.79 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.166 0.432 . . . . 75.43 112.166 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -90.14 158.19 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.522 -0.547 . . . . 72.21 109.522 172.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.9 m -92.76 -34.75 13.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.785 0.326 . . . . 73.04 110.384 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.99 109.51 3.12 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.64 -0.79 . . . . 74.11 111.439 175.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.99 -66.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.608 2.206 . . . . 75.42 112.007 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.589 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 5.4 p-10 -71.17 -20.61 62.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.094 -0.503 . . . . 73.12 110.629 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.403 ' HB1' ' HB3' ' A' ' 34' ' ' GLU . . . -56.46 -45.91 80.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.523 -0.762 . . . . 74.33 112.43 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.92 -54.79 25.21 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.548 0.573 . . . . 61.12 112.548 -173.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.655 ' HD2' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -63.64 -32.58 74.1 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.904 -0.318 . . . . 74.14 110.995 -177.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.499 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . . . -68.94 -44.72 72.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.282 0.563 . . . . 65.44 110.262 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 24' ' ' VAL . 38.4 ttp180 -60.09 -46.86 88.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.258 -0.883 . . . . 73.12 110.912 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.39 89.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.95 -0.568 . . . . 71.41 111.671 -177.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.56 -38.15 90.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.975 0.417 . . . . 70.44 111.268 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.22 -16.97 57.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.043 -0.526 . . . . 62.25 112.327 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 20' ' ' ARG . 96.0 t -57.53 -39.27 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.951 0.405 . . . . 73.23 111.254 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -70.02 -13.13 62.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.376 -0.375 . . . . 74.53 111.318 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.66 12.31 36.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.36 -0.382 . . . . 74.13 111.15 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.48 114.42 3.82 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.242 0.544 . . . . 75.52 110.693 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.26 93.64 0.66 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.449 2.099 . . . . 53.33 112.699 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.26 43.88 94.58 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.694 -0.684 . . . . 65.11 112.615 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.407 ' HA2' ' HG3' ' A' ' 53' ' ' PRO . . . -110.66 -172.96 19.99 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.585 -0.817 . . . . 72.23 112.638 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.748 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 37.9 m -92.06 114.52 27.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.859 0.361 . . . . 74.35 111.205 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.93 119.83 39.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.824 -0.625 . . . . 75.22 109.999 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.84 161.04 12.88 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.551 -0.833 . . . . 73.43 112.755 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.403 ' HB3' ' HB1' ' A' ' 16' ' ' ALA . 1.6 mp0 -67.17 137.26 56.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.058 -0.349 . . . . 74.21 110.058 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.734 HG13 ' HA ' ' A' ' 48' ' ' VAL . 31.1 m -134.01 154.42 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.254 -0.43 . . . . 75.13 111.269 -174.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -106.67 160.63 15.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.276 -0.42 . . . . 72.5 110.118 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 p -71.52 148.75 46.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.055 0.455 . . . . 72.43 111.625 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.59 97.08 6.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 74.45 110.201 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.1 m -89.54 117.6 28.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.984 -0.553 . . . . 74.44 110.532 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.88 -139.19 6.66 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.782 -0.723 . . . . 72.21 112.199 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -95.78 178.06 5.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.969 0.414 . . . . 65.55 110.716 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.49 -168.18 19.5 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.054 -0.593 . . . . 72.34 112.362 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.25 8.45 14.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.939 0.399 . . . . 73.23 110.504 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.24 170.34 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 75.41 110.663 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.11 -36.93 0.17 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.478 -0.328 . . . . 74.34 111.531 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.541 ' HE2' ' HB2' ' A' ' 15' ' ' ASP . 76.3 m-85 -124.61 131.74 53.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.955 -0.387 . . . . 72.32 109.955 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.3 112.28 2.06 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.204 -0.998 . . . . 64.42 110.971 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.734 ' HA ' HG13 ' A' ' 35' ' ' VAL . 12.0 t -109.07 126.17 66.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.736 0.303 . . . . 74.24 111.08 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.517 ' H ' HG13 ' A' ' 35' ' ' VAL . 3.4 pp -87.07 130.71 34.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.215 -0.448 . . . . 75.15 109.992 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.17 114.17 25.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.638 0.733 . . . . 73.34 110.498 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.748 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 11.6 m -97.92 122.83 41.5 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.411 -0.813 . . . . 72.03 110.77 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.474 ' C ' ' H ' ' A' ' 54' ' ' ASP . 8.0 mpt_? -74.32 140.35 76.07 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.686 -0.857 . . . . 74.35 108.686 171.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.407 ' HG3' ' HA2' ' A' ' 30' ' ' GLY . 16.4 Cg_exo -68.88 17.95 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.17 2.58 . . . . 62.5 112.957 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.474 ' H ' ' C ' ' A' ' 52' ' ' ARG . 12.3 t70 -109.42 -15.64 14.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.138 0.494 . . . . 73.43 110.331 177.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.22 -19.31 8.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.621 -0.8 . . . . 71.43 112.424 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.89 115.28 18.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.412 0.625 . . . . 73.23 111.091 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -115.74 120.51 39.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.609 -0.723 . . . . 63.54 110.482 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 73' ' ' PRO . 31.5 m -123.62 163.45 22.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.37 -0.377 . . . . 74.43 110.302 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -122.85 133.92 54.41 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.044 0.45 . . . . 62.2 110.039 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.401 HG12 HD11 ' A' ' 62' ' ' LEU . 22.8 t -101.61 120.13 50.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.482 -0.562 . . . . 52.42 109.482 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -92.2 121.66 33.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.562 . . . . 74.52 110.229 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.35 156.69 22.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.893 -1.049 . . . . 75.23 110.929 -172.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 67' ' ' ARG . 10.9 t70 -90.73 172.11 8.88 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.313 -0.858 . . . . 72.41 109.722 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -50.23 -44.57 53.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.546 0.738 . . . . 61.54 112.352 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 67' ' ' ARG . 27.1 m-20 -96.52 26.14 4.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.911 0.386 . . . . 74.25 110.604 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.499 ' CE1' ' HA ' ' A' ' 19' ' ' ALA . 26.2 m-85 67.1 32.67 6.06 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.216 0.821 . . . . 75.23 113.216 174.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.519 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -77.94 126.82 31.4 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.172 -0.677 . . . . 74.34 109.172 169.168 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.655 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.5 p -69.55 120.65 17.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.053 0.454 . . . . 73.45 110.371 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.9 mt -96.18 -62.58 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.24 -0.436 . . . . 75.53 110.896 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -150.71 170.19 19.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 72.4 110.092 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.0 m -147.61 115.79 6.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.041 0.448 . . . . 65.35 110.363 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -133.08 159.45 72.59 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.022 -0.535 . . . . 62.11 110.194 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HA ' HG12 ' A' ' 58' ' ' VAL . 18.3 Cg_endo -59.91 143.1 99.64 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.733 2.289 . . . . 62.44 112.476 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.56 122.22 36.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.873 -0.603 . . . . 71.34 110.804 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -144.95 111.43 5.69 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.029 -0.36 . . . . 64.51 110.029 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.76 88.51 0.22 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.05 -0.595 . . . . 71.51 111.73 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -63.05 -36.04 82.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.696 0.284 . . . . 75.55 111.15 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.87 -41.28 0.39 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.264 -0.969 . . . . 71.14 112.865 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -71.93 123.03 9.42 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.912 -0.661 . . . . 73.14 113.278 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.2 mt -122.85 117.26 25.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.473 -0.565 . . . . 70.25 109.473 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.357 -0.83 . . . . 75.51 111.032 -176.072 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.561 0 N-CA-C 111.642 -0.583 . . . . 74.11 111.642 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.33 137.11 52.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.777 0.323 . . . . 74.44 110.922 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.523 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 1.6 mpt? -90.33 116.02 27.97 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.96 -0.756 . . . . 75.43 108.96 175.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.05 81.75 3.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.155 0.503 . . . . 72.12 112.125 -172.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.523 ' CE2' ' HB3' ' A' ' 3' ' ' MET . 91.3 m-85 -121.35 57.52 1.01 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.727 0.775 . . . . 75.12 109.053 174.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.566 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 7.9 t70 -147.83 -142.75 0.13 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.389 -1.337 . . . . 70.32 107.389 -177.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.61 175.83 33.06 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.007 -1.092 . . . . 70.34 112.581 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.6 -178.67 6.95 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.649 -0.5 . . . . 75.11 109.649 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -92.66 -9.55 40.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.439 0.638 . . . . 73.1 109.585 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.13 53.92 2.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.55 -0.75 . . . . 74.44 109.363 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 m -60.14 96.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.858 0.837 . . . . 73.32 112.186 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 t -93.72 -21.83 19.1 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.104 -0.953 . . . . 73.13 109.021 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.739 ' HA3' ' HB3' ' A' ' 16' ' ' ALA . . . -152.27 143.76 10.76 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.153 -0.93 . . . . 65.13 111.096 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -60.75 -68.91 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.819 2.346 . . . . 64.04 111.876 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.566 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 10.8 m-20 -90.01 -22.29 21.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.519 -0.549 . . . . 74.13 109.519 176.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.739 ' HB3' ' HA3' ' A' ' 13' ' ' GLY . . . -58.91 -37.34 76.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.077 -0.965 . . . . 74.12 111.445 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 14.9 t70 -55.57 -57.77 10.56 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.165 -0.471 . . . . 71.12 111.545 -175.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.566 ' NE ' ' HA ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -69.07 -35.75 76.87 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.945 0.35 . . . . 75.15 111.945 -176.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.48 -42.45 78.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.101 0.477 . . . . 74.04 110.812 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -71.12 -36.91 72.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.839 -0.619 . . . . 73.32 110.56 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.25 -24.07 66.52 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.431 -0.349 . . . . 70.21 111.49 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 -29.89 33.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.402 -0.363 . . . . 74.02 111.152 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.41 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -62.21 -31.77 72.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.045 -0.525 . . . . 72.55 112.034 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.6 p -69.02 -14.01 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.819 0.343 . . . . 74.12 111.731 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -85.36 -31.85 22.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.858 0.361 . . . . 75.54 110.357 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.13 -32.23 39.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.067 -0.515 . . . . 54.33 111.382 -176.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 14.6 p -111.15 133.9 21.21 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.854 0.359 . . . . 72.55 110.53 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 27' ' ' VAL . 8.9 Cg_endo -82.49 99.88 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.828 2.352 . . . . 71.41 111.871 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.45 39.44 97.8 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.039 -0.601 . . . . 71.42 112.184 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.432 ' HA3' ' CG2' ' A' ' 27' ' ' VAL . . . -104.49 168.12 16.12 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.591 -0.814 . . . . 72.04 112.411 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 1.03 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 39.8 m -82.04 106.11 13.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.233 0.539 . . . . 75.11 111.201 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.87 111.91 22.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.395 -0.821 . . . . 61.13 109.29 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.37 162.87 17.86 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.184 -0.532 . . . . 72.51 112.839 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -61.72 106.94 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 74.31 110.232 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.603 HG12 ' HA ' ' A' ' 48' ' ' VAL . 33.9 m -91.25 150.3 3.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.921 -0.581 . . . . 71.25 110.845 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -108.67 150.06 28.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.272 -0.422 . . . . 73.25 110.032 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.74 131.01 39.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.183 0.516 . . . . 73.1 110.999 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.83 133.8 38.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.674 -0.694 . . . . 73.21 110.365 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -91.49 117.67 29.9 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.936 -0.765 . . . . 63.11 108.936 168.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.67 93.62 0.15 Allowed Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.214 -0.993 . . . . 75.12 112.612 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -51.4 114.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.504 -0.554 . . . . 73.15 109.504 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.14 -54.61 0.61 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.736 -0.745 . . . . 55.32 112.149 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -175.13 -38.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.804 0.298 . . . . 74.14 111.804 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.88 130.28 45.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.048 0.452 . . . . 71.11 111.796 -174.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.78 -36.4 0.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.756 -0.656 . . . . 73.1 110.788 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.547 ' HE2' ' HB3' ' A' ' 15' ' ' ASP . 91.8 m-85 -124.84 133.65 53.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 74.22 110.49 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.29 113.46 2.03 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.335 -0.706 . . . . 74.13 111.335 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.603 ' HA ' HG12 ' A' ' 35' ' ' VAL . 45.7 t -101.18 112.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.734 0.302 . . . . 73.32 111.01 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.597 ' HG ' HG11 ' A' ' 35' ' ' VAL . 2.3 pp -85.8 117.05 24.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 74.44 110.042 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.67 114.42 47.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.661 -0.7 . . . . 74.51 110.277 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 1.03 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 20.3 m -96.13 104.92 16.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.233 -0.44 . . . . 74.51 110.461 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -67.04 138.71 95.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.165 -0.68 . . . . 73.52 109.165 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HD3' ' HA2' ' A' ' 30' ' ' GLY . 17.9 Cg_endo -60.05 -7.94 7.21 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.131 2.554 . . . . 70.21 112.998 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -74.25 -14.45 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 73.32 110.537 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.34 33.36 5.17 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.398 -0.906 . . . . 71.35 112.662 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 t -131.84 142.27 49.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.905 0.383 . . . . 72.51 110.949 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.477 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 58.9 ttt180 -110.08 122.69 48.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 72.41 111.362 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.48 139.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.406 -0.59 . . . . 73.42 109.406 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -108.2 136.12 48.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.217 0.532 . . . . 73.25 110.858 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.503 HG22 HG23 ' A' ' 71' ' ' THR . 23.6 t -106.01 118.18 53.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.514 -0.766 . . . . 62.1 109.672 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -89.55 125.32 35.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.09 -0.504 . . . . 72.24 111.521 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.809 HD13 ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -117.16 147.21 42.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.474 -0.784 . . . . 73.03 109.816 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.862 ' HB3' HD21 ' A' ' 69' ' ' LEU . 1.9 p-10 -91.96 -167.1 1.69 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.951 -0.3 . . . . 74.44 110.439 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -55.27 -38.08 68.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.014 -0.539 . . . . 74.55 111.933 -176.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -89.67 16.45 7.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.019 0.377 . . . . 75.22 112.019 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 65.83 21.84 11.46 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.208 0.528 . . . . 75.22 111.127 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.703 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 9.0 tpt180 -88.34 134.84 33.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.212 -0.449 . . . . 75.04 110.178 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.809 ' HA ' HD13 ' A' ' 62' ' ' LEU . 4.5 p -61.58 116.05 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.242 0.544 . . . . 72.01 111.256 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.862 HD21 ' HB3' ' A' ' 63' ' ' ASP . 85.5 mt -84.42 -49.06 9.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.754 -0.657 . . . . 64.32 109.611 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -170.35 -179.34 3.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.487 -0.778 . . . . 73.42 108.981 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.503 HG23 HG22 ' A' ' 60' ' ' VAL . 23.8 m -145.83 108.22 4.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.741 0.305 . . . . 75.04 110.352 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 1.5 pm0 -120.86 147.07 45.26 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.899 0.381 . . . . 71.12 111.077 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 24.0 Cg_exo -63.72 132.34 34.78 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.944 2.429 . . . . 63.14 112.022 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.477 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . . . -107.73 100.09 9.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.461 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -87.82 137.15 32.58 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.118 -0.492 . . . . 64.13 110.109 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.46 -26.49 74.07 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.954 -0.566 . . . . 74.2 113.04 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -82.81 -59.79 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.947 -0.39 . . . . 64.23 109.947 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.39 -34.46 0.55 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 114.86 0.704 . . . . 64.31 114.86 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.79 132.93 46.89 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 116.933 0.366 . . . . 73.1 113.733 -172.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.0 mt -123.21 127.12 48.18 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.898 -0.408 . . . . 74.14 109.898 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.903 -0.57 . . . . 74.45 110.095 177.592 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 111.674 -0.57 . . . . 70.33 111.674 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.16 88.01 4.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.439 . . . . 61.23 110.511 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.09 138.75 31.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.017 -0.538 . . . . 73.35 110.336 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.09 77.88 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.218 -0.447 . . . . 74.31 111.109 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.667 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 88.2 m-85 -131.76 56.45 1.82 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 74.32 110.551 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.8 t70 175.6 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.732 -0.667 . . . . 72.02 110.071 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.0 -80.71 1.53 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.052 -0.819 . . . . 60.44 111.052 174.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -146.51 133.4 20.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.15 0.5 . . . . 74.53 110.064 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -75.96 4.85 7.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.8 -0.636 . . . . 73.24 111.779 -170.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.12 -17.16 60.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.569 -0.287 . . . . 72.55 111.697 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.573 HG22 ' HB2' ' A' ' 17' ' ' ASP . 35.5 m -92.34 162.85 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.762 0.315 . . . . 75.22 111.278 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.5 p -101.44 -0.16 35.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.288 -0.414 . . . . 72.54 111.6 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.01 105.45 1.99 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.727 -0.749 . . . . 75.51 111.608 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 22.4 Cg_endo -62.08 -50.9 4.23 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.68 2.254 . . . . 73.02 111.986 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -71.14 -35.05 71.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.953 -0.567 . . . . 75.55 110.427 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.537 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -62.31 -43.57 98.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.842 -0.617 . . . . 72.22 110.833 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.573 ' HB2' HG22 ' A' ' 11' ' ' VAL . 8.8 t70 -56.43 -53.66 54.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 72.33 111.739 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.667 ' HD2' ' HA ' ' A' ' 5' ' ' PHE . 12.0 mmt180 -56.76 -51.01 70.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.966 -0.561 . . . . 75.11 111.315 -171.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.831 ' HB3' HG23 ' A' ' 35' ' ' VAL . . . -78.64 -33.2 47.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.932 -0.576 . . . . 72.33 111.865 -174.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -69.62 -34.58 74.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 73.53 110.107 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.15 85.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 64.33 110.598 176.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.72 -32.29 63.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 70.03 110.877 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.431 ' O ' HG11 ' A' ' 27' ' ' VAL . . . -56.27 -31.26 63.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.824 -0.626 . . . . 73.41 111.818 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.36 -32.19 40.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.978 0.418 . . . . 64.23 111.085 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.44 -13.73 25.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.267 -0.424 . . . . 63.2 110.815 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.57 ' HB1' HG11 ' A' ' 50' ' ' VAL . . . -85.76 -29.65 23.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.276 -0.42 . . . . 73.33 111.283 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.929 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 9.9 p -111.02 128.05 25.93 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.887 0.375 . . . . 73.34 110.399 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 27' ' ' VAL . 3.0 Cg_exo -72.95 93.06 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.798 2.332 . . . . 75.21 112.37 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.23 21.43 72.04 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.146 -0.549 . . . . 71.41 112.972 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.84 -164.43 32.71 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.732 -0.747 . . . . 74.33 112.255 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.453 ' CG2' ' HB ' ' A' ' 51' ' ' THR . 4.9 t -103.64 136.34 43.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.061 0.458 . . . . 64.53 110.469 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.16 110.23 22.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 64.55 110.365 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.78 160.75 31.53 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.686 -0.769 . . . . 74.45 112.222 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -75.32 140.99 43.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 75.54 110.22 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.831 HG23 ' HB3' ' A' ' 19' ' ' ALA . 12.8 m -116.02 155.88 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.949 -0.569 . . . . 73.3 111.837 -169.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -114.46 156.96 23.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 75.34 109.502 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 p -74.04 123.56 24.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.606 0.241 . . . . 75.32 110.817 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.9 134.33 47.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.844 -0.428 . . . . 73.53 109.844 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.5 m -121.55 118.21 28.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.779 0.323 . . . . 72.52 110.408 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.98 -148.34 7.92 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.173 -0.771 . . . . 71.04 111.173 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -111.32 116.67 31.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.035 0.445 . . . . 64.32 110.426 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.84 -170.8 29.94 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.013 -0.835 . . . . 73.23 111.013 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.51 -5.39 49.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.911 0.386 . . . . 73.52 110.789 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.76 112.04 14.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 72.03 110.851 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.73 -16.73 11.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.098 -0.501 . . . . 71.34 111.061 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.426 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 90.9 m-85 -130.88 132.33 45.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.492 -0.322 . . . . 72.24 110.736 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.31 112.84 2.57 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.668 -0.777 . . . . 72.45 111.21 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.791 HG23 ' HB2' ' A' ' 19' ' ' ALA . 38.8 t -99.95 119.81 48.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.666 0.269 . . . . 71.35 111.035 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.503 HD22 HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -94.12 107.79 19.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.339 0.59 . . . . 74.15 110.336 177.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.929 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 2.7 m -115.12 102.5 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.528 0.68 . . . . 74.45 110.663 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.453 ' HB ' ' CG2' ' A' ' 31' ' ' THR . 10.0 m -92.64 122.67 35.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.358 -0.837 . . . . 75.32 110.867 -175.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HD2' HG22 ' A' ' 27' ' ' VAL . 12.6 mpt_? -79.53 153.05 76.05 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.163 -0.472 . . . . 71.52 110.36 177.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.2 1.78 3.23 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.967 2.445 . . . . 62.43 111.44 174.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -85.66 -13.49 48.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.101 -0.954 . . . . 71.21 109.816 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.08 -7.33 48.08 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.843 -0.694 . . . . 64.11 112.668 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 t -91.8 126.88 37.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 75.23 111.364 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.506 HH22 ' HB2' ' A' ' 77' ' ' ASP . 35.8 ttp180 -107.93 124.27 49.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.609 -0.723 . . . . 63.21 109.45 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 30.2 t -122.46 137.05 57.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.509 -0.314 . . . . 75.24 110.935 -175.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 74' ' ' ALA . 34.0 mt-10 -93.07 122.4 35.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.012 0.434 . . . . 74.55 110.747 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.452 HG22 HG23 ' A' ' 71' ' ' THR . 16.9 t -103.12 109.34 26.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.689 -0.856 . . . . 74.23 108.689 173.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.5 m170 -90.15 127.03 36.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.889 0.376 . . . . 65.13 110.297 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.727 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -112.86 159.82 18.65 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.611 -0.722 . . . . 74.12 112.185 -171.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.646 ' HB2' HD22 ' A' ' 69' ' ' LEU . 16.0 t70 -90.5 169.84 10.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.559 -1.2 . . . . 75.54 109.797 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -31.54 64.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.766 0.426 . . . . 75.23 111.102 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -94.35 17.33 13.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.551 -0.295 . . . . 74.21 111.122 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 64.02 38.87 8.31 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.827 0.677 . . . . 72.31 112.827 175.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -99.32 147.52 25.11 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.631 -0.507 . . . . 74.24 109.631 169.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.727 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.4 p -74.25 119.85 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.333 0.587 . . . . 75.24 110.561 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.646 HD22 ' HB2' ' A' ' 63' ' ' ASP . 93.0 mt -89.12 -47.42 8.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.867 -0.606 . . . . 72.51 110.339 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -164.55 156.47 16.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.117 -0.492 . . . . 75.33 110.498 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.452 HG23 HG22 ' A' ' 60' ' ' VAL . 8.0 m -124.23 118.04 25.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.858 -0.61 . . . . 71.52 109.977 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -134.1 121.58 15.73 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 74.51 111.319 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 37.3 Cg_exo -61.59 120.19 7.7 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.751 2.301 . . . . 74.43 111.3 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HB2' ' HG3' ' A' ' 59' ' ' GLU . . . -143.25 164.92 28.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.981 0.419 . . . . 62.05 111.637 -173.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -116.79 124.01 48.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.94 -0.573 . . . . 71.35 110.064 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -104.56 18.38 44.51 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.787 -0.72 . . . . 54.55 111.992 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.506 ' HB2' HH22 ' A' ' 57' ' ' ARG . 18.0 t70 -97.76 -50.17 4.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.878 -0.415 . . . . 73.33 109.878 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.37 93.1 0.2 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.707 -0.758 . . . . 72.14 112.547 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.61 138.9 14.39 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.867 -0.682 . . . . 63.43 111.916 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.1 mt -106.64 115.8 30.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.706 0.289 . . . . 75.33 110.734 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-N 115.968 -0.56 . . . . 65.33 110.379 177.28 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.921 -0.472 . . . . 65.31 111.921 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.01 117.06 9.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.769 0.318 . . . . 74.35 110.706 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -92.83 143.8 25.91 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.753 -0.462 . . . . 73.53 109.753 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.43 72.78 2.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.192 0.52 . . . . 64.22 112.068 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -128.14 108.01 10.28 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.078 -0.712 . . . . 75.33 109.078 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.629 ' H ' ' HD3' ' A' ' 18' ' ' ARG . 29.7 t70 67.62 110.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.109 0.88 . . . . 74.32 111.233 -173.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.81 -77.76 0.11 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.705 -0.759 . . . . 54.35 112.092 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.717 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 9.3 tp10 -85.96 157.34 20.16 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.059 -0.348 . . . . 64.44 110.059 177.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -83.88 -9.39 58.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.579 0.704 . . . . 44.1 109.642 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.717 ' H ' ' HG3' ' A' ' 8' ' ' GLU . 10.6 mm-40 -84.56 88.57 7.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.191 -0.913 . . . . 75.23 109.561 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.62 90.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.131 0.491 . . . . 63.43 110.713 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.8 p -93.86 -5.56 47.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.949 -0.569 . . . . 73.35 110.597 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.73 146.77 5.68 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.033 -0.827 . . . . 71.22 111.033 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.431 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 25.2 Cg_endo -62.18 -53.82 1.78 Allowed 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.668 2.246 . . . . 73.21 112.156 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -97.85 -37.67 9.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.959 -0.564 . . . . 74.23 110.905 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.67 -48.79 58.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.77 -0.65 . . . . 74.34 112.213 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -65.68 -50.96 62.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.277 0.561 . . . . 74.34 111.569 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.683 HH11 ' HG2' ' A' ' 18' ' ' ARG . 12.5 mtt-85 -72.75 -37.39 67.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.549 -0.75 . . . . 72.3 111.592 -168.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.528 ' HB3' HG22 ' A' ' 48' ' ' VAL . . . -67.15 -42.01 85.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.07 0.462 . . . . 62.14 110.237 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -62.65 -46.19 89.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.546 -0.752 . . . . 74.41 110.775 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.27 -21.78 63.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 72.33 111.607 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.1 -40.04 16.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.905 0.383 . . . . 71.04 111.338 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.568 ' HB3' HG11 ' A' ' 48' ' ' VAL . . . -69.73 -22.44 63.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.457 0.54 . . . . 64.03 112.457 -174.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 p -63.43 -22.99 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.831 0.348 . . . . 71.04 111.128 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -78.03 -16.43 58.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.662 0.268 . . . . 73.2 111.216 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.88 -14.37 23.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.932 0.396 . . . . 70.4 111.302 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.431 ' CG2' ' HA3' ' A' ' 30' ' ' GLY . 7.3 p -116.14 122.2 32.61 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.047 0.451 . . . . 73.31 110.992 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -74.93 100.89 1.4 Allowed 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.899 2.399 . . . . 74.23 112.239 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.85 38.21 91.99 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.88 -0.6 . . . . 72.13 112.501 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.431 ' HA3' ' CG2' ' A' ' 27' ' ' VAL . . . -102.87 -172.1 26.5 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.71 -0.757 . . . . 54.31 112.526 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.1 m -98.88 115.36 28.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.746 0.308 . . . . 61.44 110.577 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.84 105.0 15.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.903 -0.59 . . . . 65.32 110.093 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.09 161.98 18.3 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.944 -0.646 . . . . 71.32 112.445 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.04 141.26 52.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.051 0.453 . . . . 75.03 110.437 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.81 HG11 ' HA ' ' A' ' 48' ' ' VAL . 34.9 m -126.73 156.0 37.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.937 -0.574 . . . . 73.44 111.451 -172.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -105.52 155.82 18.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.03 -0.532 . . . . 71.31 110.053 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.95 124.07 25.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.282 -0.417 . . . . 75.4 110.449 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.69 122.34 21.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.889 0.376 . . . . 75.04 110.24 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.0 t -77.43 129.41 35.72 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.182 -0.463 . . . . 72.34 110.078 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.94 -150.95 9.55 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.638 -0.792 . . . . 72.44 112.216 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -151.25 132.42 14.43 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.06 -0.719 . . . . 72.3 109.06 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.65 -135.17 9.68 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.624 -0.798 . . . . 63.44 112.283 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.577 ' O ' ' HA ' ' A' ' 63' ' ' ASP . . . -87.69 -30.84 20.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.693 0.282 . . . . 75.21 110.744 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.22 102.71 3.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.087 0.47 . . . . 73.54 111.076 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.07 -42.86 2.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.857 -0.61 . . . . 54.4 111.072 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 46.0 m-85 -114.61 133.58 55.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.528 -0.305 . . . . 73.3 110.229 -177.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.83 112.94 2.34 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.865 -0.894 . . . . 75.11 110.865 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.81 ' HA ' HG11 ' A' ' 35' ' ' VAL . 6.3 t -110.25 139.61 32.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.838 0.351 . . . . 74.12 110.642 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 49' ' ' LEU . 2.8 pp -105.16 126.74 52.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.136 0.493 . . . . 73.45 110.813 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 m -129.09 120.3 51.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.17 0.51 . . . . 74.44 110.791 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -102.94 126.33 50.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.843 -0.617 . . . . 55.42 110.831 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.536 ' HB2' HG21 ' A' ' 56' ' ' THR . 10.6 mpt_? -81.56 152.28 69.64 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.341 -0.614 . . . . 72.13 109.341 173.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.48 -23.15 46.13 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.823 2.348 . . . . 74.34 112.839 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.61 -27.48 68.97 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.917 0.389 . . . . 75.21 111.168 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.72 -12.67 15.25 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.692 -0.766 . . . . 74.24 112.107 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.536 HG21 ' HB2' ' A' ' 52' ' ' ARG . 5.5 t -72.23 128.63 36.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.505 0.669 . . . . 71.11 110.46 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 57' ' ' ARG . 12.2 ttt180 -118.48 119.75 35.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.447 -0.797 . . . . 75.11 109.385 -175.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -107.51 137.22 39.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.219 -0.446 . . . . 71.12 111.16 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.55 112.21 24.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.407 0.623 . . . . 74.21 109.432 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.469 HG21 HG22 ' A' ' 71' ' ' THR . 25.4 t -97.37 114.61 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.995 -0.548 . . . . 73.33 109.973 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -89.59 122.85 33.12 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.081 0.467 . . . . 74.41 110.528 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.627 HD13 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -113.07 145.93 40.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.1 -0.955 . . . . 74.13 110.144 -177.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.577 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 20.7 p30 -91.91 -167.71 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.008 0.432 . . . . 74.0 111.431 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -65.99 -17.98 65.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.588 -0.733 . . . . 73.31 111.849 -172.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -109.54 13.51 23.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.752 -0.204 . . . . 73.11 110.904 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 65.37 30.76 10.86 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.279 0.561 . . . . 72.14 111.229 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.402 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . 26.2 ttp180 -93.52 137.37 32.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.532 -0.758 . . . . 74.33 109.795 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.627 ' HA ' HD13 ' A' ' 62' ' ' LEU . 5.5 p -65.06 117.18 5.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.362 0.601 . . . . 71.23 111.574 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 63' ' ' ASP . 96.2 mt -90.93 -60.01 2.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.679 -0.692 . . . . 74.52 110.991 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -157.52 147.59 20.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 61.33 110.085 -172.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.469 HG22 HG21 ' A' ' 60' ' ' VAL . 17.0 p -124.01 109.52 13.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.901 0.382 . . . . 75.31 110.901 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -107.35 155.44 39.47 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.077 -0.51 . . . . 71.55 110.828 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -74.57 122.29 7.3 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.467 2.112 . . . . 74.0 110.885 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.16 156.48 23.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.416 -0.357 . . . . 54.01 110.298 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -86.77 136.39 33.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.393 -0.367 . . . . 65.41 110.336 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.73 1.71 58.31 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.514 -0.85 . . . . 71.25 112.908 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -97.9 -56.35 2.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.988 0.423 . . . . 70.22 110.609 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.35 -30.84 6.27 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.768 -0.651 . . . . 64.12 111.573 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.53 75.32 2.14 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.047 -0.597 . . . . 70.11 111.901 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.7 mt -68.51 134.73 50.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.898 0.38 . . . . 73.2 111.236 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.073 -0.965 . . . . 71.45 110.297 177.804 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.532 0 N-CA-C 111.77 -0.532 . . . . 73.4 111.77 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.439 ' HB3' HH22 ' A' ' 67' ' ' ARG . . . -129.99 87.61 2.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.987 0.423 . . . . 74.03 111.109 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -106.87 93.88 4.81 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.697 -0.853 . . . . 64.15 108.697 173.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.35 75.12 3.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.047 0.451 . . . . 72.34 111.77 -174.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.91 54.69 0.74 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.65 0.738 . . . . 74.24 109.117 172.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.577 ' N ' ' HD2' ' A' ' 18' ' ' ARG . 25.1 t70 174.23 101.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.075 -1.421 . . . . 71.31 107.84 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.76 -78.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.865 -0.683 . . . . 65.04 112.814 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.656 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 11.2 tt0 -156.26 -166.1 2.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.676 0.274 . . . . 74.32 110.708 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.656 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 4.8 m-20 -66.5 -6.66 15.63 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.939 0.718 . . . . 73.42 112.939 -172.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.79 84.16 1.88 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.034 0.445 . . . . 72.23 111.047 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -91.95 87.42 2.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.416 -0.587 . . . . 75.22 109.416 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 t -114.24 130.22 56.64 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.632 -0.713 . . . . 62.11 110.098 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.65 -151.5 41.38 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.233 -0.984 . . . . 61.44 111.703 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.468 ' HB2' ' H ' ' A' ' 15' ' ' ASP . 63.9 Cg_endo -73.29 -142.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.772 2.315 . . . . 73.14 112.144 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.595 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 3.2 m-20 -74.41 12.08 0.85 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.398 0.518 . . . . 72.42 112.398 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.62 ' HA ' HG23 ' A' ' 35' ' ' VAL . . . -49.72 -34.15 18.06 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.9 0.381 . . . . 72.23 111.353 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.71 -42.38 71.44 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.393 -0.821 . . . . 74.12 112.278 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' A' ' 15' ' ' ASP . 12.1 mmt180 -64.71 -57.91 7.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.287 0.565 . . . . 75.51 111.123 -170.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.735 ' HB1' HG21 ' A' ' 35' ' ' VAL . . . -73.38 -26.94 61.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.522 -0.763 . . . . 74.45 111.946 -173.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -66.73 -35.84 81.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 74.34 110.858 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.49 -39.51 88.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 74.52 110.862 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.35 -28.88 63.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.028 -0.533 . . . . 73.44 111.297 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 -27.36 68.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.08 -0.509 . . . . 71.2 111.859 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.0 t -59.47 -38.26 74.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.458 . . . . 64.32 111.266 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -81.13 -12.38 59.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.289 -0.414 . . . . 71.23 111.143 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.63 -6.87 58.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 75.31 111.452 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.05 124.08 7.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.017 0.437 . . . . 74.11 111.483 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.75 105.68 2.11 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.401 2.067 . . . . 75.43 112.136 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.78 39.54 89.94 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.081 -0.581 . . . . 72.32 112.417 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.714 ' HA2' ' HD3' ' A' ' 53' ' ' PRO . . . -101.92 -147.77 20.25 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.581 -0.819 . . . . 73.24 112.697 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.655 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 58.6 m -137.63 131.26 31.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.699 0.285 . . . . 71.34 110.574 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.05 120.44 41.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.298 -0.41 . . . . 74.43 110.641 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.68 161.16 13.33 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.841 -0.695 . . . . 53.45 111.582 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' O ' HD23 ' A' ' 49' ' ' LEU . 1.4 mp0 -62.5 128.13 34.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.338 . . . . 71.34 110.428 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.735 HG21 ' HB1' ' A' ' 19' ' ' ALA . 19.8 m -90.21 154.77 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.013 -0.539 . . . . 74.03 110.769 -175.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -112.67 153.61 27.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.14 -0.482 . . . . 72.44 111.059 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 m -85.22 115.27 22.9 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.702 -0.851 . . . . 74.42 108.702 171.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -75.61 130.18 38.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.242 0.544 . . . . 75.54 111.9 -172.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.2 p -88.9 118.27 28.49 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.962 -0.755 . . . . 72.31 108.962 171.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.95 -125.04 0.8 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.9 -1.143 . . . . 73.44 113.338 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.88 158.36 44.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.724 0.297 . . . . 73.5 110.481 -172.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.9 -116.18 4.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.05 -0.595 . . . . 63.12 113.077 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.84 10.06 5.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.559 0.219 . . . . 72.02 111.219 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.06 107.07 3.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.053 -0.351 . . . . 72.24 110.053 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.72 -54.35 2.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.094 -0.503 . . . . 74.12 111.646 -175.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -115.64 133.41 56.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.0 0.428 . . . . 74.2 111.405 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.18 112.49 3.06 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.675 -0.774 . . . . 65.41 111.261 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.57 HG22 ' HB3' ' A' ' 19' ' ' ALA . 27.4 t -95.24 109.72 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.633 0.254 . . . . 74.43 110.687 -175.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.623 HD21 ' H ' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -85.51 102.7 13.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.28 0.562 . . . . 74.13 110.74 -179.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.3 t -97.1 110.34 24.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.716 -0.674 . . . . 74.52 110.016 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.655 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 14.0 m -91.92 116.6 29.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.11 -0.495 . . . . 75.45 110.548 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -96.94 135.84 21.86 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.185 -0.461 . . . . 72.2 110.023 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.714 ' HD3' ' HA2' ' A' ' 30' ' ' GLY . 37.1 Cg_endo -65.68 -8.81 20.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.878 2.386 . . . . 71.25 111.386 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -64.12 -26.75 68.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.89 -1.05 . . . . 75.52 110.487 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.46 32.64 2.28 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.67 -0.776 . . . . 73.44 112.352 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 t -145.38 144.93 30.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.102 0.477 . . . . 73.43 110.956 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -107.89 118.5 36.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.705 -0.68 . . . . 73.32 109.263 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 45.5 t -112.33 115.7 50.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.771 -0.455 . . . . 70.12 109.771 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 12.4 pt-20 -101.81 113.21 26.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.659 0.742 . . . . 74.42 110.823 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.604 HG22 HG21 ' A' ' 71' ' ' THR . 18.6 t -89.12 118.57 34.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.179 -0.918 . . . . 75.2 109.224 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -93.35 123.22 36.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.345 -0.389 . . . . 73.23 110.345 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.528 HD13 ' HA ' ' A' ' 68' ' ' VAL . 1.0 OUTLIER -115.64 152.21 33.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.889 -0.596 . . . . 65.04 111.157 -174.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.584 ' HB3' HD21 ' A' ' 69' ' ' LEU . 3.7 p-10 -94.47 -164.52 1.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.882 -0.599 . . . . 75.15 110.531 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.6 mtt-85 -71.66 -24.57 61.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.121 -0.491 . . . . 71.54 111.26 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.45 0.08 56.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.04 0.448 . . . . 73.15 109.801 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 67.99 32.48 5.05 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.332 -0.849 . . . . 73.22 110.678 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.439 HH22 ' HB3' ' A' ' 2' ' ' ALA . 1.6 mpt_? -101.06 154.53 18.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.065 -0.516 . . . . 75.43 109.884 175.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.528 ' HA ' HD13 ' A' ' 62' ' ' LEU . 7.1 p -71.13 118.8 16.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.41 0.624 . . . . 75.53 111.435 -176.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 63' ' ' ASP . 96.1 mt -85.52 -51.21 6.66 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.002 -0.74 . . . . 75.32 109.002 172.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -155.05 166.15 34.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.676 -0.693 . . . . 75.44 109.923 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.604 HG21 HG22 ' A' ' 60' ' ' VAL . 27.7 m -148.49 109.1 4.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.564 -0.532 . . . . 75.23 109.564 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -130.57 135.98 28.23 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.139 0.495 . . . . 72.32 111.649 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 6.0 Cg_exo -79.79 92.83 1.09 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.863 2.375 . . . . 72.12 110.531 171.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.35 110.31 21.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.171 -0.468 . . . . 73.22 111.161 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.21 109.34 20.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 73.15 109.93 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.35 162.06 10.9 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.853 -0.689 . . . . 74.35 111.871 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -97.34 -31.2 12.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.044 0.449 . . . . 73.22 110.062 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.52 67.12 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.829 -0.701 . . . . 64.03 111.907 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.02 74.39 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.032 -0.604 . . . . 64.22 112.128 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.9 mt -119.81 121.08 38.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.859 0.361 . . . . 75.41 110.15 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.32 -0.848 . . . . 73.42 110.101 -179.845 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 112.083 -0.407 . . . . 63.4 112.083 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.73 116.43 20.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.027 0.442 . . . . 72.04 110.728 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -91.09 154.33 19.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.41 -0.589 . . . . 73.45 109.41 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.23 67.23 8.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.29 0.567 . . . . 70.22 110.735 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -131.85 57.63 1.77 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.638 -0.71 . . . . 74.15 110.007 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -127.11 -58.07 1.29 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.707 -0.679 . . . . 71.53 109.338 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.89 178.66 51.1 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.911 -0.662 . . . . 72.05 112.319 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.773 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 24.6 tt0 -124.07 -172.21 2.49 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 122.681 -0.305 . . . . 75.04 110.185 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.773 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 11.9 m-20 -77.83 -9.28 58.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.588 -0.278 . . . . 74.32 111.594 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.39 93.94 7.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.412 . . . . 73.43 110.342 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -76.27 86.92 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.456 0.646 . . . . 73.24 109.79 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 t -107.11 -0.12 23.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.593 -0.73 . . . . 75.12 110.483 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.38 175.96 23.72 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.403 -0.679 . . . . 74.24 111.403 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.506 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 5.7 Cg_exo -76.14 -76.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.614 2.21 . . . . 74.31 111.818 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -70.8 -35.65 72.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.698 -0.683 . . . . 74.12 111.104 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HA ' HG21 ' A' ' 35' ' ' VAL . . . -54.21 -49.31 69.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 75.45 111.478 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.52 -43.65 89.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 71.11 111.407 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 14' ' ' PRO . 7.2 mmt85 -64.07 -41.81 97.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.175 -0.466 . . . . 65.23 110.96 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.66 ' HB1' HG22 ' A' ' 35' ' ' VAL . . . -81.08 -35.01 32.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.248 -0.433 . . . . 75.03 112.061 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -65.21 -28.5 69.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.013 0.435 . . . . 74.45 110.291 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.39 -38.22 84.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 75.21 110.779 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.35 -30.86 57.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.047 0.451 . . . . 65.24 111.073 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.532 ' HB2' ' CG1' ' A' ' 50' ' ' VAL . . . -55.88 -35.88 66.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.568 -0.742 . . . . 62.44 112.076 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.4 t -55.77 -40.51 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 75.05 111.808 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -86.86 -12.86 46.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.262 -0.426 . . . . 75.23 111.319 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.4 -34.7 17.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.416 -0.356 . . . . 64.23 111.105 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 14.3 p -91.63 130.53 38.74 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.936 0.398 . . . . 74.33 110.593 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.94 86.71 0.73 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.44 2.093 . . . . 74.12 112.42 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.47 38.73 96.15 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.733 -0.667 . . . . 73.2 112.586 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.58 -175.88 19.2 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.587 -0.816 . . . . 72.05 112.481 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.7 m -96.35 126.63 41.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.865 0.364 . . . . 64.11 110.986 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.09 131.28 37.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.086 -0.506 . . . . 72.42 109.824 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.96 162.01 15.89 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.543 -0.837 . . . . 74.22 112.378 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -55.05 119.85 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.128 0.489 . . . . 73.53 110.917 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.66 HG22 ' HB1' ' A' ' 19' ' ' ALA . 17.9 m -96.38 155.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.472 -0.785 . . . . 74.11 110.373 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -125.9 144.94 50.47 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.428 -0.351 . . . . 72.44 110.129 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.3 p -76.7 142.3 40.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.245 -0.434 . . . . 74.55 110.355 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -83.66 84.24 7.62 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.758 -0.83 . . . . 73.34 108.758 172.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -72.93 123.27 23.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.189 -0.914 . . . . 75.24 110.335 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.2 -26.93 6.55 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.763 -0.935 . . . . 63.53 110.763 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.26 146.47 28.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.263 -0.469 . . . . 71.21 110.303 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.95 -40.05 4.17 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.788 -0.72 . . . . 64.43 112.122 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.33 -65.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.697 0.284 . . . . 62.21 111.15 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.12 93.68 5.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.058 0.456 . . . . 70.53 110.901 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.52 -40.32 19.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.889 -0.596 . . . . 70.3 111.162 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -115.79 143.26 45.65 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.556 -0.293 . . . . 73.35 110.564 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -124.21 112.23 1.77 Allowed Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.793 -0.923 . . . . 74.42 110.793 171.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 19' ' ' ALA . 89.0 t -96.82 110.73 25.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.72 0.295 . . . . 74.42 110.639 -176.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.53 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.5 pp -96.42 115.23 27.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.399 0.618 . . . . 72.04 110.873 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 5.1 m -115.1 126.55 72.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.636 -0.711 . . . . 64.22 110.533 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.2 m -92.23 106.63 18.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.919 -0.582 . . . . 75.23 110.153 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 52' ' ' ARG . 56.6 mtt180 -72.0 149.38 92.3 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.891 -0.411 . . . . 75.44 109.891 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.91 -12.05 27.42 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.555 2.17 . . . . 65.03 111.11 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -68.61 -26.72 65.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.97 -1.013 . . . . 74.4 110.541 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.97 -17.21 15.33 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.851 -0.69 . . . . 72.33 112.755 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 t -89.57 149.35 22.9 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.878 0.371 . . . . 74.55 111.287 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -103.31 119.99 39.92 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.383 -0.599 . . . . 71.51 109.383 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 58.8 t -102.74 124.18 56.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.439 -0.578 . . . . 75.44 109.439 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 9.7 pt-20 -108.9 111.58 23.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.843 0.83 . . . . 75.12 110.314 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.645 HG22 HG22 ' A' ' 71' ' ' THR . 16.6 t -86.69 116.39 29.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.433 -0.803 . . . . 73.11 109.881 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -79.76 118.35 21.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.244 -0.435 . . . . 75.24 110.218 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.686 HD11 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -115.67 154.6 29.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.618 -0.719 . . . . 72.24 111.575 -173.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.669 ' HB2' HD23 ' A' ' 69' ' ' LEU . 20.6 t70 -89.87 173.77 8.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.168 -0.924 . . . . 71.31 109.421 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -52.02 -37.74 54.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.946 0.498 . . . . 73.31 111.615 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.26 14.82 11.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.441 . . . . 73.0 111.542 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.417 ' CD2' HD22 ' A' ' 62' ' ' LEU . 7.7 m-85 65.63 25.42 11.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.144 0.497 . . . . 71.41 111.475 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -80.48 137.52 36.48 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.971 -0.752 . . . . 62.43 108.971 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.686 ' HA ' HD11 ' A' ' 62' ' ' LEU . 8.6 p -70.91 125.6 29.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.313 0.578 . . . . 63.32 111.187 -176.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.669 HD23 ' HB2' ' A' ' 63' ' ' ASP . 71.6 mt -97.26 -58.58 1.98 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.664 -0.698 . . . . 70.22 109.674 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -155.7 141.11 17.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.947 -0.569 . . . . 71.34 110.088 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.645 HG22 HG22 ' A' ' 60' ' ' VAL . 18.5 m -107.8 111.6 23.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.544 -0.539 . . . . 64.34 109.544 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 12.3 pt-20 -135.32 129.24 18.67 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.18 0.514 . . . . 73.35 112.072 -173.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 2.0 Cg_endo -82.52 130.56 6.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.825 2.35 . . . . 62.05 110.263 169.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.57 172.16 7.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.969 0.414 . . . . 61.02 111.652 -175.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -122.16 -177.47 3.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.797 -0.638 . . . . 75.32 109.834 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.24 79.17 0.37 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.841 -0.695 . . . . 74.4 112.313 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -85.36 -53.79 5.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.084 0.469 . . . . 75.33 109.812 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.16 -32.67 6.43 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.884 -0.674 . . . . 75.52 112.853 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.64 93.36 1.14 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.851 -0.69 . . . . 54.51 111.52 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.5 92.61 7.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.819 0.342 . . . . 73.3 110.868 -177.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.414 -0.803 . . . . 74.53 109.73 177.816 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 112.143 -0.383 . . . . 54.03 112.143 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.61 142.33 36.43 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.804 -0.233 . . . . 75.4 110.729 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -84.6 161.12 20.26 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.968 -0.382 . . . . 74.41 109.968 177.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' A' ' 18' ' ' ARG . . . -80.86 73.75 7.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.033 0.444 . . . . 65.43 110.892 -178.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -135.14 93.71 3.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.115 0.483 . . . . 73.42 110.511 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -150.29 -77.97 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.819 -0.808 . . . . 74.33 108.819 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.578 ' HA2' ' OD1' ' A' ' 17' ' ' ASP . . . 79.0 140.06 1.81 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.824 -0.625 . . . . 74.52 114.029 171.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.536 ' O ' HG23 ' A' ' 11' ' ' VAL . 34.5 tt0 -80.98 134.03 35.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.582 -0.895 . . . . 74.1 108.582 171.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.35 1.89 20.44 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.997 0.369 . . . . 75.13 111.997 -170.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.89 8.01 20.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.826 0.306 . . . . 75.04 111.826 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.617 HG21 ' HB2' ' A' ' 17' ' ' ASP . 28.5 m -84.11 159.03 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.735 -0.386 . . . . 73.44 109.996 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 p -94.37 -25.22 17.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.86 -0.336 . . . . 72.12 111.293 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.409 ' HA2' ' HD2' ' A' ' 14' ' ' PRO . . . -95.1 111.23 4.16 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.853 -0.689 . . . . 61.1 111.581 174.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD2' ' HA2' ' A' ' 13' ' ' GLY . 13.5 Cg_endo -56.76 -55.83 2.41 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.983 2.456 . . . . 74.21 112.695 -175.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -89.06 -9.2 52.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.029 0.442 . . . . 55.13 110.698 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 1.076 ' HA ' HG21 ' A' ' 35' ' ' VAL . . . -66.28 -43.44 86.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.531 -0.759 . . . . 74.1 111.937 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.617 ' HB2' HG21 ' A' ' 11' ' ' VAL . 8.6 t70 -52.47 -57.46 9.82 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.066 -0.516 . . . . 75.12 112.148 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.505 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -71.42 -31.7 67.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.242 0.46 . . . . 75.53 112.242 -173.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.635 ' HB1' ' HE1' ' A' ' 66' ' ' PHE . . . -69.01 -39.91 79.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.075 0.464 . . . . 74.45 110.5 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -25.87 55.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.953 -0.567 . . . . 73.52 110.503 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.38 -32.91 62.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.354 . . . . 73.34 110.939 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.08 -26.89 62.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.178 0.513 . . . . 61.34 111.09 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.541 ' HB1' HG11 ' A' ' 48' ' ' VAL . . . -71.5 -23.15 61.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.915 -0.584 . . . . 61.22 111.442 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -63.13 -25.03 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.17 0.51 . . . . 74.03 111.239 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -80.31 -13.64 59.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.874 0.368 . . . . 74.25 110.963 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.49 1.3 29.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.264 -0.425 . . . . 73.33 111.381 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.08 116.34 5.63 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.144 0.497 . . . . 73.15 111.272 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.21 96.02 0.53 Allowed 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.484 2.123 . . . . 74.34 112.392 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.25 42.21 83.93 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.796 -0.638 . . . . 42.24 112.594 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.03 162.57 20.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.633 -0.794 . . . . 73.54 112.367 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.53 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 28.1 m -87.58 112.0 21.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.952 0.406 . . . . 74.34 110.617 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.53 131.78 53.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.102 -0.499 . . . . 75.33 110.612 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 49' ' ' LEU . . . -106.97 160.74 14.09 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.517 -0.849 . . . . 54.21 111.168 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.76 136.02 57.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.416 0.627 . . . . 70.35 110.323 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 1.076 HG21 ' HA ' ' A' ' 16' ' ' ALA . 2.5 m -90.7 157.1 2.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.148 -0.933 . . . . 75.43 111.437 -169.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -104.71 141.83 35.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.875 -0.602 . . . . 75.5 110.074 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.73 104.23 5.3 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.693 -0.685 . . . . 75.44 109.931 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -72.62 138.39 46.74 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.918 -0.401 . . . . 74.22 109.918 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -127.46 153.51 46.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.272 -0.422 . . . . 73.24 110.66 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.47 -19.03 49.44 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.908 -0.663 . . . . 72.32 111.838 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.0 154.51 17.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.458 -0.571 . . . . 73.34 109.458 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.81 -31.48 20.85 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.903 -0.665 . . . . 74.2 112.715 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.618 ' O ' ' HA ' ' A' ' 63' ' ' ASP . . . -111.72 -52.46 2.78 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.75 -0.265 . . . . 74.35 110.976 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 101.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.248 0.547 . . . . 54.23 110.918 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.44 -13.64 14.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 74.24 111.229 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.529 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 20.4 m-85 -135.27 132.64 38.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.723 -0.473 . . . . 70.04 109.723 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.577 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -115.35 112.56 2.72 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.748 -0.739 . . . . 75.13 111.535 177.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.621 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 22.1 t -96.4 129.67 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 122.253 0.221 . . . . 74.34 110.996 -175.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.535 HD11 ' HA3' ' A' ' 33' ' ' GLY . 1.1 pp -101.91 111.22 23.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.214 0.53 . . . . 74.12 110.452 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.1 t -114.65 119.9 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.774 -0.648 . . . . 72.25 110.952 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.53 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 23.8 m -101.32 104.46 15.46 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.75 -0.463 . . . . 71.44 109.75 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.9 mtt180 -75.62 147.98 82.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.034 -0.53 . . . . 74.11 110.646 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.99 -18.22 41.8 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.169 2.579 . . . . 71.15 112.543 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -70.17 -15.05 62.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.545 . . . . 64.32 110.896 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.9 32.69 7.02 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.587 -0.816 . . . . 61.45 112.39 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -130.09 147.79 51.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.772 0.32 . . . . 71.53 110.372 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -107.17 120.99 43.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.201 -0.454 . . . . 75.15 110.543 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 57.1 t -119.48 133.66 65.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.762 -0.653 . . . . 64.34 109.629 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 11.5 pt-20 -107.6 124.18 49.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.34 0.591 . . . . 75.01 110.479 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.621 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 25.9 t -94.92 125.98 47.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.425 -0.807 . . . . 74.42 109.853 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -99.16 123.61 43.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.1 0.476 . . . . 72.31 110.509 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -112.17 149.85 31.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.652 -0.704 . . . . 75.52 111.083 -176.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.62 ' HB2' HD21 ' A' ' 69' ' ' LEU . 18.4 t70 -90.19 171.53 9.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.962 -0.563 . . . . 74.33 109.883 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.448 ' H ' ' HG3' ' A' ' 64' ' ' ARG . 0.3 OUTLIER -42.81 -51.92 5.24 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.033 0.933 . . . . 74.33 111.949 -178.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -86.0 18.46 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.875 -0.602 . . . . 74.05 111.203 -174.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.635 ' HE1' ' HB1' ' A' ' 19' ' ' ALA . 6.3 m-85 66.97 27.98 8.66 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.872 -0.603 . . . . 75.44 111.586 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -80.32 124.02 28.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.949 -0.76 . . . . 73.52 108.949 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.654 ' HA ' HD13 ' A' ' 62' ' ' LEU . 7.3 p -63.53 122.83 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.169 0.509 . . . . 75.32 110.536 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' A' ' 63' ' ' ASP . 97.7 mt -87.89 -57.62 2.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.116 -0.493 . . . . 74.33 110.682 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -170.89 176.72 4.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.696 -0.483 . . . . 72.44 109.696 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.581 HG21 HG21 ' A' ' 60' ' ' VAL . 16.8 p -140.24 109.42 6.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.317 -0.402 . . . . 73.13 110.656 -177.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -117.74 129.66 25.21 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 121.141 0.496 . . . . 62.11 111.052 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 57.3 Cg_endo -73.91 105.04 1.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.383 2.056 . . . . 75.04 111.948 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.37 93.2 4.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.149 -0.478 . . . . 74.12 111.01 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.15 133.22 34.06 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.674 -0.694 . . . . 75.22 109.266 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -56.79 108.15 1.14 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.09 -0.505 . . . . 34.22 113.237 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -90.38 -40.1 12.28 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.67 -0.493 . . . . 72.33 109.67 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.08 -92.25 0.15 Allowed Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.599 -0.728 . . . . 72.23 111.694 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.97 -157.97 26.44 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.067 -0.587 . . . . 71.45 111.849 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.663 HD22 ' H ' ' A' ' 80' ' ' LEU . 2.5 pt? -79.75 155.65 27.84 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.922 -0.399 . . . . 62.11 109.922 176.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.516 -0.754 . . . . 72.53 109.38 -177.258 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.434 ' HG3' ' HD2' ' A' ' 5' ' ' PHE . 10.6 tpt . . . . . 0 C--O 1.235 0.334 0 N-CA-C 109.958 -0.386 . . . . 52.12 109.958 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.27 66.81 2.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.411 0.523 . . . . 72.53 112.411 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.434 ' HD2' ' HG3' ' A' ' 3' ' ' MET . 91.8 m-85 -145.35 90.49 2.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.774 -0.648 . . . . 73.54 109.33 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -131.96 -74.5 0.51 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.874 -0.331 . . . . 74.13 110.802 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.727 ' HA2' ' NH1' ' A' ' 18' ' ' ARG . . . 115.75 85.37 1.22 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 119.977 -1.106 . . . . 55.11 113.713 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.708 ' HG3' ' HG2' ' A' ' 10' ' ' GLU . 10.6 tp10 -71.36 146.1 49.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.643 -0.873 . . . . 62.41 108.643 171.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -91.81 -8.5 46.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.379 0.511 . . . . 60.42 112.379 -168.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.708 ' HG2' ' HG3' ' A' ' 8' ' ' GLU . 12.6 pt-20 -90.79 3.42 54.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.868 0.322 . . . . 75.31 111.868 -175.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.054 HG21 ' HB2' ' A' ' 17' ' ' ASP . 27.4 m -113.24 157.59 13.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.684 0.278 . . . . 72.21 110.98 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -101.49 -11.3 19.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.366 . . . . 61.21 111.038 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.07 143.16 15.61 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.612 -0.804 . . . . 33.2 111.983 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.16 -67.28 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.414 2.076 . . . . 71.34 112.222 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -70.17 -26.53 63.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.043 -0.526 . . . . 72.23 109.927 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.648 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -55.83 -27.1 49.76 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.278 -0.874 . . . . 71.53 111.503 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 1.054 ' HB2' HG21 ' A' ' 11' ' ' VAL . 3.9 t70 -85.36 -55.6 3.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.985 -0.552 . . . . 62.52 111.265 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.727 ' NH1' ' HA2' ' A' ' 7' ' ' GLY . 17.0 mmt-85 -59.26 -46.4 88.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.805 -0.634 . . . . 73.34 111.01 -170.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.749 ' HB2' ' HE1' ' A' ' 66' ' ' PHE . . . -73.36 -35.78 66.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.461 . . . . 42.45 111.478 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 24' ' ' VAL . 46.3 ttt-85 -65.89 -41.69 91.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.906 -0.588 . . . . 65.44 110.512 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.15 86.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.972 0.415 . . . . 62.23 111.088 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.64 76.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.102 -0.499 . . . . 74.01 110.812 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.567 ' HB2' HG11 ' A' ' 48' ' ' VAL . . . -63.9 -43.89 94.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 70.01 111.506 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 20' ' ' ARG . 57.5 t -56.76 -32.07 37.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 74.24 110.986 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -80.72 -13.0 59.38 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.844 -0.617 . . . . 71.2 111.269 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.02 -30.14 12.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.402 -0.363 . . . . 70.31 111.559 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.7 120.35 43.98 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.234 0.54 . . . . 64.13 111.095 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.1 99.66 0.91 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.566 2.177 . . . . 71.22 112.72 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.4 35.14 77.89 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.931 -0.577 . . . . 51.11 112.726 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.11 177.31 33.77 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.574 -0.822 . . . . 51.21 112.335 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.695 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 31.4 m -79.48 116.37 19.66 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.203 -0.295 . . . . 63.31 110.203 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.85 133.43 53.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.295 -0.411 . . . . 54.34 110.339 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -125.28 162.13 19.62 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.497 -0.641 . . . . 51.34 111.497 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -63.89 142.3 58.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.368 0.604 . . . . 73.01 110.937 178.099 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.648 HG22 ' HA ' ' A' ' 16' ' ' ALA . 12.1 m -104.29 155.71 5.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.646 -0.706 . . . . 74.24 110.884 -173.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -119.12 156.62 29.44 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.81 -0.441 . . . . 64.53 109.81 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.3 p -73.47 125.78 28.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.396 -0.366 . . . . 71.24 111.093 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' OE1' ' HD2' ' A' ' 61' ' ' HIS . 38.0 mt-10 -79.79 -166.61 1.03 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.859 -0.61 . . . . 72.4 109.846 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -60.05 129.15 40.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.455 -0.339 . . . . 73.45 110.653 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.35 91.12 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.975 -0.557 . . . . 70.33 112.712 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -83.92 113.39 20.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.867 0.365 . . . . 73.03 110.287 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.14 -156.21 26.78 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.78 -0.646 . . . . 61.2 111.5 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.04 -41.16 5.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.044 0.449 . . . . 62.55 110.427 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.02 112.21 23.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.639 . . . . 72.14 110.195 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.63 -26.39 12.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.977 -0.556 . . . . 61.15 111.009 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -126.35 132.52 51.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.079 -0.509 . . . . 72.43 110.186 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.76 112.26 2.94 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.533 -0.841 . . . . 65.41 111.536 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.606 HG22 ' HB1' ' A' ' 19' ' ' ALA . 39.0 t -97.59 109.29 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.752 0.31 . . . . 63.21 111.117 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 pp -86.86 117.38 25.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.178 0.513 . . . . 63.25 110.631 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.454 HG11 ' HB1' ' A' ' 23' ' ' ALA . 16.4 m -135.74 150.08 28.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.934 -0.576 . . . . 74.13 110.077 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.695 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 28.3 m -136.39 126.03 25.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.34 -0.391 . . . . 64.43 111.061 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HB2' HG23 ' A' ' 56' ' ' THR . 6.6 mpt_? -80.04 142.2 55.45 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.784 -0.821 . . . . 71.24 108.784 173.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.47 -12.7 11.53 Favored 'Trans proline' 0 N--CA 1.475 0.412 0 C-N-CA 123.338 2.692 . . . . 65.45 112.955 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -68.55 -9.51 49.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.929 -0.578 . . . . 71.24 111.158 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.85 32.41 7.2 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.605 -0.807 . . . . 54.33 111.742 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.5 t -128.28 119.42 25.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.416 0.627 . . . . 75.14 110.737 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -105.29 127.0 52.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.303 -0.862 . . . . 71.02 110.386 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.568 HG11 ' HB ' ' A' ' 71' ' ' THR . 98.3 t -131.7 138.76 52.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.97 -0.559 . . . . 74.24 109.765 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 9.4 pt-20 -106.98 121.69 44.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.463 0.649 . . . . 55.43 110.196 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.59 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 21.5 t -85.07 119.19 33.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.207 -0.906 . . . . 65.2 109.586 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.46 ' HD2' ' OE1' ' A' ' 38' ' ' GLU . 46.4 m80 -91.53 118.82 30.92 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.28 0.562 . . . . 62.5 110.495 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.638 HD23 ' HD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -109.44 147.58 32.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.897 -1.047 . . . . 74.24 110.733 -174.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.55 ' HB3' HD21 ' A' ' 69' ' ' LEU . 5.4 p-10 -90.89 -163.2 1.0 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.229 -0.441 . . . . 73.21 110.071 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -66.9 -15.9 63.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.266 -0.424 . . . . 73.45 111.779 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -121.31 16.88 11.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 61.23 111.236 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.749 ' HE1' ' HB2' ' A' ' 19' ' ' ALA . 31.8 m-85 65.67 29.38 10.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.964 -0.562 . . . . 73.05 112.244 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -89.26 134.68 33.95 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.922 -0.77 . . . . 64.13 108.922 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -63.19 113.06 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.434 0.635 . . . . 24.0 111.006 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 63' ' ' ASP . 87.9 mt -83.84 -52.23 6.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.774 -0.648 . . . . 73.31 110.1 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -173.81 160.09 3.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.993 -0.549 . . . . 55.44 110.047 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.568 ' HB ' HG11 ' A' ' 58' ' ' VAL . 19.8 p -128.93 111.43 13.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.039 -0.528 . . . . 62.31 111.121 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 1.7 pm0 -112.84 143.84 29.86 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.315 -0.402 . . . . 64.32 110.692 176.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 39.3 Cg_exo -61.23 128.88 26.44 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.127 2.551 . . . . 43.45 112.048 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.522 ' HB2' ' HG2' ' A' ' 59' ' ' GLU . . . -104.99 122.74 46.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.911 -0.586 . . . . 73.33 110.936 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 115.858 -0.61 . . . . 61.05 109.784 179.101 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 C--O 1.233 0.214 0 N-CA-C 109.958 -0.386 . . . . 74.43 109.958 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.22 69.78 9.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.185 -0.461 . . . . 74.1 111.8 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -98.6 113.1 25.01 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.201 -0.666 . . . . 73.44 109.201 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.429 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 19.3 t70 63.91 101.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.915 0.759 . . . . 74.43 110.331 -171.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.41 ' H ' ' CZ ' ' A' ' 18' ' ' ARG . . . -93.72 -108.04 1.95 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.71 -0.677 . . . . 73.31 112.49 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.619 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 31.2 tt0 -107.51 177.41 4.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.802 0.334 . . . . 73.03 110.678 -177.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.619 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 28.4 t70 -75.14 -8.94 57.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.943 -0.571 . . . . 62.4 111.829 -175.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -65.56 97.36 0.3 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.957 0.408 . . . . 55.11 110.703 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 51.7 t -83.04 86.17 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.457 0.646 . . . . 74.34 111.006 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 t -101.66 -13.33 17.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.757 0.789 . . . . 65.34 109.066 171.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.686 ' HA3' ' HB3' ' A' ' 16' ' ' ALA . . . 170.71 135.81 1.98 Allowed Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.592 -1.185 . . . . 73.3 110.345 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -54.67 -70.15 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 123.016 2.478 . . . . 70.15 112.153 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -89.69 -20.72 23.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.827 -0.624 . . . . 74.51 110.147 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.686 ' HB3' ' HA3' ' A' ' 13' ' ' GLY . . . -59.65 -49.54 77.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.424 -0.807 . . . . 70.41 111.311 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -58.0 -40.93 81.94 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.203 0.525 . . . . 74.43 111.469 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.429 ' NE ' ' HA ' ' A' ' 6' ' ' ASP . 17.4 mmt180 -65.06 -43.91 90.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.595 -0.73 . . . . 63.53 110.827 -171.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.92 -28.1 28.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.438 -0.346 . . . . 62.03 111.347 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.94 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 63.0 ttt180 -65.7 -35.99 82.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.507 -0.315 . . . . 74.11 110.364 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -62.77 -34.01 76.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.854 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.09 -35.59 61.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 70.54 110.348 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.47 ' HB2' HG13 ' A' ' 48' ' ' VAL . . . -58.92 -55.45 34.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 73.44 111.032 177.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.19 -11.04 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.37 0.605 . . . . 44.31 110.891 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 5.7 tp60 -88.25 -24.64 23.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 73.45 110.11 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.5 18.87 20.46 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.055 -0.52 . . . . 64.42 111.753 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.03 125.19 11.39 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 121.014 0.435 . . . . 72.21 110.35 176.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.93 82.56 1.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.431 2.087 . . . . 51.2 112.584 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.94 28.47 71.79 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.772 -0.649 . . . . 74.2 112.875 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.55 175.44 29.15 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.712 -0.756 . . . . 62.33 112.113 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.796 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 58.0 m -78.09 105.9 9.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.267 0.556 . . . . 73.24 110.964 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.6 120.62 37.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.684 -0.689 . . . . 51.4 109.881 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.501 ' HA3' HD11 ' A' ' 49' ' ' LEU . . . -101.19 160.43 18.51 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.524 -0.846 . . . . 23.42 112.285 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.94 ' HG2' ' HD2' ' A' ' 20' ' ' ARG . 23.4 mt-10 -79.25 151.64 31.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.984 -0.376 . . . . 52.24 109.984 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.512 HG12 HD23 ' A' ' 49' ' ' LEU . 26.7 m -128.72 155.54 40.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.956 -0.565 . . . . 60.52 111.547 -171.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.13 158.85 17.88 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.419 -0.585 . . . . 75.03 109.419 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -72.92 113.28 9.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.012 0.434 . . . . 34.2 110.972 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.21 139.54 56.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 72.1 109.632 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.5 p -138.48 173.89 11.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.832 0.349 . . . . 63.43 111.422 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.74 -115.02 3.27 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.797 -0.716 . . . . 41.15 112.132 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -131.03 172.58 11.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.819 0.342 . . . . 74.43 110.46 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.9 -139.77 14.56 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.169 -0.772 . . . . 51.11 111.169 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 -12.98 4.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.894 0.347 . . . . 65.21 111.456 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.45 133.05 38.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 70.12 111.261 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.77 -28.72 2.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.947 -0.57 . . . . 65.11 110.75 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -131.23 155.77 46.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.435 -0.348 . . . . 71.42 110.274 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.83 145.39 16.82 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.469 -0.872 . . . . 71.31 112.193 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.47 HG13 ' HB2' ' A' ' 23' ' ' ALA . 70.1 t -128.91 105.4 12.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.308 -0.627 . . . . 73.42 109.308 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.512 HD23 HG12 ' A' ' 35' ' ' VAL . 3.3 pp -102.18 123.82 46.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.423 0.63 . . . . 74.2 110.648 -177.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 m -124.61 120.64 59.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.463 -0.79 . . . . 71.34 110.42 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.796 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 12.5 m -92.71 104.28 16.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.822 -0.626 . . . . 60.22 109.995 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -66.09 139.9 96.77 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.877 -0.601 . . . . 75.02 109.438 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.93 -9.56 6.19 Favored 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.169 2.579 . . . . 74.53 112.939 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.99 -13.7 60.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 72.12 110.475 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.28 33.01 5.85 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.771 -0.728 . . . . 41.35 112.563 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -131.2 143.02 50.28 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.096 -0.335 . . . . 62.22 110.096 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 74' ' ' ALA . 24.8 ttp180 -107.23 119.7 40.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.886 0.374 . . . . 75.14 110.087 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.39 114.79 48.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.122 -0.49 . . . . 73.22 110.021 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.54 112.02 24.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.554 0.693 . . . . 72.44 110.431 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.5 t -88.66 124.45 41.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.195 -0.911 . . . . 73.53 109.891 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 70' ' ' ASP . 35.9 m170 -96.06 122.6 39.07 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.909 -0.587 . . . . 74.22 110.667 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -109.78 154.95 22.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.71 -0.677 . . . . 64.14 110.468 -177.123 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 1.011 ' HB3' HD11 ' A' ' 69' ' ' LEU . 3.9 p30 -92.14 -164.23 1.15 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.977 0.417 . . . . 74.3 110.481 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.445 ' HG3' ' H ' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -62.81 -29.16 70.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.725 -0.671 . . . . 73.23 111.191 -175.554 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -100.27 17.27 21.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.175 -0.466 . . . . 64.01 111.316 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 69.02 19.86 7.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.848 -0.615 . . . . 75.11 111.507 172.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.529 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . 40.3 ttm180 -90.63 145.81 24.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.769 0.319 . . . . 70.02 110.522 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.548 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.3 p -67.06 126.47 26.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.211 0.529 . . . . 64.53 110.904 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 1.011 HD11 ' HB3' ' A' ' 63' ' ' ASP . 61.3 mt -112.72 -61.39 1.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.898 -0.592 . . . . 72.22 111.016 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 61' ' ' HIS . 23.0 t70 -132.03 139.83 48.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.551 -0.749 . . . . 72.1 111.315 -169.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.2 m -117.52 110.43 17.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.357 -0.383 . . . . 73.3 110.364 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -114.96 117.53 41.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.953 0.406 . . . . 64.23 111.872 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.23 93.99 0.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.757 2.305 . . . . 44.22 109.998 168.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 57' ' ' ARG . . . -124.92 147.3 48.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.388 -0.369 . . . . 73.02 111.292 -172.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 116.065 -0.516 . . . . 64.24 109.927 177.865 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.836 -0.431 . . . . 74.41 109.836 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.39 66.85 4.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.268 0.556 . . . . 63.31 111.507 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -113.12 57.5 0.67 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.492 0.663 . . . . 72.41 109.308 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -153.69 117.72 4.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.004 -0.998 . . . . 74.33 109.179 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.81 155.07 25.93 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.776 -0.726 . . . . 72.22 111.614 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.46 165.76 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.523 0.678 . . . . 72.54 111.678 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.55 2.8 55.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.038 -0.983 . . . . 73.33 111.197 -173.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.89 22.26 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 53.14 112.092 -173.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.487 HG21 ' HB2' ' A' ' 17' ' ' ASP . 19.6 m -131.08 173.58 14.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.417 -0.356 . . . . 60.12 110.234 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -93.38 102.4 14.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.922 -0.77 . . . . 74.21 108.922 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.88 92.99 0.54 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.347 -1.101 . . . . 72.32 110.347 -169.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.28 -13.36 19.72 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 123.233 2.622 . . . . 75.31 114.13 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.577 ' HA ' ' CG ' ' A' ' 18' ' ' ARG . 54.0 m-20 -73.04 -15.63 61.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.26 0.552 . . . . 75.23 109.721 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -68.41 -31.99 71.73 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.263 -0.88 . . . . 75.32 109.974 171.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HB2' HG21 ' A' ' 11' ' ' VAL . 11.6 t70 -83.41 -28.33 28.94 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.168 -0.469 . . . . 73.51 111.584 -173.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.577 ' CG ' ' HA ' ' A' ' 15' ' ' ASP . 5.5 mmt180 -54.28 -55.1 31.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.56 0.695 . . . . 74.24 109.931 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.855 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -81.15 -21.61 39.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.247 -0.888 . . . . 73.02 111.141 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 28.0 ttt180 -66.54 -36.24 82.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.0 0.428 . . . . 74.14 110.372 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.34 70.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.291 0.567 . . . . 74.05 110.484 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.27 -38.13 36.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 73.3 110.268 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.402 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -56.48 -48.85 76.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.712 -0.676 . . . . 62.34 111.777 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 p -66.2 -18.69 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.996 0.427 . . . . 62.51 111.213 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.76 -19.69 21.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.973 0.416 . . . . 71.25 110.695 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.55 -31.54 22.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.068 -0.515 . . . . 73.23 111.427 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 23' ' ' ALA . 7.1 p -117.0 120.33 33.96 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.955 0.407 . . . . 62.21 110.541 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.83 104.59 1.19 Allowed 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.741 2.294 . . . . 63.24 112.625 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.19 26.19 71.43 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.913 -0.585 . . . . 23.45 112.584 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.5 -173.28 35.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.743 -0.742 . . . . 40.44 112.068 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.797 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 63.6 m -90.25 111.44 22.62 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.971 0.415 . . . . 72.44 110.745 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.03 100.64 11.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.644 -0.707 . . . . 73.5 109.592 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.605 ' HA3' HD11 ' A' ' 49' ' ' LEU . . . -89.45 160.95 29.58 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.786 -0.721 . . . . 61.44 112.309 -176.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -70.13 127.67 33.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.275 0.56 . . . . 74.21 110.125 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.707 HG21 ' HB3' ' A' ' 19' ' ' ALA . 20.4 m -103.96 153.92 6.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.699 -0.682 . . . . 70.22 111.417 -173.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -106.73 155.57 19.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.39 -0.368 . . . . 64.54 110.283 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.3 m -76.64 111.29 11.98 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.85 -0.426 . . . . 43.22 109.85 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 36.1 mt-10 -78.62 111.24 14.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.174 0.511 . . . . 74.22 110.449 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.4 p -117.66 124.68 49.14 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.011 -0.541 . . . . 72.44 110.646 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.63 -110.69 0.38 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.46 -0.876 . . . . 72.32 112.618 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -113.94 165.77 12.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.957 0.408 . . . . 71.23 111.291 -174.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.97 -150.27 29.03 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.848 -0.691 . . . . 71.43 111.959 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.13 4.95 10.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.143 0.497 . . . . 72.3 110.695 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.51 103.01 12.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 62.31 110.4 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 38' ' ' GLU . . . -103.85 -13.64 16.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.138 -0.483 . . . . 44.24 111.019 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -141.74 133.69 27.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 72.24 110.191 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -116.41 113.62 2.85 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.859 -0.686 . . . . 43.11 111.785 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.855 HG22 ' HB1' ' A' ' 19' ' ' ALA . 34.7 t -95.5 117.09 38.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 110.031 -0.359 . . . . 61.41 110.031 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.605 HD11 ' HA3' ' A' ' 33' ' ' GLY . 1.3 pp -98.39 107.64 20.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.473 0.654 . . . . 63.11 110.276 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.2 m -110.19 107.05 21.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 62.31 110.761 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.797 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 22.4 m -95.6 113.76 25.44 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.845 -0.616 . . . . 64.51 110.76 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -71.21 146.08 91.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.176 -0.676 . . . . 71.2 109.176 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.98 -2.84 6.09 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.718 2.279 . . . . 62.55 112.17 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -83.08 0.5 44.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.682 -0.69 . . . . 73.54 110.539 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.18 33.21 12.24 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.635 -0.793 . . . . 71.52 112.579 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t -135.9 125.56 25.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.136 0.493 . . . . 74.14 110.886 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 54.3 ttt180 -103.75 126.26 50.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.931 -0.577 . . . . 75.0 110.648 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 49.4 t -112.96 132.77 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.184 -0.462 . . . . 72.01 110.262 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -93.06 108.32 19.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.282 -0.417 . . . . 71.54 110.383 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.776 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 21.6 t -89.28 108.36 19.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.204 -0.665 . . . . 71.5 109.204 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -90.1 127.16 36.02 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.989 0.423 . . . . 64.52 110.823 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.705 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -115.74 159.36 21.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.513 -0.767 . . . . 61.14 111.103 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.463 ' HB2' HD21 ' A' ' 69' ' ' LEU . 11.2 t70 -90.43 173.73 7.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.047 -0.979 . . . . 52.31 110.138 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -57.58 -29.43 64.44 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.451 0.7 . . . . 74.41 111.411 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -89.18 5.35 45.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.084 0.469 . . . . 72.11 110.37 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 71.34 21.65 4.55 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.404 -0.816 . . . . 75.2 110.592 -176.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.49 133.13 37.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.894 -0.593 . . . . 74.41 109.877 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.705 ' HA ' HD12 ' A' ' 62' ' ' LEU . 7.2 p -65.55 131.23 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.879 0.371 . . . . 74.11 111.004 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.463 HD21 ' HB2' ' A' ' 63' ' ' ASP . 92.1 mt -101.19 -64.25 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.292 -0.413 . . . . 71.11 110.561 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -166.61 175.8 7.71 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.702 -0.481 . . . . 64.53 109.702 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.426 HG22 HG22 ' A' ' 60' ' ' VAL . 46.9 p -139.09 114.22 9.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.721 0.296 . . . . 70.24 111.384 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -125.4 139.53 34.1 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.096 -0.335 . . . . 75.35 110.096 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 40.6 Cg_endo -69.22 152.08 72.09 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.407 2.071 . . . . 64.54 112.3 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.06 111.56 23.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.324 -0.398 . . . . 71.11 111.598 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.9 t0 . . . . . 0 C--N 1.325 -0.48 0 N-CA-C 109.243 -0.651 . . . . 60.2 109.243 175.613 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.413 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 4.5 mpp? . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.904 0.383 . . . . 73.54 110.209 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.01 89.7 6.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 63.11 111.136 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.432 ' HZ ' ' HA ' ' A' ' 65' ' ' ASP . 79.1 m-85 -117.55 58.14 0.8 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.338 0.59 . . . . 73.24 109.899 175.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -146.56 145.4 30.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.537 -0.756 . . . . 63.52 109.306 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.14 164.9 35.1 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.562 -0.828 . . . . 65.25 111.664 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.93 162.05 20.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.056 0.428 . . . . 75.22 110.706 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -95.22 -10.19 31.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.36 -0.382 . . . . 73.53 111.513 -172.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -85.74 5.1 33.79 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.166 0.432 . . . . 60.11 112.166 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 17' ' ' ASP . 27.8 m -90.14 158.19 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.522 -0.547 . . . . 64.12 109.522 172.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.9 m -92.76 -34.75 13.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.785 0.326 . . . . 70.5 110.384 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.99 109.51 3.12 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.64 -0.79 . . . . 74.11 111.439 175.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.99 -66.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.608 2.206 . . . . 53.44 112.007 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.609 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 5.4 p-10 -71.17 -20.61 62.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.094 -0.503 . . . . 72.14 110.629 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 34' ' ' GLU . . . -56.46 -45.91 80.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.523 -0.762 . . . . 42.5 112.43 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.424 ' HB2' HG21 ' A' ' 11' ' ' VAL . 32.6 t70 -64.92 -54.79 25.21 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.548 0.573 . . . . 61.12 112.548 -173.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.728 ' H ' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -63.64 -32.58 74.1 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.904 -0.318 . . . . 74.14 110.995 -177.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.504 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . . . -68.94 -44.72 72.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.282 0.563 . . . . 61.0 110.262 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.455 ' O ' HG23 ' A' ' 24' ' ' VAL . 38.4 ttp180 -60.09 -46.86 88.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.258 -0.883 . . . . 51.04 110.912 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.39 89.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.95 -0.568 . . . . 71.41 111.671 -177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.56 -38.15 90.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.975 0.417 . . . . 65.22 111.268 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.22 -16.97 57.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.043 -0.526 . . . . 62.25 112.327 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 20' ' ' ARG . 96.0 t -57.53 -39.27 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.951 0.405 . . . . 73.23 111.254 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -70.02 -13.13 62.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.376 -0.375 . . . . 74.53 111.318 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.66 12.31 36.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.36 -0.382 . . . . 74.13 111.15 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.48 114.42 3.82 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.242 0.544 . . . . 75.52 110.693 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.26 93.64 0.66 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.449 2.099 . . . . 53.13 112.699 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.26 43.88 94.58 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.694 -0.684 . . . . 54.05 112.615 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.437 ' HA2' ' HG3' ' A' ' 53' ' ' PRO . . . -110.66 -172.96 19.99 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.585 -0.817 . . . . 33.51 112.638 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.759 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 37.9 m -92.06 114.52 27.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.859 0.361 . . . . 74.35 111.205 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.93 119.83 39.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.824 -0.625 . . . . 44.22 109.999 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.84 161.04 12.88 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.551 -0.833 . . . . 73.43 112.755 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' HB3' ' HB1' ' A' ' 16' ' ' ALA . 1.6 mp0 -67.17 137.26 56.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.058 -0.349 . . . . 71.31 110.058 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.762 HG11 ' HA ' ' A' ' 48' ' ' VAL . 31.1 m -134.01 154.42 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.254 -0.43 . . . . 75.13 111.269 -174.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -106.67 160.63 15.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.276 -0.42 . . . . 70.03 110.118 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 p -71.52 148.75 46.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.055 0.455 . . . . 72.43 111.625 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.59 97.08 6.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 64.22 110.201 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.1 m -89.54 117.6 28.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.984 -0.553 . . . . 74.44 110.532 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.88 -139.19 6.66 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.782 -0.723 . . . . 72.21 112.199 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -95.78 178.06 5.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.969 0.414 . . . . 63.35 110.716 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.49 -168.18 19.5 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.054 -0.593 . . . . 72.34 112.362 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.25 8.45 14.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.939 0.399 . . . . 73.23 110.504 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.24 170.34 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 42.15 110.663 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.11 -36.93 0.17 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.478 -0.328 . . . . 74.34 111.531 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.558 ' HE2' ' HB2' ' A' ' 15' ' ' ASP . 76.3 m-85 -124.61 131.74 53.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.955 -0.387 . . . . 72.25 109.955 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.3 112.28 2.06 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.204 -0.998 . . . . 64.42 110.971 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.762 ' HA ' HG11 ' A' ' 35' ' ' VAL . 12.0 t -109.07 126.17 66.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.736 0.303 . . . . 74.24 111.08 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.494 ' H ' HG11 ' A' ' 35' ' ' VAL . 3.4 pp -87.07 130.71 34.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.215 -0.448 . . . . 75.15 109.992 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.17 114.17 25.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.638 0.733 . . . . 73.34 110.498 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.759 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 11.6 m -97.92 122.83 41.5 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.411 -0.813 . . . . 71.13 110.77 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.435 ' C ' ' H ' ' A' ' 54' ' ' ASP . 8.0 mpt_? -74.32 140.35 76.07 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.686 -0.857 . . . . 74.35 108.686 171.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.437 ' HG3' ' HA2' ' A' ' 30' ' ' GLY . 16.4 Cg_exo -68.88 17.95 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.17 2.58 . . . . 34.51 112.957 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 52' ' ' ARG . 12.3 t70 -109.42 -15.64 14.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.138 0.494 . . . . 73.43 110.331 177.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.22 -19.31 8.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.621 -0.8 . . . . 45.43 112.424 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.89 115.28 18.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.412 0.625 . . . . 64.5 111.091 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 57' ' ' ARG . 34.2 ttp180 -115.74 120.51 39.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.609 -0.723 . . . . 63.43 110.482 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.482 HG12 ' HA ' ' A' ' 73' ' ' PRO . 31.5 m -123.62 163.45 22.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.37 -0.377 . . . . 73.41 110.302 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -122.85 133.92 54.41 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.044 0.45 . . . . 61.12 110.039 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.415 HG12 HD13 ' A' ' 62' ' ' LEU . 22.8 t -101.61 120.13 50.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.482 -0.562 . . . . 52.42 109.482 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -92.2 121.66 33.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.562 . . . . 74.52 110.229 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.649 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.35 156.69 22.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.893 -1.049 . . . . 75.23 110.929 -172.502 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 67' ' ' ARG . 10.9 t70 -90.73 172.11 8.88 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.313 -0.858 . . . . 60.35 109.722 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -50.23 -44.57 53.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.546 0.738 . . . . 60.0 112.352 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 67' ' ' ARG . 27.1 m-20 -96.52 26.14 4.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.911 0.386 . . . . 74.25 110.604 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 19' ' ' ALA . 26.2 m-85 67.1 32.67 6.06 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.216 0.821 . . . . 63.53 113.216 174.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -77.94 126.82 31.4 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.172 -0.677 . . . . 74.34 109.172 169.168 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.649 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.5 p -69.55 120.65 17.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.053 0.454 . . . . 73.45 110.371 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.9 mt -96.18 -62.58 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.24 -0.436 . . . . 71.2 110.896 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -150.71 170.19 19.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 70.21 110.092 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.0 m -147.61 115.79 6.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.041 0.448 . . . . 61.25 110.363 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -133.08 159.45 72.59 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.022 -0.535 . . . . 60.14 110.194 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.482 ' HA ' HG12 ' A' ' 58' ' ' VAL . 18.3 Cg_endo -59.91 143.1 99.64 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.733 2.289 . . . . 42.14 112.476 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.56 122.22 36.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.873 -0.603 . . . . 71.34 110.804 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--N 1.323 -0.573 0 N-CA-C 110.029 -0.36 . . . . 64.51 110.029 179.505 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.533 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 1.6 mpt? . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.96 -0.756 . . . . 74.32 108.96 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.05 81.75 3.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.155 0.503 . . . . 70.43 112.125 -172.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 3' ' ' MET . 91.3 m-85 -121.35 57.52 1.01 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.727 0.775 . . . . 75.12 109.053 174.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.582 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 7.9 t70 -147.83 -142.75 0.13 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.389 -1.337 . . . . 70.32 107.389 -177.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.61 175.83 33.06 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.007 -1.092 . . . . 70.34 112.581 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.6 -178.67 6.95 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.649 -0.5 . . . . 75.11 109.649 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -92.66 -9.55 40.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.439 0.638 . . . . 64.5 109.585 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.13 53.92 2.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.55 -0.75 . . . . 71.1 109.363 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 m -60.14 96.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.858 0.837 . . . . 73.32 112.186 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 t -93.72 -21.83 19.1 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.104 -0.953 . . . . 52.11 109.021 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.755 ' HA3' ' HB3' ' A' ' 16' ' ' ALA . . . -152.27 143.76 10.76 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.153 -0.93 . . . . 41.22 111.096 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -60.75 -68.91 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.819 2.346 . . . . 64.04 111.876 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.577 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 10.8 m-20 -90.01 -22.29 21.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.519 -0.549 . . . . 74.13 109.519 176.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.755 ' HB3' ' HA3' ' A' ' 13' ' ' GLY . . . -58.91 -37.34 76.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.077 -0.965 . . . . 74.12 111.445 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 14.9 t70 -55.57 -57.77 10.56 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.165 -0.471 . . . . 54.53 111.545 -175.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.593 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -69.07 -35.75 76.87 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.945 0.35 . . . . 75.15 111.945 -176.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.411 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -68.48 -42.45 78.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.101 0.477 . . . . 63.24 110.812 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -71.12 -36.91 72.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.839 -0.619 . . . . 71.12 110.56 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.25 -24.07 66.52 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.431 -0.349 . . . . 70.21 111.49 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 -29.89 33.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.402 -0.363 . . . . 54.24 111.152 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.419 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -62.21 -31.77 72.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.045 -0.525 . . . . 72.55 112.034 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.6 p -69.02 -14.01 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.819 0.343 . . . . 74.12 111.731 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -85.36 -31.85 22.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.858 0.361 . . . . 63.12 110.357 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.13 -32.23 39.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.067 -0.515 . . . . 43.14 111.382 -176.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.462 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 14.6 p -111.15 133.9 21.21 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.854 0.359 . . . . 64.25 110.53 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 27' ' ' VAL . 8.9 Cg_endo -82.49 99.88 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.828 2.352 . . . . 62.21 111.871 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.45 39.44 97.8 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.039 -0.601 . . . . 65.25 112.184 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' HA3' ' CG2' ' A' ' 27' ' ' VAL . . . -104.49 168.12 16.12 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.591 -0.814 . . . . 72.04 112.411 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 1.032 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 39.8 m -82.04 106.11 13.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.233 0.539 . . . . 61.41 111.201 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.87 111.91 22.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.395 -0.821 . . . . 51.11 109.29 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.37 162.87 17.86 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.184 -0.532 . . . . 72.51 112.839 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -61.72 106.94 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 72.21 110.232 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.645 HG11 ' HA ' ' A' ' 48' ' ' VAL . 33.9 m -91.25 150.3 3.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.921 -0.581 . . . . 64.21 110.845 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -108.67 150.06 28.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.272 -0.422 . . . . 73.1 110.032 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.74 131.01 39.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.183 0.516 . . . . 71.42 110.999 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.83 133.8 38.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.674 -0.694 . . . . 62.22 110.365 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -91.49 117.67 29.9 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.936 -0.765 . . . . 50.22 108.936 168.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.67 93.62 0.15 Allowed Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.214 -0.993 . . . . 75.12 112.612 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -51.4 114.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.504 -0.554 . . . . 70.12 109.504 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.14 -54.61 0.61 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.736 -0.745 . . . . 55.32 112.149 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -175.13 -38.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.804 0.298 . . . . 74.14 111.804 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.88 130.28 45.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.048 0.452 . . . . 44.14 111.796 -174.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.78 -36.4 0.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.756 -0.656 . . . . 73.1 110.788 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.543 ' HE2' ' HB3' ' A' ' 15' ' ' ASP . 91.8 m-85 -124.84 133.65 53.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 74.22 110.49 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.29 113.46 2.03 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.335 -0.706 . . . . 74.13 111.335 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.645 ' HA ' HG11 ' A' ' 35' ' ' VAL . 45.7 t -101.18 112.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.734 0.302 . . . . 73.32 111.01 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.62 ' HG ' HG12 ' A' ' 35' ' ' VAL . 2.3 pp -85.8 117.05 24.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 74.44 110.042 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.67 114.42 47.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.661 -0.7 . . . . 63.02 110.277 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 1.032 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 20.3 m -96.13 104.92 16.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.233 -0.44 . . . . 73.43 110.461 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -67.04 138.71 95.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.165 -0.68 . . . . 73.52 109.165 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HD3' ' HA2' ' A' ' 30' ' ' GLY . 17.9 Cg_endo -60.05 -7.94 7.21 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.131 2.554 . . . . 70.21 112.998 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -74.25 -14.45 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 70.24 110.537 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.34 33.36 5.17 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.398 -0.906 . . . . 71.35 112.662 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 t -131.84 142.27 49.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.905 0.383 . . . . 72.51 110.949 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 58.9 ttt180 -110.08 122.69 48.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 72.41 111.362 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.48 139.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.406 -0.59 . . . . 73.42 109.406 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -108.2 136.12 48.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.217 0.532 . . . . 73.25 110.858 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 71' ' ' THR . 23.6 t -106.01 118.18 53.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.514 -0.766 . . . . 62.1 109.672 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -89.55 125.32 35.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.09 -0.504 . . . . 72.24 111.521 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.816 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -117.16 147.21 42.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.474 -0.784 . . . . 61.25 109.816 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.872 ' HB3' HD21 ' A' ' 69' ' ' LEU . 1.9 p-10 -91.96 -167.1 1.69 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.951 -0.3 . . . . 74.44 110.439 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -55.27 -38.08 68.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.014 -0.539 . . . . 74.55 111.933 -176.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -89.67 16.45 7.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.019 0.377 . . . . 75.22 112.019 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 65.83 21.84 11.46 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.208 0.528 . . . . 75.22 111.127 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.713 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 9.0 tpt180 -88.34 134.84 33.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.212 -0.449 . . . . 75.04 110.178 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.816 ' HA ' HD12 ' A' ' 62' ' ' LEU . 4.5 p -61.58 116.05 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.242 0.544 . . . . 62.3 111.256 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.872 HD21 ' HB3' ' A' ' 63' ' ' ASP . 85.5 mt -84.42 -49.06 9.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.754 -0.657 . . . . 64.32 109.611 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -170.35 -179.34 3.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.487 -0.778 . . . . 73.42 108.981 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.539 HG23 HG22 ' A' ' 60' ' ' VAL . 23.8 m -145.83 108.22 4.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.741 0.305 . . . . 61.04 110.352 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 1.5 pm0 -120.86 147.07 45.26 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.899 0.381 . . . . 71.12 111.077 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 24.0 Cg_exo -63.72 132.34 34.78 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.944 2.429 . . . . 61.51 112.022 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . . . -107.73 100.09 9.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.461 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 C--N 1.321 -0.633 0 CA-C-N 116.118 -0.492 . . . . 64.13 110.109 179.766 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.884 0.374 . . . . 73.35 110.336 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.09 77.88 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.218 -0.447 . . . . 74.12 111.109 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.67 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 88.2 m-85 -131.76 56.45 1.82 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 74.32 110.551 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.8 t70 175.6 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.732 -0.667 . . . . 72.02 110.071 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.0 -80.71 1.53 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.052 -0.819 . . . . 43.23 111.052 174.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -146.51 133.4 20.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.15 0.5 . . . . 74.53 110.064 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -75.96 4.85 7.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.8 -0.636 . . . . 73.24 111.779 -170.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.12 -17.16 60.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.569 -0.287 . . . . 72.55 111.697 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.582 HG21 ' HB2' ' A' ' 17' ' ' ASP . 35.5 m -92.34 162.85 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.762 0.315 . . . . 75.22 111.278 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.5 p -101.44 -0.16 35.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.288 -0.414 . . . . 72.54 111.6 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.01 105.45 1.99 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.727 -0.749 . . . . 75.51 111.608 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 22.4 Cg_endo -62.08 -50.9 4.23 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.68 2.254 . . . . 73.02 111.986 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -71.14 -35.05 71.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.953 -0.567 . . . . 75.55 110.427 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -62.31 -43.57 98.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.842 -0.617 . . . . 72.22 110.833 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.582 ' HB2' HG21 ' A' ' 11' ' ' VAL . 8.8 t70 -56.43 -53.66 54.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 70.33 111.739 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.67 ' HD2' ' HA ' ' A' ' 5' ' ' PHE . 12.0 mmt180 -56.76 -51.01 70.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.966 -0.561 . . . . 75.11 111.315 -171.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.841 ' HB3' HG21 ' A' ' 35' ' ' VAL . . . -78.64 -33.2 47.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.932 -0.576 . . . . 60.54 111.865 -174.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -69.62 -34.58 74.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 73.53 110.107 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.15 85.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 64.32 110.598 176.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.72 -32.29 63.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 70.03 110.877 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.442 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -56.27 -31.26 63.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.824 -0.626 . . . . 73.21 111.818 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.36 -32.19 40.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.978 0.418 . . . . 64.23 111.085 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -94.44 -13.73 25.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.267 -0.424 . . . . 54.42 110.815 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.558 ' HB3' HG11 ' A' ' 50' ' ' VAL . . . -85.76 -29.65 23.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.276 -0.42 . . . . 62.52 111.283 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.923 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 9.9 p -111.02 128.05 25.93 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.887 0.375 . . . . 73.34 110.399 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 27' ' ' VAL . 3.0 Cg_exo -72.95 93.06 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.798 2.332 . . . . 73.11 112.37 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.23 21.43 72.04 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.146 -0.549 . . . . 63.2 112.972 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.84 -164.43 32.71 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.732 -0.747 . . . . 74.33 112.255 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.46 ' CG2' ' HB ' ' A' ' 51' ' ' THR . 4.9 t -103.64 136.34 43.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.061 0.458 . . . . 64.53 110.469 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.16 110.23 22.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 64.11 110.365 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.78 160.75 31.53 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.686 -0.769 . . . . 54.25 112.222 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -75.32 140.99 43.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 64.41 110.22 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.841 HG21 ' HB3' ' A' ' 19' ' ' ALA . 12.8 m -116.02 155.88 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.949 -0.569 . . . . 64.55 111.837 -169.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -114.46 156.96 23.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 52.52 109.502 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 p -74.04 123.56 24.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.606 0.241 . . . . 74.34 110.817 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.9 134.33 47.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.844 -0.428 . . . . 73.53 109.844 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.5 m -121.55 118.21 28.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.779 0.323 . . . . 72.52 110.408 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.98 -148.34 7.92 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.173 -0.771 . . . . 71.04 111.173 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -111.32 116.67 31.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.035 0.445 . . . . 64.32 110.426 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.84 -170.8 29.94 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.013 -0.835 . . . . 53.53 111.013 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.51 -5.39 49.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.911 0.386 . . . . 73.1 110.789 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.76 112.04 14.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 61.05 110.851 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.73 -16.73 11.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.098 -0.501 . . . . 63.45 111.061 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.457 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 90.9 m-85 -130.88 132.33 45.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.492 -0.322 . . . . 72.24 110.736 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.31 112.84 2.57 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.668 -0.777 . . . . 72.45 111.21 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.799 HG22 ' HB1' ' A' ' 19' ' ' ALA . 38.8 t -99.95 119.81 48.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.666 0.269 . . . . 45.21 111.035 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.534 HD23 HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -94.12 107.79 19.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.339 0.59 . . . . 61.32 110.336 177.426 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.923 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 2.7 m -115.12 102.5 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.528 0.68 . . . . 74.02 110.663 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.46 ' HB ' ' CG2' ' A' ' 31' ' ' THR . 10.0 m -92.64 122.67 35.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.358 -0.837 . . . . 75.32 110.867 -175.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HD2' HG23 ' A' ' 27' ' ' VAL . 12.6 mpt_? -79.53 153.05 76.05 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.163 -0.472 . . . . 63.11 110.36 177.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.2 1.78 3.23 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.967 2.445 . . . . 62.43 111.44 174.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -85.66 -13.49 48.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.101 -0.954 . . . . 71.21 109.816 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.08 -7.33 48.08 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.843 -0.694 . . . . 64.11 112.668 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 t -91.8 126.88 37.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 75.23 111.364 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 35.8 ttp180 -107.93 124.27 49.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.609 -0.723 . . . . 63.21 109.45 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.676 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 30.2 t -122.46 137.05 57.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.509 -0.314 . . . . 63.14 110.935 -175.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.478 ' HG3' ' HB3' ' A' ' 74' ' ' ALA . 34.0 mt-10 -93.07 122.4 35.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.012 0.434 . . . . 73.23 110.747 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.468 HG22 HG23 ' A' ' 71' ' ' THR . 16.9 t -103.12 109.34 26.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.689 -0.856 . . . . 74.23 108.689 173.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.5 m170 -90.15 127.03 36.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.889 0.376 . . . . 63.14 110.297 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.758 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -112.86 159.82 18.65 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.611 -0.722 . . . . 74.12 112.185 -171.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.659 ' HB2' HD21 ' A' ' 69' ' ' LEU . 16.0 t70 -90.5 169.84 10.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.559 -1.2 . . . . 75.54 109.797 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -31.54 64.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.766 0.426 . . . . 75.02 111.102 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -94.35 17.33 13.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.551 -0.295 . . . . 74.21 111.122 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 64.02 38.87 8.31 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.827 0.677 . . . . 72.31 112.827 175.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -99.32 147.52 25.11 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.631 -0.507 . . . . 74.24 109.631 169.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.758 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.4 p -74.25 119.85 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.333 0.587 . . . . 75.24 110.561 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 63' ' ' ASP . 93.0 mt -89.12 -47.42 8.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.867 -0.606 . . . . 72.13 110.339 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -164.55 156.47 16.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.117 -0.492 . . . . 75.33 110.498 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.468 HG23 HG22 ' A' ' 60' ' ' VAL . 8.0 m -124.23 118.04 25.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.858 -0.61 . . . . 71.52 109.977 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 8.7 pt-20 -134.1 121.58 15.73 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 71.34 111.319 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 37.3 Cg_exo -61.59 120.19 7.7 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.751 2.301 . . . . 73.03 111.3 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.478 ' HB3' ' HG3' ' A' ' 59' ' ' GLU . . . -143.25 164.92 28.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.981 0.419 . . . . 62.05 111.637 -173.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.94 -0.573 . . . . 54.41 110.064 177.606 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.753 -0.462 . . . . 73.53 109.753 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . . . -75.43 72.78 2.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.192 0.52 . . . . 64.22 112.068 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -128.14 108.01 10.28 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.078 -0.712 . . . . 74.52 109.078 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.658 ' H ' ' HD3' ' A' ' 18' ' ' ARG . 29.7 t70 67.62 110.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.109 0.88 . . . . 74.32 111.233 -173.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.81 -77.76 0.11 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.705 -0.759 . . . . 54.35 112.092 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.776 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 9.3 tp10 -85.96 157.34 20.16 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.059 -0.348 . . . . 64.44 110.059 177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -83.88 -9.39 58.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.579 0.704 . . . . 44.1 109.642 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.776 ' H ' ' HG3' ' A' ' 8' ' ' GLU . 10.6 mm-40 -84.56 88.57 7.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.191 -0.913 . . . . 75.23 109.561 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.62 90.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.131 0.491 . . . . 63.43 110.713 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.8 p -93.86 -5.56 47.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.949 -0.569 . . . . 73.35 110.597 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.73 146.77 5.68 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.033 -0.827 . . . . 71.22 111.033 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 25.2 Cg_endo -62.18 -53.82 1.78 Allowed 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.668 2.246 . . . . 63.04 112.156 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -97.85 -37.67 9.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.959 -0.564 . . . . 74.23 110.905 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.67 -48.79 58.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.77 -0.65 . . . . 74.34 112.213 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -65.68 -50.96 62.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.277 0.561 . . . . 53.41 111.569 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.691 HH11 ' HG2' ' A' ' 18' ' ' ARG . 12.5 mtt-85 -72.75 -37.39 67.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.549 -0.75 . . . . 65.22 111.592 -168.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.534 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -67.15 -42.01 85.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.07 0.462 . . . . 53.44 110.237 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -62.65 -46.19 89.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.546 -0.752 . . . . 73.33 110.775 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.27 -21.78 63.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 72.33 111.607 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . . . -86.1 -40.04 16.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.905 0.383 . . . . 65.5 111.338 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.553 ' HB2' HG11 ' A' ' 48' ' ' VAL . . . -69.73 -22.44 63.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.457 0.54 . . . . 64.03 112.457 -174.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 p -63.43 -22.99 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.831 0.348 . . . . 71.04 111.128 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -78.03 -16.43 58.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.662 0.268 . . . . 71.32 111.216 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.88 -14.37 23.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.932 0.396 . . . . 43.24 111.302 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.516 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 7.3 p -116.14 122.2 32.61 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.047 0.451 . . . . 73.31 110.992 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 27' ' ' VAL . 3.3 Cg_exo -74.93 100.89 1.4 Allowed 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.899 2.399 . . . . 74.23 112.239 -178.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.85 38.21 91.99 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.88 -0.6 . . . . 72.13 112.501 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.435 ' HA3' ' CG2' ' A' ' 27' ' ' VAL . . . -102.87 -172.1 26.5 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.71 -0.757 . . . . 15.03 112.526 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.1 m -98.88 115.36 28.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.746 0.308 . . . . 60.25 110.577 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.84 105.0 15.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.903 -0.59 . . . . 54.53 110.093 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.09 161.98 18.3 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.944 -0.646 . . . . 43.31 112.445 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.04 141.26 52.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.051 0.453 . . . . 75.03 110.437 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.821 HG11 ' HA ' ' A' ' 48' ' ' VAL . 34.9 m -126.73 156.0 37.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.937 -0.574 . . . . 64.32 111.451 -172.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -105.52 155.82 18.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.03 -0.532 . . . . 64.32 110.053 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.95 124.07 25.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.282 -0.417 . . . . 75.4 110.449 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.69 122.34 21.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.889 0.376 . . . . 75.04 110.24 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.0 t -77.43 129.41 35.72 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.182 -0.463 . . . . 72.34 110.078 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.94 -150.95 9.55 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.638 -0.792 . . . . 72.44 112.216 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -151.25 132.42 14.43 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.06 -0.719 . . . . 41.31 109.06 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.65 -135.17 9.68 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.624 -0.798 . . . . 63.44 112.283 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 63' ' ' ASP . . . -87.69 -30.84 20.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.693 0.282 . . . . 74.44 110.744 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.22 102.71 3.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.087 0.47 . . . . 62.34 111.076 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.07 -42.86 2.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.857 -0.61 . . . . 54.4 111.072 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.444 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 46.0 m-85 -114.61 133.58 55.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.528 -0.305 . . . . 73.3 110.229 -177.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.83 112.94 2.34 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.865 -0.894 . . . . 75.11 110.865 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.821 ' HA ' HG11 ' A' ' 35' ' ' VAL . 6.3 t -110.25 139.61 32.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.838 0.351 . . . . 42.02 110.642 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.8 pp -105.16 126.74 52.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.136 0.493 . . . . 73.45 110.813 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.403 ' CG1' ' HB1' ' A' ' 23' ' ' ALA . 2.4 m -129.09 120.3 51.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.17 0.51 . . . . 74.42 110.791 176.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -102.94 126.33 50.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.843 -0.617 . . . . 55.42 110.831 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.535 ' HB2' HG23 ' A' ' 56' ' ' THR . 10.6 mpt_? -81.56 152.28 69.64 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.341 -0.614 . . . . 72.13 109.341 173.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.48 -23.15 46.13 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.823 2.348 . . . . 74.34 112.839 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.61 -27.48 68.97 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.917 0.389 . . . . 55.03 111.168 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.72 -12.67 15.25 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.692 -0.766 . . . . 74.24 112.107 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.535 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.5 t -72.23 128.63 36.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.505 0.669 . . . . 63.31 110.46 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 57' ' ' ARG . 12.2 ttt180 -118.48 119.75 35.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.447 -0.797 . . . . 71.31 109.385 -175.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -107.51 137.22 39.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.219 -0.446 . . . . 61.4 111.16 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.55 112.21 24.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.407 0.623 . . . . 74.21 109.432 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 71' ' ' THR . 25.4 t -97.37 114.61 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.995 -0.548 . . . . 71.14 109.973 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -89.59 122.85 33.12 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.081 0.467 . . . . 74.41 110.528 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.619 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -113.07 145.93 40.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.1 -0.955 . . . . 62.32 110.144 -177.126 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.586 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 20.7 p30 -91.91 -167.71 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.008 0.432 . . . . 74.0 111.431 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -65.99 -17.98 65.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.588 -0.733 . . . . 73.31 111.849 -172.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -109.54 13.51 23.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.752 -0.204 . . . . 73.11 110.904 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 65.37 30.76 10.86 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.279 0.561 . . . . 65.31 111.229 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.403 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . 26.2 ttp180 -93.52 137.37 32.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.532 -0.758 . . . . 70.01 109.795 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.619 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.5 p -65.06 117.18 5.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.362 0.601 . . . . 71.23 111.574 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.549 HD21 ' HB3' ' A' ' 63' ' ' ASP . 96.2 mt -90.93 -60.01 2.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.679 -0.692 . . . . 72.51 110.991 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -157.52 147.59 20.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 61.33 110.085 -172.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.483 HG22 HG22 ' A' ' 60' ' ' VAL . 17.0 p -124.01 109.52 13.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.901 0.382 . . . . 75.31 110.901 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 11.0 mm-40 -107.35 155.44 39.47 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.077 -0.51 . . . . 62.42 110.828 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 5.1 Cg_exo -74.57 122.29 7.3 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.467 2.112 . . . . 74.0 110.885 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.16 156.48 23.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.416 -0.357 . . . . 54.01 110.298 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 116.393 -0.367 . . . . 62.43 110.336 -179.51 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 CA--C 1.515 -0.372 0 N-CA-C 108.697 -0.853 . . . . 64.15 108.697 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.35 75.12 3.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.047 0.451 . . . . 72.34 111.77 -174.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.91 54.69 0.74 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.65 0.738 . . . . 74.24 109.117 172.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.586 ' N ' ' HD2' ' A' ' 18' ' ' ARG . 25.1 t70 174.23 101.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.075 -1.421 . . . . 71.31 107.84 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.76 -78.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.865 -0.683 . . . . 65.04 112.814 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.662 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 11.2 tt0 -156.26 -166.1 2.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.676 0.274 . . . . 73.22 110.708 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.662 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 4.8 m-20 -66.5 -6.66 15.63 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.939 0.718 . . . . 63.14 112.939 -172.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.79 84.16 1.88 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.034 0.445 . . . . 72.23 111.047 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -91.95 87.42 2.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.416 -0.587 . . . . 73.12 109.416 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 t -114.24 130.22 56.64 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.632 -0.713 . . . . 62.11 110.098 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.65 -151.5 41.38 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.233 -0.984 . . . . 61.32 111.703 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.495 ' HB2' ' H ' ' A' ' 15' ' ' ASP . 63.9 Cg_endo -73.29 -142.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.772 2.315 . . . . 71.04 112.144 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 3.2 m-20 -74.41 12.08 0.85 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.398 0.518 . . . . 71.44 112.398 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.642 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -49.72 -34.15 18.06 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.9 0.381 . . . . 43.01 111.353 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.71 -42.38 71.44 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.393 -0.821 . . . . 63.25 112.278 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 15' ' ' ASP . 12.1 mmt180 -64.71 -57.91 7.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.287 0.565 . . . . 75.51 111.123 -170.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.765 ' HB3' HG21 ' A' ' 35' ' ' VAL . . . -73.38 -26.94 61.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.522 -0.763 . . . . 74.45 111.946 -173.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -66.73 -35.84 81.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 74.34 110.858 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.49 -39.51 88.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 74.52 110.862 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.35 -28.88 63.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.028 -0.533 . . . . 42.2 111.297 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 -27.36 68.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.08 -0.509 . . . . 62.42 111.859 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.0 t -59.47 -38.26 74.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.458 . . . . 64.32 111.266 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -81.13 -12.38 59.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.289 -0.414 . . . . 71.23 111.143 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.63 -6.87 58.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 60.11 111.452 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.05 124.08 7.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.017 0.437 . . . . 61.42 111.483 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.75 105.68 2.11 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.401 2.067 . . . . 75.43 112.136 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.78 39.54 89.94 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.081 -0.581 . . . . 72.32 112.417 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.736 ' HA2' ' HD3' ' A' ' 53' ' ' PRO . . . -101.92 -147.77 20.25 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.581 -0.819 . . . . 61.25 112.697 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.668 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 58.6 m -137.63 131.26 31.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.699 0.285 . . . . 61.21 110.574 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.05 120.44 41.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.298 -0.41 . . . . 52.13 110.641 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.68 161.16 13.33 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.841 -0.695 . . . . 51.1 111.582 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.443 ' O ' HD21 ' A' ' 49' ' ' LEU . 1.4 mp0 -62.5 128.13 34.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.338 . . . . 65.0 110.428 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.765 HG21 ' HB3' ' A' ' 19' ' ' ALA . 19.8 m -90.21 154.77 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.013 -0.539 . . . . 71.03 110.769 -175.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -112.67 153.61 27.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.14 -0.482 . . . . 72.44 111.059 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 m -85.22 115.27 22.9 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.702 -0.851 . . . . 74.42 108.702 171.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -75.61 130.18 38.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.242 0.544 . . . . 75.54 111.9 -172.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.2 p -88.9 118.27 28.49 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.962 -0.755 . . . . 72.24 108.962 171.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.95 -125.04 0.8 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.9 -1.143 . . . . 71.3 113.338 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.88 158.36 44.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.724 0.297 . . . . 72.52 110.481 -172.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.9 -116.18 4.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.05 -0.595 . . . . 63.11 113.077 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.84 10.06 5.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.559 0.219 . . . . 72.02 111.219 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.06 107.07 3.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.053 -0.351 . . . . 72.24 110.053 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.72 -54.35 2.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.094 -0.503 . . . . 74.12 111.646 -175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -115.64 133.41 56.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.0 0.428 . . . . 74.2 111.405 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.18 112.49 3.06 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.675 -0.774 . . . . 65.41 111.261 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.606 HG22 ' HB1' ' A' ' 19' ' ' ALA . 27.4 t -95.24 109.72 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.633 0.254 . . . . 74.43 110.687 -175.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.694 ' H ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -85.51 102.7 13.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.28 0.562 . . . . 65.05 110.74 -179.228 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.3 t -97.1 110.34 24.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.716 -0.674 . . . . 32.14 110.016 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.668 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 14.0 m -91.92 116.6 29.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.11 -0.495 . . . . 75.13 110.548 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -96.94 135.84 21.86 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.185 -0.461 . . . . 54.31 110.023 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.736 ' HD3' ' HA2' ' A' ' 30' ' ' GLY . 37.1 Cg_endo -65.68 -8.81 20.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.878 2.386 . . . . 45.3 111.386 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -64.12 -26.75 68.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.89 -1.05 . . . . 75.52 110.487 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.46 32.64 2.28 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.67 -0.776 . . . . 73.44 112.352 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 t -145.38 144.93 30.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.102 0.477 . . . . 72.33 110.956 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -107.89 118.5 36.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.705 -0.68 . . . . 73.32 109.263 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 45.5 t -112.33 115.7 50.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.771 -0.455 . . . . 70.12 109.771 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 12.4 pt-20 -101.81 113.21 26.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.659 0.742 . . . . 73.34 110.823 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.608 HG22 HG23 ' A' ' 71' ' ' THR . 18.6 t -89.12 118.57 34.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.179 -0.918 . . . . 54.33 109.224 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -93.35 123.22 36.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.345 -0.389 . . . . 65.42 110.345 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 68' ' ' VAL . 1.0 OUTLIER -115.64 152.21 33.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.889 -0.596 . . . . 65.04 111.157 -174.418 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.594 ' HB3' HD21 ' A' ' 69' ' ' LEU . 3.7 p-10 -94.47 -164.52 1.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.882 -0.599 . . . . 75.15 110.531 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.6 mtt-85 -71.66 -24.57 61.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.121 -0.491 . . . . 70.11 111.26 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.45 0.08 56.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.04 0.448 . . . . 73.15 109.801 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 67.99 32.48 5.05 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.332 -0.849 . . . . 55.14 110.678 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -101.06 154.53 18.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.065 -0.516 . . . . 73.23 109.884 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.578 ' HA ' HD12 ' A' ' 62' ' ' LEU . 7.1 p -71.13 118.8 16.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.41 0.624 . . . . 53.23 111.435 -176.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 63' ' ' ASP . 96.1 mt -85.52 -51.21 6.66 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.002 -0.74 . . . . 75.32 109.002 172.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -155.05 166.15 34.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.676 -0.693 . . . . 75.44 109.923 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.608 HG23 HG22 ' A' ' 60' ' ' VAL . 27.7 m -148.49 109.1 4.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.564 -0.532 . . . . 74.01 109.564 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 2.2 pm0 -130.57 135.98 28.23 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.139 0.495 . . . . 61.52 111.649 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 6.0 Cg_exo -79.79 92.83 1.09 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.863 2.375 . . . . 72.12 110.531 171.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.35 110.31 21.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.171 -0.468 . . . . 73.22 111.161 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 73.15 109.93 177.678 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 CA--C 1.518 -0.28 0 N-CA-C 109.41 -0.589 . . . . 73.45 109.41 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.23 67.23 8.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.29 0.567 . . . . 70.22 110.735 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -131.85 57.63 1.77 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.638 -0.71 . . . . 73.33 110.007 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -127.11 -58.07 1.29 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.707 -0.679 . . . . 71.53 109.338 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.89 178.66 51.1 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.911 -0.662 . . . . 72.05 112.319 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.799 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 24.6 tt0 -124.07 -172.21 2.49 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 122.681 -0.305 . . . . 75.04 110.185 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.799 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 11.9 m-20 -77.83 -9.28 58.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.588 -0.278 . . . . 74.32 111.594 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.39 93.94 7.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.412 . . . . 73.13 110.342 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -76.27 86.92 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.456 0.646 . . . . 62.22 109.79 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 t -107.11 -0.12 23.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.593 -0.73 . . . . 72.51 110.483 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.38 175.96 23.72 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.403 -0.679 . . . . 74.24 111.403 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.523 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 5.7 Cg_exo -76.14 -76.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.614 2.21 . . . . 55.33 111.818 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -70.8 -35.65 72.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.698 -0.683 . . . . 74.12 111.104 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.517 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -54.21 -49.31 69.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 75.45 111.478 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.52 -43.65 89.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 71.11 111.407 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 14' ' ' PRO . 7.2 mmt85 -64.07 -41.81 97.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.175 -0.466 . . . . 60.41 110.96 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.677 ' HB3' HG21 ' A' ' 35' ' ' VAL . . . -81.08 -35.01 32.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.248 -0.433 . . . . 54.04 112.061 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -65.21 -28.5 69.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.013 0.435 . . . . 73.23 110.291 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.39 -38.22 84.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 75.21 110.779 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.35 -30.86 57.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.047 0.451 . . . . 33.45 111.073 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.514 ' HB1' ' CG1' ' A' ' 50' ' ' VAL . . . -55.88 -35.88 66.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.568 -0.742 . . . . 61.04 112.076 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.4 t -55.77 -40.51 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 64.12 111.808 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -86.86 -12.86 46.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.262 -0.426 . . . . 73.32 111.319 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.4 -34.7 17.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.416 -0.356 . . . . 64.23 111.105 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.568 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 14.3 p -91.63 130.53 38.74 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.936 0.398 . . . . 74.33 110.593 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.94 86.71 0.73 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.44 2.093 . . . . 73.4 112.42 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.47 38.73 96.15 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.733 -0.667 . . . . 51.13 112.586 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.58 -175.88 19.2 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.587 -0.816 . . . . 71.35 112.481 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.7 m -96.35 126.63 41.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.865 0.364 . . . . 64.11 110.986 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.09 131.28 37.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.086 -0.506 . . . . 72.42 109.824 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.96 162.01 15.89 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.543 -0.837 . . . . 63.12 112.378 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -55.05 119.85 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.128 0.489 . . . . 70.22 110.917 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.677 HG21 ' HB3' ' A' ' 19' ' ' ALA . 17.9 m -96.38 155.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.472 -0.785 . . . . 74.11 110.373 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -125.9 144.94 50.47 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.428 -0.351 . . . . 72.44 110.129 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.3 p -76.7 142.3 40.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.245 -0.434 . . . . 74.55 110.355 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -83.66 84.24 7.62 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.758 -0.83 . . . . 73.33 108.758 172.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -72.93 123.27 23.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.189 -0.914 . . . . 75.24 110.335 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.2 -26.93 6.55 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.763 -0.935 . . . . 63.53 110.763 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.26 146.47 28.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.263 -0.469 . . . . 52.31 110.303 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.95 -40.05 4.17 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.788 -0.72 . . . . 64.43 112.122 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.33 -65.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.697 0.284 . . . . 61.33 111.15 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.12 93.68 5.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.058 0.456 . . . . 61.13 110.901 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.52 -40.32 19.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.889 -0.596 . . . . 64.21 111.162 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -115.79 143.26 45.65 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.556 -0.293 . . . . 73.35 110.564 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -124.21 112.23 1.77 Allowed Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.793 -0.923 . . . . 65.11 110.793 171.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.561 HG22 ' HB1' ' A' ' 19' ' ' ALA . 89.0 t -96.82 110.73 25.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.72 0.295 . . . . 74.42 110.639 -176.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.537 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.5 pp -96.42 115.23 27.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.399 0.618 . . . . 72.04 110.873 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.568 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 5.1 m -115.1 126.55 72.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.636 -0.711 . . . . 64.22 110.533 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.2 m -92.23 106.63 18.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.919 -0.582 . . . . 75.23 110.153 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 52' ' ' ARG . 56.6 mtt180 -72.0 149.38 92.3 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.891 -0.411 . . . . 75.44 109.891 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.91 -12.05 27.42 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.555 2.17 . . . . 65.03 111.11 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -68.61 -26.72 65.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.97 -1.013 . . . . 74.4 110.541 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.97 -17.21 15.33 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.851 -0.69 . . . . 72.33 112.755 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 t -89.57 149.35 22.9 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.878 0.371 . . . . 74.55 111.287 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -103.31 119.99 39.92 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.383 -0.599 . . . . 63.32 109.383 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 58.8 t -102.74 124.18 56.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.439 -0.578 . . . . 44.24 109.439 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 9.7 pt-20 -108.9 111.58 23.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.843 0.83 . . . . 75.12 110.314 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.658 HG22 HG23 ' A' ' 71' ' ' THR . 16.6 t -86.69 116.39 29.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.433 -0.803 . . . . 54.2 109.881 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -79.76 118.35 21.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.244 -0.435 . . . . 74.52 110.218 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.695 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -115.67 154.6 29.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.618 -0.719 . . . . 72.24 111.575 -173.452 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.681 ' HB2' HD21 ' A' ' 69' ' ' LEU . 20.6 t70 -89.87 173.77 8.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.168 -0.924 . . . . 71.31 109.421 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -52.02 -37.74 54.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.946 0.498 . . . . 73.22 111.615 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.26 14.82 11.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.441 . . . . 73.0 111.542 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.42 ' CD2' HD23 ' A' ' 62' ' ' LEU . 7.7 m-85 65.63 25.42 11.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.144 0.497 . . . . 71.41 111.475 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -80.48 137.52 36.48 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.971 -0.752 . . . . 62.43 108.971 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.695 ' HA ' HD12 ' A' ' 62' ' ' LEU . 8.6 p -70.91 125.6 29.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.313 0.578 . . . . 53.23 111.187 -176.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 63' ' ' ASP . 71.6 mt -97.26 -58.58 1.98 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.664 -0.698 . . . . 70.05 109.674 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -155.7 141.11 17.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.947 -0.569 . . . . 63.42 110.088 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.658 HG23 HG22 ' A' ' 60' ' ' VAL . 18.5 m -107.8 111.6 23.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.544 -0.539 . . . . 54.31 109.544 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 12.3 pt-20 -135.32 129.24 18.67 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.18 0.514 . . . . 73.35 112.072 -173.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 2.0 Cg_endo -82.52 130.56 6.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.825 2.35 . . . . 62.05 110.263 169.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.57 172.16 7.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.969 0.414 . . . . 40.4 111.652 -175.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.797 -0.638 . . . . 75.32 109.834 179.136 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 mpp? . . . . . 0 C--O 1.233 0.204 0 N-CA-C 109.968 -0.382 . . . . 73.22 109.968 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HB1' ' HB2' ' A' ' 18' ' ' ARG . . . -80.86 73.75 7.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.033 0.444 . . . . 65.43 110.892 -178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -135.14 93.71 3.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.115 0.483 . . . . 51.33 110.511 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -150.29 -77.97 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.819 -0.808 . . . . 63.01 108.819 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.585 ' HA2' ' OD1' ' A' ' 17' ' ' ASP . . . 79.0 140.06 1.81 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.824 -0.625 . . . . 74.34 114.029 171.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.547 ' O ' HG22 ' A' ' 11' ' ' VAL . 34.5 tt0 -80.98 134.03 35.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.582 -0.895 . . . . 72.43 108.582 171.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.35 1.89 20.44 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.997 0.369 . . . . 75.13 111.997 -170.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.89 8.01 20.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.826 0.306 . . . . 70.33 111.826 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 17' ' ' ASP . 28.5 m -84.11 159.03 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.735 -0.386 . . . . 51.1 109.996 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 p -94.37 -25.22 17.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.86 -0.336 . . . . 72.12 111.293 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.428 ' HA2' ' HD2' ' A' ' 14' ' ' PRO . . . -95.1 111.23 4.16 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.853 -0.689 . . . . 61.1 111.581 174.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.428 ' HD2' ' HA2' ' A' ' 13' ' ' GLY . 13.5 Cg_endo -56.76 -55.83 2.41 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.983 2.456 . . . . 64.55 112.695 -175.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -89.06 -9.2 52.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.029 0.442 . . . . 55.13 110.698 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 1.119 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -66.28 -43.44 86.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.531 -0.759 . . . . 74.1 111.937 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.639 ' HB2' HG21 ' A' ' 11' ' ' VAL . 8.6 t70 -52.47 -57.46 9.82 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.066 -0.516 . . . . 75.12 112.148 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.563 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -71.42 -31.7 67.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.242 0.46 . . . . 63.3 112.242 -173.004 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.641 ' HB2' ' HE1' ' A' ' 66' ' ' PHE . . . -69.01 -39.91 79.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.075 0.464 . . . . 42.53 110.5 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -25.87 55.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.953 -0.567 . . . . 73.52 110.503 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.38 -32.91 62.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.354 . . . . 52.14 110.939 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.08 -26.89 62.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.178 0.513 . . . . 61.34 111.09 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.554 ' HB2' HG11 ' A' ' 48' ' ' VAL . . . -71.5 -23.15 61.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.915 -0.584 . . . . 33.13 111.442 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -63.13 -25.03 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.17 0.51 . . . . 55.35 111.239 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -80.31 -13.64 59.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.874 0.368 . . . . 73.51 110.963 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.49 1.3 29.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.264 -0.425 . . . . 70.4 111.381 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.08 116.34 5.63 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.144 0.497 . . . . 73.15 111.272 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.21 96.02 0.53 Allowed 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.484 2.123 . . . . 74.12 112.392 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.25 42.21 83.93 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.796 -0.638 . . . . 42.24 112.594 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.03 162.57 20.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.633 -0.794 . . . . 73.54 112.367 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.545 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 28.1 m -87.58 112.0 21.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.952 0.406 . . . . 74.34 110.617 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.53 131.78 53.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.102 -0.499 . . . . 75.33 110.612 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.559 ' HA3' HD11 ' A' ' 49' ' ' LEU . . . -106.97 160.74 14.09 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.517 -0.849 . . . . 54.21 111.168 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.76 136.02 57.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.416 0.627 . . . . 70.35 110.323 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.119 HG22 ' HA ' ' A' ' 16' ' ' ALA . 2.5 m -90.7 157.1 2.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.148 -0.933 . . . . 73.34 111.437 -169.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -104.71 141.83 35.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.875 -0.602 . . . . 75.5 110.074 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.73 104.23 5.3 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.693 -0.685 . . . . 70.53 109.931 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -72.62 138.39 46.74 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.918 -0.401 . . . . 61.13 109.918 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -127.46 153.51 46.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.272 -0.422 . . . . 73.24 110.66 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.47 -19.03 49.44 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.908 -0.663 . . . . 65.44 111.838 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.0 154.51 17.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.458 -0.571 . . . . 73.34 109.458 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.81 -31.48 20.85 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.903 -0.665 . . . . 74.2 112.715 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.638 ' O ' ' HA ' ' A' ' 63' ' ' ASP . . . -111.72 -52.46 2.78 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.75 -0.265 . . . . 71.24 110.976 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 101.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.248 0.547 . . . . 54.23 110.918 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.44 -13.64 14.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 63.2 111.229 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.553 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 20.4 m-85 -135.27 132.64 38.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.723 -0.473 . . . . 63.41 109.723 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.58 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -115.35 112.56 2.72 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.748 -0.739 . . . . 55.42 111.535 177.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.641 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 22.1 t -96.4 129.67 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 122.253 0.221 . . . . 60.51 110.996 -175.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.559 HD11 ' HA3' ' A' ' 33' ' ' GLY . 1.1 pp -101.91 111.22 23.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.214 0.53 . . . . 63.21 110.452 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.1 t -114.65 119.9 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.774 -0.648 . . . . 53.24 110.952 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.545 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 23.8 m -101.32 104.46 15.46 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.75 -0.463 . . . . 64.03 109.75 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 52' ' ' ARG . 41.9 mtt180 -75.62 147.98 82.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.034 -0.53 . . . . 74.11 110.646 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.99 -18.22 41.8 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.169 2.579 . . . . 64.11 112.543 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -70.17 -15.05 62.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.545 . . . . 64.32 110.896 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.9 32.69 7.02 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.587 -0.816 . . . . 61.45 112.39 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -130.09 147.79 51.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.772 0.32 . . . . 63.13 110.372 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -107.17 120.99 43.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.201 -0.454 . . . . 74.1 110.543 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.685 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 57.1 t -119.48 133.66 65.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.762 -0.653 . . . . 61.34 109.629 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 11.5 pt-20 -107.6 124.18 49.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.34 0.591 . . . . 75.01 110.479 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.641 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 25.9 t -94.92 125.98 47.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.425 -0.807 . . . . 61.15 109.853 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -99.16 123.61 43.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.1 0.476 . . . . 72.31 110.509 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -112.17 149.85 31.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.652 -0.704 . . . . 54.43 111.083 -176.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.638 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 18.4 t70 -90.19 171.53 9.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.962 -0.563 . . . . 74.33 109.883 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.47 ' H ' ' HG3' ' A' ' 64' ' ' ARG . 0.3 OUTLIER -42.81 -51.92 5.24 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.033 0.933 . . . . 72.5 111.949 -178.113 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -86.0 18.46 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.875 -0.602 . . . . 65.4 111.203 -174.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.641 ' HE1' ' HB2' ' A' ' 19' ' ' ALA . 6.3 m-85 66.97 27.98 8.66 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.872 -0.603 . . . . 63.33 111.586 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 67' ' ' ARG . 7.4 tpt180 -80.32 124.02 28.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.949 -0.76 . . . . 73.52 108.949 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.669 ' HA ' HD12 ' A' ' 62' ' ' LEU . 7.3 p -63.53 122.83 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.169 0.509 . . . . 75.32 110.536 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.598 HD21 ' HB2' ' A' ' 63' ' ' ASP . 97.7 mt -87.89 -57.62 2.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.116 -0.493 . . . . 70.23 110.682 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -170.89 176.72 4.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.696 -0.483 . . . . 72.44 109.696 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.607 HG22 HG22 ' A' ' 60' ' ' VAL . 16.8 p -140.24 109.42 6.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.317 -0.402 . . . . 64.1 110.656 -177.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -117.74 129.66 25.21 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 121.141 0.496 . . . . 62.11 111.052 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 57.3 Cg_endo -73.91 105.04 1.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.383 2.056 . . . . 75.04 111.948 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.37 93.2 4.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.149 -0.478 . . . . 74.12 111.01 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.674 -0.694 . . . . 75.22 109.266 175.962 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.962 -0.455 . . . . 71.5 111.962 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.66 124.84 34.95 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.984 -0.376 . . . . 45.55 109.984 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.434 ' HG3' ' HD2' ' A' ' 5' ' ' PHE . 10.6 tpt -75.2 133.54 41.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.127 -0.488 . . . . 52.12 109.958 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.27 66.81 2.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.411 0.523 . . . . 72.53 112.411 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.434 ' HD2' ' HG3' ' A' ' 3' ' ' MET . 91.8 m-85 -145.35 90.49 2.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.774 -0.648 . . . . 73.54 109.33 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -131.96 -74.5 0.51 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.874 -0.331 . . . . 74.13 110.802 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.727 ' HA2' ' NH1' ' A' ' 18' ' ' ARG . . . 115.75 85.37 1.22 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 119.977 -1.106 . . . . 55.11 113.713 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.708 ' HG3' ' HG2' ' A' ' 10' ' ' GLU . 10.6 tp10 -71.36 146.1 49.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.643 -0.873 . . . . 62.41 108.643 171.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -91.81 -8.5 46.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.379 0.511 . . . . 60.42 112.379 -168.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.708 ' HG2' ' HG3' ' A' ' 8' ' ' GLU . 12.6 pt-20 -90.79 3.42 54.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.868 0.322 . . . . 75.31 111.868 -175.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.054 HG21 ' HB2' ' A' ' 17' ' ' ASP . 27.4 m -113.24 157.59 13.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.684 0.278 . . . . 72.21 110.98 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -101.49 -11.3 19.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.366 . . . . 61.21 111.038 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.07 143.16 15.61 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.612 -0.804 . . . . 33.2 111.983 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.16 -67.28 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.414 2.076 . . . . 71.34 112.222 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -70.17 -26.53 63.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.043 -0.526 . . . . 72.23 109.927 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.648 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -55.83 -27.1 49.76 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.278 -0.874 . . . . 71.53 111.503 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 1.054 ' HB2' HG21 ' A' ' 11' ' ' VAL . 3.9 t70 -85.36 -55.6 3.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.985 -0.552 . . . . 62.52 111.265 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.727 ' NH1' ' HA2' ' A' ' 7' ' ' GLY . 17.0 mmt-85 -59.26 -46.4 88.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.805 -0.634 . . . . 73.34 111.01 -170.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.749 ' HB2' ' HE1' ' A' ' 66' ' ' PHE . . . -73.36 -35.78 66.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.461 . . . . 42.45 111.478 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 24' ' ' VAL . 46.3 ttt-85 -65.89 -41.69 91.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.906 -0.588 . . . . 65.44 110.512 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.15 86.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.972 0.415 . . . . 62.23 111.088 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.64 76.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.102 -0.499 . . . . 74.01 110.812 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.567 ' HB2' HG11 ' A' ' 48' ' ' VAL . . . -63.9 -43.89 94.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 70.01 111.506 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 20' ' ' ARG . 57.5 t -56.76 -32.07 37.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 74.24 110.986 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -80.72 -13.0 59.38 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.844 -0.617 . . . . 71.2 111.269 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.02 -30.14 12.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.402 -0.363 . . . . 70.31 111.559 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.7 120.35 43.98 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.234 0.54 . . . . 64.13 111.095 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.1 99.66 0.91 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.566 2.177 . . . . 71.22 112.72 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.4 35.14 77.89 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.931 -0.577 . . . . 51.11 112.726 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.11 177.31 33.77 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.574 -0.822 . . . . 51.21 112.335 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.695 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 31.4 m -79.48 116.37 19.66 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.203 -0.295 . . . . 63.31 110.203 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.85 133.43 53.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.295 -0.411 . . . . 54.34 110.339 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -125.28 162.13 19.62 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.497 -0.641 . . . . 51.34 111.497 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -63.89 142.3 58.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.368 0.604 . . . . 73.01 110.937 178.099 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.648 HG22 ' HA ' ' A' ' 16' ' ' ALA . 12.1 m -104.29 155.71 5.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.646 -0.706 . . . . 74.24 110.884 -173.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -119.12 156.62 29.44 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.81 -0.441 . . . . 64.53 109.81 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.3 p -73.47 125.78 28.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.396 -0.366 . . . . 71.24 111.093 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' OE1' ' HD2' ' A' ' 61' ' ' HIS . 38.0 mt-10 -79.79 -166.61 1.03 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.859 -0.61 . . . . 72.4 109.846 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -60.05 129.15 40.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.455 -0.339 . . . . 73.45 110.653 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.35 91.12 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.975 -0.557 . . . . 70.33 112.712 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -83.92 113.39 20.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.867 0.365 . . . . 73.03 110.287 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.14 -156.21 26.78 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.78 -0.646 . . . . 61.2 111.5 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.04 -41.16 5.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.044 0.449 . . . . 62.55 110.427 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.02 112.21 23.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.639 . . . . 72.14 110.195 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.63 -26.39 12.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.977 -0.556 . . . . 61.15 111.009 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -126.35 132.52 51.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.079 -0.509 . . . . 72.43 110.186 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.76 112.26 2.94 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.533 -0.841 . . . . 65.41 111.536 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.606 HG22 ' HB1' ' A' ' 19' ' ' ALA . 39.0 t -97.59 109.29 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.752 0.31 . . . . 63.21 111.117 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 pp -86.86 117.38 25.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.178 0.513 . . . . 63.25 110.631 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.454 HG11 ' HB1' ' A' ' 23' ' ' ALA . 16.4 m -135.74 150.08 28.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.934 -0.576 . . . . 74.13 110.077 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.695 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 28.3 m -136.39 126.03 25.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.34 -0.391 . . . . 64.43 111.061 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HB2' HG23 ' A' ' 56' ' ' THR . 6.6 mpt_? -80.04 142.2 55.45 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.784 -0.821 . . . . 71.24 108.784 173.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.47 -12.7 11.53 Favored 'Trans proline' 0 N--CA 1.475 0.412 0 C-N-CA 123.338 2.692 . . . . 65.45 112.955 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -68.55 -9.51 49.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.929 -0.578 . . . . 71.24 111.158 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.85 32.41 7.2 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.605 -0.807 . . . . 54.33 111.742 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.5 t -128.28 119.42 25.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.416 0.627 . . . . 75.14 110.737 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -105.29 127.0 52.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.303 -0.862 . . . . 71.02 110.386 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.568 HG11 ' HB ' ' A' ' 71' ' ' THR . 98.3 t -131.7 138.76 52.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.97 -0.559 . . . . 74.24 109.765 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 9.4 pt-20 -106.98 121.69 44.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.463 0.649 . . . . 55.43 110.196 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.59 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 21.5 t -85.07 119.19 33.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.207 -0.906 . . . . 65.2 109.586 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.46 ' HD2' ' OE1' ' A' ' 38' ' ' GLU . 46.4 m80 -91.53 118.82 30.92 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.28 0.562 . . . . 62.5 110.495 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.638 HD23 ' HD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -109.44 147.58 32.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.897 -1.047 . . . . 74.24 110.733 -174.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.55 ' HB3' HD21 ' A' ' 69' ' ' LEU . 5.4 p-10 -90.89 -163.2 1.0 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.229 -0.441 . . . . 73.21 110.071 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -66.9 -15.9 63.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.266 -0.424 . . . . 73.45 111.779 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -121.31 16.88 11.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 61.23 111.236 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.749 ' HE1' ' HB2' ' A' ' 19' ' ' ALA . 31.8 m-85 65.67 29.38 10.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.964 -0.562 . . . . 73.05 112.244 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -89.26 134.68 33.95 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.922 -0.77 . . . . 64.13 108.922 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -63.19 113.06 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.434 0.635 . . . . 24.0 111.006 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 63' ' ' ASP . 87.9 mt -83.84 -52.23 6.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.774 -0.648 . . . . 73.31 110.1 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -173.81 160.09 3.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.993 -0.549 . . . . 55.44 110.047 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.568 ' HB ' HG11 ' A' ' 58' ' ' VAL . 19.8 p -128.93 111.43 13.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.039 -0.528 . . . . 62.31 111.121 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 1.7 pm0 -112.84 143.84 29.86 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.315 -0.402 . . . . 64.32 110.692 176.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 39.3 Cg_exo -61.23 128.88 26.44 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.127 2.551 . . . . 43.45 112.048 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.522 ' HB2' ' HG2' ' A' ' 59' ' ' GLU . . . -104.99 122.74 46.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.911 -0.586 . . . . 73.33 110.936 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -111.04 175.35 5.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.858 -0.61 . . . . 61.05 109.784 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -130.87 34.37 2.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.531 -0.842 . . . . 63.12 112.677 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -94.37 -19.14 20.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.081 0.467 . . . . 70.14 110.321 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.37 89.03 1.45 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.816 -0.706 . . . . 64.23 112.72 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.52 -177.07 51.62 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.472 -0.651 . . . . 42.13 111.472 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 80' ' ' LEU . 2.0 pt? -145.36 114.59 7.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.868 0.366 . . . . 52.52 110.638 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.703 -0.665 . . . . 74.21 109.429 178.17 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 112.138 -0.385 . . . . 44.44 112.138 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.53 170.9 7.65 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.159 -0.312 . . . . 65.2 110.159 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -71.14 121.9 19.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.958 -0.386 . . . . 74.43 109.958 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.22 69.78 9.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.185 -0.461 . . . . 74.1 111.8 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -98.6 113.1 25.01 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.201 -0.666 . . . . 73.44 109.201 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.429 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 19.3 t70 63.91 101.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.915 0.759 . . . . 74.43 110.331 -171.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.41 ' H ' ' CZ ' ' A' ' 18' ' ' ARG . . . -93.72 -108.04 1.95 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.71 -0.677 . . . . 73.31 112.49 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.619 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 31.2 tt0 -107.51 177.41 4.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.802 0.334 . . . . 73.03 110.678 -177.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.619 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 28.4 t70 -75.14 -8.94 57.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.943 -0.571 . . . . 62.4 111.829 -175.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -65.56 97.36 0.3 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.957 0.408 . . . . 55.11 110.703 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 51.7 t -83.04 86.17 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.457 0.646 . . . . 74.34 111.006 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 t -101.66 -13.33 17.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.757 0.789 . . . . 65.34 109.066 171.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.686 ' HA3' ' HB3' ' A' ' 16' ' ' ALA . . . 170.71 135.81 1.98 Allowed Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.592 -1.185 . . . . 73.3 110.345 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -54.67 -70.15 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 123.016 2.478 . . . . 70.15 112.153 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -89.69 -20.72 23.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.827 -0.624 . . . . 74.51 110.147 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.686 ' HB3' ' HA3' ' A' ' 13' ' ' GLY . . . -59.65 -49.54 77.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.424 -0.807 . . . . 70.41 111.311 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -58.0 -40.93 81.94 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.203 0.525 . . . . 74.43 111.469 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.429 ' NE ' ' HA ' ' A' ' 6' ' ' ASP . 17.4 mmt180 -65.06 -43.91 90.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.595 -0.73 . . . . 63.53 110.827 -171.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.92 -28.1 28.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.438 -0.346 . . . . 62.03 111.347 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.94 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 63.0 ttt180 -65.7 -35.99 82.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.507 -0.315 . . . . 74.11 110.364 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -62.77 -34.01 76.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.854 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.09 -35.59 61.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 70.54 110.348 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.47 ' HB2' HG13 ' A' ' 48' ' ' VAL . . . -58.92 -55.45 34.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 73.44 111.032 177.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.19 -11.04 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.37 0.605 . . . . 44.31 110.891 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 5.7 tp60 -88.25 -24.64 23.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 73.45 110.11 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.5 18.87 20.46 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.055 -0.52 . . . . 64.42 111.753 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.03 125.19 11.39 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 121.014 0.435 . . . . 72.21 110.35 176.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.93 82.56 1.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.431 2.087 . . . . 51.2 112.584 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.94 28.47 71.79 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.772 -0.649 . . . . 74.2 112.875 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.55 175.44 29.15 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.712 -0.756 . . . . 62.33 112.113 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.796 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 58.0 m -78.09 105.9 9.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.267 0.556 . . . . 73.24 110.964 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.6 120.62 37.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.684 -0.689 . . . . 51.4 109.881 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.501 ' HA3' HD11 ' A' ' 49' ' ' LEU . . . -101.19 160.43 18.51 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.524 -0.846 . . . . 23.42 112.285 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.94 ' HG2' ' HD2' ' A' ' 20' ' ' ARG . 23.4 mt-10 -79.25 151.64 31.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.984 -0.376 . . . . 52.24 109.984 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.512 HG12 HD23 ' A' ' 49' ' ' LEU . 26.7 m -128.72 155.54 40.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.956 -0.565 . . . . 60.52 111.547 -171.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.13 158.85 17.88 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.419 -0.585 . . . . 75.03 109.419 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -72.92 113.28 9.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.012 0.434 . . . . 34.2 110.972 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.21 139.54 56.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 72.1 109.632 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.5 p -138.48 173.89 11.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.832 0.349 . . . . 63.43 111.422 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.74 -115.02 3.27 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.797 -0.716 . . . . 41.15 112.132 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -131.03 172.58 11.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.819 0.342 . . . . 74.43 110.46 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.9 -139.77 14.56 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.169 -0.772 . . . . 51.11 111.169 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 -12.98 4.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.894 0.347 . . . . 65.21 111.456 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.45 133.05 38.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 70.12 111.261 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.77 -28.72 2.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.947 -0.57 . . . . 65.11 110.75 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -131.23 155.77 46.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.435 -0.348 . . . . 71.42 110.274 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.83 145.39 16.82 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.469 -0.872 . . . . 71.31 112.193 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.47 HG13 ' HB2' ' A' ' 23' ' ' ALA . 70.1 t -128.91 105.4 12.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.308 -0.627 . . . . 73.42 109.308 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.512 HD23 HG12 ' A' ' 35' ' ' VAL . 3.3 pp -102.18 123.82 46.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.423 0.63 . . . . 74.2 110.648 -177.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 m -124.61 120.64 59.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.463 -0.79 . . . . 71.34 110.42 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.796 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 12.5 m -92.71 104.28 16.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.822 -0.626 . . . . 60.22 109.995 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -66.09 139.9 96.77 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.877 -0.601 . . . . 75.02 109.438 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.93 -9.56 6.19 Favored 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.169 2.579 . . . . 74.53 112.939 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.99 -13.7 60.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 72.12 110.475 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.28 33.01 5.85 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.771 -0.728 . . . . 41.35 112.563 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -131.2 143.02 50.28 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.096 -0.335 . . . . 62.22 110.096 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 74' ' ' ALA . 24.8 ttp180 -107.23 119.7 40.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.886 0.374 . . . . 75.14 110.087 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.39 114.79 48.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.122 -0.49 . . . . 73.22 110.021 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.54 112.02 24.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.554 0.693 . . . . 72.44 110.431 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.5 t -88.66 124.45 41.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.195 -0.911 . . . . 73.53 109.891 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 70' ' ' ASP . 35.9 m170 -96.06 122.6 39.07 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.909 -0.587 . . . . 74.22 110.667 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -109.78 154.95 22.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.71 -0.677 . . . . 64.14 110.468 -177.123 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 1.011 ' HB3' HD11 ' A' ' 69' ' ' LEU . 3.9 p30 -92.14 -164.23 1.15 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.977 0.417 . . . . 74.3 110.481 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.445 ' HG3' ' H ' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -62.81 -29.16 70.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.725 -0.671 . . . . 73.23 111.191 -175.554 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -100.27 17.27 21.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.175 -0.466 . . . . 64.01 111.316 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 69.02 19.86 7.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.848 -0.615 . . . . 75.11 111.507 172.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.529 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . 40.3 ttm180 -90.63 145.81 24.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.769 0.319 . . . . 70.02 110.522 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.548 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.3 p -67.06 126.47 26.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.211 0.529 . . . . 64.53 110.904 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 1.011 HD11 ' HB3' ' A' ' 63' ' ' ASP . 61.3 mt -112.72 -61.39 1.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.898 -0.592 . . . . 72.22 111.016 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 61' ' ' HIS . 23.0 t70 -132.03 139.83 48.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.551 -0.749 . . . . 72.1 111.315 -169.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.2 m -117.52 110.43 17.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.357 -0.383 . . . . 73.3 110.364 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -114.96 117.53 41.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.953 0.406 . . . . 64.23 111.872 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.23 93.99 0.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.757 2.305 . . . . 44.22 109.998 168.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 57' ' ' ARG . . . -124.92 147.3 48.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.388 -0.369 . . . . 73.02 111.292 -172.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -109.24 155.49 21.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.065 -0.516 . . . . 64.24 109.927 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.61 2.43 67.28 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.547 -0.835 . . . . 73.34 114.013 -172.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.98 -57.81 3.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.671 0.735 . . . . 72.33 110.927 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.17 -101.02 2.39 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.752 -0.737 . . . . 32.4 112.435 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.46 -172.06 45.07 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.865 -0.683 . . . . 73.42 112.222 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.85 HD23 ' HG3' ' A' ' 81' ' ' GLU . 9.1 tt -108.75 130.36 55.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.026 -0.731 . . . . 62.31 109.026 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.85 ' HG3' HD23 ' A' ' 80' ' ' LEU . 52.5 mt-10 . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.724 -0.655 . . . . 65.42 110.283 -173.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.493 0 N-CA-C 111.58 -0.608 . . . . 35.31 111.58 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.3 108.35 5.2 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.796 -0.446 . . . . 54.33 109.796 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -72.84 152.07 41.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.886 -0.597 . . . . 74.41 109.836 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.39 66.85 4.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.268 0.556 . . . . 63.31 111.507 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -113.12 57.5 0.67 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.492 0.663 . . . . 72.41 109.308 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -153.69 117.72 4.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.004 -0.998 . . . . 74.33 109.179 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.81 155.07 25.93 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.776 -0.726 . . . . 72.22 111.614 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.46 165.76 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.523 0.678 . . . . 72.54 111.678 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.55 2.8 55.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.038 -0.983 . . . . 73.33 111.197 -173.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.89 22.26 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 53.14 112.092 -173.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.487 HG21 ' HB2' ' A' ' 17' ' ' ASP . 19.6 m -131.08 173.58 14.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.417 -0.356 . . . . 60.12 110.234 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -93.38 102.4 14.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.922 -0.77 . . . . 74.21 108.922 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.88 92.99 0.54 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.347 -1.101 . . . . 72.32 110.347 -169.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.28 -13.36 19.72 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 123.233 2.622 . . . . 75.31 114.13 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.577 ' HA ' ' CG ' ' A' ' 18' ' ' ARG . 54.0 m-20 -73.04 -15.63 61.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.26 0.552 . . . . 75.23 109.721 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -68.41 -31.99 71.73 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.263 -0.88 . . . . 75.32 109.974 171.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HB2' HG21 ' A' ' 11' ' ' VAL . 11.6 t70 -83.41 -28.33 28.94 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.168 -0.469 . . . . 73.51 111.584 -173.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.577 ' CG ' ' HA ' ' A' ' 15' ' ' ASP . 5.5 mmt180 -54.28 -55.1 31.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.56 0.695 . . . . 74.24 109.931 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.855 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -81.15 -21.61 39.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.247 -0.888 . . . . 73.02 111.141 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 28.0 ttt180 -66.54 -36.24 82.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.0 0.428 . . . . 74.14 110.372 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.34 70.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.291 0.567 . . . . 74.05 110.484 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.27 -38.13 36.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 73.3 110.268 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.402 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -56.48 -48.85 76.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.712 -0.676 . . . . 62.34 111.777 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 p -66.2 -18.69 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.996 0.427 . . . . 62.51 111.213 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.76 -19.69 21.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.973 0.416 . . . . 71.25 110.695 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.55 -31.54 22.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.068 -0.515 . . . . 73.23 111.427 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 23' ' ' ALA . 7.1 p -117.0 120.33 33.96 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.955 0.407 . . . . 62.21 110.541 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.83 104.59 1.19 Allowed 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.741 2.294 . . . . 63.24 112.625 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.19 26.19 71.43 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.913 -0.585 . . . . 23.45 112.584 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.5 -173.28 35.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.743 -0.742 . . . . 40.44 112.068 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.797 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 63.6 m -90.25 111.44 22.62 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.971 0.415 . . . . 72.44 110.745 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.03 100.64 11.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.644 -0.707 . . . . 73.5 109.592 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.605 ' HA3' HD11 ' A' ' 49' ' ' LEU . . . -89.45 160.95 29.58 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.786 -0.721 . . . . 61.44 112.309 -176.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -70.13 127.67 33.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.275 0.56 . . . . 74.21 110.125 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.707 HG21 ' HB3' ' A' ' 19' ' ' ALA . 20.4 m -103.96 153.92 6.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.699 -0.682 . . . . 70.22 111.417 -173.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -106.73 155.57 19.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.39 -0.368 . . . . 64.54 110.283 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.3 m -76.64 111.29 11.98 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.85 -0.426 . . . . 43.22 109.85 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 36.1 mt-10 -78.62 111.24 14.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.174 0.511 . . . . 74.22 110.449 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.4 p -117.66 124.68 49.14 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.011 -0.541 . . . . 72.44 110.646 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.63 -110.69 0.38 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.46 -0.876 . . . . 72.32 112.618 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -113.94 165.77 12.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.957 0.408 . . . . 71.23 111.291 -174.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.97 -150.27 29.03 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.848 -0.691 . . . . 71.43 111.959 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.13 4.95 10.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.143 0.497 . . . . 72.3 110.695 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.51 103.01 12.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 62.31 110.4 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 38' ' ' GLU . . . -103.85 -13.64 16.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.138 -0.483 . . . . 44.24 111.019 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -141.74 133.69 27.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 72.24 110.191 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -116.41 113.62 2.85 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.859 -0.686 . . . . 43.11 111.785 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.855 HG22 ' HB1' ' A' ' 19' ' ' ALA . 34.7 t -95.5 117.09 38.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 110.031 -0.359 . . . . 61.41 110.031 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.605 HD11 ' HA3' ' A' ' 33' ' ' GLY . 1.3 pp -98.39 107.64 20.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.473 0.654 . . . . 63.11 110.276 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.2 m -110.19 107.05 21.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 62.31 110.761 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.797 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 22.4 m -95.6 113.76 25.44 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.845 -0.616 . . . . 64.51 110.76 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -71.21 146.08 91.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.176 -0.676 . . . . 71.2 109.176 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.98 -2.84 6.09 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.718 2.279 . . . . 62.55 112.17 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -83.08 0.5 44.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.682 -0.69 . . . . 73.54 110.539 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.18 33.21 12.24 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.635 -0.793 . . . . 71.52 112.579 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t -135.9 125.56 25.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.136 0.493 . . . . 74.14 110.886 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 54.3 ttt180 -103.75 126.26 50.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.931 -0.577 . . . . 75.0 110.648 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 49.4 t -112.96 132.77 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.184 -0.462 . . . . 72.01 110.262 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -93.06 108.32 19.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.282 -0.417 . . . . 71.54 110.383 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.776 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 21.6 t -89.28 108.36 19.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.204 -0.665 . . . . 71.5 109.204 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -90.1 127.16 36.02 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.989 0.423 . . . . 64.52 110.823 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.705 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -115.74 159.36 21.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.513 -0.767 . . . . 61.14 111.103 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.463 ' HB2' HD21 ' A' ' 69' ' ' LEU . 11.2 t70 -90.43 173.73 7.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.047 -0.979 . . . . 52.31 110.138 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -57.58 -29.43 64.44 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.451 0.7 . . . . 74.41 111.411 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -89.18 5.35 45.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.084 0.469 . . . . 72.11 110.37 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 71.34 21.65 4.55 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.404 -0.816 . . . . 75.2 110.592 -176.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.49 133.13 37.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.894 -0.593 . . . . 74.41 109.877 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.705 ' HA ' HD12 ' A' ' 62' ' ' LEU . 7.2 p -65.55 131.23 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.879 0.371 . . . . 74.11 111.004 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.463 HD21 ' HB2' ' A' ' 63' ' ' ASP . 92.1 mt -101.19 -64.25 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.292 -0.413 . . . . 71.11 110.561 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -166.61 175.8 7.71 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.702 -0.481 . . . . 64.53 109.702 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.426 HG22 HG22 ' A' ' 60' ' ' VAL . 46.9 p -139.09 114.22 9.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.721 0.296 . . . . 70.24 111.384 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -125.4 139.53 34.1 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.096 -0.335 . . . . 75.35 110.096 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 40.6 Cg_endo -69.22 152.08 72.09 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.407 2.071 . . . . 64.54 112.3 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.06 111.56 23.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.324 -0.398 . . . . 71.11 111.598 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -139.5 111.49 7.4 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.243 -0.651 . . . . 60.2 109.243 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -108.83 57.17 0.44 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.81 -0.71 . . . . 61.21 113.65 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -97.01 -48.88 5.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.157 -0.682 . . . . 74.13 109.157 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -132.12 56.0 0.75 Allowed Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.923 -1.035 . . . . 70.13 110.824 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.22 73.57 2.57 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.027 -0.606 . . . . 73.34 112.067 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.1 mt -119.18 143.29 47.32 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.505 -0.554 . . . . 53.31 109.505 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.355 -0.831 . . . . 74.22 108.774 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.647 -0.581 . . . . 71.34 111.647 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.69 113.02 25.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.88 0.372 . . . . 42.22 110.607 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.413 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 4.5 mpp? -84.4 108.43 17.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.154 -0.476 . . . . 73.54 110.209 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.01 89.7 6.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 63.11 111.136 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.432 ' HZ ' ' HA ' ' A' ' 65' ' ' ASP . 79.1 m-85 -117.55 58.14 0.8 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.338 0.59 . . . . 73.24 109.899 175.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -146.56 145.4 30.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.537 -0.756 . . . . 63.52 109.306 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.14 164.9 35.1 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.562 -0.828 . . . . 65.25 111.664 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.93 162.05 20.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.056 0.428 . . . . 75.22 110.706 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -95.22 -10.19 31.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.36 -0.382 . . . . 73.53 111.513 -172.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -85.74 5.1 33.79 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.166 0.432 . . . . 60.11 112.166 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 17' ' ' ASP . 27.8 m -90.14 158.19 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.522 -0.547 . . . . 64.12 109.522 172.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.9 m -92.76 -34.75 13.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.785 0.326 . . . . 70.5 110.384 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.99 109.51 3.12 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.64 -0.79 . . . . 74.11 111.439 175.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.99 -66.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.608 2.206 . . . . 53.44 112.007 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.609 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 5.4 p-10 -71.17 -20.61 62.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.094 -0.503 . . . . 72.14 110.629 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 34' ' ' GLU . . . -56.46 -45.91 80.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.523 -0.762 . . . . 42.5 112.43 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.424 ' HB2' HG21 ' A' ' 11' ' ' VAL . 32.6 t70 -64.92 -54.79 25.21 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.548 0.573 . . . . 61.12 112.548 -173.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.728 ' H ' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -63.64 -32.58 74.1 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.904 -0.318 . . . . 74.14 110.995 -177.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.504 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . . . -68.94 -44.72 72.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.282 0.563 . . . . 61.0 110.262 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.455 ' O ' HG23 ' A' ' 24' ' ' VAL . 38.4 ttp180 -60.09 -46.86 88.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.258 -0.883 . . . . 51.04 110.912 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.39 89.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.95 -0.568 . . . . 71.41 111.671 -177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.56 -38.15 90.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.975 0.417 . . . . 65.22 111.268 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.22 -16.97 57.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.043 -0.526 . . . . 62.25 112.327 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 20' ' ' ARG . 96.0 t -57.53 -39.27 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.951 0.405 . . . . 73.23 111.254 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -70.02 -13.13 62.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.376 -0.375 . . . . 74.53 111.318 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.66 12.31 36.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.36 -0.382 . . . . 74.13 111.15 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.48 114.42 3.82 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.242 0.544 . . . . 75.52 110.693 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.26 93.64 0.66 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.449 2.099 . . . . 53.13 112.699 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.26 43.88 94.58 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.694 -0.684 . . . . 54.05 112.615 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.437 ' HA2' ' HG3' ' A' ' 53' ' ' PRO . . . -110.66 -172.96 19.99 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.585 -0.817 . . . . 33.51 112.638 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.759 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 37.9 m -92.06 114.52 27.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.859 0.361 . . . . 74.35 111.205 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.93 119.83 39.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.824 -0.625 . . . . 44.22 109.999 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.84 161.04 12.88 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.551 -0.833 . . . . 73.43 112.755 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' HB3' ' HB1' ' A' ' 16' ' ' ALA . 1.6 mp0 -67.17 137.26 56.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.058 -0.349 . . . . 71.31 110.058 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.762 HG11 ' HA ' ' A' ' 48' ' ' VAL . 31.1 m -134.01 154.42 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.254 -0.43 . . . . 75.13 111.269 -174.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -106.67 160.63 15.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.276 -0.42 . . . . 70.03 110.118 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 p -71.52 148.75 46.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.055 0.455 . . . . 72.43 111.625 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.59 97.08 6.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 64.22 110.201 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.1 m -89.54 117.6 28.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.984 -0.553 . . . . 74.44 110.532 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.88 -139.19 6.66 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.782 -0.723 . . . . 72.21 112.199 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -95.78 178.06 5.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.969 0.414 . . . . 63.35 110.716 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.49 -168.18 19.5 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.054 -0.593 . . . . 72.34 112.362 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.25 8.45 14.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.939 0.399 . . . . 73.23 110.504 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.24 170.34 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 42.15 110.663 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.11 -36.93 0.17 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.478 -0.328 . . . . 74.34 111.531 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.558 ' HE2' ' HB2' ' A' ' 15' ' ' ASP . 76.3 m-85 -124.61 131.74 53.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.955 -0.387 . . . . 72.25 109.955 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.3 112.28 2.06 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.204 -0.998 . . . . 64.42 110.971 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.762 ' HA ' HG11 ' A' ' 35' ' ' VAL . 12.0 t -109.07 126.17 66.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.736 0.303 . . . . 74.24 111.08 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.494 ' H ' HG11 ' A' ' 35' ' ' VAL . 3.4 pp -87.07 130.71 34.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.215 -0.448 . . . . 75.15 109.992 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.17 114.17 25.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.638 0.733 . . . . 73.34 110.498 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.759 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 11.6 m -97.92 122.83 41.5 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.411 -0.813 . . . . 71.13 110.77 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.435 ' C ' ' H ' ' A' ' 54' ' ' ASP . 8.0 mpt_? -74.32 140.35 76.07 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.686 -0.857 . . . . 74.35 108.686 171.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.437 ' HG3' ' HA2' ' A' ' 30' ' ' GLY . 16.4 Cg_exo -68.88 17.95 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.17 2.58 . . . . 34.51 112.957 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 52' ' ' ARG . 12.3 t70 -109.42 -15.64 14.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.138 0.494 . . . . 73.43 110.331 177.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.22 -19.31 8.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.621 -0.8 . . . . 45.43 112.424 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.89 115.28 18.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.412 0.625 . . . . 64.5 111.091 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 57' ' ' ARG . 34.2 ttp180 -115.74 120.51 39.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.609 -0.723 . . . . 63.43 110.482 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.482 HG12 ' HA ' ' A' ' 73' ' ' PRO . 31.5 m -123.62 163.45 22.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.37 -0.377 . . . . 73.41 110.302 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -122.85 133.92 54.41 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.044 0.45 . . . . 61.12 110.039 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.415 HG12 HD13 ' A' ' 62' ' ' LEU . 22.8 t -101.61 120.13 50.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.482 -0.562 . . . . 52.42 109.482 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -92.2 121.66 33.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.562 . . . . 74.52 110.229 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.649 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.35 156.69 22.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.893 -1.049 . . . . 75.23 110.929 -172.502 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 67' ' ' ARG . 10.9 t70 -90.73 172.11 8.88 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.313 -0.858 . . . . 60.35 109.722 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -50.23 -44.57 53.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.546 0.738 . . . . 60.0 112.352 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 67' ' ' ARG . 27.1 m-20 -96.52 26.14 4.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.911 0.386 . . . . 74.25 110.604 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 19' ' ' ALA . 26.2 m-85 67.1 32.67 6.06 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.216 0.821 . . . . 63.53 113.216 174.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -77.94 126.82 31.4 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.172 -0.677 . . . . 74.34 109.172 169.168 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.649 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.5 p -69.55 120.65 17.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.053 0.454 . . . . 73.45 110.371 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.9 mt -96.18 -62.58 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.24 -0.436 . . . . 71.2 110.896 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -150.71 170.19 19.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 70.21 110.092 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.0 m -147.61 115.79 6.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.041 0.448 . . . . 61.25 110.363 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -133.08 159.45 72.59 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.022 -0.535 . . . . 60.14 110.194 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.482 ' HA ' HG12 ' A' ' 58' ' ' VAL . 18.3 Cg_endo -59.91 143.1 99.64 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.733 2.289 . . . . 42.14 112.476 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.56 122.22 36.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.873 -0.603 . . . . 71.34 110.804 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -144.95 111.43 5.69 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.029 -0.36 . . . . 64.51 110.029 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.76 88.51 0.22 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.05 -0.595 . . . . 71.51 111.73 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -63.05 -36.04 82.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.696 0.284 . . . . 75.55 111.15 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.87 -41.28 0.39 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.264 -0.969 . . . . 44.13 112.865 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -71.93 123.03 9.42 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.912 -0.661 . . . . 73.14 113.278 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.2 mt -122.85 117.26 25.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.473 -0.565 . . . . 70.25 109.473 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.357 -0.83 . . . . 75.51 111.032 -176.072 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.561 0 N-CA-C 111.642 -0.583 . . . . 74.11 111.642 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.33 137.11 52.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.777 0.323 . . . . 61.4 110.922 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.533 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 1.6 mpt? -90.33 116.02 27.97 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.96 -0.756 . . . . 74.32 108.96 175.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.05 81.75 3.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.155 0.503 . . . . 70.43 112.125 -172.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 3' ' ' MET . 91.3 m-85 -121.35 57.52 1.01 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.727 0.775 . . . . 75.12 109.053 174.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.582 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 7.9 t70 -147.83 -142.75 0.13 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.389 -1.337 . . . . 70.32 107.389 -177.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.61 175.83 33.06 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.007 -1.092 . . . . 70.34 112.581 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.6 -178.67 6.95 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.649 -0.5 . . . . 75.11 109.649 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -92.66 -9.55 40.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.439 0.638 . . . . 64.5 109.585 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.13 53.92 2.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.55 -0.75 . . . . 71.1 109.363 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 m -60.14 96.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.858 0.837 . . . . 73.32 112.186 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 t -93.72 -21.83 19.1 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.104 -0.953 . . . . 52.11 109.021 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.755 ' HA3' ' HB3' ' A' ' 16' ' ' ALA . . . -152.27 143.76 10.76 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.153 -0.93 . . . . 41.22 111.096 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -60.75 -68.91 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.819 2.346 . . . . 64.04 111.876 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.577 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 10.8 m-20 -90.01 -22.29 21.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.519 -0.549 . . . . 74.13 109.519 176.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.755 ' HB3' ' HA3' ' A' ' 13' ' ' GLY . . . -58.91 -37.34 76.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.077 -0.965 . . . . 74.12 111.445 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 14.9 t70 -55.57 -57.77 10.56 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.165 -0.471 . . . . 54.53 111.545 -175.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.593 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -69.07 -35.75 76.87 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.945 0.35 . . . . 75.15 111.945 -176.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.411 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -68.48 -42.45 78.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.101 0.477 . . . . 63.24 110.812 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -71.12 -36.91 72.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.839 -0.619 . . . . 71.12 110.56 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.25 -24.07 66.52 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.431 -0.349 . . . . 70.21 111.49 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 -29.89 33.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.402 -0.363 . . . . 54.24 111.152 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.419 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -62.21 -31.77 72.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.045 -0.525 . . . . 72.55 112.034 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.6 p -69.02 -14.01 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.819 0.343 . . . . 74.12 111.731 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -85.36 -31.85 22.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.858 0.361 . . . . 63.12 110.357 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.13 -32.23 39.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.067 -0.515 . . . . 43.14 111.382 -176.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.462 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 14.6 p -111.15 133.9 21.21 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.854 0.359 . . . . 64.25 110.53 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 27' ' ' VAL . 8.9 Cg_endo -82.49 99.88 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.828 2.352 . . . . 62.21 111.871 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.45 39.44 97.8 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.039 -0.601 . . . . 65.25 112.184 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' HA3' ' CG2' ' A' ' 27' ' ' VAL . . . -104.49 168.12 16.12 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.591 -0.814 . . . . 72.04 112.411 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 1.032 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 39.8 m -82.04 106.11 13.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.233 0.539 . . . . 61.41 111.201 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.87 111.91 22.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.395 -0.821 . . . . 51.11 109.29 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.37 162.87 17.86 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.184 -0.532 . . . . 72.51 112.839 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -61.72 106.94 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 72.21 110.232 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.645 HG11 ' HA ' ' A' ' 48' ' ' VAL . 33.9 m -91.25 150.3 3.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.921 -0.581 . . . . 64.21 110.845 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -108.67 150.06 28.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.272 -0.422 . . . . 73.1 110.032 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.74 131.01 39.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.183 0.516 . . . . 71.42 110.999 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.83 133.8 38.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.674 -0.694 . . . . 62.22 110.365 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -91.49 117.67 29.9 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.936 -0.765 . . . . 50.22 108.936 168.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.67 93.62 0.15 Allowed Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.214 -0.993 . . . . 75.12 112.612 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -51.4 114.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.504 -0.554 . . . . 70.12 109.504 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.14 -54.61 0.61 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.736 -0.745 . . . . 55.32 112.149 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -175.13 -38.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.804 0.298 . . . . 74.14 111.804 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.88 130.28 45.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.048 0.452 . . . . 44.14 111.796 -174.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.78 -36.4 0.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.756 -0.656 . . . . 73.1 110.788 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.543 ' HE2' ' HB3' ' A' ' 15' ' ' ASP . 91.8 m-85 -124.84 133.65 53.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 74.22 110.49 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.29 113.46 2.03 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.335 -0.706 . . . . 74.13 111.335 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.645 ' HA ' HG11 ' A' ' 35' ' ' VAL . 45.7 t -101.18 112.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.734 0.302 . . . . 73.32 111.01 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.62 ' HG ' HG12 ' A' ' 35' ' ' VAL . 2.3 pp -85.8 117.05 24.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 74.44 110.042 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.67 114.42 47.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.661 -0.7 . . . . 63.02 110.277 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 1.032 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 20.3 m -96.13 104.92 16.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.233 -0.44 . . . . 73.43 110.461 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -67.04 138.71 95.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.165 -0.68 . . . . 73.52 109.165 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HD3' ' HA2' ' A' ' 30' ' ' GLY . 17.9 Cg_endo -60.05 -7.94 7.21 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.131 2.554 . . . . 70.21 112.998 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -74.25 -14.45 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 70.24 110.537 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.34 33.36 5.17 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.398 -0.906 . . . . 71.35 112.662 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 t -131.84 142.27 49.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.905 0.383 . . . . 72.51 110.949 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 58.9 ttt180 -110.08 122.69 48.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 72.41 111.362 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.48 139.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.406 -0.59 . . . . 73.42 109.406 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -108.2 136.12 48.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.217 0.532 . . . . 73.25 110.858 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 71' ' ' THR . 23.6 t -106.01 118.18 53.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.514 -0.766 . . . . 62.1 109.672 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -89.55 125.32 35.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.09 -0.504 . . . . 72.24 111.521 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.816 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -117.16 147.21 42.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.474 -0.784 . . . . 61.25 109.816 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.872 ' HB3' HD21 ' A' ' 69' ' ' LEU . 1.9 p-10 -91.96 -167.1 1.69 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.951 -0.3 . . . . 74.44 110.439 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -55.27 -38.08 68.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.014 -0.539 . . . . 74.55 111.933 -176.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -89.67 16.45 7.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.019 0.377 . . . . 75.22 112.019 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 65.83 21.84 11.46 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.208 0.528 . . . . 75.22 111.127 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.713 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 9.0 tpt180 -88.34 134.84 33.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.212 -0.449 . . . . 75.04 110.178 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.816 ' HA ' HD12 ' A' ' 62' ' ' LEU . 4.5 p -61.58 116.05 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.242 0.544 . . . . 62.3 111.256 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.872 HD21 ' HB3' ' A' ' 63' ' ' ASP . 85.5 mt -84.42 -49.06 9.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.754 -0.657 . . . . 64.32 109.611 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -170.35 -179.34 3.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.487 -0.778 . . . . 73.42 108.981 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.539 HG23 HG22 ' A' ' 60' ' ' VAL . 23.8 m -145.83 108.22 4.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.741 0.305 . . . . 61.04 110.352 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 1.5 pm0 -120.86 147.07 45.26 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.899 0.381 . . . . 71.12 111.077 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 24.0 Cg_exo -63.72 132.34 34.78 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.944 2.429 . . . . 61.51 112.022 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . . . -107.73 100.09 9.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.461 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -87.82 137.15 32.58 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.118 -0.492 . . . . 64.13 110.109 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.46 -26.49 74.07 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.954 -0.566 . . . . 31.11 113.04 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -82.81 -59.79 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.947 -0.39 . . . . 64.23 109.947 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.39 -34.46 0.55 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 114.86 0.704 . . . . 53.44 114.86 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.79 132.93 46.89 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 116.933 0.366 . . . . 73.1 113.733 -172.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.0 mt -123.21 127.12 48.18 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.898 -0.408 . . . . 72.54 109.898 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.903 -0.57 . . . . 74.45 110.095 177.592 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 111.674 -0.57 . . . . 70.33 111.674 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.16 88.01 4.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.439 . . . . 61.23 110.511 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.09 138.75 31.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.017 -0.538 . . . . 73.35 110.336 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.09 77.88 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.218 -0.447 . . . . 74.12 111.109 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.67 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 88.2 m-85 -131.76 56.45 1.82 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 74.32 110.551 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.8 t70 175.6 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.732 -0.667 . . . . 72.02 110.071 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.0 -80.71 1.53 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.052 -0.819 . . . . 43.23 111.052 174.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -146.51 133.4 20.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.15 0.5 . . . . 74.53 110.064 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -75.96 4.85 7.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.8 -0.636 . . . . 73.24 111.779 -170.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.12 -17.16 60.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.569 -0.287 . . . . 72.55 111.697 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.582 HG21 ' HB2' ' A' ' 17' ' ' ASP . 35.5 m -92.34 162.85 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.762 0.315 . . . . 75.22 111.278 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.5 p -101.44 -0.16 35.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.288 -0.414 . . . . 72.54 111.6 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.01 105.45 1.99 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.727 -0.749 . . . . 75.51 111.608 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 22.4 Cg_endo -62.08 -50.9 4.23 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.68 2.254 . . . . 73.02 111.986 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -71.14 -35.05 71.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.953 -0.567 . . . . 75.55 110.427 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -62.31 -43.57 98.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.842 -0.617 . . . . 72.22 110.833 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.582 ' HB2' HG21 ' A' ' 11' ' ' VAL . 8.8 t70 -56.43 -53.66 54.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 70.33 111.739 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.67 ' HD2' ' HA ' ' A' ' 5' ' ' PHE . 12.0 mmt180 -56.76 -51.01 70.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.966 -0.561 . . . . 75.11 111.315 -171.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.841 ' HB3' HG21 ' A' ' 35' ' ' VAL . . . -78.64 -33.2 47.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.932 -0.576 . . . . 60.54 111.865 -174.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -69.62 -34.58 74.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 73.53 110.107 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.15 85.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 64.32 110.598 176.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.72 -32.29 63.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 70.03 110.877 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.442 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -56.27 -31.26 63.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.824 -0.626 . . . . 73.21 111.818 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.36 -32.19 40.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.978 0.418 . . . . 64.23 111.085 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -94.44 -13.73 25.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.267 -0.424 . . . . 54.42 110.815 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.558 ' HB3' HG11 ' A' ' 50' ' ' VAL . . . -85.76 -29.65 23.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.276 -0.42 . . . . 62.52 111.283 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.923 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 9.9 p -111.02 128.05 25.93 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.887 0.375 . . . . 73.34 110.399 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 27' ' ' VAL . 3.0 Cg_exo -72.95 93.06 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.798 2.332 . . . . 73.11 112.37 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.23 21.43 72.04 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.146 -0.549 . . . . 63.2 112.972 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.84 -164.43 32.71 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.732 -0.747 . . . . 74.33 112.255 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.46 ' CG2' ' HB ' ' A' ' 51' ' ' THR . 4.9 t -103.64 136.34 43.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.061 0.458 . . . . 64.53 110.469 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.16 110.23 22.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 64.11 110.365 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.78 160.75 31.53 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.686 -0.769 . . . . 54.25 112.222 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -75.32 140.99 43.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 64.41 110.22 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.841 HG21 ' HB3' ' A' ' 19' ' ' ALA . 12.8 m -116.02 155.88 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.949 -0.569 . . . . 64.55 111.837 -169.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -114.46 156.96 23.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 52.52 109.502 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 p -74.04 123.56 24.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.606 0.241 . . . . 74.34 110.817 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.9 134.33 47.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.844 -0.428 . . . . 73.53 109.844 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.5 m -121.55 118.21 28.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.779 0.323 . . . . 72.52 110.408 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.98 -148.34 7.92 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.173 -0.771 . . . . 71.04 111.173 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -111.32 116.67 31.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.035 0.445 . . . . 64.32 110.426 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.84 -170.8 29.94 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.013 -0.835 . . . . 53.53 111.013 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.51 -5.39 49.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.911 0.386 . . . . 73.1 110.789 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.76 112.04 14.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 61.05 110.851 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.73 -16.73 11.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.098 -0.501 . . . . 63.45 111.061 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.457 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 90.9 m-85 -130.88 132.33 45.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.492 -0.322 . . . . 72.24 110.736 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.31 112.84 2.57 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.668 -0.777 . . . . 72.45 111.21 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.799 HG22 ' HB1' ' A' ' 19' ' ' ALA . 38.8 t -99.95 119.81 48.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.666 0.269 . . . . 45.21 111.035 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.534 HD23 HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -94.12 107.79 19.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.339 0.59 . . . . 61.32 110.336 177.426 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.923 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 2.7 m -115.12 102.5 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.528 0.68 . . . . 74.02 110.663 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.46 ' HB ' ' CG2' ' A' ' 31' ' ' THR . 10.0 m -92.64 122.67 35.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.358 -0.837 . . . . 75.32 110.867 -175.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HD2' HG23 ' A' ' 27' ' ' VAL . 12.6 mpt_? -79.53 153.05 76.05 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.163 -0.472 . . . . 63.11 110.36 177.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.2 1.78 3.23 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.967 2.445 . . . . 62.43 111.44 174.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -85.66 -13.49 48.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.101 -0.954 . . . . 71.21 109.816 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.08 -7.33 48.08 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.843 -0.694 . . . . 64.11 112.668 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 t -91.8 126.88 37.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 75.23 111.364 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.549 HH22 ' HB2' ' A' ' 77' ' ' ASP . 35.8 ttp180 -107.93 124.27 49.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.609 -0.723 . . . . 63.21 109.45 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.676 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 30.2 t -122.46 137.05 57.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.509 -0.314 . . . . 63.14 110.935 -175.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.478 ' HG3' ' HB3' ' A' ' 74' ' ' ALA . 34.0 mt-10 -93.07 122.4 35.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.012 0.434 . . . . 73.23 110.747 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.468 HG22 HG23 ' A' ' 71' ' ' THR . 16.9 t -103.12 109.34 26.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.689 -0.856 . . . . 74.23 108.689 173.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.5 m170 -90.15 127.03 36.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.889 0.376 . . . . 63.14 110.297 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.758 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -112.86 159.82 18.65 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.611 -0.722 . . . . 74.12 112.185 -171.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.659 ' HB2' HD21 ' A' ' 69' ' ' LEU . 16.0 t70 -90.5 169.84 10.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.559 -1.2 . . . . 75.54 109.797 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -31.54 64.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.766 0.426 . . . . 75.02 111.102 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -94.35 17.33 13.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.551 -0.295 . . . . 74.21 111.122 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 64.02 38.87 8.31 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.827 0.677 . . . . 72.31 112.827 175.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -99.32 147.52 25.11 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.631 -0.507 . . . . 74.24 109.631 169.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.758 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.4 p -74.25 119.85 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.333 0.587 . . . . 75.24 110.561 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 63' ' ' ASP . 93.0 mt -89.12 -47.42 8.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.867 -0.606 . . . . 72.13 110.339 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -164.55 156.47 16.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.117 -0.492 . . . . 75.33 110.498 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.468 HG23 HG22 ' A' ' 60' ' ' VAL . 8.0 m -124.23 118.04 25.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.858 -0.61 . . . . 71.52 109.977 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 8.7 pt-20 -134.1 121.58 15.73 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 71.34 111.319 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 37.3 Cg_exo -61.59 120.19 7.7 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.751 2.301 . . . . 73.03 111.3 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.478 ' HB3' ' HG3' ' A' ' 59' ' ' GLU . . . -143.25 164.92 28.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.981 0.419 . . . . 62.05 111.637 -173.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -116.79 124.01 48.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.94 -0.573 . . . . 54.41 110.064 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -104.56 18.38 44.51 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.787 -0.72 . . . . 54.55 111.992 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.549 ' HB2' HH22 ' A' ' 57' ' ' ARG . 18.0 t70 -97.76 -50.17 4.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.878 -0.415 . . . . 45.44 109.878 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.37 93.1 0.2 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.707 -0.758 . . . . 70.55 112.547 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.61 138.9 14.39 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.867 -0.682 . . . . 54.33 111.916 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.1 mt -106.64 115.8 30.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.706 0.289 . . . . 62.13 110.734 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-N 115.968 -0.56 . . . . 52.24 110.379 177.28 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.921 -0.472 . . . . 32.5 111.921 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.01 117.06 9.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.769 0.318 . . . . 52.42 110.706 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -92.83 143.8 25.91 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.753 -0.462 . . . . 73.53 109.753 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . . . -75.43 72.78 2.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.192 0.52 . . . . 64.22 112.068 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -128.14 108.01 10.28 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.078 -0.712 . . . . 74.52 109.078 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.658 ' H ' ' HD3' ' A' ' 18' ' ' ARG . 29.7 t70 67.62 110.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.109 0.88 . . . . 74.32 111.233 -173.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.81 -77.76 0.11 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.705 -0.759 . . . . 54.35 112.092 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.776 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 9.3 tp10 -85.96 157.34 20.16 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.059 -0.348 . . . . 64.44 110.059 177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -83.88 -9.39 58.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.579 0.704 . . . . 44.1 109.642 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.776 ' H ' ' HG3' ' A' ' 8' ' ' GLU . 10.6 mm-40 -84.56 88.57 7.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.191 -0.913 . . . . 75.23 109.561 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.62 90.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.131 0.491 . . . . 63.43 110.713 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.8 p -93.86 -5.56 47.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.949 -0.569 . . . . 73.35 110.597 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.73 146.77 5.68 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.033 -0.827 . . . . 71.22 111.033 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 25.2 Cg_endo -62.18 -53.82 1.78 Allowed 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.668 2.246 . . . . 63.04 112.156 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -97.85 -37.67 9.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.959 -0.564 . . . . 74.23 110.905 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.67 -48.79 58.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.77 -0.65 . . . . 74.34 112.213 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -65.68 -50.96 62.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.277 0.561 . . . . 53.41 111.569 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.691 HH11 ' HG2' ' A' ' 18' ' ' ARG . 12.5 mtt-85 -72.75 -37.39 67.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.549 -0.75 . . . . 65.22 111.592 -168.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.534 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -67.15 -42.01 85.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.07 0.462 . . . . 53.44 110.237 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -62.65 -46.19 89.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.546 -0.752 . . . . 73.33 110.775 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.27 -21.78 63.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 72.33 111.607 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . . . -86.1 -40.04 16.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.905 0.383 . . . . 65.5 111.338 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.553 ' HB2' HG11 ' A' ' 48' ' ' VAL . . . -69.73 -22.44 63.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.457 0.54 . . . . 64.03 112.457 -174.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 p -63.43 -22.99 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.831 0.348 . . . . 71.04 111.128 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -78.03 -16.43 58.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.662 0.268 . . . . 71.32 111.216 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.88 -14.37 23.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.932 0.396 . . . . 43.24 111.302 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.516 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 7.3 p -116.14 122.2 32.61 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.047 0.451 . . . . 73.31 110.992 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 27' ' ' VAL . 3.3 Cg_exo -74.93 100.89 1.4 Allowed 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.899 2.399 . . . . 74.23 112.239 -178.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.85 38.21 91.99 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.88 -0.6 . . . . 72.13 112.501 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.435 ' HA3' ' CG2' ' A' ' 27' ' ' VAL . . . -102.87 -172.1 26.5 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.71 -0.757 . . . . 15.03 112.526 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.1 m -98.88 115.36 28.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.746 0.308 . . . . 60.25 110.577 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.84 105.0 15.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.903 -0.59 . . . . 54.53 110.093 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.09 161.98 18.3 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.944 -0.646 . . . . 43.31 112.445 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.04 141.26 52.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.051 0.453 . . . . 75.03 110.437 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.821 HG11 ' HA ' ' A' ' 48' ' ' VAL . 34.9 m -126.73 156.0 37.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.937 -0.574 . . . . 64.32 111.451 -172.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -105.52 155.82 18.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.03 -0.532 . . . . 64.32 110.053 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.95 124.07 25.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.282 -0.417 . . . . 75.4 110.449 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.69 122.34 21.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.889 0.376 . . . . 75.04 110.24 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.0 t -77.43 129.41 35.72 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.182 -0.463 . . . . 72.34 110.078 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.94 -150.95 9.55 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.638 -0.792 . . . . 72.44 112.216 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -151.25 132.42 14.43 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.06 -0.719 . . . . 41.31 109.06 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.65 -135.17 9.68 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.624 -0.798 . . . . 63.44 112.283 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 63' ' ' ASP . . . -87.69 -30.84 20.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.693 0.282 . . . . 74.44 110.744 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.22 102.71 3.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.087 0.47 . . . . 62.34 111.076 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.07 -42.86 2.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.857 -0.61 . . . . 54.4 111.072 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.444 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 46.0 m-85 -114.61 133.58 55.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.528 -0.305 . . . . 73.3 110.229 -177.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.83 112.94 2.34 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.865 -0.894 . . . . 75.11 110.865 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.821 ' HA ' HG11 ' A' ' 35' ' ' VAL . 6.3 t -110.25 139.61 32.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.838 0.351 . . . . 42.02 110.642 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.8 pp -105.16 126.74 52.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.136 0.493 . . . . 73.45 110.813 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.403 ' CG1' ' HB1' ' A' ' 23' ' ' ALA . 2.4 m -129.09 120.3 51.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.17 0.51 . . . . 74.42 110.791 176.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -102.94 126.33 50.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.843 -0.617 . . . . 55.42 110.831 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.535 ' HB2' HG23 ' A' ' 56' ' ' THR . 10.6 mpt_? -81.56 152.28 69.64 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.341 -0.614 . . . . 72.13 109.341 173.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.48 -23.15 46.13 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.823 2.348 . . . . 74.34 112.839 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.61 -27.48 68.97 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.917 0.389 . . . . 55.03 111.168 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.72 -12.67 15.25 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.692 -0.766 . . . . 74.24 112.107 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.535 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.5 t -72.23 128.63 36.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.505 0.669 . . . . 63.31 110.46 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 57' ' ' ARG . 12.2 ttt180 -118.48 119.75 35.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.447 -0.797 . . . . 71.31 109.385 -175.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -107.51 137.22 39.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.219 -0.446 . . . . 61.4 111.16 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.55 112.21 24.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.407 0.623 . . . . 74.21 109.432 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 71' ' ' THR . 25.4 t -97.37 114.61 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.995 -0.548 . . . . 71.14 109.973 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -89.59 122.85 33.12 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.081 0.467 . . . . 74.41 110.528 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.619 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -113.07 145.93 40.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.1 -0.955 . . . . 62.32 110.144 -177.126 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.586 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 20.7 p30 -91.91 -167.71 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.008 0.432 . . . . 74.0 111.431 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -65.99 -17.98 65.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.588 -0.733 . . . . 73.31 111.849 -172.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -109.54 13.51 23.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.752 -0.204 . . . . 73.11 110.904 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 65.37 30.76 10.86 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.279 0.561 . . . . 65.31 111.229 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.403 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . 26.2 ttp180 -93.52 137.37 32.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.532 -0.758 . . . . 70.01 109.795 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.619 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.5 p -65.06 117.18 5.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.362 0.601 . . . . 71.23 111.574 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.549 HD21 ' HB3' ' A' ' 63' ' ' ASP . 96.2 mt -90.93 -60.01 2.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.679 -0.692 . . . . 72.51 110.991 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -157.52 147.59 20.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 61.33 110.085 -172.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.483 HG22 HG22 ' A' ' 60' ' ' VAL . 17.0 p -124.01 109.52 13.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.901 0.382 . . . . 75.31 110.901 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 11.0 mm-40 -107.35 155.44 39.47 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.077 -0.51 . . . . 62.42 110.828 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 5.1 Cg_exo -74.57 122.29 7.3 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.467 2.112 . . . . 74.0 110.885 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.16 156.48 23.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.416 -0.357 . . . . 54.01 110.298 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.402 ' HB2' HD21 ' A' ' 80' ' ' LEU . 24.2 t70 -86.77 136.39 33.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.393 -0.367 . . . . 62.43 110.336 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.73 1.71 58.31 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.514 -0.85 . . . . 71.25 112.908 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -97.9 -56.35 2.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.988 0.423 . . . . 63.24 110.609 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.35 -30.84 6.27 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.768 -0.651 . . . . 54.43 111.573 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.53 75.32 2.14 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.047 -0.597 . . . . 70.11 111.901 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 75' ' ' ASP . 56.7 mt -68.51 134.73 50.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.898 0.38 . . . . 53.11 111.236 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.073 -0.965 . . . . 64.15 110.297 177.804 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.532 0 N-CA-C 111.77 -0.532 . . . . 73.4 111.77 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.465 ' HB3' HH22 ' A' ' 67' ' ' ARG . . . -129.99 87.61 2.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.987 0.423 . . . . 74.03 111.109 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -106.87 93.88 4.81 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.697 -0.853 . . . . 64.15 108.697 173.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.35 75.12 3.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.047 0.451 . . . . 72.34 111.77 -174.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.91 54.69 0.74 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.65 0.738 . . . . 74.24 109.117 172.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.586 ' N ' ' HD2' ' A' ' 18' ' ' ARG . 25.1 t70 174.23 101.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.075 -1.421 . . . . 71.31 107.84 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.76 -78.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.865 -0.683 . . . . 65.04 112.814 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.662 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 11.2 tt0 -156.26 -166.1 2.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.676 0.274 . . . . 73.22 110.708 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.662 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 4.8 m-20 -66.5 -6.66 15.63 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.939 0.718 . . . . 63.14 112.939 -172.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.79 84.16 1.88 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.034 0.445 . . . . 72.23 111.047 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -91.95 87.42 2.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.416 -0.587 . . . . 73.12 109.416 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 t -114.24 130.22 56.64 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.632 -0.713 . . . . 62.11 110.098 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.65 -151.5 41.38 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.233 -0.984 . . . . 61.32 111.703 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.495 ' HB2' ' H ' ' A' ' 15' ' ' ASP . 63.9 Cg_endo -73.29 -142.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.772 2.315 . . . . 71.04 112.144 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 3.2 m-20 -74.41 12.08 0.85 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.398 0.518 . . . . 71.44 112.398 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.642 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -49.72 -34.15 18.06 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.9 0.381 . . . . 43.01 111.353 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.71 -42.38 71.44 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.393 -0.821 . . . . 63.25 112.278 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 15' ' ' ASP . 12.1 mmt180 -64.71 -57.91 7.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.287 0.565 . . . . 75.51 111.123 -170.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.765 ' HB3' HG21 ' A' ' 35' ' ' VAL . . . -73.38 -26.94 61.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.522 -0.763 . . . . 74.45 111.946 -173.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -66.73 -35.84 81.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 74.34 110.858 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.49 -39.51 88.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 74.52 110.862 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.35 -28.88 63.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.028 -0.533 . . . . 42.2 111.297 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 -27.36 68.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.08 -0.509 . . . . 62.42 111.859 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.0 t -59.47 -38.26 74.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.458 . . . . 64.32 111.266 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -81.13 -12.38 59.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.289 -0.414 . . . . 71.23 111.143 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.63 -6.87 58.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 60.11 111.452 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.05 124.08 7.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.017 0.437 . . . . 61.42 111.483 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.75 105.68 2.11 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.401 2.067 . . . . 75.43 112.136 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.78 39.54 89.94 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.081 -0.581 . . . . 72.32 112.417 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.736 ' HA2' ' HD3' ' A' ' 53' ' ' PRO . . . -101.92 -147.77 20.25 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.581 -0.819 . . . . 61.25 112.697 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.668 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 58.6 m -137.63 131.26 31.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.699 0.285 . . . . 61.21 110.574 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.05 120.44 41.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.298 -0.41 . . . . 52.13 110.641 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.68 161.16 13.33 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.841 -0.695 . . . . 51.1 111.582 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.443 ' O ' HD21 ' A' ' 49' ' ' LEU . 1.4 mp0 -62.5 128.13 34.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.338 . . . . 65.0 110.428 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.765 HG21 ' HB3' ' A' ' 19' ' ' ALA . 19.8 m -90.21 154.77 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.013 -0.539 . . . . 71.03 110.769 -175.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -112.67 153.61 27.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.14 -0.482 . . . . 72.44 111.059 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 m -85.22 115.27 22.9 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.702 -0.851 . . . . 74.42 108.702 171.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -75.61 130.18 38.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.242 0.544 . . . . 75.54 111.9 -172.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.2 p -88.9 118.27 28.49 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.962 -0.755 . . . . 72.24 108.962 171.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.95 -125.04 0.8 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.9 -1.143 . . . . 71.3 113.338 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.88 158.36 44.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.724 0.297 . . . . 72.52 110.481 -172.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.9 -116.18 4.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.05 -0.595 . . . . 63.11 113.077 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.84 10.06 5.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.559 0.219 . . . . 72.02 111.219 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.06 107.07 3.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.053 -0.351 . . . . 72.24 110.053 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.72 -54.35 2.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.094 -0.503 . . . . 74.12 111.646 -175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -115.64 133.41 56.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.0 0.428 . . . . 74.2 111.405 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.18 112.49 3.06 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.675 -0.774 . . . . 65.41 111.261 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.606 HG22 ' HB1' ' A' ' 19' ' ' ALA . 27.4 t -95.24 109.72 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.633 0.254 . . . . 74.43 110.687 -175.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.694 ' H ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -85.51 102.7 13.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.28 0.562 . . . . 65.05 110.74 -179.228 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.3 t -97.1 110.34 24.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.716 -0.674 . . . . 32.14 110.016 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.668 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 14.0 m -91.92 116.6 29.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.11 -0.495 . . . . 75.13 110.548 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -96.94 135.84 21.86 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.185 -0.461 . . . . 54.31 110.023 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.736 ' HD3' ' HA2' ' A' ' 30' ' ' GLY . 37.1 Cg_endo -65.68 -8.81 20.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.878 2.386 . . . . 45.3 111.386 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -64.12 -26.75 68.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.89 -1.05 . . . . 75.52 110.487 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.46 32.64 2.28 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.67 -0.776 . . . . 73.44 112.352 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 t -145.38 144.93 30.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.102 0.477 . . . . 72.33 110.956 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -107.89 118.5 36.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.705 -0.68 . . . . 73.32 109.263 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 45.5 t -112.33 115.7 50.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.771 -0.455 . . . . 70.12 109.771 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 12.4 pt-20 -101.81 113.21 26.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.659 0.742 . . . . 73.34 110.823 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.608 HG22 HG23 ' A' ' 71' ' ' THR . 18.6 t -89.12 118.57 34.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.179 -0.918 . . . . 54.33 109.224 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -93.35 123.22 36.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.345 -0.389 . . . . 65.42 110.345 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 68' ' ' VAL . 1.0 OUTLIER -115.64 152.21 33.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.889 -0.596 . . . . 65.04 111.157 -174.418 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.594 ' HB3' HD21 ' A' ' 69' ' ' LEU . 3.7 p-10 -94.47 -164.52 1.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.882 -0.599 . . . . 75.15 110.531 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.6 mtt-85 -71.66 -24.57 61.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.121 -0.491 . . . . 70.11 111.26 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.45 0.08 56.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.04 0.448 . . . . 73.15 109.801 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 67.99 32.48 5.05 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.332 -0.849 . . . . 55.14 110.678 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.465 HH22 ' HB3' ' A' ' 2' ' ' ALA . 1.6 mpt_? -101.06 154.53 18.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.065 -0.516 . . . . 73.23 109.884 175.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.578 ' HA ' HD12 ' A' ' 62' ' ' LEU . 7.1 p -71.13 118.8 16.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.41 0.624 . . . . 53.23 111.435 -176.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 63' ' ' ASP . 96.1 mt -85.52 -51.21 6.66 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.002 -0.74 . . . . 75.32 109.002 172.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -155.05 166.15 34.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.676 -0.693 . . . . 75.44 109.923 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.608 HG23 HG22 ' A' ' 60' ' ' VAL . 27.7 m -148.49 109.1 4.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.564 -0.532 . . . . 74.01 109.564 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 2.2 pm0 -130.57 135.98 28.23 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.139 0.495 . . . . 61.52 111.649 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 6.0 Cg_exo -79.79 92.83 1.09 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.863 2.375 . . . . 72.12 110.531 171.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.35 110.31 21.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.171 -0.468 . . . . 73.22 111.161 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.21 109.34 20.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 73.15 109.93 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.35 162.06 10.9 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.853 -0.689 . . . . 74.35 111.871 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -97.34 -31.2 12.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.044 0.449 . . . . 73.22 110.062 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.52 67.12 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.829 -0.701 . . . . 31.43 111.907 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.02 74.39 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.032 -0.604 . . . . 61.1 112.128 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.9 mt -119.81 121.08 38.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.859 0.361 . . . . 60.1 110.15 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.32 -0.848 . . . . 73.42 110.101 -179.845 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 112.083 -0.407 . . . . 42.45 112.083 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.73 116.43 20.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.027 0.442 . . . . 71.14 110.728 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -91.09 154.33 19.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.41 -0.589 . . . . 73.45 109.41 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.23 67.23 8.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.29 0.567 . . . . 70.22 110.735 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -131.85 57.63 1.77 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.638 -0.71 . . . . 73.33 110.007 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -127.11 -58.07 1.29 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.707 -0.679 . . . . 71.53 109.338 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.89 178.66 51.1 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.911 -0.662 . . . . 72.05 112.319 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.799 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 24.6 tt0 -124.07 -172.21 2.49 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 122.681 -0.305 . . . . 75.04 110.185 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.799 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 11.9 m-20 -77.83 -9.28 58.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.588 -0.278 . . . . 74.32 111.594 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.39 93.94 7.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.412 . . . . 73.13 110.342 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -76.27 86.92 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.456 0.646 . . . . 62.22 109.79 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 t -107.11 -0.12 23.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.593 -0.73 . . . . 72.51 110.483 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.38 175.96 23.72 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.403 -0.679 . . . . 74.24 111.403 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.523 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 5.7 Cg_exo -76.14 -76.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.614 2.21 . . . . 55.33 111.818 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -70.8 -35.65 72.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.698 -0.683 . . . . 74.12 111.104 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.517 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -54.21 -49.31 69.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 75.45 111.478 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.52 -43.65 89.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 71.11 111.407 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 14' ' ' PRO . 7.2 mmt85 -64.07 -41.81 97.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.175 -0.466 . . . . 60.41 110.96 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.677 ' HB3' HG21 ' A' ' 35' ' ' VAL . . . -81.08 -35.01 32.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.248 -0.433 . . . . 54.04 112.061 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -65.21 -28.5 69.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.013 0.435 . . . . 73.23 110.291 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.39 -38.22 84.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 75.21 110.779 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.35 -30.86 57.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.047 0.451 . . . . 33.45 111.073 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.514 ' HB1' ' CG1' ' A' ' 50' ' ' VAL . . . -55.88 -35.88 66.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.568 -0.742 . . . . 61.04 112.076 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.4 t -55.77 -40.51 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 64.12 111.808 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -86.86 -12.86 46.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.262 -0.426 . . . . 73.32 111.319 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.4 -34.7 17.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.416 -0.356 . . . . 64.23 111.105 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.568 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 14.3 p -91.63 130.53 38.74 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.936 0.398 . . . . 74.33 110.593 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.94 86.71 0.73 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.44 2.093 . . . . 73.4 112.42 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.47 38.73 96.15 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.733 -0.667 . . . . 51.13 112.586 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.58 -175.88 19.2 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.587 -0.816 . . . . 71.35 112.481 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.7 m -96.35 126.63 41.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.865 0.364 . . . . 64.11 110.986 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.09 131.28 37.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.086 -0.506 . . . . 72.42 109.824 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.96 162.01 15.89 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.543 -0.837 . . . . 63.12 112.378 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -55.05 119.85 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.128 0.489 . . . . 70.22 110.917 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.677 HG21 ' HB3' ' A' ' 19' ' ' ALA . 17.9 m -96.38 155.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.472 -0.785 . . . . 74.11 110.373 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -125.9 144.94 50.47 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.428 -0.351 . . . . 72.44 110.129 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.3 p -76.7 142.3 40.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.245 -0.434 . . . . 74.55 110.355 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -83.66 84.24 7.62 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.758 -0.83 . . . . 73.33 108.758 172.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -72.93 123.27 23.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.189 -0.914 . . . . 75.24 110.335 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.2 -26.93 6.55 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.763 -0.935 . . . . 63.53 110.763 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.26 146.47 28.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.263 -0.469 . . . . 52.31 110.303 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.95 -40.05 4.17 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.788 -0.72 . . . . 64.43 112.122 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.33 -65.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.697 0.284 . . . . 61.33 111.15 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.12 93.68 5.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.058 0.456 . . . . 61.13 110.901 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.52 -40.32 19.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.889 -0.596 . . . . 64.21 111.162 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -115.79 143.26 45.65 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.556 -0.293 . . . . 73.35 110.564 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -124.21 112.23 1.77 Allowed Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.793 -0.923 . . . . 65.11 110.793 171.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.561 HG22 ' HB1' ' A' ' 19' ' ' ALA . 89.0 t -96.82 110.73 25.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.72 0.295 . . . . 74.42 110.639 -176.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.537 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.5 pp -96.42 115.23 27.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.399 0.618 . . . . 72.04 110.873 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.568 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 5.1 m -115.1 126.55 72.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.636 -0.711 . . . . 64.22 110.533 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.2 m -92.23 106.63 18.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.919 -0.582 . . . . 75.23 110.153 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 52' ' ' ARG . 56.6 mtt180 -72.0 149.38 92.3 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.891 -0.411 . . . . 75.44 109.891 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.91 -12.05 27.42 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.555 2.17 . . . . 65.03 111.11 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -68.61 -26.72 65.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.97 -1.013 . . . . 74.4 110.541 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.97 -17.21 15.33 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.851 -0.69 . . . . 72.33 112.755 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 t -89.57 149.35 22.9 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.878 0.371 . . . . 74.55 111.287 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -103.31 119.99 39.92 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.383 -0.599 . . . . 63.32 109.383 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 58.8 t -102.74 124.18 56.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.439 -0.578 . . . . 44.24 109.439 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 9.7 pt-20 -108.9 111.58 23.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.843 0.83 . . . . 75.12 110.314 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.658 HG22 HG23 ' A' ' 71' ' ' THR . 16.6 t -86.69 116.39 29.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.433 -0.803 . . . . 54.2 109.881 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -79.76 118.35 21.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.244 -0.435 . . . . 74.52 110.218 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.695 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -115.67 154.6 29.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.618 -0.719 . . . . 72.24 111.575 -173.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.681 ' HB2' HD21 ' A' ' 69' ' ' LEU . 20.6 t70 -89.87 173.77 8.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.168 -0.924 . . . . 71.31 109.421 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -52.02 -37.74 54.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.946 0.498 . . . . 73.22 111.615 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.26 14.82 11.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.441 . . . . 73.0 111.542 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.42 ' CD2' HD23 ' A' ' 62' ' ' LEU . 7.7 m-85 65.63 25.42 11.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.144 0.497 . . . . 71.41 111.475 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -80.48 137.52 36.48 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.971 -0.752 . . . . 62.43 108.971 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.695 ' HA ' HD12 ' A' ' 62' ' ' LEU . 8.6 p -70.91 125.6 29.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.313 0.578 . . . . 53.23 111.187 -176.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 63' ' ' ASP . 71.6 mt -97.26 -58.58 1.98 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.664 -0.698 . . . . 70.05 109.674 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -155.7 141.11 17.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.947 -0.569 . . . . 63.42 110.088 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.658 HG23 HG22 ' A' ' 60' ' ' VAL . 18.5 m -107.8 111.6 23.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.544 -0.539 . . . . 54.31 109.544 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 12.3 pt-20 -135.32 129.24 18.67 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.18 0.514 . . . . 73.35 112.072 -173.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 2.0 Cg_endo -82.52 130.56 6.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.825 2.35 . . . . 62.05 110.263 169.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.57 172.16 7.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.969 0.414 . . . . 40.4 111.652 -175.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -122.16 -177.47 3.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.797 -0.638 . . . . 75.32 109.834 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.24 79.17 0.37 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.841 -0.695 . . . . 74.4 112.313 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -85.36 -53.79 5.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.084 0.469 . . . . 75.33 109.812 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.16 -32.67 6.43 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.884 -0.674 . . . . 62.04 112.853 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.64 93.36 1.14 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.851 -0.69 . . . . 54.15 111.52 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.5 92.61 7.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.819 0.342 . . . . 64.43 110.868 -177.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.414 -0.803 . . . . 74.53 109.73 177.816 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 112.143 -0.383 . . . . 54.03 112.143 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.61 142.33 36.43 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.804 -0.233 . . . . 60.22 110.729 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -84.6 161.12 20.26 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.968 -0.382 . . . . 73.22 109.968 177.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HB1' ' HB2' ' A' ' 18' ' ' ARG . . . -80.86 73.75 7.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.033 0.444 . . . . 65.43 110.892 -178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -135.14 93.71 3.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.115 0.483 . . . . 51.33 110.511 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -150.29 -77.97 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.819 -0.808 . . . . 63.01 108.819 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.585 ' HA2' ' OD1' ' A' ' 17' ' ' ASP . . . 79.0 140.06 1.81 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.824 -0.625 . . . . 74.34 114.029 171.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.547 ' O ' HG22 ' A' ' 11' ' ' VAL . 34.5 tt0 -80.98 134.03 35.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.582 -0.895 . . . . 72.43 108.582 171.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.35 1.89 20.44 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.997 0.369 . . . . 75.13 111.997 -170.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.89 8.01 20.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.826 0.306 . . . . 70.33 111.826 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 17' ' ' ASP . 28.5 m -84.11 159.03 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.735 -0.386 . . . . 51.1 109.996 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 p -94.37 -25.22 17.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.86 -0.336 . . . . 72.12 111.293 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.428 ' HA2' ' HD2' ' A' ' 14' ' ' PRO . . . -95.1 111.23 4.16 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.853 -0.689 . . . . 61.1 111.581 174.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.428 ' HD2' ' HA2' ' A' ' 13' ' ' GLY . 13.5 Cg_endo -56.76 -55.83 2.41 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.983 2.456 . . . . 64.55 112.695 -175.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -89.06 -9.2 52.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.029 0.442 . . . . 55.13 110.698 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 1.119 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -66.28 -43.44 86.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.531 -0.759 . . . . 74.1 111.937 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.639 ' HB2' HG21 ' A' ' 11' ' ' VAL . 8.6 t70 -52.47 -57.46 9.82 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.066 -0.516 . . . . 75.12 112.148 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.563 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -71.42 -31.7 67.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.242 0.46 . . . . 63.3 112.242 -173.004 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.641 ' HB2' ' HE1' ' A' ' 66' ' ' PHE . . . -69.01 -39.91 79.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.075 0.464 . . . . 42.53 110.5 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -25.87 55.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.953 -0.567 . . . . 73.52 110.503 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.38 -32.91 62.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.354 . . . . 52.14 110.939 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.08 -26.89 62.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.178 0.513 . . . . 61.34 111.09 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.554 ' HB2' HG11 ' A' ' 48' ' ' VAL . . . -71.5 -23.15 61.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.915 -0.584 . . . . 33.13 111.442 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -63.13 -25.03 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.17 0.51 . . . . 55.35 111.239 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -80.31 -13.64 59.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.874 0.368 . . . . 73.51 110.963 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.49 1.3 29.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.264 -0.425 . . . . 70.4 111.381 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.08 116.34 5.63 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.144 0.497 . . . . 73.15 111.272 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.21 96.02 0.53 Allowed 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.484 2.123 . . . . 74.12 112.392 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.25 42.21 83.93 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.796 -0.638 . . . . 42.24 112.594 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.03 162.57 20.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.633 -0.794 . . . . 73.54 112.367 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.545 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 28.1 m -87.58 112.0 21.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.952 0.406 . . . . 74.34 110.617 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.53 131.78 53.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.102 -0.499 . . . . 75.33 110.612 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.559 ' HA3' HD11 ' A' ' 49' ' ' LEU . . . -106.97 160.74 14.09 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.517 -0.849 . . . . 54.21 111.168 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.76 136.02 57.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.416 0.627 . . . . 70.35 110.323 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.119 HG22 ' HA ' ' A' ' 16' ' ' ALA . 2.5 m -90.7 157.1 2.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.148 -0.933 . . . . 73.34 111.437 -169.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -104.71 141.83 35.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.875 -0.602 . . . . 75.5 110.074 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.73 104.23 5.3 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.693 -0.685 . . . . 70.53 109.931 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -72.62 138.39 46.74 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.918 -0.401 . . . . 61.13 109.918 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -127.46 153.51 46.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.272 -0.422 . . . . 73.24 110.66 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.47 -19.03 49.44 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.908 -0.663 . . . . 65.44 111.838 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.0 154.51 17.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.458 -0.571 . . . . 73.34 109.458 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.81 -31.48 20.85 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.903 -0.665 . . . . 74.2 112.715 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.638 ' O ' ' HA ' ' A' ' 63' ' ' ASP . . . -111.72 -52.46 2.78 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.75 -0.265 . . . . 71.24 110.976 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 101.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.248 0.547 . . . . 54.23 110.918 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.44 -13.64 14.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 63.2 111.229 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.553 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 20.4 m-85 -135.27 132.64 38.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.723 -0.473 . . . . 63.41 109.723 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.58 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -115.35 112.56 2.72 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.748 -0.739 . . . . 55.42 111.535 177.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.641 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 22.1 t -96.4 129.67 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 122.253 0.221 . . . . 60.51 110.996 -175.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.559 HD11 ' HA3' ' A' ' 33' ' ' GLY . 1.1 pp -101.91 111.22 23.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.214 0.53 . . . . 63.21 110.452 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.1 t -114.65 119.9 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.774 -0.648 . . . . 53.24 110.952 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.545 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 23.8 m -101.32 104.46 15.46 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.75 -0.463 . . . . 64.03 109.75 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 52' ' ' ARG . 41.9 mtt180 -75.62 147.98 82.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.034 -0.53 . . . . 74.11 110.646 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.99 -18.22 41.8 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.169 2.579 . . . . 64.11 112.543 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -70.17 -15.05 62.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.545 . . . . 64.32 110.896 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.9 32.69 7.02 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.587 -0.816 . . . . 61.45 112.39 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -130.09 147.79 51.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.772 0.32 . . . . 63.13 110.372 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -107.17 120.99 43.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.201 -0.454 . . . . 74.1 110.543 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.685 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 57.1 t -119.48 133.66 65.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.762 -0.653 . . . . 61.34 109.629 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 11.5 pt-20 -107.6 124.18 49.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.34 0.591 . . . . 75.01 110.479 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.641 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 25.9 t -94.92 125.98 47.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.425 -0.807 . . . . 61.15 109.853 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -99.16 123.61 43.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.1 0.476 . . . . 72.31 110.509 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -112.17 149.85 31.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.652 -0.704 . . . . 54.43 111.083 -176.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.638 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 18.4 t70 -90.19 171.53 9.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.962 -0.563 . . . . 74.33 109.883 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.47 ' H ' ' HG3' ' A' ' 64' ' ' ARG . 0.3 OUTLIER -42.81 -51.92 5.24 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.033 0.933 . . . . 72.5 111.949 -178.113 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -86.0 18.46 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.875 -0.602 . . . . 65.4 111.203 -174.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.641 ' HE1' ' HB2' ' A' ' 19' ' ' ALA . 6.3 m-85 66.97 27.98 8.66 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.872 -0.603 . . . . 63.33 111.586 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 67' ' ' ARG . 7.4 tpt180 -80.32 124.02 28.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.949 -0.76 . . . . 73.52 108.949 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.669 ' HA ' HD12 ' A' ' 62' ' ' LEU . 7.3 p -63.53 122.83 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.169 0.509 . . . . 75.32 110.536 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.598 HD21 ' HB2' ' A' ' 63' ' ' ASP . 97.7 mt -87.89 -57.62 2.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.116 -0.493 . . . . 70.23 110.682 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -170.89 176.72 4.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.696 -0.483 . . . . 72.44 109.696 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.607 HG22 HG22 ' A' ' 60' ' ' VAL . 16.8 p -140.24 109.42 6.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.317 -0.402 . . . . 64.1 110.656 -177.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -117.74 129.66 25.21 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 121.141 0.496 . . . . 62.11 111.052 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 57.3 Cg_endo -73.91 105.04 1.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.383 2.056 . . . . 75.04 111.948 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.37 93.2 4.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.149 -0.478 . . . . 74.12 111.01 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.15 133.22 34.06 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.674 -0.694 . . . . 75.22 109.266 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -56.79 108.15 1.14 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.09 -0.505 . . . . 11.1 113.237 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -90.38 -40.1 12.28 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.67 -0.493 . . . . 63.14 109.67 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.08 -92.25 0.15 Allowed Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.599 -0.728 . . . . 72.23 111.694 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.97 -157.97 26.44 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.067 -0.587 . . . . 71.45 111.849 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.73 HD23 ' H ' ' A' ' 80' ' ' LEU . 2.5 pt? -79.75 155.65 27.84 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.922 -0.399 . . . . 42.31 109.922 176.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.516 -0.754 . . . . 72.12 109.38 -177.258 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.434 ' HG3' ' HD2' ' A' ' 5' ' ' PHE . 10.6 tpt . . . . . 0 C--O 1.235 0.334 0 N-CA-C 109.958 -0.386 . . . . 52.119999999999997 109.958 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.27 66.81 2.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.411 0.523 . . . . 72.530000000000001 112.411 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.434 ' HD2' ' HG3' ' A' ' 3' ' ' MET . 91.8 m-85 -145.35 90.49 2.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.774 -0.648 . . . . 73.540000000000006 109.33 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -131.96 -74.5 0.51 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.874 -0.331 . . . . 74.129999999999995 110.802 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.727 ' HA2' ' NH1' ' A' ' 18' ' ' ARG . . . 115.75 85.37 1.22 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 119.977 -1.106 . . . . 55.109999999999999 113.713 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.708 ' HG3' ' HG2' ' A' ' 10' ' ' GLU . 10.6 tp10 -71.36 146.1 49.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.643 -0.873 . . . . 62.409999999999997 108.643 171.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -91.81 -8.5 46.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.379 0.511 . . . . 60.420000000000002 112.379 -168.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.708 ' HG2' ' HG3' ' A' ' 8' ' ' GLU . 12.6 pt-20 -90.79 3.42 54.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.868 0.322 . . . . 75.310000000000002 111.868 -175.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.054 HG21 ' HB2' ' A' ' 17' ' ' ASP . 27.4 m -113.24 157.59 13.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.684 0.278 . . . . 72.209999999999994 110.98 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -101.49 -11.3 19.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.366 . . . . 61.210000000000001 111.038 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.07 143.16 15.61 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.612 -0.804 . . . . 33.200000000000003 111.983 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.16 -67.28 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.414 2.076 . . . . 71.340000000000003 112.222 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -70.17 -26.53 63.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.043 -0.526 . . . . 72.230000000000004 109.927 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.648 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -55.83 -27.1 49.76 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.278 -0.874 . . . . 71.530000000000001 111.503 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 1.054 ' HB2' HG21 ' A' ' 11' ' ' VAL . 3.9 t70 -85.36 -55.6 3.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.985 -0.552 . . . . 62.520000000000003 111.265 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.727 ' NH1' ' HA2' ' A' ' 7' ' ' GLY . 17.0 mmt-85 -59.26 -46.4 88.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.805 -0.634 . . . . 73.340000000000003 111.01 -170.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.749 ' HB2' ' HE1' ' A' ' 66' ' ' PHE . . . -73.36 -35.78 66.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.461 . . . . 42.450000000000003 111.478 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 24' ' ' VAL . 46.3 ttt-85 -65.89 -41.69 91.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.906 -0.588 . . . . 65.439999999999998 110.512 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.15 86.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.972 0.415 . . . . 62.229999999999997 111.088 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.64 76.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.102 -0.499 . . . . 74.010000000000005 110.812 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.567 ' HB2' HG11 ' A' ' 48' ' ' VAL . . . -63.9 -43.89 94.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 70.010000000000005 111.506 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 20' ' ' ARG . 57.5 t -56.76 -32.07 37.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 74.239999999999995 110.986 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -80.72 -13.0 59.38 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.844 -0.617 . . . . 71.200000000000003 111.269 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.02 -30.14 12.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.402 -0.363 . . . . 70.310000000000002 111.559 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.7 120.35 43.98 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.234 0.54 . . . . 64.129999999999995 111.095 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.1 99.66 0.91 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.566 2.177 . . . . 71.219999999999999 112.72 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.4 35.14 77.89 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.931 -0.577 . . . . 51.109999999999999 112.726 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.11 177.31 33.77 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.574 -0.822 . . . . 51.210000000000001 112.335 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.695 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 31.4 m -79.48 116.37 19.66 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.203 -0.295 . . . . 63.310000000000002 110.203 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.85 133.43 53.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.295 -0.411 . . . . 54.340000000000003 110.339 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -125.28 162.13 19.62 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.497 -0.641 . . . . 51.340000000000003 111.497 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -63.89 142.3 58.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.368 0.604 . . . . 73.010000000000005 110.937 178.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.648 HG22 ' HA ' ' A' ' 16' ' ' ALA . 12.1 m -104.29 155.71 5.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.646 -0.706 . . . . 74.239999999999995 110.884 -173.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -119.12 156.62 29.44 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.81 -0.441 . . . . 64.530000000000001 109.81 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.3 p -73.47 125.78 28.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.396 -0.366 . . . . 71.239999999999995 111.093 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' OE1' ' HD2' ' A' ' 61' ' ' HIS . 38.0 mt-10 -79.79 -166.61 1.03 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.859 -0.61 . . . . 72.400000000000006 109.846 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -60.05 129.15 40.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.455 -0.339 . . . . 73.450000000000003 110.653 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.35 91.12 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.975 -0.557 . . . . 70.329999999999998 112.712 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -83.92 113.39 20.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.867 0.365 . . . . 73.030000000000001 110.287 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.14 -156.21 26.78 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.78 -0.646 . . . . 61.200000000000003 111.5 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.04 -41.16 5.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.044 0.449 . . . . 62.549999999999997 110.427 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.02 112.21 23.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.639 . . . . 72.140000000000001 110.195 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.63 -26.39 12.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.977 -0.556 . . . . 61.149999999999999 111.009 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -126.35 132.52 51.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.079 -0.509 . . . . 72.430000000000007 110.186 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.76 112.26 2.94 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.533 -0.841 . . . . 65.409999999999997 111.536 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.606 HG22 ' HB1' ' A' ' 19' ' ' ALA . 39.0 t -97.59 109.29 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.752 0.31 . . . . 63.210000000000001 111.117 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 pp -86.86 117.38 25.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.178 0.513 . . . . 63.25 110.631 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.454 HG11 ' HB1' ' A' ' 23' ' ' ALA . 16.4 m -135.74 150.08 28.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.934 -0.576 . . . . 74.129999999999995 110.077 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.695 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 28.3 m -136.39 126.03 25.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.34 -0.391 . . . . 64.430000000000007 111.061 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HB2' HG23 ' A' ' 56' ' ' THR . 6.6 mpt_? -80.04 142.2 55.45 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.784 -0.821 . . . . 71.239999999999995 108.784 173.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.47 -12.7 11.53 Favored 'Trans proline' 0 N--CA 1.475 0.412 0 C-N-CA 123.338 2.692 . . . . 65.450000000000003 112.955 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -68.55 -9.51 49.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.929 -0.578 . . . . 71.239999999999995 111.158 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.85 32.41 7.2 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.605 -0.807 . . . . 54.329999999999998 111.742 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.5 t -128.28 119.42 25.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.416 0.627 . . . . 75.140000000000001 110.737 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -105.29 127.0 52.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.303 -0.862 . . . . 71.019999999999996 110.386 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.568 HG11 ' HB ' ' A' ' 71' ' ' THR . 98.3 t -131.7 138.76 52.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.97 -0.559 . . . . 74.239999999999995 109.765 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 9.4 pt-20 -106.98 121.69 44.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.463 0.649 . . . . 55.43 110.196 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.59 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 21.5 t -85.07 119.19 33.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.207 -0.906 . . . . 65.200000000000003 109.586 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.46 ' HD2' ' OE1' ' A' ' 38' ' ' GLU . 46.4 m80 -91.53 118.82 30.92 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.28 0.562 . . . . 62.5 110.495 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.638 HD23 ' HD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -109.44 147.58 32.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.897 -1.047 . . . . 74.239999999999995 110.733 -174.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.55 ' HB3' HD21 ' A' ' 69' ' ' LEU . 5.4 p-10 -90.89 -163.2 1.0 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.229 -0.441 . . . . 73.209999999999994 110.071 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -66.9 -15.9 63.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.266 -0.424 . . . . 73.450000000000003 111.779 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -121.31 16.88 11.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 61.229999999999997 111.236 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.749 ' HE1' ' HB2' ' A' ' 19' ' ' ALA . 31.8 m-85 65.67 29.38 10.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.964 -0.562 . . . . 73.049999999999997 112.244 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -89.26 134.68 33.95 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.922 -0.77 . . . . 64.129999999999995 108.922 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -63.19 113.06 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.434 0.635 . . . . 24.0 111.006 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 63' ' ' ASP . 87.9 mt -83.84 -52.23 6.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.774 -0.648 . . . . 73.310000000000002 110.1 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -173.81 160.09 3.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.993 -0.549 . . . . 55.439999999999998 110.047 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.568 ' HB ' HG11 ' A' ' 58' ' ' VAL . 19.8 p -128.93 111.43 13.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.039 -0.528 . . . . 62.310000000000002 111.121 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 1.7 pm0 -112.84 143.84 29.86 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.315 -0.402 . . . . 64.319999999999993 110.692 176.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 39.3 Cg_exo -61.23 128.88 26.44 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.127 2.551 . . . . 43.450000000000003 112.048 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.522 ' HB2' ' HG2' ' A' ' 59' ' ' GLU . . . -104.99 122.74 46.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.911 -0.586 . . . . 73.329999999999998 110.936 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 115.858 -0.61 . . . . 61.049999999999997 109.784 179.101 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 C--O 1.233 0.214 0 N-CA-C 109.958 -0.386 . . . . 74.430000000000007 109.958 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.22 69.78 9.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.185 -0.461 . . . . 74.099999999999994 111.8 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -98.6 113.1 25.01 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.201 -0.666 . . . . 73.439999999999998 109.201 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.429 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 19.3 t70 63.91 101.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.915 0.759 . . . . 74.430000000000007 110.331 -171.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.41 ' H ' ' CZ ' ' A' ' 18' ' ' ARG . . . -93.72 -108.04 1.95 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.71 -0.677 . . . . 73.310000000000002 112.49 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.619 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 31.2 tt0 -107.51 177.41 4.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.802 0.334 . . . . 73.030000000000001 110.678 -177.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.619 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 28.4 t70 -75.14 -8.94 57.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.943 -0.571 . . . . 62.399999999999999 111.829 -175.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -65.56 97.36 0.3 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.957 0.408 . . . . 55.109999999999999 110.703 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 51.7 t -83.04 86.17 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.457 0.646 . . . . 74.340000000000003 111.006 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 t -101.66 -13.33 17.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.757 0.789 . . . . 65.340000000000003 109.066 171.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.686 ' HA3' ' HB3' ' A' ' 16' ' ' ALA . . . 170.71 135.81 1.98 Allowed Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.592 -1.185 . . . . 73.299999999999997 110.345 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -54.67 -70.15 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 123.016 2.478 . . . . 70.150000000000006 112.153 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -89.69 -20.72 23.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.827 -0.624 . . . . 74.510000000000005 110.147 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.686 ' HB3' ' HA3' ' A' ' 13' ' ' GLY . . . -59.65 -49.54 77.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.424 -0.807 . . . . 70.409999999999997 111.311 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -58.0 -40.93 81.94 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.203 0.525 . . . . 74.430000000000007 111.469 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.429 ' NE ' ' HA ' ' A' ' 6' ' ' ASP . 17.4 mmt180 -65.06 -43.91 90.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.595 -0.73 . . . . 63.530000000000001 110.827 -171.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.92 -28.1 28.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.438 -0.346 . . . . 62.030000000000001 111.347 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.94 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 63.0 ttt180 -65.7 -35.99 82.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.507 -0.315 . . . . 74.109999999999999 110.364 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -62.77 -34.01 76.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 72.329999999999998 110.854 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.09 -35.59 61.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 70.540000000000006 110.348 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.47 ' HB2' HG13 ' A' ' 48' ' ' VAL . . . -58.92 -55.45 34.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 73.439999999999998 111.032 177.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.19 -11.04 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.37 0.605 . . . . 44.310000000000002 110.891 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.5 tp-100 -88.25 -24.64 23.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 73.450000000000003 110.11 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.5 18.87 20.46 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.055 -0.52 . . . . 64.420000000000002 111.753 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.03 125.19 11.39 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 121.014 0.435 . . . . 72.209999999999994 110.35 176.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.93 82.56 1.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.431 2.087 . . . . 51.200000000000003 112.584 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.94 28.47 71.79 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.772 -0.649 . . . . 74.200000000000003 112.875 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.55 175.44 29.15 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.712 -0.756 . . . . 62.329999999999998 112.113 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.796 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 58.0 m -78.09 105.9 9.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.267 0.556 . . . . 73.239999999999995 110.964 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.6 120.62 37.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.684 -0.689 . . . . 51.399999999999999 109.881 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.501 ' HA3' HD11 ' A' ' 49' ' ' LEU . . . -101.19 160.43 18.51 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.524 -0.846 . . . . 23.420000000000002 112.285 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.94 ' HG2' ' HD2' ' A' ' 20' ' ' ARG . 23.4 mt-10 -79.25 151.64 31.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.984 -0.376 . . . . 52.240000000000002 109.984 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.512 HG12 HD23 ' A' ' 49' ' ' LEU . 26.7 m -128.72 155.54 40.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.956 -0.565 . . . . 60.520000000000003 111.547 -171.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.13 158.85 17.88 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.419 -0.585 . . . . 75.030000000000001 109.419 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -72.92 113.28 9.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.012 0.434 . . . . 34.200000000000003 110.972 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.21 139.54 56.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 72.099999999999994 109.632 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.5 p -138.48 173.89 11.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.832 0.349 . . . . 63.43 111.422 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.74 -115.02 3.27 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.797 -0.716 . . . . 41.149999999999999 112.132 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -131.03 172.58 11.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.819 0.342 . . . . 74.430000000000007 110.46 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.9 -139.77 14.56 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.169 -0.772 . . . . 51.109999999999999 111.169 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 -12.98 4.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.894 0.347 . . . . 65.209999999999994 111.456 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.45 133.05 38.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 70.120000000000005 111.261 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.77 -28.72 2.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.947 -0.57 . . . . 65.109999999999999 110.75 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -131.23 155.77 46.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.435 -0.348 . . . . 71.420000000000002 110.274 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.83 145.39 16.82 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.469 -0.872 . . . . 71.310000000000002 112.193 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.47 HG13 ' HB2' ' A' ' 23' ' ' ALA . 70.1 t -128.91 105.4 12.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.308 -0.627 . . . . 73.420000000000002 109.308 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.512 HD23 HG12 ' A' ' 35' ' ' VAL . 3.3 pp -102.18 123.82 46.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.423 0.63 . . . . 74.200000000000003 110.648 -177.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 m -124.61 120.64 59.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.463 -0.79 . . . . 71.340000000000003 110.42 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.796 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 12.5 m -92.71 104.28 16.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.822 -0.626 . . . . 60.219999999999999 109.995 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -66.09 139.9 96.77 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.877 -0.601 . . . . 75.019999999999996 109.438 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.93 -9.56 6.19 Favored 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.169 2.579 . . . . 74.530000000000001 112.939 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.99 -13.7 60.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 72.120000000000005 110.475 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.28 33.01 5.85 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.771 -0.728 . . . . 41.350000000000001 112.563 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -131.2 143.02 50.28 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.096 -0.335 . . . . 62.219999999999999 110.096 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 74' ' ' ALA . 24.8 ttp180 -107.23 119.7 40.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.886 0.374 . . . . 75.140000000000001 110.087 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.39 114.79 48.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.122 -0.49 . . . . 73.219999999999999 110.021 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.54 112.02 24.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.554 0.693 . . . . 72.439999999999998 110.431 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.5 t -88.66 124.45 41.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.195 -0.911 . . . . 73.530000000000001 109.891 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 70' ' ' ASP . 35.9 m170 -96.06 122.6 39.07 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.909 -0.587 . . . . 74.219999999999999 110.667 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -109.78 154.95 22.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.71 -0.677 . . . . 64.140000000000001 110.468 -177.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 1.011 ' HB3' HD11 ' A' ' 69' ' ' LEU . 3.9 p30 -92.14 -164.23 1.15 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.977 0.417 . . . . 74.299999999999997 110.481 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.445 ' HG3' ' H ' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -62.81 -29.16 70.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.725 -0.671 . . . . 73.230000000000004 111.191 -175.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -100.27 17.27 21.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.175 -0.466 . . . . 64.010000000000005 111.316 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 69.02 19.86 7.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.848 -0.615 . . . . 75.109999999999999 111.507 172.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.529 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . 40.3 ttm180 -90.63 145.81 24.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.769 0.319 . . . . 70.019999999999996 110.522 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.548 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.3 p -67.06 126.47 26.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.211 0.529 . . . . 64.530000000000001 110.904 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 1.011 HD11 ' HB3' ' A' ' 63' ' ' ASP . 61.3 mt -112.72 -61.39 1.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.898 -0.592 . . . . 72.219999999999999 111.016 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 61' ' ' HIS . 23.0 t70 -132.03 139.83 48.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.551 -0.749 . . . . 72.099999999999994 111.315 -169.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.2 m -117.52 110.43 17.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.357 -0.383 . . . . 73.299999999999997 110.364 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -114.96 117.53 41.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.953 0.406 . . . . 64.230000000000004 111.872 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.23 93.99 0.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.757 2.305 . . . . 44.219999999999999 109.998 168.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 57' ' ' ARG . . . -124.92 147.3 48.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.388 -0.369 . . . . 73.019999999999996 111.292 -172.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 116.065 -0.516 . . . . 64.239999999999995 109.927 177.865 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.836 -0.431 . . . . 74.409999999999997 109.836 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.39 66.85 4.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.268 0.556 . . . . 63.310000000000002 111.507 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -113.12 57.5 0.67 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.492 0.663 . . . . 72.409999999999997 109.308 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -153.69 117.72 4.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.004 -0.998 . . . . 74.329999999999998 109.179 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.81 155.07 25.93 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.776 -0.726 . . . . 72.219999999999999 111.614 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.46 165.76 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.523 0.678 . . . . 72.540000000000006 111.678 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.55 2.8 55.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.038 -0.983 . . . . 73.329999999999998 111.197 -173.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.89 22.26 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 53.140000000000001 112.092 -173.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.487 HG21 ' HB2' ' A' ' 17' ' ' ASP . 19.6 m -131.08 173.58 14.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.417 -0.356 . . . . 60.119999999999997 110.234 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -93.38 102.4 14.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.922 -0.77 . . . . 74.209999999999994 108.922 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.88 92.99 0.54 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.347 -1.101 . . . . 72.319999999999993 110.347 -169.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.28 -13.36 19.72 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 123.233 2.622 . . . . 75.310000000000002 114.13 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.577 ' HA ' ' CG ' ' A' ' 18' ' ' ARG . 54.0 m-20 -73.04 -15.63 61.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.26 0.552 . . . . 75.230000000000004 109.721 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -68.41 -31.99 71.73 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.263 -0.88 . . . . 75.319999999999993 109.974 171.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HB2' HG21 ' A' ' 11' ' ' VAL . 11.6 t70 -83.41 -28.33 28.94 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.168 -0.469 . . . . 73.510000000000005 111.584 -173.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.577 ' CG ' ' HA ' ' A' ' 15' ' ' ASP . 5.5 mmt180 -54.28 -55.1 31.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.56 0.695 . . . . 74.239999999999995 109.931 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.855 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -81.15 -21.61 39.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.247 -0.888 . . . . 73.019999999999996 111.141 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 28.0 ttt180 -66.54 -36.24 82.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.0 0.428 . . . . 74.140000000000001 110.372 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.34 70.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.291 0.567 . . . . 74.049999999999997 110.484 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.27 -38.13 36.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 73.299999999999997 110.268 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.402 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -56.48 -48.85 76.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.712 -0.676 . . . . 62.340000000000003 111.777 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 p -66.2 -18.69 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.996 0.427 . . . . 62.509999999999998 111.213 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.76 -19.69 21.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.973 0.416 . . . . 71.25 110.695 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.55 -31.54 22.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.068 -0.515 . . . . 73.230000000000004 111.427 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 23' ' ' ALA . 7.1 p -117.0 120.33 33.96 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.955 0.407 . . . . 62.210000000000001 110.541 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.83 104.59 1.19 Allowed 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.741 2.294 . . . . 63.240000000000002 112.625 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.19 26.19 71.43 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.913 -0.585 . . . . 23.449999999999999 112.584 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.5 -173.28 35.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.743 -0.742 . . . . 40.439999999999998 112.068 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.797 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 63.6 m -90.25 111.44 22.62 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.971 0.415 . . . . 72.439999999999998 110.745 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.03 100.64 11.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.644 -0.707 . . . . 73.5 109.592 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.605 ' HA3' HD11 ' A' ' 49' ' ' LEU . . . -89.45 160.95 29.58 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.786 -0.721 . . . . 61.439999999999998 112.309 -176.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -70.13 127.67 33.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.275 0.56 . . . . 74.209999999999994 110.125 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.707 HG21 ' HB3' ' A' ' 19' ' ' ALA . 20.4 m -103.96 153.92 6.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.699 -0.682 . . . . 70.219999999999999 111.417 -173.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -106.73 155.57 19.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.39 -0.368 . . . . 64.540000000000006 110.283 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.3 m -76.64 111.29 11.98 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.85 -0.426 . . . . 43.219999999999999 109.85 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 36.1 mt-10 -78.62 111.24 14.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.174 0.511 . . . . 74.219999999999999 110.449 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.4 p -117.66 124.68 49.14 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.011 -0.541 . . . . 72.439999999999998 110.646 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.63 -110.69 0.38 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.46 -0.876 . . . . 72.319999999999993 112.618 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -113.94 165.77 12.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.957 0.408 . . . . 71.230000000000004 111.291 -174.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.97 -150.27 29.03 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.848 -0.691 . . . . 71.430000000000007 111.959 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.13 4.95 10.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.143 0.497 . . . . 72.299999999999997 110.695 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.51 103.01 12.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 62.310000000000002 110.4 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 38' ' ' GLU . . . -103.85 -13.64 16.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.138 -0.483 . . . . 44.240000000000002 111.019 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -141.74 133.69 27.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 72.239999999999995 110.191 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -116.41 113.62 2.85 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.859 -0.686 . . . . 43.109999999999999 111.785 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.855 HG22 ' HB1' ' A' ' 19' ' ' ALA . 34.7 t -95.5 117.09 38.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 110.031 -0.359 . . . . 61.409999999999997 110.031 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.605 HD11 ' HA3' ' A' ' 33' ' ' GLY . 1.3 pp -98.39 107.64 20.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.473 0.654 . . . . 63.109999999999999 110.276 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.2 m -110.19 107.05 21.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 62.310000000000002 110.761 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.797 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 22.4 m -95.6 113.76 25.44 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.845 -0.616 . . . . 64.510000000000005 110.76 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -71.21 146.08 91.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.176 -0.676 . . . . 71.200000000000003 109.176 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.98 -2.84 6.09 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.718 2.279 . . . . 62.549999999999997 112.17 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -83.08 0.5 44.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.682 -0.69 . . . . 73.540000000000006 110.539 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.18 33.21 12.24 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.635 -0.793 . . . . 71.519999999999996 112.579 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t -135.9 125.56 25.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.136 0.493 . . . . 74.140000000000001 110.886 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 54.3 ttt180 -103.75 126.26 50.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.931 -0.577 . . . . 75.0 110.648 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 49.4 t -112.96 132.77 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.184 -0.462 . . . . 72.010000000000005 110.262 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -93.06 108.32 19.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.282 -0.417 . . . . 71.540000000000006 110.383 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.776 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 21.6 t -89.28 108.36 19.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.204 -0.665 . . . . 71.5 109.204 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -90.1 127.16 36.02 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.989 0.423 . . . . 64.519999999999996 110.823 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.705 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -115.74 159.36 21.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.513 -0.767 . . . . 61.140000000000001 111.103 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.463 ' HB2' HD21 ' A' ' 69' ' ' LEU . 11.2 t70 -90.43 173.73 7.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.047 -0.979 . . . . 52.310000000000002 110.138 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -57.58 -29.43 64.44 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.451 0.7 . . . . 74.409999999999997 111.411 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -89.18 5.35 45.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.084 0.469 . . . . 72.109999999999999 110.37 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 71.34 21.65 4.55 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.404 -0.816 . . . . 75.200000000000003 110.592 -176.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.49 133.13 37.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.894 -0.593 . . . . 74.409999999999997 109.877 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.705 ' HA ' HD12 ' A' ' 62' ' ' LEU . 7.2 p -65.55 131.23 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.879 0.371 . . . . 74.109999999999999 111.004 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.463 HD21 ' HB2' ' A' ' 63' ' ' ASP . 92.1 mt -101.19 -64.25 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.292 -0.413 . . . . 71.109999999999999 110.561 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -166.61 175.8 7.71 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.702 -0.481 . . . . 64.530000000000001 109.702 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.426 HG22 HG22 ' A' ' 60' ' ' VAL . 46.9 p -139.09 114.22 9.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.721 0.296 . . . . 70.239999999999995 111.384 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -125.4 139.53 34.1 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.096 -0.335 . . . . 75.349999999999994 110.096 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 40.6 Cg_endo -69.22 152.08 72.09 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.407 2.071 . . . . 64.540000000000006 112.3 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.06 111.56 23.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.324 -0.398 . . . . 71.109999999999999 111.598 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.9 t0 . . . . . 0 C--N 1.325 -0.48 0 N-CA-C 109.243 -0.651 . . . . 60.200000000000003 109.243 175.613 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.413 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 4.5 mpp? . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.904 0.383 . . . . 73.540000000000006 110.209 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.01 89.7 6.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 63.109999999999999 111.136 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.432 ' HZ ' ' HA ' ' A' ' 65' ' ' ASP . 79.1 m-85 -117.55 58.14 0.8 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.338 0.59 . . . . 73.239999999999995 109.899 175.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -146.56 145.4 30.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.537 -0.756 . . . . 63.520000000000003 109.306 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.14 164.9 35.1 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.562 -0.828 . . . . 65.25 111.664 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.93 162.05 20.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.056 0.428 . . . . 75.219999999999999 110.706 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -95.22 -10.19 31.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.36 -0.382 . . . . 73.530000000000001 111.513 -172.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -85.74 5.1 33.79 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.166 0.432 . . . . 60.109999999999999 112.166 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 17' ' ' ASP . 27.8 m -90.14 158.19 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.522 -0.547 . . . . 64.120000000000005 109.522 172.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.9 m -92.76 -34.75 13.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.785 0.326 . . . . 70.5 110.384 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.99 109.51 3.12 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.64 -0.79 . . . . 74.109999999999999 111.439 175.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.99 -66.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.608 2.206 . . . . 53.439999999999998 112.007 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.609 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 5.4 p-10 -71.17 -20.61 62.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.094 -0.503 . . . . 72.140000000000001 110.629 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 34' ' ' GLU . . . -56.46 -45.91 80.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.523 -0.762 . . . . 42.5 112.43 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.424 ' HB2' HG21 ' A' ' 11' ' ' VAL . 32.6 t70 -64.92 -54.79 25.21 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.548 0.573 . . . . 61.119999999999997 112.548 -173.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.728 ' HD2' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -63.64 -32.58 74.1 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.904 -0.318 . . . . 74.140000000000001 110.995 -177.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.504 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . . . -68.94 -44.72 72.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.282 0.563 . . . . 61.0 110.262 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.455 ' O ' HG23 ' A' ' 24' ' ' VAL . 38.4 ttp180 -60.09 -46.86 88.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.258 -0.883 . . . . 51.039999999999999 110.912 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.39 89.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.95 -0.568 . . . . 71.409999999999997 111.671 -177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.56 -38.15 90.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.975 0.417 . . . . 65.219999999999999 111.268 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.22 -16.97 57.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.043 -0.526 . . . . 62.25 112.327 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 20' ' ' ARG . 96.0 t -57.53 -39.27 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.951 0.405 . . . . 73.230000000000004 111.254 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.413 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 2.3 mp0 -70.02 -13.13 62.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.376 -0.375 . . . . 74.530000000000001 111.318 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.66 12.31 36.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.36 -0.382 . . . . 74.129999999999995 111.15 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.48 114.42 3.82 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.242 0.544 . . . . 75.519999999999996 110.693 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.26 93.64 0.66 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.449 2.099 . . . . 53.130000000000003 112.699 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.26 43.88 94.58 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.694 -0.684 . . . . 54.049999999999997 112.615 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.437 ' HA2' ' HG3' ' A' ' 53' ' ' PRO . . . -110.66 -172.96 19.99 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.585 -0.817 . . . . 33.509999999999998 112.638 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.759 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 37.9 m -92.06 114.52 27.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.859 0.361 . . . . 74.349999999999994 111.205 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.93 119.83 39.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.824 -0.625 . . . . 44.219999999999999 109.999 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.84 161.04 12.88 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.551 -0.833 . . . . 73.430000000000007 112.755 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' HB3' ' HB1' ' A' ' 16' ' ' ALA . 1.6 mp0 -67.17 137.26 56.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.058 -0.349 . . . . 71.310000000000002 110.058 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.762 HG11 ' HA ' ' A' ' 48' ' ' VAL . 31.1 m -134.01 154.42 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.254 -0.43 . . . . 75.129999999999995 111.269 -174.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -106.67 160.63 15.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.276 -0.42 . . . . 70.030000000000001 110.118 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 p -71.52 148.75 46.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.055 0.455 . . . . 72.430000000000007 111.625 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.59 97.08 6.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 64.219999999999999 110.201 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.1 m -89.54 117.6 28.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.984 -0.553 . . . . 74.439999999999998 110.532 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.88 -139.19 6.66 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.782 -0.723 . . . . 72.209999999999994 112.199 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -95.78 178.06 5.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.969 0.414 . . . . 63.350000000000001 110.716 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.49 -168.18 19.5 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.054 -0.593 . . . . 72.340000000000003 112.362 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.25 8.45 14.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.939 0.399 . . . . 73.230000000000004 110.504 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.24 170.34 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 42.149999999999999 110.663 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.11 -36.93 0.17 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.478 -0.328 . . . . 74.340000000000003 111.531 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.558 ' HE2' ' HB2' ' A' ' 15' ' ' ASP . 76.3 m-85 -124.61 131.74 53.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.955 -0.387 . . . . 72.25 109.955 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.3 112.28 2.06 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.204 -0.998 . . . . 64.420000000000002 110.971 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.762 ' HA ' HG11 ' A' ' 35' ' ' VAL . 12.0 t -109.07 126.17 66.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.736 0.303 . . . . 74.239999999999995 111.08 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.494 ' H ' HG11 ' A' ' 35' ' ' VAL . 3.4 pp -87.07 130.71 34.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.215 -0.448 . . . . 75.150000000000006 109.992 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.17 114.17 25.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.638 0.733 . . . . 73.340000000000003 110.498 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.759 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 11.6 m -97.92 122.83 41.5 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.411 -0.813 . . . . 71.129999999999995 110.77 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.435 ' C ' ' H ' ' A' ' 54' ' ' ASP . 8.0 mpt_? -74.32 140.35 76.07 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.686 -0.857 . . . . 74.349999999999994 108.686 171.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.437 ' HG3' ' HA2' ' A' ' 30' ' ' GLY . 16.4 Cg_exo -68.88 17.95 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.17 2.58 . . . . 34.509999999999998 112.957 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 52' ' ' ARG . 12.3 t70 -109.42 -15.64 14.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.138 0.494 . . . . 73.430000000000007 110.331 177.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.22 -19.31 8.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.621 -0.8 . . . . 45.43 112.424 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.89 115.28 18.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.412 0.625 . . . . 64.5 111.091 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 57' ' ' ARG . 34.2 ttp180 -115.74 120.51 39.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.609 -0.723 . . . . 63.43 110.482 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.482 HG12 ' HA ' ' A' ' 73' ' ' PRO . 31.5 m -123.62 163.45 22.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.37 -0.377 . . . . 73.409999999999997 110.302 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -122.85 133.92 54.41 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.044 0.45 . . . . 61.119999999999997 110.039 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.415 HG12 HD13 ' A' ' 62' ' ' LEU . 22.8 t -101.61 120.13 50.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.482 -0.562 . . . . 52.420000000000002 109.482 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -92.2 121.66 33.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.562 . . . . 74.519999999999996 110.229 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.649 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.35 156.69 22.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.893 -1.049 . . . . 75.230000000000004 110.929 -172.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 67' ' ' ARG . 10.9 t70 -90.73 172.11 8.88 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.313 -0.858 . . . . 60.350000000000001 109.722 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -50.23 -44.57 53.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.546 0.738 . . . . 60.0 112.352 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 67' ' ' ARG . 27.1 m-20 -96.52 26.14 4.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.911 0.386 . . . . 74.25 110.604 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 19' ' ' ALA . 26.2 m-85 67.1 32.67 6.06 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.216 0.821 . . . . 63.530000000000001 113.216 174.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -77.94 126.82 31.4 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.172 -0.677 . . . . 74.340000000000003 109.172 169.168 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.649 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.5 p -69.55 120.65 17.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.053 0.454 . . . . 73.450000000000003 110.371 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.9 mt -96.18 -62.58 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.24 -0.436 . . . . 71.200000000000003 110.896 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -150.71 170.19 19.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 70.209999999999994 110.092 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.0 m -147.61 115.79 6.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.041 0.448 . . . . 61.25 110.363 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -133.08 159.45 72.59 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.022 -0.535 . . . . 60.140000000000001 110.194 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.482 ' HA ' HG12 ' A' ' 58' ' ' VAL . 18.3 Cg_endo -59.91 143.1 99.64 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.733 2.289 . . . . 42.140000000000001 112.476 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.56 122.22 36.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.873 -0.603 . . . . 71.340000000000003 110.804 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--N 1.323 -0.573 0 N-CA-C 110.029 -0.36 . . . . 64.510000000000005 110.029 179.505 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.533 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 1.6 mpt? . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.96 -0.756 . . . . 74.319999999999993 108.96 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.05 81.75 3.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.155 0.503 . . . . 70.430000000000007 112.125 -172.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 3' ' ' MET . 91.3 m-85 -121.35 57.52 1.01 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.727 0.775 . . . . 75.120000000000005 109.053 174.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.582 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 7.9 t70 -147.83 -142.75 0.13 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.389 -1.337 . . . . 70.319999999999993 107.389 -177.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.61 175.83 33.06 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.007 -1.092 . . . . 70.340000000000003 112.581 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.6 -178.67 6.95 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.649 -0.5 . . . . 75.109999999999999 109.649 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -92.66 -9.55 40.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.439 0.638 . . . . 64.5 109.585 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.13 53.92 2.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.55 -0.75 . . . . 71.099999999999994 109.363 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 m -60.14 96.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.858 0.837 . . . . 73.319999999999993 112.186 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 t -93.72 -21.83 19.1 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.104 -0.953 . . . . 52.109999999999999 109.021 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.755 ' HA3' ' HB3' ' A' ' 16' ' ' ALA . . . -152.27 143.76 10.76 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.153 -0.93 . . . . 41.219999999999999 111.096 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -60.75 -68.91 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.819 2.346 . . . . 64.040000000000006 111.876 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.577 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 10.8 m-20 -90.01 -22.29 21.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.519 -0.549 . . . . 74.129999999999995 109.519 176.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.755 ' HB3' ' HA3' ' A' ' 13' ' ' GLY . . . -58.91 -37.34 76.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.077 -0.965 . . . . 74.120000000000005 111.445 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 14.9 t70 -55.57 -57.77 10.56 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.165 -0.471 . . . . 54.530000000000001 111.545 -175.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.593 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -69.07 -35.75 76.87 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.945 0.35 . . . . 75.150000000000006 111.945 -176.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.411 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -68.48 -42.45 78.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.101 0.477 . . . . 63.240000000000002 110.812 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -71.12 -36.91 72.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.839 -0.619 . . . . 71.120000000000005 110.56 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.25 -24.07 66.52 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.431 -0.349 . . . . 70.209999999999994 111.49 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 -29.89 33.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.402 -0.363 . . . . 54.240000000000002 111.152 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.419 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -62.21 -31.77 72.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.045 -0.525 . . . . 72.549999999999997 112.034 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.6 p -69.02 -14.01 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.819 0.343 . . . . 74.120000000000005 111.731 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -85.36 -31.85 22.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.858 0.361 . . . . 63.119999999999997 110.357 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.13 -32.23 39.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.067 -0.515 . . . . 43.140000000000001 111.382 -176.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.462 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 14.6 p -111.15 133.9 21.21 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.854 0.359 . . . . 64.25 110.53 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 27' ' ' VAL . 8.9 Cg_endo -82.49 99.88 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.828 2.352 . . . . 62.210000000000001 111.871 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.45 39.44 97.8 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.039 -0.601 . . . . 65.25 112.184 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' HA3' ' CG2' ' A' ' 27' ' ' VAL . . . -104.49 168.12 16.12 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.591 -0.814 . . . . 72.040000000000006 112.411 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 1.032 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 39.8 m -82.04 106.11 13.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.233 0.539 . . . . 61.409999999999997 111.201 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.87 111.91 22.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.395 -0.821 . . . . 51.109999999999999 109.29 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.37 162.87 17.86 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.184 -0.532 . . . . 72.510000000000005 112.839 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -61.72 106.94 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 72.209999999999994 110.232 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.645 HG11 ' HA ' ' A' ' 48' ' ' VAL . 33.9 m -91.25 150.3 3.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.921 -0.581 . . . . 64.209999999999994 110.845 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -108.67 150.06 28.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.272 -0.422 . . . . 73.099999999999994 110.032 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.74 131.01 39.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.183 0.516 . . . . 71.420000000000002 110.999 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.83 133.8 38.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.674 -0.694 . . . . 62.219999999999999 110.365 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -91.49 117.67 29.9 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.936 -0.765 . . . . 50.219999999999999 108.936 168.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.67 93.62 0.15 Allowed Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.214 -0.993 . . . . 75.120000000000005 112.612 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -51.4 114.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.504 -0.554 . . . . 70.120000000000005 109.504 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.14 -54.61 0.61 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.736 -0.745 . . . . 55.32 112.149 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -175.13 -38.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.804 0.298 . . . . 74.140000000000001 111.804 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.88 130.28 45.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.048 0.452 . . . . 44.140000000000001 111.796 -174.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.78 -36.4 0.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.756 -0.656 . . . . 73.099999999999994 110.788 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.543 ' HE2' ' HB3' ' A' ' 15' ' ' ASP . 91.8 m-85 -124.84 133.65 53.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 74.219999999999999 110.49 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.29 113.46 2.03 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.335 -0.706 . . . . 74.129999999999995 111.335 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.645 ' HA ' HG11 ' A' ' 35' ' ' VAL . 45.7 t -101.18 112.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.734 0.302 . . . . 73.319999999999993 111.01 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.62 ' HG ' HG12 ' A' ' 35' ' ' VAL . 2.3 pp -85.8 117.05 24.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 74.439999999999998 110.042 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.67 114.42 47.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.661 -0.7 . . . . 63.020000000000003 110.277 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 1.032 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 20.3 m -96.13 104.92 16.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.233 -0.44 . . . . 73.430000000000007 110.461 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -67.04 138.71 95.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.165 -0.68 . . . . 73.519999999999996 109.165 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HD3' ' HA2' ' A' ' 30' ' ' GLY . 17.9 Cg_endo -60.05 -7.94 7.21 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.131 2.554 . . . . 70.209999999999994 112.998 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -74.25 -14.45 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 70.239999999999995 110.537 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.34 33.36 5.17 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.398 -0.906 . . . . 71.349999999999994 112.662 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 t -131.84 142.27 49.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.905 0.383 . . . . 72.510000000000005 110.949 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 58.9 ttt180 -110.08 122.69 48.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 72.409999999999997 111.362 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.48 139.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.406 -0.59 . . . . 73.420000000000002 109.406 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -108.2 136.12 48.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.217 0.532 . . . . 73.25 110.858 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 71' ' ' THR . 23.6 t -106.01 118.18 53.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.514 -0.766 . . . . 62.100000000000001 109.672 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -89.55 125.32 35.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.09 -0.504 . . . . 72.239999999999995 111.521 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.816 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -117.16 147.21 42.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.474 -0.784 . . . . 61.25 109.816 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.872 ' HB3' HD21 ' A' ' 69' ' ' LEU . 1.9 p-10 -91.96 -167.1 1.69 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.951 -0.3 . . . . 74.439999999999998 110.439 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -55.27 -38.08 68.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.014 -0.539 . . . . 74.549999999999997 111.933 -176.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -89.67 16.45 7.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.019 0.377 . . . . 75.219999999999999 112.019 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 65.83 21.84 11.46 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.208 0.528 . . . . 75.219999999999999 111.127 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.713 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 9.0 tpt180 -88.34 134.84 33.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.212 -0.449 . . . . 75.040000000000006 110.178 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.816 ' HA ' HD12 ' A' ' 62' ' ' LEU . 4.5 p -61.58 116.05 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.242 0.544 . . . . 62.299999999999997 111.256 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.872 HD21 ' HB3' ' A' ' 63' ' ' ASP . 85.5 mt -84.42 -49.06 9.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.754 -0.657 . . . . 64.319999999999993 109.611 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -170.35 -179.34 3.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.487 -0.778 . . . . 73.420000000000002 108.981 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.539 HG23 HG22 ' A' ' 60' ' ' VAL . 23.8 m -145.83 108.22 4.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.741 0.305 . . . . 61.039999999999999 110.352 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 1.5 pm0 -120.86 147.07 45.26 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.899 0.381 . . . . 71.120000000000005 111.077 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 24.0 Cg_exo -63.72 132.34 34.78 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.944 2.429 . . . . 61.509999999999998 112.022 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . . . -107.73 100.09 9.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.148 -0.478 . . . . 74.340000000000003 110.461 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 C--N 1.321 -0.633 0 CA-C-N 116.118 -0.492 . . . . 64.129999999999995 110.109 179.766 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.884 0.374 . . . . 73.349999999999994 110.336 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.09 77.88 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.218 -0.447 . . . . 74.120000000000005 111.109 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.67 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 88.2 m-85 -131.76 56.45 1.82 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 74.319999999999993 110.551 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.8 t70 175.6 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.732 -0.667 . . . . 72.019999999999996 110.071 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.0 -80.71 1.53 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.052 -0.819 . . . . 43.229999999999997 111.052 174.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -146.51 133.4 20.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.15 0.5 . . . . 74.530000000000001 110.064 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -75.96 4.85 7.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.8 -0.636 . . . . 73.239999999999995 111.779 -170.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.12 -17.16 60.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.569 -0.287 . . . . 72.549999999999997 111.697 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.582 HG21 ' HB2' ' A' ' 17' ' ' ASP . 35.5 m -92.34 162.85 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.762 0.315 . . . . 75.219999999999999 111.278 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.5 p -101.44 -0.16 35.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.288 -0.414 . . . . 72.540000000000006 111.6 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.01 105.45 1.99 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.727 -0.749 . . . . 75.510000000000005 111.608 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 22.4 Cg_endo -62.08 -50.9 4.23 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.68 2.254 . . . . 73.019999999999996 111.986 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -71.14 -35.05 71.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.953 -0.567 . . . . 75.549999999999997 110.427 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -62.31 -43.57 98.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.842 -0.617 . . . . 72.219999999999999 110.833 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.582 ' HB2' HG21 ' A' ' 11' ' ' VAL . 8.8 t70 -56.43 -53.66 54.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 70.329999999999998 111.739 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.67 ' HD2' ' HA ' ' A' ' 5' ' ' PHE . 12.0 mmt180 -56.76 -51.01 70.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.966 -0.561 . . . . 75.109999999999999 111.315 -171.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.841 ' HB3' HG21 ' A' ' 35' ' ' VAL . . . -78.64 -33.2 47.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.932 -0.576 . . . . 60.539999999999999 111.865 -174.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -69.62 -34.58 74.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 73.530000000000001 110.107 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.15 85.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 64.319999999999993 110.598 176.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.72 -32.29 63.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 70.030000000000001 110.877 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.442 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -56.27 -31.26 63.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.824 -0.626 . . . . 73.209999999999994 111.818 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.36 -32.19 40.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.978 0.418 . . . . 64.230000000000004 111.085 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.44 -13.73 25.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.267 -0.424 . . . . 54.420000000000002 110.815 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.558 ' HB3' HG11 ' A' ' 50' ' ' VAL . . . -85.76 -29.65 23.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.276 -0.42 . . . . 62.520000000000003 111.283 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.923 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 9.9 p -111.02 128.05 25.93 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.887 0.375 . . . . 73.340000000000003 110.399 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 27' ' ' VAL . 3.0 Cg_exo -72.95 93.06 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.798 2.332 . . . . 73.109999999999999 112.37 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.23 21.43 72.04 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.146 -0.549 . . . . 63.200000000000003 112.972 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.84 -164.43 32.71 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.732 -0.747 . . . . 74.329999999999998 112.255 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.46 ' CG2' ' HB ' ' A' ' 51' ' ' THR . 4.9 t -103.64 136.34 43.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.061 0.458 . . . . 64.530000000000001 110.469 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.16 110.23 22.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 64.109999999999999 110.365 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.78 160.75 31.53 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.686 -0.769 . . . . 54.25 112.222 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -75.32 140.99 43.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 64.409999999999997 110.22 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.841 HG21 ' HB3' ' A' ' 19' ' ' ALA . 12.8 m -116.02 155.88 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.949 -0.569 . . . . 64.549999999999997 111.837 -169.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -114.46 156.96 23.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 52.520000000000003 109.502 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 p -74.04 123.56 24.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.606 0.241 . . . . 74.340000000000003 110.817 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.9 134.33 47.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.844 -0.428 . . . . 73.530000000000001 109.844 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.5 m -121.55 118.21 28.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.779 0.323 . . . . 72.519999999999996 110.408 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.98 -148.34 7.92 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.173 -0.771 . . . . 71.040000000000006 111.173 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -111.32 116.67 31.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.035 0.445 . . . . 64.319999999999993 110.426 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.84 -170.8 29.94 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.013 -0.835 . . . . 53.530000000000001 111.013 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.51 -5.39 49.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.911 0.386 . . . . 73.099999999999994 110.789 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.76 112.04 14.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 61.049999999999997 110.851 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.73 -16.73 11.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.098 -0.501 . . . . 63.450000000000003 111.061 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.457 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 90.9 m-85 -130.88 132.33 45.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.492 -0.322 . . . . 72.239999999999995 110.736 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.31 112.84 2.57 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.668 -0.777 . . . . 72.450000000000003 111.21 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.799 HG22 ' HB1' ' A' ' 19' ' ' ALA . 38.8 t -99.95 119.81 48.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.666 0.269 . . . . 45.210000000000001 111.035 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.534 HD23 HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -94.12 107.79 19.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.339 0.59 . . . . 61.32 110.336 177.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.923 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 2.7 m -115.12 102.5 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.528 0.68 . . . . 74.019999999999996 110.663 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.46 ' HB ' ' CG2' ' A' ' 31' ' ' THR . 10.0 m -92.64 122.67 35.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.358 -0.837 . . . . 75.319999999999993 110.867 -175.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HD2' HG23 ' A' ' 27' ' ' VAL . 12.6 mpt_? -79.53 153.05 76.05 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.163 -0.472 . . . . 63.109999999999999 110.36 177.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.2 1.78 3.23 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.967 2.445 . . . . 62.43 111.44 174.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -85.66 -13.49 48.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.101 -0.954 . . . . 71.209999999999994 109.816 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.08 -7.33 48.08 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.843 -0.694 . . . . 64.109999999999999 112.668 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 t -91.8 126.88 37.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 75.230000000000004 111.364 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 35.8 ttp180 -107.93 124.27 49.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.609 -0.723 . . . . 63.210000000000001 109.45 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.676 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 30.2 t -122.46 137.05 57.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.509 -0.314 . . . . 63.140000000000001 110.935 -175.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.478 ' HG3' ' HB3' ' A' ' 74' ' ' ALA . 34.0 mt-10 -93.07 122.4 35.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.012 0.434 . . . . 73.230000000000004 110.747 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.468 HG22 HG23 ' A' ' 71' ' ' THR . 16.9 t -103.12 109.34 26.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.689 -0.856 . . . . 74.230000000000004 108.689 173.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.5 m170 -90.15 127.03 36.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.889 0.376 . . . . 63.140000000000001 110.297 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.758 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -112.86 159.82 18.65 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.611 -0.722 . . . . 74.120000000000005 112.185 -171.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.659 ' HB2' HD21 ' A' ' 69' ' ' LEU . 16.0 t70 -90.5 169.84 10.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.559 -1.2 . . . . 75.540000000000006 109.797 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -31.54 64.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.766 0.426 . . . . 75.019999999999996 111.102 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -94.35 17.33 13.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.551 -0.295 . . . . 74.209999999999994 111.122 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 64.02 38.87 8.31 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.827 0.677 . . . . 72.310000000000002 112.827 175.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -99.32 147.52 25.11 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.631 -0.507 . . . . 74.239999999999995 109.631 169.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.758 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.4 p -74.25 119.85 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.333 0.587 . . . . 75.239999999999995 110.561 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 63' ' ' ASP . 93.0 mt -89.12 -47.42 8.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.867 -0.606 . . . . 72.129999999999995 110.339 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -164.55 156.47 16.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.117 -0.492 . . . . 75.329999999999998 110.498 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.468 HG23 HG22 ' A' ' 60' ' ' VAL . 8.0 m -124.23 118.04 25.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.858 -0.61 . . . . 71.519999999999996 109.977 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 8.7 pt-20 -134.1 121.58 15.73 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 71.340000000000003 111.319 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 37.3 Cg_exo -61.59 120.19 7.7 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.751 2.301 . . . . 73.030000000000001 111.3 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.478 ' HB3' ' HG3' ' A' ' 59' ' ' GLU . . . -143.25 164.92 28.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.981 0.419 . . . . 62.049999999999997 111.637 -173.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.94 -0.573 . . . . 54.409999999999997 110.064 177.606 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.753 -0.462 . . . . 73.530000000000001 109.753 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . . . -75.43 72.78 2.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.192 0.52 . . . . 64.219999999999999 112.068 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -128.14 108.01 10.28 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.078 -0.712 . . . . 74.519999999999996 109.078 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.658 ' H ' ' HD3' ' A' ' 18' ' ' ARG . 29.7 t70 67.62 110.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.109 0.88 . . . . 74.319999999999993 111.233 -173.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.81 -77.76 0.11 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.705 -0.759 . . . . 54.350000000000001 112.092 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.776 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 9.3 tp10 -85.96 157.34 20.16 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.059 -0.348 . . . . 64.439999999999998 110.059 177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -83.88 -9.39 58.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.579 0.704 . . . . 44.100000000000001 109.642 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.776 ' H ' ' HG3' ' A' ' 8' ' ' GLU . 10.6 mm-40 -84.56 88.57 7.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.191 -0.913 . . . . 75.230000000000004 109.561 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.62 90.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.131 0.491 . . . . 63.43 110.713 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.8 p -93.86 -5.56 47.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.949 -0.569 . . . . 73.349999999999994 110.597 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.73 146.77 5.68 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.033 -0.827 . . . . 71.219999999999999 111.033 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 25.2 Cg_endo -62.18 -53.82 1.78 Allowed 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.668 2.246 . . . . 63.039999999999999 112.156 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -97.85 -37.67 9.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.959 -0.564 . . . . 74.230000000000004 110.905 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.67 -48.79 58.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.77 -0.65 . . . . 74.340000000000003 112.213 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -65.68 -50.96 62.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.277 0.561 . . . . 53.409999999999997 111.569 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.691 ' HG2' HH11 ' A' ' 18' ' ' ARG . 12.5 mtt-85 -72.75 -37.39 67.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.549 -0.75 . . . . 65.219999999999999 111.592 -168.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.534 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -67.15 -42.01 85.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.07 0.462 . . . . 53.439999999999998 110.237 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -62.65 -46.19 89.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.546 -0.752 . . . . 73.329999999999998 110.775 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.27 -21.78 63.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 72.329999999999998 111.607 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . . . -86.1 -40.04 16.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.905 0.383 . . . . 65.5 111.338 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.553 ' HB2' HG11 ' A' ' 48' ' ' VAL . . . -69.73 -22.44 63.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.457 0.54 . . . . 64.030000000000001 112.457 -174.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 p -63.43 -22.99 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.831 0.348 . . . . 71.040000000000006 111.128 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -78.03 -16.43 58.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.662 0.268 . . . . 71.319999999999993 111.216 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.88 -14.37 23.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.932 0.396 . . . . 43.240000000000002 111.302 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.516 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 7.3 p -116.14 122.2 32.61 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.047 0.451 . . . . 73.310000000000002 110.992 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 27' ' ' VAL . 3.3 Cg_exo -74.93 100.89 1.4 Allowed 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.899 2.399 . . . . 74.230000000000004 112.239 -178.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.85 38.21 91.99 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.88 -0.6 . . . . 72.129999999999995 112.501 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.435 ' HA3' ' CG2' ' A' ' 27' ' ' VAL . . . -102.87 -172.1 26.5 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.71 -0.757 . . . . 15.029999999999999 112.526 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.1 m -98.88 115.36 28.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.746 0.308 . . . . 60.25 110.577 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.84 105.0 15.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.903 -0.59 . . . . 54.530000000000001 110.093 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.09 161.98 18.3 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.944 -0.646 . . . . 43.310000000000002 112.445 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.04 141.26 52.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.051 0.453 . . . . 75.030000000000001 110.437 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.821 HG11 ' HA ' ' A' ' 48' ' ' VAL . 34.9 m -126.73 156.0 37.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.937 -0.574 . . . . 64.319999999999993 111.451 -172.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -105.52 155.82 18.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.03 -0.532 . . . . 64.319999999999993 110.053 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.95 124.07 25.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.282 -0.417 . . . . 75.400000000000006 110.449 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.69 122.34 21.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.889 0.376 . . . . 75.040000000000006 110.24 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.0 t -77.43 129.41 35.72 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.078 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.94 -150.95 9.55 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.638 -0.792 . . . . 72.439999999999998 112.216 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -151.25 132.42 14.43 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.06 -0.719 . . . . 41.310000000000002 109.06 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.65 -135.17 9.68 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.624 -0.798 . . . . 63.439999999999998 112.283 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 63' ' ' ASP . . . -87.69 -30.84 20.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.693 0.282 . . . . 74.439999999999998 110.744 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.22 102.71 3.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.087 0.47 . . . . 62.340000000000003 111.076 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.07 -42.86 2.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.857 -0.61 . . . . 54.399999999999999 111.072 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.444 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 46.0 m-85 -114.61 133.58 55.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.528 -0.305 . . . . 73.299999999999997 110.229 -177.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.83 112.94 2.34 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.865 -0.894 . . . . 75.109999999999999 110.865 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.821 ' HA ' HG11 ' A' ' 35' ' ' VAL . 6.3 t -110.25 139.61 32.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.838 0.351 . . . . 42.020000000000003 110.642 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.8 pp -105.16 126.74 52.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.136 0.493 . . . . 73.450000000000003 110.813 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.403 ' CG1' ' HB1' ' A' ' 23' ' ' ALA . 2.4 m -129.09 120.3 51.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.17 0.51 . . . . 74.420000000000002 110.791 176.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -102.94 126.33 50.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.843 -0.617 . . . . 55.420000000000002 110.831 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.535 ' HB2' HG23 ' A' ' 56' ' ' THR . 10.6 mpt_? -81.56 152.28 69.64 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.341 -0.614 . . . . 72.129999999999995 109.341 173.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.48 -23.15 46.13 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.823 2.348 . . . . 74.340000000000003 112.839 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.61 -27.48 68.97 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.917 0.389 . . . . 55.030000000000001 111.168 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.72 -12.67 15.25 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.692 -0.766 . . . . 74.239999999999995 112.107 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.535 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.5 t -72.23 128.63 36.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.505 0.669 . . . . 63.310000000000002 110.46 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 57' ' ' ARG . 12.2 ttt180 -118.48 119.75 35.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.447 -0.797 . . . . 71.310000000000002 109.385 -175.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -107.51 137.22 39.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.219 -0.446 . . . . 61.399999999999999 111.16 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.55 112.21 24.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.407 0.623 . . . . 74.209999999999994 109.432 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 71' ' ' THR . 25.4 t -97.37 114.61 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.995 -0.548 . . . . 71.140000000000001 109.973 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -89.59 122.85 33.12 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.081 0.467 . . . . 74.409999999999997 110.528 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.619 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -113.07 145.93 40.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.1 -0.955 . . . . 62.32 110.144 -177.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.586 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 20.7 p30 -91.91 -167.71 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.008 0.432 . . . . 74.0 111.431 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -65.99 -17.98 65.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.588 -0.733 . . . . 73.310000000000002 111.849 -172.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -109.54 13.51 23.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.752 -0.204 . . . . 73.109999999999999 110.904 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 65.37 30.76 10.86 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.279 0.561 . . . . 65.310000000000002 111.229 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.403 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . 26.2 ttp180 -93.52 137.37 32.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.532 -0.758 . . . . 70.010000000000005 109.795 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.619 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.5 p -65.06 117.18 5.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.362 0.601 . . . . 71.230000000000004 111.574 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.549 HD21 ' HB3' ' A' ' 63' ' ' ASP . 96.2 mt -90.93 -60.01 2.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.679 -0.692 . . . . 72.510000000000005 110.991 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -157.52 147.59 20.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 61.329999999999998 110.085 -172.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.483 HG22 HG22 ' A' ' 60' ' ' VAL . 17.0 p -124.01 109.52 13.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.901 0.382 . . . . 75.310000000000002 110.901 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 11.0 mm-40 -107.35 155.44 39.47 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.077 -0.51 . . . . 62.420000000000002 110.828 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 5.1 Cg_exo -74.57 122.29 7.3 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.467 2.112 . . . . 74.0 110.885 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.16 156.48 23.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.416 -0.357 . . . . 54.009999999999998 110.298 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 116.393 -0.367 . . . . 62.43 110.336 -179.51 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 CA--C 1.515 -0.372 0 N-CA-C 108.697 -0.853 . . . . 64.150000000000006 108.697 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.35 75.12 3.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.047 0.451 . . . . 72.340000000000003 111.77 -174.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.91 54.69 0.74 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.65 0.738 . . . . 74.239999999999995 109.117 172.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.586 ' N ' ' HD2' ' A' ' 18' ' ' ARG . 25.1 t70 174.23 101.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.075 -1.421 . . . . 71.310000000000002 107.84 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.76 -78.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.865 -0.683 . . . . 65.040000000000006 112.814 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.662 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 11.2 tt0 -156.26 -166.1 2.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.676 0.274 . . . . 73.219999999999999 110.708 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.662 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 4.8 m-20 -66.5 -6.66 15.63 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.939 0.718 . . . . 63.140000000000001 112.939 -172.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.79 84.16 1.88 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.034 0.445 . . . . 72.230000000000004 111.047 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -91.95 87.42 2.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.416 -0.587 . . . . 73.120000000000005 109.416 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 t -114.24 130.22 56.64 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.632 -0.713 . . . . 62.109999999999999 110.098 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.65 -151.5 41.38 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.233 -0.984 . . . . 61.32 111.703 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.495 ' HB2' ' H ' ' A' ' 15' ' ' ASP . 63.9 Cg_endo -73.29 -142.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.772 2.315 . . . . 71.040000000000006 112.144 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 3.2 m-20 -74.41 12.08 0.85 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.398 0.518 . . . . 71.439999999999998 112.398 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.642 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -49.72 -34.15 18.06 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.9 0.381 . . . . 43.009999999999998 111.353 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.71 -42.38 71.44 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.393 -0.821 . . . . 63.25 112.278 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 15' ' ' ASP . 12.1 mmt180 -64.71 -57.91 7.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.287 0.565 . . . . 75.510000000000005 111.123 -170.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.765 ' HB3' HG21 ' A' ' 35' ' ' VAL . . . -73.38 -26.94 61.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.522 -0.763 . . . . 74.450000000000003 111.946 -173.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -66.73 -35.84 81.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 74.340000000000003 110.858 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.49 -39.51 88.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 74.519999999999996 110.862 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.35 -28.88 63.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.028 -0.533 . . . . 42.200000000000003 111.297 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 -27.36 68.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.08 -0.509 . . . . 62.420000000000002 111.859 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.0 t -59.47 -38.26 74.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.458 . . . . 64.319999999999993 111.266 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -81.13 -12.38 59.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.289 -0.414 . . . . 71.230000000000004 111.143 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.63 -6.87 58.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 60.109999999999999 111.452 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.05 124.08 7.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.017 0.437 . . . . 61.420000000000002 111.483 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.75 105.68 2.11 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.401 2.067 . . . . 75.430000000000007 112.136 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.78 39.54 89.94 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.081 -0.581 . . . . 72.319999999999993 112.417 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.736 ' HA2' ' HD3' ' A' ' 53' ' ' PRO . . . -101.92 -147.77 20.25 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.581 -0.819 . . . . 61.25 112.697 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.668 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 58.6 m -137.63 131.26 31.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.699 0.285 . . . . 61.210000000000001 110.574 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.05 120.44 41.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.298 -0.41 . . . . 52.130000000000003 110.641 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.68 161.16 13.33 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.841 -0.695 . . . . 51.100000000000001 111.582 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.443 ' O ' HD21 ' A' ' 49' ' ' LEU . 1.4 mp0 -62.5 128.13 34.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.338 . . . . 65.0 110.428 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.765 HG21 ' HB3' ' A' ' 19' ' ' ALA . 19.8 m -90.21 154.77 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.013 -0.539 . . . . 71.030000000000001 110.769 -175.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -112.67 153.61 27.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.14 -0.482 . . . . 72.439999999999998 111.059 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 m -85.22 115.27 22.9 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.702 -0.851 . . . . 74.420000000000002 108.702 171.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -75.61 130.18 38.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.242 0.544 . . . . 75.540000000000006 111.9 -172.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.2 p -88.9 118.27 28.49 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.962 -0.755 . . . . 72.239999999999995 108.962 171.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.95 -125.04 0.8 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.9 -1.143 . . . . 71.299999999999997 113.338 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.88 158.36 44.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.724 0.297 . . . . 72.519999999999996 110.481 -172.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.9 -116.18 4.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.05 -0.595 . . . . 63.109999999999999 113.077 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.84 10.06 5.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.559 0.219 . . . . 72.019999999999996 111.219 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.06 107.07 3.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.053 -0.351 . . . . 72.239999999999995 110.053 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.72 -54.35 2.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.094 -0.503 . . . . 74.120000000000005 111.646 -175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -115.64 133.41 56.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.0 0.428 . . . . 74.200000000000003 111.405 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.18 112.49 3.06 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.675 -0.774 . . . . 65.409999999999997 111.261 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.606 HG22 ' HB1' ' A' ' 19' ' ' ALA . 27.4 t -95.24 109.72 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.633 0.254 . . . . 74.430000000000007 110.687 -175.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.694 HD23 ' H ' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -85.51 102.7 13.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.28 0.562 . . . . 65.049999999999997 110.74 -179.228 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.3 t -97.1 110.34 24.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.716 -0.674 . . . . 32.140000000000001 110.016 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.668 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 14.0 m -91.92 116.6 29.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.11 -0.495 . . . . 75.129999999999995 110.548 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -96.94 135.84 21.86 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.185 -0.461 . . . . 54.310000000000002 110.023 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.736 ' HD3' ' HA2' ' A' ' 30' ' ' GLY . 37.1 Cg_endo -65.68 -8.81 20.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.878 2.386 . . . . 45.299999999999997 111.386 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -64.12 -26.75 68.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.89 -1.05 . . . . 75.519999999999996 110.487 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.46 32.64 2.28 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.67 -0.776 . . . . 73.439999999999998 112.352 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 t -145.38 144.93 30.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.102 0.477 . . . . 72.329999999999998 110.956 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -107.89 118.5 36.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.705 -0.68 . . . . 73.319999999999993 109.263 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 45.5 t -112.33 115.7 50.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.771 -0.455 . . . . 70.120000000000005 109.771 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 12.4 pt-20 -101.81 113.21 26.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.659 0.742 . . . . 73.340000000000003 110.823 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.608 HG22 HG23 ' A' ' 71' ' ' THR . 18.6 t -89.12 118.57 34.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.179 -0.918 . . . . 54.329999999999998 109.224 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -93.35 123.22 36.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.345 -0.389 . . . . 65.420000000000002 110.345 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 68' ' ' VAL . 1.0 OUTLIER -115.64 152.21 33.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.889 -0.596 . . . . 65.040000000000006 111.157 -174.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.594 ' HB3' HD21 ' A' ' 69' ' ' LEU . 3.7 p-10 -94.47 -164.52 1.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.882 -0.599 . . . . 75.150000000000006 110.531 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.6 mtt-85 -71.66 -24.57 61.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.121 -0.491 . . . . 70.109999999999999 111.26 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.45 0.08 56.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.04 0.448 . . . . 73.150000000000006 109.801 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 67.99 32.48 5.05 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.332 -0.849 . . . . 55.140000000000001 110.678 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -101.06 154.53 18.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.065 -0.516 . . . . 73.230000000000004 109.884 175.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.578 ' HA ' HD12 ' A' ' 62' ' ' LEU . 7.1 p -71.13 118.8 16.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.41 0.624 . . . . 53.229999999999997 111.435 -176.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 63' ' ' ASP . 96.1 mt -85.52 -51.21 6.66 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.002 -0.74 . . . . 75.319999999999993 109.002 172.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -155.05 166.15 34.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.676 -0.693 . . . . 75.439999999999998 109.923 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.608 HG23 HG22 ' A' ' 60' ' ' VAL . 27.7 m -148.49 109.1 4.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.564 -0.532 . . . . 74.010000000000005 109.564 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 2.2 pm0 -130.57 135.98 28.23 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.139 0.495 . . . . 61.520000000000003 111.649 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 6.0 Cg_exo -79.79 92.83 1.09 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.863 2.375 . . . . 72.120000000000005 110.531 171.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.35 110.31 21.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.171 -0.468 . . . . 73.219999999999999 111.161 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 73.150000000000006 109.93 177.678 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 CA--C 1.518 -0.28 0 N-CA-C 109.41 -0.589 . . . . 73.450000000000003 109.41 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.23 67.23 8.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.29 0.567 . . . . 70.219999999999999 110.735 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -131.85 57.63 1.77 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.638 -0.71 . . . . 73.329999999999998 110.007 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -127.11 -58.07 1.29 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.707 -0.679 . . . . 71.530000000000001 109.338 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.89 178.66 51.1 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.911 -0.662 . . . . 72.049999999999997 112.319 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.799 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 24.6 tt0 -124.07 -172.21 2.49 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 122.681 -0.305 . . . . 75.040000000000006 110.185 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.799 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 11.9 m-20 -77.83 -9.28 58.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.588 -0.278 . . . . 74.319999999999993 111.594 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.39 93.94 7.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.412 . . . . 73.129999999999995 110.342 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -76.27 86.92 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.456 0.646 . . . . 62.219999999999999 109.79 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 t -107.11 -0.12 23.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.593 -0.73 . . . . 72.510000000000005 110.483 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.38 175.96 23.72 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.403 -0.679 . . . . 74.239999999999995 111.403 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.523 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 5.7 Cg_exo -76.14 -76.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.614 2.21 . . . . 55.329999999999998 111.818 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -70.8 -35.65 72.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.698 -0.683 . . . . 74.120000000000005 111.104 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.517 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -54.21 -49.31 69.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 75.450000000000003 111.478 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.52 -43.65 89.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 71.109999999999999 111.407 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 14' ' ' PRO . 7.2 mmt85 -64.07 -41.81 97.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.175 -0.466 . . . . 60.409999999999997 110.96 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.677 ' HB3' HG21 ' A' ' 35' ' ' VAL . . . -81.08 -35.01 32.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.248 -0.433 . . . . 54.039999999999999 112.061 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -65.21 -28.5 69.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.013 0.435 . . . . 73.230000000000004 110.291 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.39 -38.22 84.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 75.209999999999994 110.779 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.35 -30.86 57.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.047 0.451 . . . . 33.450000000000003 111.073 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.514 ' HB1' ' CG1' ' A' ' 50' ' ' VAL . . . -55.88 -35.88 66.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.568 -0.742 . . . . 61.039999999999999 112.076 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.4 t -55.77 -40.51 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 64.120000000000005 111.808 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -86.86 -12.86 46.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.262 -0.426 . . . . 73.319999999999993 111.319 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.4 -34.7 17.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.416 -0.356 . . . . 64.230000000000004 111.105 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.568 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 14.3 p -91.63 130.53 38.74 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.936 0.398 . . . . 74.329999999999998 110.593 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.94 86.71 0.73 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.44 2.093 . . . . 73.400000000000006 112.42 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.47 38.73 96.15 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.733 -0.667 . . . . 51.130000000000003 112.586 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.58 -175.88 19.2 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.587 -0.816 . . . . 71.349999999999994 112.481 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.7 m -96.35 126.63 41.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.865 0.364 . . . . 64.109999999999999 110.986 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.09 131.28 37.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.086 -0.506 . . . . 72.420000000000002 109.824 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.96 162.01 15.89 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.543 -0.837 . . . . 63.119999999999997 112.378 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -55.05 119.85 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.128 0.489 . . . . 70.219999999999999 110.917 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.677 HG21 ' HB3' ' A' ' 19' ' ' ALA . 17.9 m -96.38 155.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.472 -0.785 . . . . 74.109999999999999 110.373 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -125.9 144.94 50.47 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.428 -0.351 . . . . 72.439999999999998 110.129 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.3 p -76.7 142.3 40.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.245 -0.434 . . . . 74.549999999999997 110.355 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -83.66 84.24 7.62 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.758 -0.83 . . . . 73.329999999999998 108.758 172.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -72.93 123.27 23.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.189 -0.914 . . . . 75.239999999999995 110.335 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.2 -26.93 6.55 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.763 -0.935 . . . . 63.530000000000001 110.763 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.26 146.47 28.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.263 -0.469 . . . . 52.310000000000002 110.303 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.95 -40.05 4.17 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.788 -0.72 . . . . 64.430000000000007 112.122 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.33 -65.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.697 0.284 . . . . 61.329999999999998 111.15 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.12 93.68 5.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.058 0.456 . . . . 61.130000000000003 110.901 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.52 -40.32 19.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.889 -0.596 . . . . 64.209999999999994 111.162 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -115.79 143.26 45.65 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.556 -0.293 . . . . 73.349999999999994 110.564 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -124.21 112.23 1.77 Allowed Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.793 -0.923 . . . . 65.109999999999999 110.793 171.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.561 HG22 ' HB1' ' A' ' 19' ' ' ALA . 89.0 t -96.82 110.73 25.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.72 0.295 . . . . 74.420000000000002 110.639 -176.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.537 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.5 pp -96.42 115.23 27.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.399 0.618 . . . . 72.040000000000006 110.873 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.568 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 5.1 m -115.1 126.55 72.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.636 -0.711 . . . . 64.219999999999999 110.533 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.2 m -92.23 106.63 18.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.919 -0.582 . . . . 75.230000000000004 110.153 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 52' ' ' ARG . 56.6 mtt180 -72.0 149.38 92.3 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.891 -0.411 . . . . 75.439999999999998 109.891 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.91 -12.05 27.42 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.555 2.17 . . . . 65.030000000000001 111.11 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -68.61 -26.72 65.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.97 -1.013 . . . . 74.400000000000006 110.541 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.97 -17.21 15.33 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.851 -0.69 . . . . 72.329999999999998 112.755 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 t -89.57 149.35 22.9 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.878 0.371 . . . . 74.549999999999997 111.287 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -103.31 119.99 39.92 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.383 -0.599 . . . . 63.32 109.383 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 58.8 t -102.74 124.18 56.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.439 -0.578 . . . . 44.240000000000002 109.439 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 9.7 pt-20 -108.9 111.58 23.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.843 0.83 . . . . 75.120000000000005 110.314 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.658 HG22 HG23 ' A' ' 71' ' ' THR . 16.6 t -86.69 116.39 29.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.433 -0.803 . . . . 54.200000000000003 109.881 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -79.76 118.35 21.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.244 -0.435 . . . . 74.519999999999996 110.218 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.695 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -115.67 154.6 29.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.618 -0.719 . . . . 72.239999999999995 111.575 -173.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.681 ' HB2' HD21 ' A' ' 69' ' ' LEU . 20.6 t70 -89.87 173.77 8.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.168 -0.924 . . . . 71.310000000000002 109.421 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -52.02 -37.74 54.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.946 0.498 . . . . 73.219999999999999 111.615 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.26 14.82 11.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.441 . . . . 73.0 111.542 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.42 ' CD2' HD23 ' A' ' 62' ' ' LEU . 7.7 m-85 65.63 25.42 11.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.144 0.497 . . . . 71.409999999999997 111.475 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -80.48 137.52 36.48 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.971 -0.752 . . . . 62.43 108.971 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.695 ' HA ' HD12 ' A' ' 62' ' ' LEU . 8.6 p -70.91 125.6 29.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.313 0.578 . . . . 53.229999999999997 111.187 -176.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 63' ' ' ASP . 71.6 mt -97.26 -58.58 1.98 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.664 -0.698 . . . . 70.049999999999997 109.674 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -155.7 141.11 17.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.947 -0.569 . . . . 63.420000000000002 110.088 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.658 HG23 HG22 ' A' ' 60' ' ' VAL . 18.5 m -107.8 111.6 23.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.544 -0.539 . . . . 54.310000000000002 109.544 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 12.3 pt-20 -135.32 129.24 18.67 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.18 0.514 . . . . 73.349999999999994 112.072 -173.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 2.0 Cg_endo -82.52 130.56 6.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.825 2.35 . . . . 62.049999999999997 110.263 169.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.57 172.16 7.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.969 0.414 . . . . 40.399999999999999 111.652 -175.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.797 -0.638 . . . . 75.319999999999993 109.834 179.136 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 mpp? . . . . . 0 C--O 1.233 0.204 0 N-CA-C 109.968 -0.382 . . . . 73.219999999999999 109.968 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HB1' ' HB2' ' A' ' 18' ' ' ARG . . . -80.86 73.75 7.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.033 0.444 . . . . 65.430000000000007 110.892 -178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -135.14 93.71 3.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.115 0.483 . . . . 51.329999999999998 110.511 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -150.29 -77.97 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.819 -0.808 . . . . 63.009999999999998 108.819 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.585 ' HA2' ' OD1' ' A' ' 17' ' ' ASP . . . 79.0 140.06 1.81 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.824 -0.625 . . . . 74.340000000000003 114.029 171.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.547 ' O ' HG22 ' A' ' 11' ' ' VAL . 34.5 tt0 -80.98 134.03 35.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.582 -0.895 . . . . 72.430000000000007 108.582 171.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.35 1.89 20.44 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.997 0.369 . . . . 75.129999999999995 111.997 -170.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.89 8.01 20.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.826 0.306 . . . . 70.329999999999998 111.826 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 17' ' ' ASP . 28.5 m -84.11 159.03 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.735 -0.386 . . . . 51.100000000000001 109.996 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 p -94.37 -25.22 17.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.86 -0.336 . . . . 72.120000000000005 111.293 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.428 ' HA2' ' HD2' ' A' ' 14' ' ' PRO . . . -95.1 111.23 4.16 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.853 -0.689 . . . . 61.100000000000001 111.581 174.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.428 ' HD2' ' HA2' ' A' ' 13' ' ' GLY . 13.5 Cg_endo -56.76 -55.83 2.41 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.983 2.456 . . . . 64.549999999999997 112.695 -175.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -89.06 -9.2 52.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.029 0.442 . . . . 55.130000000000003 110.698 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 1.119 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -66.28 -43.44 86.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.531 -0.759 . . . . 74.099999999999994 111.937 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.639 ' HB2' HG21 ' A' ' 11' ' ' VAL . 8.6 t70 -52.47 -57.46 9.82 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.066 -0.516 . . . . 75.120000000000005 112.148 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.563 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -71.42 -31.7 67.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.242 0.46 . . . . 63.299999999999997 112.242 -173.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.641 ' HB2' ' HE1' ' A' ' 66' ' ' PHE . . . -69.01 -39.91 79.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.075 0.464 . . . . 42.530000000000001 110.5 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -25.87 55.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.953 -0.567 . . . . 73.519999999999996 110.503 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.38 -32.91 62.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.354 . . . . 52.140000000000001 110.939 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.08 -26.89 62.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.178 0.513 . . . . 61.340000000000003 111.09 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.554 ' HB2' HG11 ' A' ' 48' ' ' VAL . . . -71.5 -23.15 61.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.915 -0.584 . . . . 33.130000000000003 111.442 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -63.13 -25.03 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.17 0.51 . . . . 55.350000000000001 111.239 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -80.31 -13.64 59.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.874 0.368 . . . . 73.510000000000005 110.963 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.49 1.3 29.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.264 -0.425 . . . . 70.400000000000006 111.381 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.08 116.34 5.63 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.144 0.497 . . . . 73.150000000000006 111.272 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.21 96.02 0.53 Allowed 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.484 2.123 . . . . 74.120000000000005 112.392 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.25 42.21 83.93 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.796 -0.638 . . . . 42.240000000000002 112.594 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.03 162.57 20.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.633 -0.794 . . . . 73.540000000000006 112.367 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.545 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 28.1 m -87.58 112.0 21.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.952 0.406 . . . . 74.340000000000003 110.617 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.53 131.78 53.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.102 -0.499 . . . . 75.329999999999998 110.612 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.559 ' HA3' HD11 ' A' ' 49' ' ' LEU . . . -106.97 160.74 14.09 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.517 -0.849 . . . . 54.210000000000001 111.168 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.76 136.02 57.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.416 0.627 . . . . 70.349999999999994 110.323 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.119 HG22 ' HA ' ' A' ' 16' ' ' ALA . 2.5 m -90.7 157.1 2.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.148 -0.933 . . . . 73.340000000000003 111.437 -169.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -104.71 141.83 35.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.875 -0.602 . . . . 75.5 110.074 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.73 104.23 5.3 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.693 -0.685 . . . . 70.530000000000001 109.931 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -72.62 138.39 46.74 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.918 -0.401 . . . . 61.130000000000003 109.918 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -127.46 153.51 46.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.272 -0.422 . . . . 73.239999999999995 110.66 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.47 -19.03 49.44 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.908 -0.663 . . . . 65.439999999999998 111.838 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.0 154.51 17.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.458 -0.571 . . . . 73.340000000000003 109.458 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.81 -31.48 20.85 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.903 -0.665 . . . . 74.200000000000003 112.715 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.638 ' O ' ' HA ' ' A' ' 63' ' ' ASP . . . -111.72 -52.46 2.78 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.75 -0.265 . . . . 71.239999999999995 110.976 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 101.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.248 0.547 . . . . 54.229999999999997 110.918 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.44 -13.64 14.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 63.200000000000003 111.229 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.553 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 20.4 m-85 -135.27 132.64 38.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.723 -0.473 . . . . 63.409999999999997 109.723 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.58 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -115.35 112.56 2.72 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.748 -0.739 . . . . 55.420000000000002 111.535 177.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.641 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 22.1 t -96.4 129.67 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 122.253 0.221 . . . . 60.509999999999998 110.996 -175.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.559 HD11 ' HA3' ' A' ' 33' ' ' GLY . 1.1 pp -101.91 111.22 23.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.214 0.53 . . . . 63.210000000000001 110.452 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.1 t -114.65 119.9 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.774 -0.648 . . . . 53.240000000000002 110.952 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.545 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 23.8 m -101.32 104.46 15.46 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.75 -0.463 . . . . 64.030000000000001 109.75 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 52' ' ' ARG . 41.9 mtt180 -75.62 147.98 82.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.034 -0.53 . . . . 74.109999999999999 110.646 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.99 -18.22 41.8 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.169 2.579 . . . . 64.109999999999999 112.543 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -70.17 -15.05 62.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.545 . . . . 64.319999999999993 110.896 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.9 32.69 7.02 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.587 -0.816 . . . . 61.450000000000003 112.39 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -130.09 147.79 51.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.772 0.32 . . . . 63.130000000000003 110.372 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -107.17 120.99 43.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.201 -0.454 . . . . 74.099999999999994 110.543 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.685 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 57.1 t -119.48 133.66 65.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.762 -0.653 . . . . 61.340000000000003 109.629 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 11.5 pt-20 -107.6 124.18 49.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.34 0.591 . . . . 75.010000000000005 110.479 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.641 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 25.9 t -94.92 125.98 47.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.425 -0.807 . . . . 61.149999999999999 109.853 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -99.16 123.61 43.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.1 0.476 . . . . 72.310000000000002 110.509 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -112.17 149.85 31.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.652 -0.704 . . . . 54.43 111.083 -176.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.638 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 18.4 t70 -90.19 171.53 9.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.962 -0.563 . . . . 74.329999999999998 109.883 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.47 ' H ' ' HG3' ' A' ' 64' ' ' ARG . 0.3 OUTLIER -42.81 -51.92 5.24 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.033 0.933 . . . . 72.5 111.949 -178.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -86.0 18.46 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.875 -0.602 . . . . 65.400000000000006 111.203 -174.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.641 ' HE1' ' HB2' ' A' ' 19' ' ' ALA . 6.3 m-85 66.97 27.98 8.66 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.872 -0.603 . . . . 63.329999999999998 111.586 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 67' ' ' ARG . 7.4 tpt180 -80.32 124.02 28.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.949 -0.76 . . . . 73.519999999999996 108.949 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.669 ' HA ' HD12 ' A' ' 62' ' ' LEU . 7.3 p -63.53 122.83 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.169 0.509 . . . . 75.319999999999993 110.536 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.598 HD21 ' HB2' ' A' ' 63' ' ' ASP . 97.7 mt -87.89 -57.62 2.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.116 -0.493 . . . . 70.230000000000004 110.682 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -170.89 176.72 4.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.696 -0.483 . . . . 72.439999999999998 109.696 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.607 HG22 HG22 ' A' ' 60' ' ' VAL . 16.8 p -140.24 109.42 6.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.317 -0.402 . . . . 64.099999999999994 110.656 -177.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -117.74 129.66 25.21 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 121.141 0.496 . . . . 62.109999999999999 111.052 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 57.3 Cg_endo -73.91 105.04 1.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.383 2.056 . . . . 75.040000000000006 111.948 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.37 93.2 4.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 111.01 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.674 -0.694 . . . . 75.219999999999999 109.266 175.962 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.962 -0.455 . . . . 71.5 111.962 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.66 124.84 34.95 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.984 -0.376 . . . . 45.549999999999997 109.984 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.434 ' HG3' ' HD2' ' A' ' 5' ' ' PHE . 10.6 tpt -75.2 133.54 41.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.127 -0.488 . . . . 52.119999999999997 109.958 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.27 66.81 2.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.411 0.523 . . . . 72.530000000000001 112.411 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.434 ' HD2' ' HG3' ' A' ' 3' ' ' MET . 91.8 m-85 -145.35 90.49 2.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.774 -0.648 . . . . 73.540000000000006 109.33 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -131.96 -74.5 0.51 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.874 -0.331 . . . . 74.129999999999995 110.802 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.727 ' HA2' ' NH1' ' A' ' 18' ' ' ARG . . . 115.75 85.37 1.22 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 119.977 -1.106 . . . . 55.109999999999999 113.713 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.708 ' HG3' ' HG2' ' A' ' 10' ' ' GLU . 10.6 tp10 -71.36 146.1 49.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.643 -0.873 . . . . 62.409999999999997 108.643 171.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -91.81 -8.5 46.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.379 0.511 . . . . 60.420000000000002 112.379 -168.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.708 ' HG2' ' HG3' ' A' ' 8' ' ' GLU . 12.6 pt-20 -90.79 3.42 54.43 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.868 0.322 . . . . 75.310000000000002 111.868 -175.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.054 HG21 ' HB2' ' A' ' 17' ' ' ASP . 27.4 m -113.24 157.59 13.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.684 0.278 . . . . 72.209999999999994 110.98 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -101.49 -11.3 19.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.366 . . . . 61.210000000000001 111.038 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.07 143.16 15.61 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.612 -0.804 . . . . 33.200000000000003 111.983 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.16 -67.28 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.414 2.076 . . . . 71.340000000000003 112.222 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -70.17 -26.53 63.96 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.043 -0.526 . . . . 72.230000000000004 109.927 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.648 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -55.83 -27.1 49.76 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.278 -0.874 . . . . 71.530000000000001 111.503 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 1.054 ' HB2' HG21 ' A' ' 11' ' ' VAL . 3.9 t70 -85.36 -55.6 3.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.985 -0.552 . . . . 62.520000000000003 111.265 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.727 ' NH1' ' HA2' ' A' ' 7' ' ' GLY . 17.0 mmt-85 -59.26 -46.4 88.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.805 -0.634 . . . . 73.340000000000003 111.01 -170.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.749 ' HB2' ' HE1' ' A' ' 66' ' ' PHE . . . -73.36 -35.78 66.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.461 . . . . 42.450000000000003 111.478 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 24' ' ' VAL . 46.3 ttt-85 -65.89 -41.69 91.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.906 -0.588 . . . . 65.439999999999998 110.512 -178.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.15 86.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.972 0.415 . . . . 62.229999999999997 111.088 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.13 -35.64 76.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.102 -0.499 . . . . 74.010000000000005 110.812 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.567 ' HB2' HG11 ' A' ' 48' ' ' VAL . . . -63.9 -43.89 94.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.916 -0.584 . . . . 70.010000000000005 111.506 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 20' ' ' ARG . 57.5 t -56.76 -32.07 37.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 74.239999999999995 110.986 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -80.72 -13.0 59.38 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.844 -0.617 . . . . 71.200000000000003 111.269 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.02 -30.14 12.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.402 -0.363 . . . . 70.310000000000002 111.559 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.7 120.35 43.98 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.234 0.54 . . . . 64.129999999999995 111.095 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.1 99.66 0.91 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.566 2.177 . . . . 71.219999999999999 112.72 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.4 35.14 77.89 Favored Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.931 -0.577 . . . . 51.109999999999999 112.726 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.11 177.31 33.77 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.574 -0.822 . . . . 51.210000000000001 112.335 -177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.695 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 31.4 m -79.48 116.37 19.66 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.203 -0.295 . . . . 63.310000000000002 110.203 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.85 133.43 53.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.295 -0.411 . . . . 54.340000000000003 110.339 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -125.28 162.13 19.62 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.497 -0.641 . . . . 51.340000000000003 111.497 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -63.89 142.3 58.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.368 0.604 . . . . 73.010000000000005 110.937 178.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.648 HG22 ' HA ' ' A' ' 16' ' ' ALA . 12.1 m -104.29 155.71 5.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.646 -0.706 . . . . 74.239999999999995 110.884 -173.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -119.12 156.62 29.44 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.81 -0.441 . . . . 64.530000000000001 109.81 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.3 p -73.47 125.78 28.7 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.396 -0.366 . . . . 71.239999999999995 111.093 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' OE1' ' HD2' ' A' ' 61' ' ' HIS . 38.0 mt-10 -79.79 -166.61 1.03 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.859 -0.61 . . . . 72.400000000000006 109.846 176.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -60.05 129.15 40.33 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.455 -0.339 . . . . 73.450000000000003 110.653 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.23 -46.35 91.12 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 115.975 -0.557 . . . . 70.329999999999998 112.712 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -83.92 113.39 20.94 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.867 0.365 . . . . 73.030000000000001 110.287 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.14 -156.21 26.78 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.78 -0.646 . . . . 61.200000000000003 111.5 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.04 -41.16 5.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.044 0.449 . . . . 62.549999999999997 110.427 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.02 112.21 23.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.793 -0.639 . . . . 72.140000000000001 110.195 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -103.63 -26.39 12.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.977 -0.556 . . . . 61.149999999999999 111.009 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -126.35 132.52 51.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.079 -0.509 . . . . 72.430000000000007 110.186 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.76 112.26 2.94 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.533 -0.841 . . . . 65.409999999999997 111.536 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.606 HG22 ' HB1' ' A' ' 19' ' ' ALA . 39.0 t -97.59 109.29 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.752 0.31 . . . . 63.210000000000001 111.117 -175.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.8 pp -86.86 117.38 25.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.178 0.513 . . . . 63.25 110.631 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.454 HG11 ' HB1' ' A' ' 23' ' ' ALA . 16.4 m -135.74 150.08 28.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.934 -0.576 . . . . 74.129999999999995 110.077 178.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.695 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 28.3 m -136.39 126.03 25.4 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.34 -0.391 . . . . 64.430000000000007 111.061 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HB2' HG23 ' A' ' 56' ' ' THR . 6.6 mpt_? -80.04 142.2 55.45 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 108.784 -0.821 . . . . 71.239999999999995 108.784 173.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.47 -12.7 11.53 Favored 'Trans proline' 0 N--CA 1.475 0.412 0 C-N-CA 123.338 2.692 . . . . 65.450000000000003 112.955 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -68.55 -9.51 49.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.929 -0.578 . . . . 71.239999999999995 111.158 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.85 32.41 7.2 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.605 -0.807 . . . . 54.329999999999998 111.742 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.5 t -128.28 119.42 25.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.416 0.627 . . . . 75.140000000000001 110.737 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -105.29 127.0 52.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.303 -0.862 . . . . 71.019999999999996 110.386 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.568 HG11 ' HB ' ' A' ' 71' ' ' THR . 98.3 t -131.7 138.76 52.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.97 -0.559 . . . . 74.239999999999995 109.765 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.522 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 9.4 pt-20 -106.98 121.69 44.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.463 0.649 . . . . 55.43 110.196 175.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.59 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 21.5 t -85.07 119.19 33.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.207 -0.906 . . . . 65.200000000000003 109.586 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.46 ' HD2' ' OE1' ' A' ' 38' ' ' GLU . 46.4 m80 -91.53 118.82 30.92 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.28 0.562 . . . . 62.5 110.495 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.638 HD23 ' HD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -109.44 147.58 32.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.897 -1.047 . . . . 74.239999999999995 110.733 -174.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.55 ' HB3' HD21 ' A' ' 69' ' ' LEU . 5.4 p-10 -90.89 -163.2 1.0 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.229 -0.441 . . . . 73.209999999999994 110.071 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -66.9 -15.9 63.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.266 -0.424 . . . . 73.450000000000003 111.779 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -121.31 16.88 11.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 61.229999999999997 111.236 -176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.749 ' HE1' ' HB2' ' A' ' 19' ' ' ALA . 31.8 m-85 65.67 29.38 10.85 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.964 -0.562 . . . . 73.049999999999997 112.244 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -89.26 134.68 33.95 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.922 -0.77 . . . . 64.129999999999995 108.922 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.8 p -63.19 113.06 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.434 0.635 . . . . 24.0 111.006 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.55 HD21 ' HB3' ' A' ' 63' ' ' ASP . 87.9 mt -83.84 -52.23 6.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.774 -0.648 . . . . 73.310000000000002 110.1 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -173.81 160.09 3.57 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.993 -0.549 . . . . 55.439999999999998 110.047 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.568 ' HB ' HG11 ' A' ' 58' ' ' VAL . 19.8 p -128.93 111.43 13.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.039 -0.528 . . . . 62.310000000000002 111.121 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 1.7 pm0 -112.84 143.84 29.86 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.315 -0.402 . . . . 64.319999999999993 110.692 176.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 39.3 Cg_exo -61.23 128.88 26.44 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.127 2.551 . . . . 43.450000000000003 112.048 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.522 ' HB2' ' HG2' ' A' ' 59' ' ' GLU . . . -104.99 122.74 46.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.911 -0.586 . . . . 73.329999999999998 110.936 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -111.04 175.35 5.45 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.858 -0.61 . . . . 61.049999999999997 109.784 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -130.87 34.37 2.66 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.531 -0.842 . . . . 63.119999999999997 112.677 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -94.37 -19.14 20.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.081 0.467 . . . . 70.140000000000001 110.321 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.37 89.03 1.45 Allowed Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.816 -0.706 . . . . 64.230000000000004 112.72 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.52 -177.07 51.62 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.472 -0.651 . . . . 42.130000000000003 111.472 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.452 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 2.0 pt? -145.36 114.59 7.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.868 0.366 . . . . 52.520000000000003 110.638 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.703 -0.665 . . . . 74.209999999999994 109.429 178.17 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 112.138 -0.385 . . . . 44.439999999999998 112.138 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.53 170.9 7.65 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.159 -0.312 . . . . 65.200000000000003 110.159 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -71.14 121.9 19.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.958 -0.386 . . . . 74.430000000000007 109.958 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.22 69.78 9.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.185 -0.461 . . . . 74.099999999999994 111.8 -175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -98.6 113.1 25.01 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.201 -0.666 . . . . 73.439999999999998 109.201 172.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.429 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 19.3 t70 63.91 101.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.915 0.759 . . . . 74.430000000000007 110.331 -171.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.41 ' H ' ' CZ ' ' A' ' 18' ' ' ARG . . . -93.72 -108.04 1.95 Allowed Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.71 -0.677 . . . . 73.310000000000002 112.49 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.619 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 31.2 tt0 -107.51 177.41 4.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.802 0.334 . . . . 73.030000000000001 110.678 -177.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.619 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 28.4 t70 -75.14 -8.94 57.98 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.943 -0.571 . . . . 62.399999999999999 111.829 -175.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -65.56 97.36 0.3 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.957 0.408 . . . . 55.109999999999999 110.703 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 51.7 t -83.04 86.17 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.457 0.646 . . . . 74.340000000000003 111.006 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.7 t -101.66 -13.33 17.85 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.757 0.789 . . . . 65.340000000000003 109.066 171.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.686 ' HA3' ' HB3' ' A' ' 16' ' ' ALA . . . 170.71 135.81 1.98 Allowed Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.592 -1.185 . . . . 73.299999999999997 110.345 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -54.67 -70.15 0.05 OUTLIER 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 123.016 2.478 . . . . 70.150000000000006 112.153 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -89.69 -20.72 23.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.827 -0.624 . . . . 74.510000000000005 110.147 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.686 ' HB3' ' HA3' ' A' ' 13' ' ' GLY . . . -59.65 -49.54 77.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.424 -0.807 . . . . 70.409999999999997 111.311 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -58.0 -40.93 81.94 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.203 0.525 . . . . 74.430000000000007 111.469 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.429 ' NE ' ' HA ' ' A' ' 6' ' ' ASP . 17.4 mmt180 -65.06 -43.91 90.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.595 -0.73 . . . . 63.530000000000001 110.827 -171.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.92 -28.1 28.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.438 -0.346 . . . . 62.030000000000001 111.347 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.94 ' HD2' ' HG2' ' A' ' 34' ' ' GLU . 63.0 ttt180 -65.7 -35.99 82.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.507 -0.315 . . . . 74.109999999999999 110.364 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 25' ' ' GLN . . . -62.77 -34.01 76.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 72.329999999999998 110.854 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.09 -35.59 61.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 70.540000000000006 110.348 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.47 ' HB2' HG13 ' A' ' 48' ' ' VAL . . . -58.92 -55.45 34.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 73.439999999999998 111.032 177.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.19 -11.04 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.37 0.605 . . . . 44.310000000000002 110.891 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 1.5 tp-100 -88.25 -24.64 23.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.937 -0.574 . . . . 73.450000000000003 110.11 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.5 18.87 20.46 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.055 -0.52 . . . . 64.420000000000002 111.753 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.03 125.19 11.39 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 121.014 0.435 . . . . 72.209999999999994 110.35 176.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.93 82.56 1.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.431 2.087 . . . . 51.200000000000003 112.584 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.94 28.47 71.79 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.772 -0.649 . . . . 74.200000000000003 112.875 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.55 175.44 29.15 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.712 -0.756 . . . . 62.329999999999998 112.113 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.796 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 58.0 m -78.09 105.9 9.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.267 0.556 . . . . 73.239999999999995 110.964 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.6 120.62 37.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.684 -0.689 . . . . 51.399999999999999 109.881 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.501 ' HA3' HD11 ' A' ' 49' ' ' LEU . . . -101.19 160.43 18.51 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.524 -0.846 . . . . 23.420000000000002 112.285 -176.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.94 ' HG2' ' HD2' ' A' ' 20' ' ' ARG . 23.4 mt-10 -79.25 151.64 31.04 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.984 -0.376 . . . . 52.240000000000002 109.984 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.512 HG12 HD23 ' A' ' 49' ' ' LEU . 26.7 m -128.72 155.54 40.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.956 -0.565 . . . . 60.520000000000003 111.547 -171.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -110.13 158.85 17.88 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.419 -0.585 . . . . 75.030000000000001 109.419 171.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -72.92 113.28 9.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.012 0.434 . . . . 34.200000000000003 110.972 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.21 139.54 56.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 72.099999999999994 109.632 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.5 p -138.48 173.89 11.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.832 0.349 . . . . 63.43 111.422 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.74 -115.02 3.27 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.797 -0.716 . . . . 41.149999999999999 112.132 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -131.03 172.58 11.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.819 0.342 . . . . 74.430000000000007 110.46 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.9 -139.77 14.56 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.169 -0.772 . . . . 51.109999999999999 111.169 -175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 -12.98 4.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.894 0.347 . . . . 65.209999999999994 111.456 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.45 133.05 38.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 70.120000000000005 111.261 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.77 -28.72 2.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.947 -0.57 . . . . 65.109999999999999 110.75 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -131.23 155.77 46.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.435 -0.348 . . . . 71.420000000000002 110.274 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.83 145.39 16.82 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.469 -0.872 . . . . 71.310000000000002 112.193 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.47 HG13 ' HB2' ' A' ' 23' ' ' ALA . 70.1 t -128.91 105.4 12.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.308 -0.627 . . . . 73.420000000000002 109.308 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.512 HD23 HG12 ' A' ' 35' ' ' VAL . 3.3 pp -102.18 123.82 46.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.423 0.63 . . . . 74.200000000000003 110.648 -177.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 m -124.61 120.64 59.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.463 -0.79 . . . . 71.340000000000003 110.42 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.796 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 12.5 m -92.71 104.28 16.57 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.822 -0.626 . . . . 60.219999999999999 109.995 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -66.09 139.9 96.77 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.877 -0.601 . . . . 75.019999999999996 109.438 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.93 -9.56 6.19 Favored 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.169 2.579 . . . . 74.530000000000001 112.939 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -74.99 -13.7 60.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.992 -0.549 . . . . 72.120000000000005 110.475 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.28 33.01 5.85 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.771 -0.728 . . . . 41.350000000000001 112.563 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 t -131.2 143.02 50.28 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.096 -0.335 . . . . 62.219999999999999 110.096 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 74' ' ' ALA . 24.8 ttp180 -107.23 119.7 40.11 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.886 0.374 . . . . 75.140000000000001 110.087 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.39 114.79 48.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.122 -0.49 . . . . 73.219999999999999 110.021 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.54 112.02 24.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.554 0.693 . . . . 72.439999999999998 110.431 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.5 t -88.66 124.45 41.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.195 -0.911 . . . . 73.530000000000001 109.891 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 70' ' ' ASP . 35.9 m170 -96.06 122.6 39.07 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.909 -0.587 . . . . 74.219999999999999 110.667 -176.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -109.78 154.95 22.23 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.71 -0.677 . . . . 64.140000000000001 110.468 -177.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 1.011 ' HB3' HD11 ' A' ' 69' ' ' LEU . 3.9 p30 -92.14 -164.23 1.15 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.977 0.417 . . . . 74.299999999999997 110.481 176.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.445 ' HG3' ' H ' ' A' ' 64' ' ' ARG . 1.0 OUTLIER -62.81 -29.16 70.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.725 -0.671 . . . . 73.230000000000004 111.191 -175.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -100.27 17.27 21.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.175 -0.466 . . . . 64.010000000000005 111.316 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 69.02 19.86 7.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.848 -0.615 . . . . 75.109999999999999 111.507 172.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.529 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . 40.3 ttm180 -90.63 145.81 24.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.769 0.319 . . . . 70.019999999999996 110.522 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.548 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.3 p -67.06 126.47 26.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.211 0.529 . . . . 64.530000000000001 110.904 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 1.011 HD11 ' HB3' ' A' ' 63' ' ' ASP . 61.3 mt -112.72 -61.39 1.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.898 -0.592 . . . . 72.219999999999999 111.016 176.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 61' ' ' HIS . 23.0 t70 -132.03 139.83 48.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.551 -0.749 . . . . 72.099999999999994 111.315 -169.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.2 m -117.52 110.43 17.96 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.357 -0.383 . . . . 73.299999999999997 110.364 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -114.96 117.53 41.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.953 0.406 . . . . 64.230000000000004 111.872 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.23 93.99 0.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.757 2.305 . . . . 44.219999999999999 109.998 168.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 57' ' ' ARG . . . -124.92 147.3 48.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.388 -0.369 . . . . 73.019999999999996 111.292 -172.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -109.24 155.49 21.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.065 -0.516 . . . . 64.239999999999995 109.927 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.61 2.43 67.28 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.547 -0.835 . . . . 73.340000000000003 114.013 -172.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -83.98 -57.81 3.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.671 0.735 . . . . 72.329999999999998 110.927 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.17 -101.02 2.39 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.752 -0.737 . . . . 32.399999999999999 112.435 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.46 -172.06 45.07 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.865 -0.683 . . . . 73.420000000000002 112.222 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.85 HD23 ' HG3' ' A' ' 81' ' ' GLU . 9.1 tt -108.75 130.36 55.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.026 -0.731 . . . . 62.310000000000002 109.026 176.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.85 ' HG3' HD23 ' A' ' 80' ' ' LEU . 52.5 mt-10 . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.724 -0.655 . . . . 65.420000000000002 110.283 -173.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.493 0 N-CA-C 111.58 -0.608 . . . . 35.310000000000002 111.58 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.3 108.35 5.2 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.796 -0.446 . . . . 54.329999999999998 109.796 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -72.84 152.07 41.7 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.886 -0.597 . . . . 74.409999999999997 109.836 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.39 66.85 4.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.268 0.556 . . . . 63.310000000000002 111.507 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -113.12 57.5 0.67 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.492 0.663 . . . . 72.409999999999997 109.308 173.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -153.69 117.72 4.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.004 -0.998 . . . . 74.329999999999998 109.179 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.81 155.07 25.93 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.776 -0.726 . . . . 72.219999999999999 111.614 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.46 165.76 20.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.523 0.678 . . . . 72.540000000000006 111.678 -177.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.55 2.8 55.45 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.038 -0.983 . . . . 73.329999999999998 111.197 -173.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -80.89 22.26 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.102 -0.499 . . . . 53.140000000000001 112.092 -173.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.487 HG21 ' HB2' ' A' ' 17' ' ' ASP . 19.6 m -131.08 173.58 14.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.417 -0.356 . . . . 60.119999999999997 110.234 177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -93.38 102.4 14.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.922 -0.77 . . . . 74.209999999999994 108.922 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.88 92.99 0.54 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.347 -1.101 . . . . 72.319999999999993 110.347 -169.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.28 -13.36 19.72 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 123.233 2.622 . . . . 75.310000000000002 114.13 -172.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.577 ' HA ' ' CG ' ' A' ' 18' ' ' ARG . 54.0 m-20 -73.04 -15.63 61.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.26 0.552 . . . . 75.230000000000004 109.721 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 20' ' ' ARG . . . -68.41 -31.99 71.73 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.263 -0.88 . . . . 75.319999999999993 109.974 171.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HB2' HG21 ' A' ' 11' ' ' VAL . 11.6 t70 -83.41 -28.33 28.94 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.168 -0.469 . . . . 73.510000000000005 111.584 -173.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.577 ' CG ' ' HA ' ' A' ' 15' ' ' ASP . 5.5 mmt180 -54.28 -55.1 31.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.56 0.695 . . . . 74.239999999999995 109.931 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.855 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -81.15 -21.61 39.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.247 -0.888 . . . . 73.019999999999996 111.141 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 16' ' ' ALA . 28.0 ttt180 -66.54 -36.24 82.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.0 0.428 . . . . 74.140000000000001 110.372 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.34 70.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.291 0.567 . . . . 74.049999999999997 110.484 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.27 -38.13 36.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.115 -0.493 . . . . 73.299999999999997 110.268 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.402 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -56.48 -48.85 76.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.712 -0.676 . . . . 62.340000000000003 111.777 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 p -66.2 -18.69 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.996 0.427 . . . . 62.509999999999998 111.213 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.76 -19.69 21.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.973 0.416 . . . . 71.25 110.695 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.55 -31.54 22.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.068 -0.515 . . . . 73.230000000000004 111.427 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 23' ' ' ALA . 7.1 p -117.0 120.33 33.96 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.955 0.407 . . . . 62.210000000000001 110.541 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.83 104.59 1.19 Allowed 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 122.741 2.294 . . . . 63.240000000000002 112.625 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.19 26.19 71.43 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.913 -0.585 . . . . 23.449999999999999 112.584 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.5 -173.28 35.23 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.743 -0.742 . . . . 40.439999999999998 112.068 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.797 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 63.6 m -90.25 111.44 22.62 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.971 0.415 . . . . 72.439999999999998 110.745 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.03 100.64 11.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.644 -0.707 . . . . 73.5 109.592 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.605 ' HA3' HD11 ' A' ' 49' ' ' LEU . . . -89.45 160.95 29.58 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.786 -0.721 . . . . 61.439999999999998 112.309 -176.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -70.13 127.67 33.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.275 0.56 . . . . 74.209999999999994 110.125 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.707 HG21 ' HB3' ' A' ' 19' ' ' ALA . 20.4 m -103.96 153.92 6.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.699 -0.682 . . . . 70.219999999999999 111.417 -173.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -106.73 155.57 19.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.39 -0.368 . . . . 64.540000000000006 110.283 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.3 m -76.64 111.29 11.98 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.85 -0.426 . . . . 43.219999999999999 109.85 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 45' ' ' ALA . 36.1 mt-10 -78.62 111.24 14.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.174 0.511 . . . . 74.219999999999999 110.449 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.4 p -117.66 124.68 49.14 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.011 -0.541 . . . . 72.439999999999998 110.646 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 170.63 -110.69 0.38 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.46 -0.876 . . . . 72.319999999999993 112.618 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -113.94 165.77 12.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.957 0.408 . . . . 71.230000000000004 111.291 -174.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.97 -150.27 29.03 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.848 -0.691 . . . . 71.430000000000007 111.959 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.13 4.95 10.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.143 0.497 . . . . 72.299999999999997 110.695 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.51 103.01 12.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.934 -0.575 . . . . 62.310000000000002 110.4 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 38' ' ' GLU . . . -103.85 -13.64 16.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.138 -0.483 . . . . 44.240000000000002 111.019 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -141.74 133.69 27.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 72.239999999999995 110.191 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.427 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -116.41 113.62 2.85 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.859 -0.686 . . . . 43.109999999999999 111.785 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.855 HG22 ' HB1' ' A' ' 19' ' ' ALA . 34.7 t -95.5 117.09 38.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 110.031 -0.359 . . . . 61.409999999999997 110.031 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.605 HD11 ' HA3' ' A' ' 33' ' ' GLY . 1.3 pp -98.39 107.64 20.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.473 0.654 . . . . 63.109999999999999 110.276 -178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.2 m -110.19 107.05 21.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.534 -0.757 . . . . 62.310000000000002 110.761 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.797 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 22.4 m -95.6 113.76 25.44 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.845 -0.616 . . . . 64.510000000000005 110.76 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -71.21 146.08 91.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.176 -0.676 . . . . 71.200000000000003 109.176 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.98 -2.84 6.09 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.718 2.279 . . . . 62.549999999999997 112.17 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -83.08 0.5 44.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.682 -0.69 . . . . 73.540000000000006 110.539 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.18 33.21 12.24 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.635 -0.793 . . . . 71.519999999999996 112.579 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.7 t -135.9 125.56 25.38 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.136 0.493 . . . . 74.140000000000001 110.886 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 54.3 ttt180 -103.75 126.26 50.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.931 -0.577 . . . . 75.0 110.648 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 49.4 t -112.96 132.77 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.184 -0.462 . . . . 72.010000000000005 110.262 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -93.06 108.32 19.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.282 -0.417 . . . . 71.540000000000006 110.383 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.776 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 21.6 t -89.28 108.36 19.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.204 -0.665 . . . . 71.5 109.204 176.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -90.1 127.16 36.02 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.989 0.423 . . . . 64.519999999999996 110.823 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.705 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -115.74 159.36 21.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.513 -0.767 . . . . 61.140000000000001 111.103 -177.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.463 ' HB2' HD21 ' A' ' 69' ' ' LEU . 11.2 t70 -90.43 173.73 7.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.047 -0.979 . . . . 52.310000000000002 110.138 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -57.58 -29.43 64.44 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.451 0.7 . . . . 74.409999999999997 111.411 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -89.18 5.35 45.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.084 0.469 . . . . 72.109999999999999 110.37 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 71.34 21.65 4.55 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.404 -0.816 . . . . 75.200000000000003 110.592 -176.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.49 133.13 37.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.894 -0.593 . . . . 74.409999999999997 109.877 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.705 ' HA ' HD12 ' A' ' 62' ' ' LEU . 7.2 p -65.55 131.23 31.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.879 0.371 . . . . 74.109999999999999 111.004 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.463 HD21 ' HB2' ' A' ' 63' ' ' ASP . 92.1 mt -101.19 -64.25 1.07 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.292 -0.413 . . . . 71.109999999999999 110.561 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -166.61 175.8 7.71 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.702 -0.481 . . . . 64.530000000000001 109.702 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.426 HG22 HG22 ' A' ' 60' ' ' VAL . 46.9 p -139.09 114.22 9.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.721 0.296 . . . . 70.239999999999995 111.384 -177.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -125.4 139.53 34.1 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.096 -0.335 . . . . 75.349999999999994 110.096 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 40.6 Cg_endo -69.22 152.08 72.09 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.407 2.071 . . . . 64.540000000000006 112.3 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.06 111.56 23.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.324 -0.398 . . . . 71.109999999999999 111.598 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -139.5 111.49 7.4 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.243 -0.651 . . . . 60.200000000000003 109.243 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -108.83 57.17 0.44 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.81 -0.71 . . . . 61.210000000000001 113.65 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -97.01 -48.88 5.23 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.157 -0.682 . . . . 74.129999999999995 109.157 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -132.12 56.0 0.75 Allowed Glycine 0 N--CA 1.443 -0.834 0 CA-C-N 114.923 -1.035 . . . . 70.129999999999995 110.824 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.22 73.57 2.57 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 121.027 -0.606 . . . . 73.340000000000003 112.067 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 96.1 mt -119.18 143.29 47.32 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.505 -0.554 . . . . 53.310000000000002 109.505 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.355 -0.831 . . . . 74.219999999999999 108.774 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.647 -0.581 . . . . 71.340000000000003 111.647 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.69 113.02 25.44 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.88 0.372 . . . . 42.219999999999999 110.607 -178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.413 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 4.5 mpp? -84.4 108.43 17.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.154 -0.476 . . . . 73.540000000000006 110.209 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.01 89.7 6.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 63.109999999999999 111.136 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.432 ' HZ ' ' HA ' ' A' ' 65' ' ' ASP . 79.1 m-85 -117.55 58.14 0.8 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.338 0.59 . . . . 73.239999999999995 109.899 175.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -146.56 145.4 30.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.537 -0.756 . . . . 63.520000000000003 109.306 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.14 164.9 35.1 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.562 -0.828 . . . . 65.25 111.664 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.93 162.05 20.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.056 0.428 . . . . 75.219999999999999 110.706 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -95.22 -10.19 31.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.36 -0.382 . . . . 73.530000000000001 111.513 -172.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -85.74 5.1 33.79 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.166 0.432 . . . . 60.109999999999999 112.166 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.424 HG21 ' HB2' ' A' ' 17' ' ' ASP . 27.8 m -90.14 158.19 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.522 -0.547 . . . . 64.120000000000005 109.522 172.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.9 m -92.76 -34.75 13.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.785 0.326 . . . . 70.5 110.384 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.99 109.51 3.12 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.64 -0.79 . . . . 74.109999999999999 111.439 175.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.99 -66.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.608 2.206 . . . . 53.439999999999998 112.007 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.609 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 5.4 p-10 -71.17 -20.61 62.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.094 -0.503 . . . . 72.140000000000001 110.629 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 34' ' ' GLU . . . -56.46 -45.91 80.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.523 -0.762 . . . . 42.5 112.43 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.424 ' HB2' HG21 ' A' ' 11' ' ' VAL . 32.6 t70 -64.92 -54.79 25.21 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.548 0.573 . . . . 61.119999999999997 112.548 -173.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.728 ' HD2' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -63.64 -32.58 74.1 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.904 -0.318 . . . . 74.140000000000001 110.995 -177.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.504 ' HA ' ' CE1' ' A' ' 66' ' ' PHE . . . -68.94 -44.72 72.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.282 0.563 . . . . 61.0 110.262 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.455 ' O ' HG23 ' A' ' 24' ' ' VAL . 38.4 ttp180 -60.09 -46.86 88.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.258 -0.883 . . . . 51.039999999999999 110.912 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.39 89.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.95 -0.568 . . . . 71.409999999999997 111.671 -177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.56 -38.15 90.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.975 0.417 . . . . 65.219999999999999 111.268 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.22 -16.97 57.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.043 -0.526 . . . . 62.25 112.327 -175.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 20' ' ' ARG . 96.0 t -57.53 -39.27 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.951 0.405 . . . . 73.230000000000004 111.254 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.413 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 2.3 mp0 -70.02 -13.13 62.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.376 -0.375 . . . . 74.530000000000001 111.318 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.66 12.31 36.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.36 -0.382 . . . . 74.129999999999995 111.15 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.48 114.42 3.82 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 121.242 0.544 . . . . 75.519999999999996 110.693 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.26 93.64 0.66 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.449 2.099 . . . . 53.130000000000003 112.699 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.26 43.88 94.58 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.694 -0.684 . . . . 54.049999999999997 112.615 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.437 ' HA2' ' HG3' ' A' ' 53' ' ' PRO . . . -110.66 -172.96 19.99 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.585 -0.817 . . . . 33.509999999999998 112.638 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.759 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 37.9 m -92.06 114.52 27.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.859 0.361 . . . . 74.349999999999994 111.205 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.93 119.83 39.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.824 -0.625 . . . . 44.219999999999999 109.999 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.84 161.04 12.88 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.551 -0.833 . . . . 73.430000000000007 112.755 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' HB3' ' HB1' ' A' ' 16' ' ' ALA . 1.6 mp0 -67.17 137.26 56.13 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.058 -0.349 . . . . 71.310000000000002 110.058 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.762 HG11 ' HA ' ' A' ' 48' ' ' VAL . 31.1 m -134.01 154.42 37.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.254 -0.43 . . . . 75.129999999999995 111.269 -174.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -106.67 160.63 15.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.276 -0.42 . . . . 70.030000000000001 110.118 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 p -71.52 148.75 46.43 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.055 0.455 . . . . 72.430000000000007 111.625 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.59 97.08 6.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 64.219999999999999 110.201 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.1 m -89.54 117.6 28.56 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.984 -0.553 . . . . 74.439999999999998 110.532 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.88 -139.19 6.66 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.782 -0.723 . . . . 72.209999999999994 112.199 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -95.78 178.06 5.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.969 0.414 . . . . 63.350000000000001 110.716 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.49 -168.18 19.5 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.054 -0.593 . . . . 72.340000000000003 112.362 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.25 8.45 14.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.939 0.399 . . . . 73.230000000000004 110.504 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.24 170.34 10.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.884 -0.598 . . . . 42.149999999999999 110.663 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.11 -36.93 0.17 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.478 -0.328 . . . . 74.340000000000003 111.531 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.558 ' HE2' ' HB2' ' A' ' 15' ' ' ASP . 76.3 m-85 -124.61 131.74 53.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.955 -0.387 . . . . 72.25 109.955 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.3 112.28 2.06 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.204 -0.998 . . . . 64.420000000000002 110.971 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.762 ' HA ' HG11 ' A' ' 35' ' ' VAL . 12.0 t -109.07 126.17 66.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.736 0.303 . . . . 74.239999999999995 111.08 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.494 ' H ' HG11 ' A' ' 35' ' ' VAL . 3.4 pp -87.07 130.71 34.38 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.215 -0.448 . . . . 75.150000000000006 109.992 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 m -131.17 114.17 25.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.638 0.733 . . . . 73.340000000000003 110.498 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.759 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 11.6 m -97.92 122.83 41.5 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.411 -0.813 . . . . 71.129999999999995 110.77 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.435 ' C ' ' H ' ' A' ' 54' ' ' ASP . 8.0 mpt_? -74.32 140.35 76.07 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 108.686 -0.857 . . . . 74.349999999999994 108.686 171.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.437 ' HG3' ' HA2' ' A' ' 30' ' ' GLY . 16.4 Cg_exo -68.88 17.95 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.17 2.58 . . . . 34.509999999999998 112.957 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 52' ' ' ARG . 12.3 t70 -109.42 -15.64 14.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.138 0.494 . . . . 73.430000000000007 110.331 177.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.22 -19.31 8.21 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.621 -0.8 . . . . 45.43 112.424 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.89 115.28 18.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.412 0.625 . . . . 64.5 111.091 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 57' ' ' ARG . 34.2 ttp180 -115.74 120.51 39.55 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.609 -0.723 . . . . 63.43 110.482 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.482 HG12 ' HA ' ' A' ' 73' ' ' PRO . 31.5 m -123.62 163.45 22.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.37 -0.377 . . . . 73.409999999999997 110.302 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -122.85 133.92 54.41 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.044 0.45 . . . . 61.119999999999997 110.039 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.415 HG12 HD13 ' A' ' 62' ' ' LEU . 22.8 t -101.61 120.13 50.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.482 -0.562 . . . . 52.420000000000002 109.482 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -92.2 121.66 33.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.562 . . . . 74.519999999999996 110.229 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.649 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -113.35 156.69 22.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.893 -1.049 . . . . 75.230000000000004 110.929 -172.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 67' ' ' ARG . 10.9 t70 -90.73 172.11 8.88 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.313 -0.858 . . . . 60.350000000000001 109.722 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -50.23 -44.57 53.38 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.546 0.738 . . . . 60.0 112.352 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 67' ' ' ARG . 27.1 m-20 -96.52 26.14 4.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.911 0.386 . . . . 74.25 110.604 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 19' ' ' ALA . 26.2 m-85 67.1 32.67 6.06 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.216 0.821 . . . . 63.530000000000001 113.216 174.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -77.94 126.82 31.4 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.172 -0.677 . . . . 74.340000000000003 109.172 169.168 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.649 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.5 p -69.55 120.65 17.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.053 0.454 . . . . 73.450000000000003 110.371 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.9 mt -96.18 -62.58 1.26 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.24 -0.436 . . . . 71.200000000000003 110.896 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -150.71 170.19 19.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 70.209999999999994 110.092 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.0 m -147.61 115.79 6.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.041 0.448 . . . . 61.25 110.363 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -133.08 159.45 72.59 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 116.022 -0.535 . . . . 60.140000000000001 110.194 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.482 ' HA ' HG12 ' A' ' 58' ' ' VAL . 18.3 Cg_endo -59.91 143.1 99.64 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.733 2.289 . . . . 42.140000000000001 112.476 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -124.56 122.22 36.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.873 -0.603 . . . . 71.340000000000003 110.804 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -144.95 111.43 5.69 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.029 -0.36 . . . . 64.510000000000005 110.029 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.76 88.51 0.22 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.05 -0.595 . . . . 71.510000000000005 111.73 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -63.05 -36.04 82.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.696 0.284 . . . . 75.549999999999997 111.15 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.87 -41.28 0.39 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.264 -0.969 . . . . 44.130000000000003 112.865 176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -71.93 123.03 9.42 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.912 -0.661 . . . . 73.140000000000001 113.278 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.2 mt -122.85 117.26 25.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.473 -0.565 . . . . 70.25 109.473 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.357 -0.83 . . . . 75.510000000000005 111.032 -176.072 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.561 0 N-CA-C 111.642 -0.583 . . . . 74.109999999999999 111.642 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.33 137.11 52.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.777 0.323 . . . . 61.399999999999999 110.922 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.533 ' HB3' ' CE2' ' A' ' 5' ' ' PHE . 1.6 mpt? -90.33 116.02 27.97 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.96 -0.756 . . . . 74.319999999999993 108.96 175.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.05 81.75 3.57 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.155 0.503 . . . . 70.430000000000007 112.125 -172.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 3' ' ' MET . 91.3 m-85 -121.35 57.52 1.01 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.727 0.775 . . . . 75.120000000000005 109.053 174.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.582 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 7.9 t70 -147.83 -142.75 0.13 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.389 -1.337 . . . . 70.319999999999993 107.389 -177.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.61 175.83 33.06 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.007 -1.092 . . . . 70.340000000000003 112.581 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -84.6 -178.67 6.95 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.649 -0.5 . . . . 75.109999999999999 109.649 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -92.66 -9.55 40.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.439 0.638 . . . . 64.5 109.585 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.13 53.92 2.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.55 -0.75 . . . . 71.099999999999994 109.363 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.8 m -60.14 96.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.858 0.837 . . . . 73.319999999999993 112.186 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 t -93.72 -21.83 19.1 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.104 -0.953 . . . . 52.109999999999999 109.021 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.755 ' HA3' ' HB3' ' A' ' 16' ' ' ALA . . . -152.27 143.76 10.76 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.153 -0.93 . . . . 41.219999999999999 111.096 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -60.75 -68.91 0.04 OUTLIER 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.819 2.346 . . . . 64.040000000000006 111.876 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.577 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 10.8 m-20 -90.01 -22.29 21.96 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.519 -0.549 . . . . 74.129999999999995 109.519 176.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.755 ' HB3' ' HA3' ' A' ' 13' ' ' GLY . . . -58.91 -37.34 76.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.077 -0.965 . . . . 74.120000000000005 111.445 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 13' ' ' GLY . 14.9 t70 -55.57 -57.77 10.56 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.165 -0.471 . . . . 54.530000000000001 111.545 -175.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.593 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -69.07 -35.75 76.87 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.945 0.35 . . . . 75.150000000000006 111.945 -176.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.411 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -68.48 -42.45 78.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.101 0.477 . . . . 63.240000000000002 110.812 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -71.12 -36.91 72.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.839 -0.619 . . . . 71.120000000000005 110.56 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.25 -24.07 66.52 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.431 -0.349 . . . . 70.209999999999994 111.49 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 -29.89 33.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.402 -0.363 . . . . 54.240000000000002 111.152 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.419 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -62.21 -31.77 72.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.045 -0.525 . . . . 72.549999999999997 112.034 -175.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.6 p -69.02 -14.01 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.819 0.343 . . . . 74.120000000000005 111.731 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -85.36 -31.85 22.74 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.858 0.361 . . . . 63.119999999999997 110.357 174.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.13 -32.23 39.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.067 -0.515 . . . . 43.140000000000001 111.382 -176.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.462 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 14.6 p -111.15 133.9 21.21 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.854 0.359 . . . . 64.25 110.53 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 27' ' ' VAL . 8.9 Cg_endo -82.49 99.88 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.828 2.352 . . . . 62.210000000000001 111.871 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.45 39.44 97.8 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.039 -0.601 . . . . 65.25 112.184 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' HA3' ' CG2' ' A' ' 27' ' ' VAL . . . -104.49 168.12 16.12 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.591 -0.814 . . . . 72.040000000000006 112.411 -178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 1.032 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 39.8 m -82.04 106.11 13.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.233 0.539 . . . . 61.409999999999997 111.201 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.87 111.91 22.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.395 -0.821 . . . . 51.109999999999999 109.29 170.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.37 162.87 17.86 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.184 -0.532 . . . . 72.510000000000005 112.839 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -61.72 106.94 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 72.209999999999994 110.232 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.645 HG11 ' HA ' ' A' ' 48' ' ' VAL . 33.9 m -91.25 150.3 3.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.921 -0.581 . . . . 64.209999999999994 110.845 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -108.67 150.06 28.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.272 -0.422 . . . . 73.099999999999994 110.032 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.74 131.01 39.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.183 0.516 . . . . 71.420000000000002 110.999 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -94.83 133.8 38.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.674 -0.694 . . . . 62.219999999999999 110.365 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -91.49 117.67 29.9 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.936 -0.765 . . . . 50.219999999999999 108.936 168.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.67 93.62 0.15 Allowed Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.214 -0.993 . . . . 75.120000000000005 112.612 -174.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -51.4 114.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.504 -0.554 . . . . 70.120000000000005 109.504 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 142.14 -54.61 0.61 Allowed Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.736 -0.745 . . . . 55.32 112.149 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -175.13 -38.76 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.804 0.298 . . . . 74.140000000000001 111.804 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.88 130.28 45.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.048 0.452 . . . . 44.140000000000001 111.796 -174.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.78 -36.4 0.51 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.756 -0.656 . . . . 73.099999999999994 110.788 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.543 ' HE2' ' HB3' ' A' ' 15' ' ' ASP . 91.8 m-85 -124.84 133.65 53.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 74.219999999999999 110.49 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.29 113.46 2.03 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.335 -0.706 . . . . 74.129999999999995 111.335 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.645 ' HA ' HG11 ' A' ' 35' ' ' VAL . 45.7 t -101.18 112.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 120.734 0.302 . . . . 73.319999999999993 111.01 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.62 ' HG ' HG12 ' A' ' 35' ' ' VAL . 2.3 pp -85.8 117.05 24.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.589 . . . . 74.439999999999998 110.042 178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.67 114.42 47.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.661 -0.7 . . . . 63.020000000000003 110.277 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 1.032 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 20.3 m -96.13 104.92 16.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.233 -0.44 . . . . 73.430000000000007 110.461 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -67.04 138.71 95.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.165 -0.68 . . . . 73.519999999999996 109.165 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HD3' ' HA2' ' A' ' 30' ' ' GLY . 17.9 Cg_endo -60.05 -7.94 7.21 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.131 2.554 . . . . 70.209999999999994 112.998 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -74.25 -14.45 60.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 70.239999999999995 110.537 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.34 33.36 5.17 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.398 -0.906 . . . . 71.349999999999994 112.662 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 t -131.84 142.27 49.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.905 0.383 . . . . 72.510000000000005 110.949 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 58.9 ttt180 -110.08 122.69 48.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 72.409999999999997 111.362 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.48 139.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.406 -0.59 . . . . 73.420000000000002 109.406 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -108.2 136.12 48.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.217 0.532 . . . . 73.25 110.858 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 71' ' ' THR . 23.6 t -106.01 118.18 53.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.514 -0.766 . . . . 62.100000000000001 109.672 178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -89.55 125.32 35.16 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.09 -0.504 . . . . 72.239999999999995 111.521 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.816 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.5 OUTLIER -117.16 147.21 42.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.474 -0.784 . . . . 61.25 109.816 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.872 ' HB3' HD21 ' A' ' 69' ' ' LEU . 1.9 p-10 -91.96 -167.1 1.69 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.951 -0.3 . . . . 74.439999999999998 110.439 178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -55.27 -38.08 68.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.014 -0.539 . . . . 74.549999999999997 111.933 -176.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -89.67 16.45 7.87 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.019 0.377 . . . . 75.219999999999999 112.019 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 65.83 21.84 11.46 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.208 0.528 . . . . 75.219999999999999 111.127 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.713 ' HB3' ' OD1' ' A' ' 63' ' ' ASP . 9.0 tpt180 -88.34 134.84 33.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.212 -0.449 . . . . 75.040000000000006 110.178 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.816 ' HA ' HD12 ' A' ' 62' ' ' LEU . 4.5 p -61.58 116.05 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.242 0.544 . . . . 62.299999999999997 111.256 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.872 HD21 ' HB3' ' A' ' 63' ' ' ASP . 85.5 mt -84.42 -49.06 9.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.754 -0.657 . . . . 64.319999999999993 109.611 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -170.35 -179.34 3.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.487 -0.778 . . . . 73.420000000000002 108.981 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.539 HG23 HG22 ' A' ' 60' ' ' VAL . 23.8 m -145.83 108.22 4.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.741 0.305 . . . . 61.039999999999999 110.352 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 1.5 pm0 -120.86 147.07 45.26 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.899 0.381 . . . . 71.120000000000005 111.077 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 24.0 Cg_exo -63.72 132.34 34.78 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.944 2.429 . . . . 61.509999999999998 112.022 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 57' ' ' ARG . . . -107.73 100.09 9.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.148 -0.478 . . . . 74.340000000000003 110.461 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -87.82 137.15 32.58 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.118 -0.492 . . . . 64.129999999999995 110.109 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.46 -26.49 74.07 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.954 -0.566 . . . . 31.109999999999999 113.04 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -82.81 -59.79 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.947 -0.39 . . . . 64.230000000000004 109.947 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.39 -34.46 0.55 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 114.86 0.704 . . . . 53.439999999999998 114.86 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.79 132.93 46.89 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 116.933 0.366 . . . . 73.099999999999994 113.733 -172.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.0 mt -123.21 127.12 48.18 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.898 -0.408 . . . . 72.540000000000006 109.898 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.903 -0.57 . . . . 74.450000000000003 110.095 177.592 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 111.674 -0.57 . . . . 70.329999999999998 111.674 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.16 88.01 4.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.021 0.439 . . . . 61.229999999999997 110.511 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.09 138.75 31.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.017 -0.538 . . . . 73.349999999999994 110.336 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.09 77.88 7.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.218 -0.447 . . . . 74.120000000000005 111.109 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.67 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 88.2 m-85 -131.76 56.45 1.82 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 74.319999999999993 110.551 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.8 t70 175.6 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.732 -0.667 . . . . 72.019999999999996 110.071 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -96.0 -80.71 1.53 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.052 -0.819 . . . . 43.229999999999997 111.052 174.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -146.51 133.4 20.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.15 0.5 . . . . 74.530000000000001 110.064 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -75.96 4.85 7.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.8 -0.636 . . . . 73.239999999999995 111.779 -170.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -74.12 -17.16 60.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.569 -0.287 . . . . 72.549999999999997 111.697 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.582 HG21 ' HB2' ' A' ' 17' ' ' ASP . 35.5 m -92.34 162.85 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.762 0.315 . . . . 75.219999999999999 111.278 -176.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.5 p -101.44 -0.16 35.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.288 -0.414 . . . . 72.540000000000006 111.6 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.01 105.45 1.99 Allowed Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.727 -0.749 . . . . 75.510000000000005 111.608 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 22.4 Cg_endo -62.08 -50.9 4.23 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.68 2.254 . . . . 73.019999999999996 111.986 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -71.14 -35.05 71.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.953 -0.567 . . . . 75.549999999999997 110.427 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -62.31 -43.57 98.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.842 -0.617 . . . . 72.219999999999999 110.833 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.582 ' HB2' HG21 ' A' ' 11' ' ' VAL . 8.8 t70 -56.43 -53.66 54.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 70.329999999999998 111.739 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.67 ' HD2' ' HA ' ' A' ' 5' ' ' PHE . 12.0 mmt180 -56.76 -51.01 70.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.966 -0.561 . . . . 75.109999999999999 111.315 -171.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.841 ' HB3' HG21 ' A' ' 35' ' ' VAL . . . -78.64 -33.2 47.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.932 -0.576 . . . . 60.539999999999999 111.865 -174.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -69.62 -34.58 74.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 73.530000000000001 110.107 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -37.15 85.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 64.319999999999993 110.598 176.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.72 -32.29 63.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 70.030000000000001 110.877 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.442 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -56.27 -31.26 63.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.824 -0.626 . . . . 73.209999999999994 111.818 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.36 -32.19 40.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.978 0.418 . . . . 64.230000000000004 111.085 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.44 -13.73 25.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.267 -0.424 . . . . 54.420000000000002 110.815 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.558 ' HB3' HG11 ' A' ' 50' ' ' VAL . . . -85.76 -29.65 23.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.276 -0.42 . . . . 62.520000000000003 111.283 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.923 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 9.9 p -111.02 128.05 25.93 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.887 0.375 . . . . 73.340000000000003 110.399 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 27' ' ' VAL . 3.0 Cg_exo -72.95 93.06 0.79 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.798 2.332 . . . . 73.109999999999999 112.37 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.23 21.43 72.04 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.146 -0.549 . . . . 63.200000000000003 112.972 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.84 -164.43 32.71 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.732 -0.747 . . . . 74.329999999999998 112.255 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.46 ' CG2' ' HB ' ' A' ' 51' ' ' THR . 4.9 t -103.64 136.34 43.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.061 0.458 . . . . 64.530000000000001 110.469 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.16 110.23 22.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.677 -0.692 . . . . 64.109999999999999 110.365 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.78 160.75 31.53 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.686 -0.769 . . . . 54.25 112.222 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -75.32 140.99 43.45 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.885 0.374 . . . . 64.409999999999997 110.22 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.841 HG21 ' HB3' ' A' ' 19' ' ' ALA . 12.8 m -116.02 155.88 17.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.949 -0.569 . . . . 64.549999999999997 111.837 -169.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -114.46 156.96 23.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 52.520000000000003 109.502 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 p -74.04 123.56 24.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.606 0.241 . . . . 74.340000000000003 110.817 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.9 134.33 47.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.844 -0.428 . . . . 73.530000000000001 109.844 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.5 m -121.55 118.21 28.71 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.779 0.323 . . . . 72.519999999999996 110.408 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.98 -148.34 7.92 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.173 -0.771 . . . . 71.040000000000006 111.173 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -111.32 116.67 31.38 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.035 0.445 . . . . 64.319999999999993 110.426 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.84 -170.8 29.94 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.013 -0.835 . . . . 53.530000000000001 111.013 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -93.51 -5.39 49.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.911 0.386 . . . . 73.099999999999994 110.789 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.76 112.04 14.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.092 -0.504 . . . . 61.049999999999997 110.851 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.73 -16.73 11.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.098 -0.501 . . . . 63.450000000000003 111.061 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.457 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 90.9 m-85 -130.88 132.33 45.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.492 -0.322 . . . . 72.239999999999995 110.736 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.31 112.84 2.57 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.668 -0.777 . . . . 72.450000000000003 111.21 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.799 HG22 ' HB1' ' A' ' 19' ' ' ALA . 38.8 t -99.95 119.81 48.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.666 0.269 . . . . 45.210000000000001 111.035 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.534 HD23 HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -94.12 107.79 19.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.339 0.59 . . . . 61.32 110.336 177.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.923 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 2.7 m -115.12 102.5 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.528 0.68 . . . . 74.019999999999996 110.663 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.46 ' HB ' ' CG2' ' A' ' 31' ' ' THR . 10.0 m -92.64 122.67 35.28 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.358 -0.837 . . . . 75.319999999999993 110.867 -175.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HD2' HG23 ' A' ' 27' ' ' VAL . 12.6 mpt_? -79.53 153.05 76.05 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.163 -0.472 . . . . 63.109999999999999 110.36 177.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.2 1.78 3.23 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.967 2.445 . . . . 62.43 111.44 174.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -85.66 -13.49 48.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.101 -0.954 . . . . 71.209999999999994 109.816 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.08 -7.33 48.08 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.843 -0.694 . . . . 64.109999999999999 112.668 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.0 t -91.8 126.88 37.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.309 0.576 . . . . 75.230000000000004 111.364 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.549 HH22 ' HB2' ' A' ' 77' ' ' ASP . 35.8 ttp180 -107.93 124.27 49.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.609 -0.723 . . . . 63.210000000000001 109.45 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.676 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 30.2 t -122.46 137.05 57.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.509 -0.314 . . . . 63.140000000000001 110.935 -175.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.478 ' HG3' ' HB3' ' A' ' 74' ' ' ALA . 34.0 mt-10 -93.07 122.4 35.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.012 0.434 . . . . 73.230000000000004 110.747 176.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.468 HG22 HG23 ' A' ' 71' ' ' THR . 16.9 t -103.12 109.34 26.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.689 -0.856 . . . . 74.230000000000004 108.689 173.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.5 m170 -90.15 127.03 36.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.889 0.376 . . . . 63.140000000000001 110.297 -176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.758 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.4 OUTLIER -112.86 159.82 18.65 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.611 -0.722 . . . . 74.120000000000005 112.185 -171.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.659 ' HB2' HD21 ' A' ' 69' ' ' LEU . 16.0 t70 -90.5 169.84 10.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.559 -1.2 . . . . 75.540000000000006 109.797 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -31.54 64.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 122.766 0.426 . . . . 75.019999999999996 111.102 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -94.35 17.33 13.09 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.551 -0.295 . . . . 74.209999999999994 111.122 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 64.02 38.87 8.31 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.827 0.677 . . . . 72.310000000000002 112.827 175.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -99.32 147.52 25.11 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.631 -0.507 . . . . 74.239999999999995 109.631 169.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.758 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.4 p -74.25 119.85 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.333 0.587 . . . . 75.239999999999995 110.561 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 63' ' ' ASP . 93.0 mt -89.12 -47.42 8.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.867 -0.606 . . . . 72.129999999999995 110.339 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -164.55 156.47 16.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.117 -0.492 . . . . 75.329999999999998 110.498 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.468 HG23 HG22 ' A' ' 60' ' ' VAL . 8.0 m -124.23 118.04 25.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.858 -0.61 . . . . 71.519999999999996 109.977 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 8.7 pt-20 -134.1 121.58 15.73 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 71.340000000000003 111.319 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.676 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 37.3 Cg_exo -61.59 120.19 7.7 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.751 2.301 . . . . 73.030000000000001 111.3 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.478 ' HB3' ' HG3' ' A' ' 59' ' ' GLU . . . -143.25 164.92 28.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.981 0.419 . . . . 62.049999999999997 111.637 -173.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -116.79 124.01 48.54 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.94 -0.573 . . . . 54.409999999999997 110.064 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -104.56 18.38 44.51 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.787 -0.72 . . . . 54.549999999999997 111.992 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.549 ' HB2' HH22 ' A' ' 57' ' ' ARG . 18.0 t70 -97.76 -50.17 4.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.878 -0.415 . . . . 45.439999999999998 109.878 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.37 93.1 0.2 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.707 -0.758 . . . . 70.549999999999997 112.547 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.61 138.9 14.39 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.867 -0.682 . . . . 54.329999999999998 111.916 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.1 mt -106.64 115.8 30.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.706 0.289 . . . . 62.130000000000003 110.734 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-N 115.968 -0.56 . . . . 52.240000000000002 110.379 177.28 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.921 -0.472 . . . . 32.5 111.921 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.01 117.06 9.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.769 0.318 . . . . 52.420000000000002 110.706 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -92.83 143.8 25.91 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.753 -0.462 . . . . 73.530000000000001 109.753 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . . . -75.43 72.78 2.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.192 0.52 . . . . 64.219999999999999 112.068 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -128.14 108.01 10.28 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.078 -0.712 . . . . 74.519999999999996 109.078 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.658 ' H ' ' HD3' ' A' ' 18' ' ' ARG . 29.7 t70 67.62 110.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.109 0.88 . . . . 74.319999999999993 111.233 -173.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -133.81 -77.76 0.11 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.705 -0.759 . . . . 54.350000000000001 112.092 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.776 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 9.3 tp10 -85.96 157.34 20.16 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 110.059 -0.348 . . . . 64.439999999999998 110.059 177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -83.88 -9.39 58.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.579 0.704 . . . . 44.100000000000001 109.642 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.776 ' H ' ' HG3' ' A' ' 8' ' ' GLU . 10.6 mm-40 -84.56 88.57 7.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.191 -0.913 . . . . 75.230000000000004 109.561 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.62 90.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.131 0.491 . . . . 63.43 110.713 -175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.8 p -93.86 -5.56 47.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.949 -0.569 . . . . 73.349999999999994 110.597 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.73 146.77 5.68 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.033 -0.827 . . . . 71.219999999999999 111.033 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 18' ' ' ARG . 25.2 Cg_endo -62.18 -53.82 1.78 Allowed 'Trans proline' 0 N--CA 1.466 -0.139 0 C-N-CA 122.668 2.246 . . . . 63.039999999999999 112.156 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -97.85 -37.67 9.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.959 -0.564 . . . . 74.230000000000004 110.905 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.67 -48.79 58.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.77 -0.65 . . . . 74.340000000000003 112.213 -176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -65.68 -50.96 62.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.277 0.561 . . . . 53.409999999999997 111.569 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.691 ' HG2' HH11 ' A' ' 18' ' ' ARG . 12.5 mtt-85 -72.75 -37.39 67.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.549 -0.75 . . . . 65.219999999999999 111.592 -168.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.534 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -67.15 -42.01 85.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.07 0.462 . . . . 53.439999999999998 110.237 177.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -62.65 -46.19 89.38 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.546 -0.752 . . . . 73.329999999999998 110.775 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.27 -21.78 63.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.049 -0.523 . . . . 72.329999999999998 111.607 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . . . -86.1 -40.04 16.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.905 0.383 . . . . 65.5 111.338 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.553 ' HB2' HG11 ' A' ' 48' ' ' VAL . . . -69.73 -22.44 63.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.457 0.54 . . . . 64.030000000000001 112.457 -174.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 p -63.43 -22.99 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.831 0.348 . . . . 71.040000000000006 111.128 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -78.03 -16.43 58.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.662 0.268 . . . . 71.319999999999993 111.216 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.88 -14.37 23.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.932 0.396 . . . . 43.240000000000002 111.302 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.516 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 7.3 p -116.14 122.2 32.61 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.047 0.451 . . . . 73.310000000000002 110.992 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 27' ' ' VAL . 3.3 Cg_exo -74.93 100.89 1.4 Allowed 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.899 2.399 . . . . 74.230000000000004 112.239 -178.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.85 38.21 91.99 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.88 -0.6 . . . . 72.129999999999995 112.501 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.435 ' HA3' ' CG2' ' A' ' 27' ' ' VAL . . . -102.87 -172.1 26.5 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.71 -0.757 . . . . 15.029999999999999 112.526 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.1 m -98.88 115.36 28.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.746 0.308 . . . . 60.25 110.577 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.84 105.0 15.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.903 -0.59 . . . . 54.530000000000001 110.093 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.09 161.98 18.3 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.944 -0.646 . . . . 43.310000000000002 112.445 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.04 141.26 52.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.051 0.453 . . . . 75.030000000000001 110.437 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.821 HG11 ' HA ' ' A' ' 48' ' ' VAL . 34.9 m -126.73 156.0 37.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.937 -0.574 . . . . 64.319999999999993 111.451 -172.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -105.52 155.82 18.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.03 -0.532 . . . . 64.319999999999993 110.053 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.95 124.07 25.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.282 -0.417 . . . . 75.400000000000006 110.449 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.69 122.34 21.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.889 0.376 . . . . 75.040000000000006 110.24 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.0 t -77.43 129.41 35.72 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.078 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.94 -150.95 9.55 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.638 -0.792 . . . . 72.439999999999998 112.216 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -151.25 132.42 14.43 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.06 -0.719 . . . . 41.310000000000002 109.06 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.65 -135.17 9.68 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.624 -0.798 . . . . 63.439999999999998 112.283 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 63' ' ' ASP . . . -87.69 -30.84 20.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.693 0.282 . . . . 74.439999999999998 110.744 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.22 102.71 3.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.087 0.47 . . . . 62.340000000000003 111.076 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.07 -42.86 2.89 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.857 -0.61 . . . . 54.399999999999999 111.072 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.444 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 46.0 m-85 -114.61 133.58 55.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.528 -0.305 . . . . 73.299999999999997 110.229 -177.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.83 112.94 2.34 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.865 -0.894 . . . . 75.109999999999999 110.865 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.821 ' HA ' HG11 ' A' ' 35' ' ' VAL . 6.3 t -110.25 139.61 32.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.838 0.351 . . . . 42.020000000000003 110.642 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.8 pp -105.16 126.74 52.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.136 0.493 . . . . 73.450000000000003 110.813 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.403 ' CG1' ' HB1' ' A' ' 23' ' ' ALA . 2.4 m -129.09 120.3 51.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.17 0.51 . . . . 74.420000000000002 110.791 176.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.2 m -102.94 126.33 50.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.843 -0.617 . . . . 55.420000000000002 110.831 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.535 ' HB2' HG23 ' A' ' 56' ' ' THR . 10.6 mpt_? -81.56 152.28 69.64 Favored Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 109.341 -0.614 . . . . 72.129999999999995 109.341 173.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.48 -23.15 46.13 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.823 2.348 . . . . 74.340000000000003 112.839 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.61 -27.48 68.97 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.917 0.389 . . . . 55.030000000000001 111.168 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.72 -12.67 15.25 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.692 -0.766 . . . . 74.239999999999995 112.107 -177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.535 HG23 ' HB2' ' A' ' 52' ' ' ARG . 5.5 t -72.23 128.63 36.25 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.505 0.669 . . . . 63.310000000000002 110.46 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 57' ' ' ARG . 12.2 ttt180 -118.48 119.75 35.48 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.447 -0.797 . . . . 71.310000000000002 109.385 -175.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 51.6 t -107.51 137.22 39.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.219 -0.446 . . . . 61.399999999999999 111.16 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -96.55 112.21 24.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.407 0.623 . . . . 74.209999999999994 109.432 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 71' ' ' THR . 25.4 t -97.37 114.61 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.995 -0.548 . . . . 71.140000000000001 109.973 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -89.59 122.85 33.12 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.081 0.467 . . . . 74.409999999999997 110.528 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.619 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -113.07 145.93 40.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.1 -0.955 . . . . 62.32 110.144 -177.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.586 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 20.7 p30 -91.91 -167.71 1.84 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.008 0.432 . . . . 74.0 111.431 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -65.99 -17.98 65.04 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.588 -0.733 . . . . 73.310000000000002 111.849 -172.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -109.54 13.51 23.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.752 -0.204 . . . . 73.109999999999999 110.904 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 65.37 30.76 10.86 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.279 0.561 . . . . 65.310000000000002 111.229 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.403 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . 26.2 ttp180 -93.52 137.37 32.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.532 -0.758 . . . . 70.010000000000005 109.795 176.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.619 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.5 p -65.06 117.18 5.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.362 0.601 . . . . 71.230000000000004 111.574 -177.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.549 HD21 ' HB3' ' A' ' 63' ' ' ASP . 96.2 mt -90.93 -60.01 2.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.679 -0.692 . . . . 72.510000000000005 110.991 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -157.52 147.59 20.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.071 -0.513 . . . . 61.329999999999998 110.085 -172.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.483 HG22 HG22 ' A' ' 60' ' ' VAL . 17.0 p -124.01 109.52 13.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.901 0.382 . . . . 75.310000000000002 110.901 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 11.0 mm-40 -107.35 155.44 39.47 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.077 -0.51 . . . . 62.420000000000002 110.828 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 5.1 Cg_exo -74.57 122.29 7.3 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.467 2.112 . . . . 74.0 110.885 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.16 156.48 23.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.416 -0.357 . . . . 54.009999999999998 110.298 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.402 ' HB2' HD21 ' A' ' 80' ' ' LEU . 24.2 t70 -86.77 136.39 33.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.393 -0.367 . . . . 62.43 110.336 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -98.73 1.71 58.31 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.514 -0.85 . . . . 71.25 112.908 -174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -97.9 -56.35 2.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.988 0.423 . . . . 63.240000000000002 110.609 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.35 -30.84 6.27 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.768 -0.651 . . . . 54.43 111.573 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.53 75.32 2.14 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.047 -0.597 . . . . 70.109999999999999 111.901 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.402 HD21 ' HB2' ' A' ' 75' ' ' ASP . 56.7 mt -68.51 134.73 50.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.898 0.38 . . . . 53.109999999999999 111.236 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.073 -0.965 . . . . 64.150000000000006 110.297 177.804 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.532 0 N-CA-C 111.77 -0.532 . . . . 73.400000000000006 111.77 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.465 ' HB3' HH22 ' A' ' 67' ' ' ARG . . . -129.99 87.61 2.55 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.987 0.423 . . . . 74.030000000000001 111.109 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -106.87 93.88 4.81 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.697 -0.853 . . . . 64.150000000000006 108.697 173.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.35 75.12 3.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.047 0.451 . . . . 72.340000000000003 111.77 -174.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.91 54.69 0.74 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.65 0.738 . . . . 74.239999999999995 109.117 172.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.586 ' N ' ' HD2' ' A' ' 18' ' ' ARG . 25.1 t70 174.23 101.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.075 -1.421 . . . . 71.310000000000002 107.84 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.76 -78.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.865 -0.683 . . . . 65.040000000000006 112.814 -172.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.662 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 11.2 tt0 -156.26 -166.1 2.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.676 0.274 . . . . 73.219999999999999 110.708 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.662 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 4.8 m-20 -66.5 -6.66 15.63 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.939 0.718 . . . . 63.140000000000001 112.939 -172.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -108.79 84.16 1.88 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.034 0.445 . . . . 72.230000000000004 111.047 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.2 t -91.95 87.42 2.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.416 -0.587 . . . . 73.120000000000005 109.416 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 t -114.24 130.22 56.64 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.632 -0.713 . . . . 62.109999999999999 110.098 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.65 -151.5 41.38 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.233 -0.984 . . . . 61.32 111.703 -177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.495 ' HB2' ' H ' ' A' ' 15' ' ' ASP . 63.9 Cg_endo -73.29 -142.2 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.772 2.315 . . . . 71.040000000000006 112.144 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.603 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 3.2 m-20 -74.41 12.08 0.85 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.398 0.518 . . . . 71.439999999999998 112.398 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.642 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -49.72 -34.15 18.06 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.9 0.381 . . . . 43.009999999999998 111.353 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.71 -42.38 71.44 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.393 -0.821 . . . . 63.25 112.278 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 15' ' ' ASP . 12.1 mmt180 -64.71 -57.91 7.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.287 0.565 . . . . 75.510000000000005 111.123 -170.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.765 ' HB3' HG21 ' A' ' 35' ' ' VAL . . . -73.38 -26.94 61.21 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.522 -0.763 . . . . 74.450000000000003 111.946 -173.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -66.73 -35.84 81.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 74.340000000000003 110.858 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.49 -39.51 88.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 74.519999999999996 110.862 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.35 -28.88 63.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.028 -0.533 . . . . 42.200000000000003 111.297 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.09 -27.36 68.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.08 -0.509 . . . . 62.420000000000002 111.859 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.0 t -59.47 -38.26 74.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.061 0.458 . . . . 64.319999999999993 111.266 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -81.13 -12.38 59.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.289 -0.414 . . . . 71.230000000000004 111.143 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.63 -6.87 58.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 60.109999999999999 111.452 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -144.05 124.08 7.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.017 0.437 . . . . 61.420000000000002 111.483 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.75 105.68 2.11 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.401 2.067 . . . . 75.430000000000007 112.136 176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.78 39.54 89.94 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.081 -0.581 . . . . 72.319999999999993 112.417 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.736 ' HA2' ' HD3' ' A' ' 53' ' ' PRO . . . -101.92 -147.77 20.25 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.581 -0.819 . . . . 61.25 112.697 -178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.668 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 58.6 m -137.63 131.26 31.28 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.699 0.285 . . . . 61.210000000000001 110.574 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.05 120.44 41.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.298 -0.41 . . . . 52.130000000000003 110.641 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.68 161.16 13.33 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.841 -0.695 . . . . 51.100000000000001 111.582 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.443 ' O ' HD21 ' A' ' 49' ' ' LEU . 1.4 mp0 -62.5 128.13 34.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.338 . . . . 65.0 110.428 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.765 HG21 ' HB3' ' A' ' 19' ' ' ALA . 19.8 m -90.21 154.77 3.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.013 -0.539 . . . . 71.030000000000001 110.769 -175.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -112.67 153.61 27.39 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.14 -0.482 . . . . 72.439999999999998 111.059 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 m -85.22 115.27 22.9 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.702 -0.851 . . . . 74.420000000000002 108.702 171.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -75.61 130.18 38.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.242 0.544 . . . . 75.540000000000006 111.9 -172.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.2 p -88.9 118.27 28.49 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.962 -0.755 . . . . 72.239999999999995 108.962 171.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.95 -125.04 0.8 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 119.9 -1.143 . . . . 71.299999999999997 113.338 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.88 158.36 44.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.724 0.297 . . . . 72.519999999999996 110.481 -172.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.9 -116.18 4.17 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.05 -0.595 . . . . 63.109999999999999 113.077 175.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.84 10.06 5.93 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.559 0.219 . . . . 72.019999999999996 111.219 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.06 107.07 3.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.053 -0.351 . . . . 72.239999999999995 110.053 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.72 -54.35 2.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.094 -0.503 . . . . 74.120000000000005 111.646 -175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -115.64 133.41 56.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.0 0.428 . . . . 74.200000000000003 111.405 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -112.18 112.49 3.06 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.675 -0.774 . . . . 65.409999999999997 111.261 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.606 HG22 ' HB1' ' A' ' 19' ' ' ALA . 27.4 t -95.24 109.72 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.633 0.254 . . . . 74.430000000000007 110.687 -175.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.694 HD23 ' H ' ' A' ' 49' ' ' LEU . 0.4 OUTLIER -85.51 102.7 13.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.28 0.562 . . . . 65.049999999999997 110.74 -179.228 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.3 t -97.1 110.34 24.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.716 -0.674 . . . . 32.140000000000001 110.016 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.668 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 14.0 m -91.92 116.6 29.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.11 -0.495 . . . . 75.129999999999995 110.548 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -96.94 135.84 21.86 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.185 -0.461 . . . . 54.310000000000002 110.023 178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.736 ' HD3' ' HA2' ' A' ' 30' ' ' GLY . 37.1 Cg_endo -65.68 -8.81 20.51 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.878 2.386 . . . . 45.299999999999997 111.386 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -64.12 -26.75 68.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.89 -1.05 . . . . 75.519999999999996 110.487 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.46 32.64 2.28 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.67 -0.776 . . . . 73.439999999999998 112.352 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 t -145.38 144.93 30.95 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.102 0.477 . . . . 72.329999999999998 110.956 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -107.89 118.5 36.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.705 -0.68 . . . . 73.319999999999993 109.263 176.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 45.5 t -112.33 115.7 50.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.771 -0.455 . . . . 70.120000000000005 109.771 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 12.4 pt-20 -101.81 113.21 26.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.659 0.742 . . . . 73.340000000000003 110.823 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.608 HG22 HG23 ' A' ' 71' ' ' THR . 18.6 t -89.12 118.57 34.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.179 -0.918 . . . . 54.329999999999998 109.224 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -93.35 123.22 36.49 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.345 -0.389 . . . . 65.420000000000002 110.345 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 68' ' ' VAL . 1.0 OUTLIER -115.64 152.21 33.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.889 -0.596 . . . . 65.040000000000006 111.157 -174.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.594 ' HB3' HD21 ' A' ' 69' ' ' LEU . 3.7 p-10 -94.47 -164.52 1.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.882 -0.599 . . . . 75.150000000000006 110.531 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.6 mtt-85 -71.66 -24.57 61.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.121 -0.491 . . . . 70.109999999999999 111.26 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.45 0.08 56.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.04 0.448 . . . . 73.150000000000006 109.801 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 67.99 32.48 5.05 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.332 -0.849 . . . . 55.140000000000001 110.678 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.465 HH22 ' HB3' ' A' ' 2' ' ' ALA . 1.6 mpt_? -101.06 154.53 18.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.065 -0.516 . . . . 73.230000000000004 109.884 175.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.578 ' HA ' HD12 ' A' ' 62' ' ' LEU . 7.1 p -71.13 118.8 16.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.41 0.624 . . . . 53.229999999999997 111.435 -176.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 63' ' ' ASP . 96.1 mt -85.52 -51.21 6.66 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.002 -0.74 . . . . 75.319999999999993 109.002 172.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -155.05 166.15 34.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.676 -0.693 . . . . 75.439999999999998 109.923 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.608 HG23 HG22 ' A' ' 60' ' ' VAL . 27.7 m -148.49 109.1 4.19 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.564 -0.532 . . . . 74.010000000000005 109.564 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 2.2 pm0 -130.57 135.98 28.23 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 121.139 0.495 . . . . 61.520000000000003 111.649 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 6.0 Cg_exo -79.79 92.83 1.09 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.863 2.375 . . . . 72.120000000000005 110.531 171.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -89.35 110.31 21.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.171 -0.468 . . . . 73.219999999999999 111.161 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -90.21 109.34 20.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.991 -0.55 . . . . 73.150000000000006 109.93 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.35 162.06 10.9 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.853 -0.689 . . . . 74.349999999999994 111.871 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -97.34 -31.2 12.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.044 0.449 . . . . 73.219999999999999 110.062 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 161.52 67.12 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.829 -0.701 . . . . 31.43 111.907 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -174.02 74.39 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.032 -0.604 . . . . 61.100000000000001 112.128 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 97.9 mt -119.81 121.08 38.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.859 0.361 . . . . 60.100000000000001 110.15 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.32 -0.848 . . . . 73.420000000000002 110.101 -179.845 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 112.083 -0.407 . . . . 42.450000000000003 112.083 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.73 116.43 20.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.027 0.442 . . . . 71.140000000000001 110.728 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -91.09 154.33 19.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.41 -0.589 . . . . 73.450000000000003 109.41 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.23 67.23 8.17 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.29 0.567 . . . . 70.219999999999999 110.735 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -131.85 57.63 1.77 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.638 -0.71 . . . . 73.329999999999998 110.007 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -127.11 -58.07 1.29 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.707 -0.679 . . . . 71.530000000000001 109.338 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.89 178.66 51.1 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.911 -0.662 . . . . 72.049999999999997 112.319 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.799 ' HG2' ' H ' ' A' ' 9' ' ' ASP . 24.6 tt0 -124.07 -172.21 2.49 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 122.681 -0.305 . . . . 75.040000000000006 110.185 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.799 ' H ' ' HG2' ' A' ' 8' ' ' GLU . 11.9 m-20 -77.83 -9.28 58.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.588 -0.278 . . . . 74.319999999999993 111.594 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -83.39 93.94 7.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.966 0.412 . . . . 73.129999999999995 110.342 174.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.1 t -76.27 86.92 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.456 0.646 . . . . 62.219999999999999 109.79 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 t -107.11 -0.12 23.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.593 -0.73 . . . . 72.510000000000005 110.483 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 151.38 175.96 23.72 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.403 -0.679 . . . . 74.239999999999995 111.403 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.523 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 5.7 Cg_exo -76.14 -76.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.614 2.21 . . . . 55.329999999999998 111.818 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -70.8 -35.65 72.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.698 -0.683 . . . . 74.120000000000005 111.104 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.517 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -54.21 -49.31 69.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.861 -0.609 . . . . 75.450000000000003 111.478 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.52 -43.65 89.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.063 -0.517 . . . . 71.109999999999999 111.407 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 14' ' ' PRO . 7.2 mmt85 -64.07 -41.81 97.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.175 -0.466 . . . . 60.409999999999997 110.96 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.677 ' HB3' HG21 ' A' ' 35' ' ' VAL . . . -81.08 -35.01 32.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.248 -0.433 . . . . 54.039999999999999 112.061 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -65.21 -28.5 69.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.013 0.435 . . . . 73.230000000000004 110.291 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.39 -38.22 84.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 75.209999999999994 110.779 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.35 -30.86 57.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.047 0.451 . . . . 33.450000000000003 111.073 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.514 ' HB1' ' CG1' ' A' ' 50' ' ' VAL . . . -55.88 -35.88 66.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.568 -0.742 . . . . 61.039999999999999 112.076 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.4 t -55.77 -40.51 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 64.120000000000005 111.808 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -86.86 -12.86 46.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.262 -0.426 . . . . 73.319999999999993 111.319 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.4 -34.7 17.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.416 -0.356 . . . . 64.230000000000004 111.105 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.568 ' HB ' ' HB ' ' A' ' 50' ' ' VAL . 14.3 p -91.63 130.53 38.74 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.936 0.398 . . . . 74.329999999999998 110.593 -178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -70.94 86.71 0.73 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.44 2.093 . . . . 73.400000000000006 112.42 178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.47 38.73 96.15 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.733 -0.667 . . . . 51.130000000000003 112.586 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.58 -175.88 19.2 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.587 -0.816 . . . . 71.349999999999994 112.481 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.7 m -96.35 126.63 41.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.865 0.364 . . . . 64.109999999999999 110.986 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.09 131.28 37.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.086 -0.506 . . . . 72.420000000000002 109.824 176.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -121.96 162.01 15.89 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.543 -0.837 . . . . 63.119999999999997 112.378 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -55.05 119.85 6.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.128 0.489 . . . . 70.219999999999999 110.917 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.677 HG21 ' HB3' ' A' ' 19' ' ' ALA . 17.9 m -96.38 155.22 3.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.472 -0.785 . . . . 74.109999999999999 110.373 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -125.9 144.94 50.47 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.428 -0.351 . . . . 72.439999999999998 110.129 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 45.3 p -76.7 142.3 40.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.245 -0.434 . . . . 74.549999999999997 110.355 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -83.66 84.24 7.62 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.758 -0.83 . . . . 73.329999999999998 108.758 172.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -72.93 123.27 23.11 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.189 -0.914 . . . . 75.239999999999995 110.335 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.2 -26.93 6.55 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.763 -0.935 . . . . 63.530000000000001 110.763 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.26 146.47 28.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.263 -0.469 . . . . 52.310000000000002 110.303 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.95 -40.05 4.17 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.788 -0.72 . . . . 64.430000000000007 112.122 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.33 -65.03 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.697 0.284 . . . . 61.329999999999998 111.15 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.12 93.68 5.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.058 0.456 . . . . 61.130000000000003 110.901 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.52 -40.32 19.32 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.889 -0.596 . . . . 64.209999999999994 111.162 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -115.79 143.26 45.65 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.556 -0.293 . . . . 73.349999999999994 110.564 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -124.21 112.23 1.77 Allowed Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.793 -0.923 . . . . 65.109999999999999 110.793 171.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.561 HG22 ' HB1' ' A' ' 19' ' ' ALA . 89.0 t -96.82 110.73 25.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.72 0.295 . . . . 74.420000000000002 110.639 -176.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.537 ' H ' HG12 ' A' ' 35' ' ' VAL . 1.5 pp -96.42 115.23 27.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.399 0.618 . . . . 72.040000000000006 110.873 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.568 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 5.1 m -115.1 126.55 72.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.636 -0.711 . . . . 64.219999999999999 110.533 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.2 m -92.23 106.63 18.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.919 -0.582 . . . . 75.230000000000004 110.153 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 52' ' ' ARG . 56.6 mtt180 -72.0 149.38 92.3 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.891 -0.411 . . . . 75.439999999999998 109.891 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.91 -12.05 27.42 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.555 2.17 . . . . 65.030000000000001 111.11 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -68.61 -26.72 65.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.97 -1.013 . . . . 74.400000000000006 110.541 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.97 -17.21 15.33 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.851 -0.69 . . . . 72.329999999999998 112.755 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 t -89.57 149.35 22.9 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.878 0.371 . . . . 74.549999999999997 111.287 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -103.31 119.99 39.92 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.383 -0.599 . . . . 63.32 109.383 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 58.8 t -102.74 124.18 56.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.439 -0.578 . . . . 44.240000000000002 109.439 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 9.7 pt-20 -108.9 111.58 23.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.843 0.83 . . . . 75.120000000000005 110.314 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.658 HG22 HG23 ' A' ' 71' ' ' THR . 16.6 t -86.69 116.39 29.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.433 -0.803 . . . . 54.200000000000003 109.881 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -79.76 118.35 21.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.244 -0.435 . . . . 74.519999999999996 110.218 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.695 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.1 OUTLIER -115.67 154.6 29.22 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.618 -0.719 . . . . 72.239999999999995 111.575 -173.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.681 ' HB2' HD21 ' A' ' 69' ' ' LEU . 20.6 t70 -89.87 173.77 8.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.168 -0.924 . . . . 71.310000000000002 109.421 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -52.02 -37.74 54.49 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 122.946 0.498 . . . . 73.219999999999999 111.615 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.26 14.82 11.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.231 -0.441 . . . . 73.0 111.542 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.42 ' CD2' HD23 ' A' ' 62' ' ' LEU . 7.7 m-85 65.63 25.42 11.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.144 0.497 . . . . 71.409999999999997 111.475 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -80.48 137.52 36.48 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.971 -0.752 . . . . 62.43 108.971 175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.695 ' HA ' HD12 ' A' ' 62' ' ' LEU . 8.6 p -70.91 125.6 29.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.313 0.578 . . . . 53.229999999999997 111.187 -176.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 63' ' ' ASP . 71.6 mt -97.26 -58.58 1.98 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.664 -0.698 . . . . 70.049999999999997 109.674 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -155.7 141.11 17.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.947 -0.569 . . . . 63.420000000000002 110.088 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.658 HG23 HG22 ' A' ' 60' ' ' VAL . 18.5 m -107.8 111.6 23.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.544 -0.539 . . . . 54.310000000000002 109.544 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 12.3 pt-20 -135.32 129.24 18.67 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 121.18 0.514 . . . . 73.349999999999994 112.072 -173.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 2.0 Cg_endo -82.52 130.56 6.12 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.825 2.35 . . . . 62.049999999999997 110.263 169.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.57 172.16 7.13 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.969 0.414 . . . . 40.399999999999999 111.652 -175.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -122.16 -177.47 3.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.797 -0.638 . . . . 75.319999999999993 109.834 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.24 79.17 0.37 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.841 -0.695 . . . . 74.400000000000006 112.313 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -85.36 -53.79 5.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.084 0.469 . . . . 75.329999999999998 109.812 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.16 -32.67 6.43 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.884 -0.674 . . . . 62.039999999999999 112.853 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.64 93.36 1.14 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.851 -0.69 . . . . 54.149999999999999 111.52 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.3 mt -82.5 92.61 7.1 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.819 0.342 . . . . 64.430000000000007 110.868 -177.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.414 -0.803 . . . . 74.530000000000001 109.73 177.816 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 112.143 -0.383 . . . . 54.030000000000001 112.143 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.61 142.33 36.43 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.804 -0.233 . . . . 60.219999999999999 110.729 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -84.6 161.12 20.26 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.968 -0.382 . . . . 73.219999999999999 109.968 177.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HB1' ' HB2' ' A' ' 18' ' ' ARG . . . -80.86 73.75 7.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.033 0.444 . . . . 65.430000000000007 110.892 -178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -135.14 93.71 3.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.115 0.483 . . . . 51.329999999999998 110.511 176.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -150.29 -77.97 0.14 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.819 -0.808 . . . . 63.009999999999998 108.819 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.585 ' HA2' ' OD1' ' A' ' 17' ' ' ASP . . . 79.0 140.06 1.81 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.824 -0.625 . . . . 74.340000000000003 114.029 171.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.547 ' O ' HG22 ' A' ' 11' ' ' VAL . 34.5 tt0 -80.98 134.03 35.62 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.582 -0.895 . . . . 72.430000000000007 108.582 171.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.35 1.89 20.44 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 111.997 0.369 . . . . 75.129999999999995 111.997 -170.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.89 8.01 20.23 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.826 0.306 . . . . 70.329999999999998 111.826 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 17' ' ' ASP . 28.5 m -84.11 159.03 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 120.735 -0.386 . . . . 51.100000000000001 109.996 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 p -94.37 -25.22 17.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.86 -0.336 . . . . 72.120000000000005 111.293 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.428 ' HA2' ' HD2' ' A' ' 14' ' ' PRO . . . -95.1 111.23 4.16 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.853 -0.689 . . . . 61.100000000000001 111.581 174.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.428 ' HD2' ' HA2' ' A' ' 13' ' ' GLY . 13.5 Cg_endo -56.76 -55.83 2.41 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.983 2.456 . . . . 64.549999999999997 112.695 -175.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -89.06 -9.2 52.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.029 0.442 . . . . 55.130000000000003 110.698 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 1.119 ' HA ' HG22 ' A' ' 35' ' ' VAL . . . -66.28 -43.44 86.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.531 -0.759 . . . . 74.099999999999994 111.937 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.639 ' HB2' HG21 ' A' ' 11' ' ' VAL . 8.6 t70 -52.47 -57.46 9.82 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.066 -0.516 . . . . 75.120000000000005 112.148 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.563 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -71.42 -31.7 67.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.242 0.46 . . . . 63.299999999999997 112.242 -173.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.641 ' HB2' ' HE1' ' A' ' 66' ' ' PHE . . . -69.01 -39.91 79.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.075 0.464 . . . . 42.530000000000001 110.5 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -25.87 55.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.953 -0.567 . . . . 73.519999999999996 110.503 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.38 -32.91 62.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.354 . . . . 52.140000000000001 110.939 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.08 -26.89 62.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.178 0.513 . . . . 61.340000000000003 111.09 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.554 ' HB2' HG11 ' A' ' 48' ' ' VAL . . . -71.5 -23.15 61.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.915 -0.584 . . . . 33.130000000000003 111.442 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -63.13 -25.03 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.17 0.51 . . . . 55.350000000000001 111.239 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -80.31 -13.64 59.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.874 0.368 . . . . 73.510000000000005 110.963 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.49 1.3 29.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.264 -0.425 . . . . 70.400000000000006 111.381 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.08 116.34 5.63 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.144 0.497 . . . . 73.150000000000006 111.272 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.21 96.02 0.53 Allowed 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.484 2.123 . . . . 74.120000000000005 112.392 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.25 42.21 83.93 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.796 -0.638 . . . . 42.240000000000002 112.594 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.03 162.57 20.15 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.633 -0.794 . . . . 73.540000000000006 112.367 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.545 ' HB ' ' HB ' ' A' ' 51' ' ' THR . 28.1 m -87.58 112.0 21.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.952 0.406 . . . . 74.340000000000003 110.617 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.53 131.78 53.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.102 -0.499 . . . . 75.329999999999998 110.612 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.559 ' HA3' HD11 ' A' ' 49' ' ' LEU . . . -106.97 160.74 14.09 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.517 -0.849 . . . . 54.210000000000001 111.168 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -62.76 136.02 57.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.416 0.627 . . . . 70.349999999999994 110.323 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.119 HG22 ' HA ' ' A' ' 16' ' ' ALA . 2.5 m -90.7 157.1 2.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.148 -0.933 . . . . 73.340000000000003 111.437 -169.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -104.71 141.83 35.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.875 -0.602 . . . . 75.5 110.074 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.73 104.23 5.3 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.693 -0.685 . . . . 70.530000000000001 109.931 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -72.62 138.39 46.74 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.918 -0.401 . . . . 61.130000000000003 109.918 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.7 t -127.46 153.51 46.21 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.272 -0.422 . . . . 73.239999999999995 110.66 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.47 -19.03 49.44 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.908 -0.663 . . . . 65.439999999999998 111.838 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.0 154.51 17.2 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.458 -0.571 . . . . 73.340000000000003 109.458 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -85.81 -31.48 20.85 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.903 -0.665 . . . . 74.200000000000003 112.715 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.638 ' O ' ' HA ' ' A' ' 63' ' ' ASP . . . -111.72 -52.46 2.78 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.75 -0.265 . . . . 71.239999999999995 110.976 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 101.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.248 0.547 . . . . 54.229999999999997 110.918 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.44 -13.64 14.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 63.200000000000003 111.229 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.553 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 20.4 m-85 -135.27 132.64 38.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.723 -0.473 . . . . 63.409999999999997 109.723 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.58 ' O ' ' HB ' ' A' ' 35' ' ' VAL . . . -115.35 112.56 2.72 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.748 -0.739 . . . . 55.420000000000002 111.535 177.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.641 ' HB ' ' HB ' ' A' ' 60' ' ' VAL . 22.1 t -96.4 129.67 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 122.253 0.221 . . . . 60.509999999999998 110.996 -175.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.559 HD11 ' HA3' ' A' ' 33' ' ' GLY . 1.1 pp -101.91 111.22 23.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.214 0.53 . . . . 63.210000000000001 110.452 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.1 t -114.65 119.9 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.774 -0.648 . . . . 53.240000000000002 110.952 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.545 ' HB ' ' HB ' ' A' ' 31' ' ' THR . 23.8 m -101.32 104.46 15.46 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.75 -0.463 . . . . 64.030000000000001 109.75 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 52' ' ' ARG . 41.9 mtt180 -75.62 147.98 82.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.034 -0.53 . . . . 74.109999999999999 110.646 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.99 -18.22 41.8 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.169 2.579 . . . . 64.109999999999999 112.543 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -70.17 -15.05 62.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.002 -0.545 . . . . 64.319999999999993 110.896 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.9 32.69 7.02 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.587 -0.816 . . . . 61.450000000000003 112.39 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -130.09 147.79 51.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.772 0.32 . . . . 63.130000000000003 110.372 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -107.17 120.99 43.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.201 -0.454 . . . . 74.099999999999994 110.543 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.685 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 57.1 t -119.48 133.66 65.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.762 -0.653 . . . . 61.340000000000003 109.629 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 11.5 pt-20 -107.6 124.18 49.57 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.34 0.591 . . . . 75.010000000000005 110.479 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.641 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 25.9 t -94.92 125.98 47.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.425 -0.807 . . . . 61.149999999999999 109.853 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -99.16 123.61 43.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.1 0.476 . . . . 72.310000000000002 110.509 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -112.17 149.85 31.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.652 -0.704 . . . . 54.43 111.083 -176.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.638 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 18.4 t70 -90.19 171.53 9.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.962 -0.563 . . . . 74.329999999999998 109.883 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.47 ' H ' ' HG3' ' A' ' 64' ' ' ARG . 0.3 OUTLIER -42.81 -51.92 5.24 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.033 0.933 . . . . 72.5 111.949 -178.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -86.0 18.46 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.875 -0.602 . . . . 65.400000000000006 111.203 -174.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.641 ' HE1' ' HB2' ' A' ' 19' ' ' ALA . 6.3 m-85 66.97 27.98 8.66 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.872 -0.603 . . . . 63.329999999999998 111.586 -178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 67' ' ' ARG . 7.4 tpt180 -80.32 124.02 28.49 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.949 -0.76 . . . . 73.519999999999996 108.949 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.669 ' HA ' HD12 ' A' ' 62' ' ' LEU . 7.3 p -63.53 122.83 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.169 0.509 . . . . 75.319999999999993 110.536 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.598 HD21 ' HB2' ' A' ' 63' ' ' ASP . 97.7 mt -87.89 -57.62 2.87 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.116 -0.493 . . . . 70.230000000000004 110.682 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -170.89 176.72 4.02 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.696 -0.483 . . . . 72.439999999999998 109.696 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.607 HG22 HG22 ' A' ' 60' ' ' VAL . 16.8 p -140.24 109.42 6.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.317 -0.402 . . . . 64.099999999999994 110.656 -177.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -117.74 129.66 25.21 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-O 121.141 0.496 . . . . 62.109999999999999 111.052 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 57.3 Cg_endo -73.91 105.04 1.94 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.383 2.056 . . . . 75.040000000000006 111.948 176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.37 93.2 4.04 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 111.01 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.15 133.22 34.06 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.674 -0.694 . . . . 75.219999999999999 109.266 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -56.79 108.15 1.14 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 116.09 -0.505 . . . . 11.1 113.237 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -90.38 -40.1 12.28 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.67 -0.493 . . . . 63.140000000000001 109.67 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.08 -92.25 0.15 Allowed Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.599 -0.728 . . . . 72.230000000000004 111.694 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.97 -157.97 26.44 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.067 -0.587 . . . . 71.450000000000003 111.849 178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.73 HD23 ' H ' ' A' ' 80' ' ' LEU . 2.5 pt? -79.75 155.65 27.84 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.922 -0.399 . . . . 42.310000000000002 109.922 176.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.516 -0.754 . . . . 72.120000000000005 109.38 -177.258 . . . . . . . . 0 0 . 1 stop_ save_